References

ASHP^®Injectable Drug Information^TM. Selected Revisions January 10, 2024. © Copyright, 2024. American Society of Health-System Pharmacists^®, 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.

References

Package insert (for brands listed after the nonproprietary name heading a monograph; date of package insert given as part of citation)
Physicians’ desk reference. 63rd ed. Montvale, NJ: Thomson PDR; 2009
Kirkland WDJones RWEllis JRCompatibility studies of parenteral admixturesAm J Hosp Pharm196118694-9
McEvoy GK, ed. AHFS drug information 2011. Bethesda, MD: American Society of Health-System Pharmacists; 2011
Sweetman SC, ed. Martindale: the complete drug reference. 37th ed. London, England: The Pharmaceutical Press; 2011
Parker EACompatibility digestAm J Hosp Pharm19702767-9
Parker EACompatibility digestAm J Hosp Pharm197027672-3
Trissel LA. Trissel’s stability of compounded formulations. 4th ed. Washington, DC: American Pharmacists Association; 2009
Patel JAPhillips GLGuide to physical compatibility of intravenous drug admixturesAm J Hosp Pharm196623409-11
Bogash RCCompatibilities and incompatibilities of some parenteral medicationBull Am Soc Hosp Pharm195512445-8
Dunworth RDKenna FRPreliminary report: incompatibility of combinations of medications in intravenous solutionsAm J Hosp Pharm196522190-1
Moorhatch PChiou WLInteractions between drugs and plastic intravenous fluid bags, part i: sorption studies on 17 drugsAm J Hosp Pharm19743172-8
Levin HJFieber RAStability data for Tubex filled by hospital pharmacistsHosp Pharm19738310-1
Powers SIncompatibilities of pre-op medicationsHosp Formul Manage1970522
Intravenous additive incompatibilities. Bethesda, MD: Pharmacy Department, National Institutes of Health; 1970 Jan
Cantania PNKing JCPhysico-chemical incompatibilities of selected cardiovascular and psychotherapeutic agents with sodium ethacrynateAm J Hosp Pharm197229141-6
USP-NF Online: 2020 U.S. Pharmacopeia National Formulary USP 42 NF 37. Rockville, MD: The United States Pharmacopeial Convention; 2020. www.uspnf.com. Updated 2019 Jun 3. Accessed 2020 Jun 5.
Kramer WInglott ASome physical and chemical incompatibilities of drugs for i.v. administrationDrug Intell Clin Pharm19715211-28
McEvoy GK, ed. American hospital formulary service drug information. Bethesda, MD: American Society of Health-System Pharmacists; prior editions
Parker EACompatibility digestAm J Hosp Pharm196926412-3
Parker EACompatibility digestAm J Hosp Pharm196926653-5
Parker EACompatibility digestAm J Hosp Pharm197027327-9
Parker EACompatibility digestAm J Hosp Pharm1974311076
Parker EACompatibility digestAm J Hosp Pharm197128805
Souney PFSolomon MAVisual compatibility of cimetidine hydrochloride with common preoperative injectable medicationsAm J Hosp Pharm1984411840-1
Riley BBIncompatibilities in intravenous solutionsJ Hosp Pharm197028228-40
Parker EALevin HJCompatibility digestAm J Hosp Pharm197532943-4
Misgen RCompatibilities and incompatibilities of some intravenous solution admixturesAm J Hosp Pharm19652292-4
Hospira, Inc. Vitamin K₁ injection (phytonadione injectable emulsion) prescribing information. Lake Forest, IL; 2021 Apr.
International Medication Systems, Limited. Phytonadione injectable emulsion prescribing information. South El Monte, CA; 2021 Dec.
USP. Phytonadione injectable emulsion. In: USP-NF. Rockville, MD: USP; May 1, 2018. DOI: doi.org/10.31003/USPNF_M64870_03_01.
Frank JTIntralipid compatibility studyDrug Intell Clin Pharm19737351-2
Yeo MTGazzaniga ABBartlett RHTotal intravenous nutrition experience with fat emulsions and hypertonic glucoseArch Surg1973106792-6
Melly MAMeng HCMicrobial growth in lipid emulsions used in parenteral nutritionArch Surg19751101479-81
Deitel MKaminsky VTotal nutrition by peripheral vein—the lipid systemCan Med Assoc J1974111152-4
Cashore WJSedaghatian MRNutritional supplements with intravenously administered lipid, protein hydrolysate, and glucose in small premature infantsPediatrics1975568-16
Lynn BIntralipid compatibility studyDrug Intell Clin Pharm1974875
Electronic Medicines Compendium. London, England: Datapharm Communications Ltd
Fortner CLGrove WRBowie DFat emulsion vehicle for intravenous administration of an aqueous insoluble drugAm J Hosp Pharm197532582-4
Riffkin CIncompatibilities of manufactured parenteral productsAm J Hosp Pharm19632019-22
Edward MpH—an important factor in the compatibility of additives in intravenous therapyAm J Hosp Pharm196724440-9
Turner FEKing JCSpectrophotometric analysis of intravenous admixtures containing metaraminol and corticosteroidsAm J Hosp Pharm197027540-7
Anderson RWLatiolais CJPhysico-chemical incompatibilities of parenteral admixtures—Aramine and Solu-CortefAm J Hosp Pharm197330128-33
Smith MCThe dextransAm J Hosp Pharm196522273-5
Stokes TFSumner EDParticulate contamination and stability of three additives in 0.9% sodium chloride injection in plastic and glass large-volume containersAm J Hosp Pharm197532821-6
Parker EASolution additive chemical incompatibility studyAm J Hosp Pharm196724434-9
Parker EACompatibility digestAm J Hosp Pharm196926543-4
Parker EAParenteral incompatibilitiesHosp Pharm1969414-22
Beatrice MGStanaszek WFAllen LVPhysicochemical stability of a preanesthetic mixture of hydroxyzine hydrochloride and atropine sulfateAm J Hosp Pharm1975321133-7
Leff RDRoberts RJEffect of intravenous fluid and drug solution coadministration on final-infusate osmolality, specific gravity, and pHAm J Hosp Pharm198239468-71
Crevar GESlotnick IJA note on the stability of actinomycin DJ Pharm Pharmacol196416429
Coles CLJLees KAAdditives to intravenous fluidsPharm J1971206153-4
Rudd LPethidine stability in intravenous solutionsMed J Aust1978234
Webb JWA pH pattern for i.v. additivesAm J Hosp Pharm19692631-5
Jones RWStanko GLPharmaceutical compatibilities of Pentothal and NembutalAm J Hosp Pharm196118700-4
Turco SJSherman NEZagar LStability of aminophylline in 5% dextrose in waterHosp Pharm197510374-5
Hodby EDHirsch JInfluence of drugs upon the anticoagulant activity of heparinCan Med Assoc J1972106562-4
Pamperl HKleinberger GMorphologic changes of Intralipid 20% liposomes in all-in-one solutions during prolonged storageInfusiontherapie1982986-91
Parker EACompatibility digestAm J Hosp Pharm197431775
Wolfert RRCox RMRoom temperature stability of drug products labeled for refrigerated storageAm J Hosp Pharm197532585-7
AnonIntravenous fatLancet197611059-60
Sachtler GDilantin for i.v. useDrug Intell Clin Pharm19737418
Burke WAI.V. drug incompatibilities—DilantinAm J IV Ther1975216-8
Baldwin JAmerson ABIntramuscular use of diphenylhydantoinAm J Hosp Pharm197330837-8
Tobias DCKellick KADilantin for i.v. useDrug Intell Clin Pharm19737418
Chan NLDilantin for i.v. useDrug Intell Clin Pharm19737419
Ammar HOSalama HAStudies on the stability of injectable solutions of some phenothiazines, part i: effect of pH and buffer systemsPharmazie197530368-9
Pickering LKRutherford IEffect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin, and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin, and piperacillinJ Pharmacol Exp Ther1981217345-9
Ho NFHGoeman JAPrediction of pharmaceutical stability of parenteral solutionsDrug Intell Clin Pharm1970469-71
American Regent, Inc. Hydroxyzine hydrochloride injection prescribing information. Shirley, NY; 2016 Oct.
USP. Hydroxyzine hydrochloride injection. In: USP-NF. Rockville, MD: USP; May 1, 2018. DOI: doi.org/10.31003/USPNF_M39470_03_01.
Trissel LA, Davignon JP, Kleinman LM, et al. NCI investigational drugs pharmaceutical data. Bethesda, MD: National Cancer Institute; 1988
Muhlhauser IBroermann CTsotsalas MMiscibility of human and bovine ultralente insulin with soluble insulinBMJ19842891656-7
Grant HRCompatibilities of intravenous admixturesHosp Pharmacist94 (Mar-Apr) 19621567-70
Hanson DBHendeles LGuide to total dose intravenous iron dextran therapyAm J Hosp Pharm197431592-5
Duke ABKelleher JSerum iron and iron binding capacity after total dose infusion of iron-dextran for iron deficiency anaemia in pregnancyJ Obstet Gynaecol Br Commonw19748111895-900
Parker EACompatibility digestAm J Hosp Pharm197532214
Gardella LAKesler HCarter JEIntropin (dopamine hydrochloride) intravenous admixture compatibility, part ii: stability with some commonly used antibiotics in 5% dextrose injectionAm J Hosp Pharm197633537-40
Gardella LAZaroslinski JFIntropin (dopamine hydrochloride) intravenous admixture compatibility, part i: stability with common intravenous fluidsAm J Hosp Pharm197532575-8
Garnett WDiluents for antineoplastic drugsDrug Intell Clin Pharm19715261
Landersjo LStjernstrom GStudies on the stability and compatibility of drugs in infusion fluids V. Effect of lactate and metal ions on the stability of benzylpenicillinActa Pharm Suec197815161-8
Notari REChin MLArabinosylcytosine stability in aqueous solutions: pH profile and shelf life predictionsJ Pharm Sci1972611189-96
Murty BSRKapoor JNProperties of mannitol injection (25%) after repeated autoclavingsAm J Hosp Pharm197532826-7
Rosch JMPazin GJFireman PReduction of amphotericin B nephrotoxicity with mannitolJAMA19762351995-6
Bergman NVellar IDPotential life-threatening variations of drug concentrations in intravenous infusion systems—potassium chloride, insulin, and heparinMed J Aust19822270-2
Parker EACompatibility digestAm J Hosp Pharm197027492-3
Feigen RDMoss KSAntibiotic stability in solutions used for intravenous nutrition and fluid therapyPediatrics1973511016-26
Zost EDYanchick VACompatibility and stability of disodium carbenicillin in combination with other drugs and large volume parenteral solutionsAm J Hosp Pharm197229135-40
Lynn BRecent work on parenteral penicillinsJ Hosp Pharm197129183-194
Tourville JSodium nitroprussideDrug Intell Clin Pharm19759361-4
AnonEditorial: Sodium nitroprusside in anaesthesiaBr Med J19752524-5
Hargrave REDegradation of solutions of sodium nitroprussideJ Hosp Pharm197432188-9
AnonSodium nitroprusside for hypertensive crisisMed Lett Drugs Ther19751782-3
Anderson RARae WStability of sodium nitroprusside solutionsAust J Pharm Sci NS11972July45-6
Schumacher GESodium nitroprusside injectionAm J Hosp Pharm196623532
Cruz JEManess DDYakatan GJKinetics and mechanism of hydrolysis of furosemideInt J Pharm19792275-81
Thomas RMeperidine HCl and heparin sodium precipitationHosp Pharm19792275-81
Fleischer NMPromethazine hydrochloride-morphine sulfate incompatibilityAm J Hosp Pharm197330665
Lynn BPharmaceutical aspects of semi-synthetic penicillinsJ Hosp Pharm19702871-86
Meisler JMSkolaut MWExtemporaneous sterile compounding in intravenous additivesAm J Hosp Pharm196623557-63
Guthaus MR (Medical Services, The Upjohn Company, Kalamazoo, MI): Personal communication; 1973 Aug 9
HamLin WE, Riebe KW, Scothorn WW, et al. Pharmacy profile of cleocin phosphate. Presented at 10th annual ASHP midyear clinical meeting. Washington, DC: 1975 Dec 11
Riebe KWOesterling TOParenteral development of clindamycin-2-phosphateBull Parenter Drug Assoc197226139-45
Therapeutic profile: cleocin phosphate. Kalamazoo, MI: The Upjohn Company; 1973
Wyatt RGOkamato GAStability of antibiotics in parenteral solutionsPediatrics19724922-9
Halasi SNairn JDStability studies of hydralazine hydrochloride in aqueous solutionsJ Parenter Sci Technol19904430-4
Whiting DATreatment of chromoblastomycosis with local concentrations of amphotericin BBr J Dermatol196779345-51
Kirschenbaum BE, Latiolais CJ. Injectable medications—a guide to stability and reconstitution. New York, NY: McMahon Group; 1993
Bair JNCarew DPTherapeutic availability of antibiotics in parenteral solutionsBull Parenter Drug Assoc196519153-63
Dancey JWCarew DPAvailability of antibiotics in combination with other additives in intravenous solutionsAm J Hosp Pharm196623543-51
Prasad VKGranatek APPhysical compatibility and chemical stability of cephapirin sodium in combination with antibiotics and large-volume parenteral solutions, part iCurr Ther Res Clin Exp197416505-39
Lynn BCarbenicillin plus gentamicinLancet19711654
Jacobs JKletter DSuperstine EIntravenous infusions of heparin and penicillinsJ Clin Pathol197326742-6
Lynn BPenicillin instability in infusionsBr Med J19711174
Information for health professionals. Wellington, New Zealand: New Zealand Medicines and Medical Devices Safety Authority
Partner Therapeutics, Inc. Leukine^® (sargramostim) for injection prescribing information. Lexington, MA; 2022 May.
McEvoy GK, ed. American hospital formulary service drug information 95. Bethesda, MD: American Society of Health-System Pharmacists; 1995
Harrison DCPractical guidelines for the use of lidocaine. Prevention and treatment of cardiac arrhythmiasJAMA19752331202-4
Collinsworth KClinical pharmacology of lidocaine as an antiarrhythmic drugWest J Med197612436-43
AnonProphylactic use of lidocaine in myocardial infarctionMed Lett Drugs Ther1976181-2
Dundee JWGamble JA, Assaf RAPlasma diazepam levels following intramuscular injection by nurses and doctorsLancet197421461
Par Pharmaceutical. Tigan^® (trimethobenzamide hydrochloride) injection prescribing information. Chestnut Ridge, NY; 2016 Apr.
Tortorici MPStability data on frozen i.m. and i.v. solutionsPharm Times19754168-72
Barbara ACClemente CPhysical incompatibility of sulfonamide compounds and polyionic solutionsN Engl J Med19662741316-7
Brooke DBequette RJChemical stability of cyclophosphamide in parenteral solutionsAm J Hosp Pharm197330134-7
Brooke DScott JAEffect of briefly heating cyclophosphamide solutionsAm J Hosp Pharm19753244-5
Gallelli JFStability studies of drugs used in intravenous solutions, part iAm J Hosp Pharm196724425-33
Dupont Pharmaceuticals. Nubain, physical compatibility. Wilmington, DE; undated
Kramer WTanja JJPrecipitates found in admixtures of potassium chloride and dextrose 5% in waterAm J Hosp Pharm197027548-53
Lawson DHClinical use of potassium supplementsAm J Hosp Pharm197532708-11
Lundgren PLandersjo LStudies on the stability and compatibility of drugs in infusion fluids, ii: factors affecting the stability of benzylpenicillinActa Pharm Suec19707509-26
Weber CRGupta VDStability of phenylephrine hydrochloride in intravenous solutionsJ Hosp Pharm197028200-8
Chiou WLMoorhatch PInteraction between vitamin A and plastic intravenous fluid bagsJ Am Med Assoc1973223328
Komesaroff DField JEPancuronium bromide: a new non-depolarizing muscle relaxantMed J Aust19691908-11
Simberkoff MSThomas LMcGregor DInactivation of penicillins by carbohydrate solutions at alkaline pHN Engl J Med1970283116-9
Hicks CIGallardo JPBStability of sodium bicarbonate injection stored in polypropylene syringesAm J Hosp Pharm197229210-6
DeLuca PPKowalski RJProblems arising from the transfer of sodium bicarbonate injection from ampuls to plastic disposable syringesAm J Hosp Pharm197229217-22
D’Arcy PFThompson KMStability of chlorpromazine hydrochloride added to intravenous infusion fluidsPharm J197321028
Nahata MCZingarelli JRHipple TFStability of caffeine injection stored in plastic and glass syringesDICP1989231035
Murabito AS (Smith Kline & French Laboratories, Philadelphia, PA): Personal communication; 1986 Dec 15
Mann JMColeman DLStability of parenteral solutions of sodium cephalothin, cephaloridine, potassium penicillin G (buffered), and vancomycin HClAm J Hosp Pharm197128760-3
Appleby DHJohn JFEffect of peritoneal dialysis solution on the antimicrobial activity of cephalosporinsNephron198230341-4
Upshaw MD (Medical Information Services, Eli Lilly and Company, Indianapolis, IN): Personal communication; 1972 Jan 10.
Gallelli JFMacLowry JDStability of antibiotics in parenteral solutionsAm J Hosp Pharm196926630-5
Dienstag JLNeu HCTobramycin: new aminoglycoside antibioticClin Med19758213-9
Struhar MHeinrich JK sorpcii pentoxifyllinu na infuznu supravu LuerFarm Obz198857405-10
Bergstrom RFFites ALStability of parenteral solutions of tobramycin sulfateAm J Hosp Pharm197532887-8
Huber RCRiffkin CInline final filters for removing particles from amphotericin B infusionsAm J Hosp Pharm197532173-6
Rebagay TRapp RBivins BResidues in antibiotic preparations, i: scanning electron microscopic studies of surface topographyAm J Hosp Pharm197633433-43
Gallelli JFAssay and stability of amphotericin B in aqueous solutionsDrug Intell19671102-5
Piecoro JJGoodman NLWheeler WEParticulate matter in reconstituted amphotericin B and assay of filtered solutions of amphotericin BAm J Hosp Pharm197532381-4
Gotz VSimon WInline filtration of amphotericin B infusionsAm J Hosp Pharm197532458
Chatterji DHiranaka PKStability of sodium oxacillin in intravenous solutionsAm J Hosp Pharm1975321130-2
Facts and Comparisons, Inc. Drug facts and comparisons. St. Louis, MO; 2003
Parodi JFStability of frozen antibiotic solutions in Viaflex infusion containersHosp Pharm197611178-9
Larsen SSStudies on stability of drugs in frozen systems. IV. The stability of benzylpenicillin sodium in frozen aqueous solutionsDan Tidsskr Farm197145307-16
Noone PPattison JRTherapeutic implications of interaction of gentamicin and penicillinsLancet19712575-8
Boulet MMarier JREffect of magnesium on formation of calcium phosphate precipitatesArch Biochem Biophys196296629-36
van den Berg LSoliman FSComposition and pH changes during freezing of solutions containing calcium and magnesium phosphateCryobiology1969610-4
Ong JTHKostenbauder HBEffect of self-association on rate of penicillin G degradation in concentrated aqueous solutionsJ Pharm Sci1975641378-80
Shoup LKThur MPStability of frozen buffered penicillin G potassium injectionHosp Formul Manage1968338-9
Boylan JCSimmons JLStability of frozen solutions of sodium cephalothin and cephaloridineAm J Hosp Pharm197229687-9
Grant NHClark DEImidazole- and base-catalyzed hydrolysis of penicillin in frozen systemsJ Am Chem Soc1961834476-7
Lindsay REHem SLDosage form for potassium penicillin G intravenous infusion solutionsDrug Devel Commun1974-51211-222
Im SLatiolais CJPhysico-chemical incompatibilities of parenteral admixtures—penicillin and tetracyclinesAm J Hosp Pharm196623333-43
Pfeifer HJWebb JWCompatibility of penicillin and ascorbic acid injectionAm J Hosp Pharm197633448-50
Rusmin SDeLuca PPEffect of inline filtration on the potency of potassium penicillin GBull Parenter Drug Assoc19763064-71
Stolar MHCarlin HSEffect of freezing on the stability of sodium methicillin injectionAm J Hosp Pharm19682532-5
Lynn BStability of methicillin in dextrose solutions at alkaline pHJ Hosp Pharm19723081-3
Lynn BPharmaceutics of the semi-synthetic penicillinsChem Drug1967187134-6
Lynn BInactivation of methicillin in dextrose solutions at alkaline pHN Engl J Med1971285690
Mattson CJ, Clark ST, Colangelo A. Stability of clindamycin phosphate in plastic syringes. Presented at 20th annual ASHP midyear clinical meeting. New Orleans, LA: 1985 Dec
Clark ST, Colangelo A. Stability of clindamycin phosphate in plastic syringes. Presented at 20th annual ASHP midyear clinical meeting. New Orleans, LA: 1985 Dec
Cohon MS (Drug Information Services, Upjohn Company, Kalamazoo, MI): Personal communications; 1986 Dec 12, 1988 Jan 27, 1988 Feb 3
USP. Methylergonovine maleate injection. In: USP-NF. Rockville, MD: USP; 2018 May 1. DOI: doi.org/10.31003/USPNF_M52590_03_01
Owen RT (UK Medical Information Section, The Wellcome Foundation Ltd., Cheshire, England): Personal communication; 1993 Aug 19.
Lesson LJWeidenheimer JFStability of tetracycline and riboflavinJ Pharm Sci196958355-7
Turco SJBurke WAMethods of ordering and use of intravenous phosphate (mEq vs mM)Hosp Pharm322, 326 (Aug) 197510320
Pinkus TFJeffrey LPIncompatibility of calcium and phosphate in parenteral alimentation solutionsAm J IV Ther1976322-4
Kaminski MVHarris DFCollin CFElectrolyte compatibility in synthetic amino acid hyperalimentation solutionAm J Hosp Pharm197431244-6
Schlicht JRAdjustments in etoposide infusion flow rates when using controllersAm J Hosp Pharm1990472656
FASS, Karolinska Institutet, Huddinge, Sweden. Available at edu.ofa.ki.effica/
Lee FAGwinn JLRoentgen patterns of extravasation of calcium gluconate in the tissues of the neonateJ Pediatr197586598-601
Weiss YAckerman CLocalized necrosis of scalp in neonates due to calcium gluconate infusions: a cautionary notePediatrics1975561084-6
Ramamurthy RSHarris VSubcutaneous calcium deposition in the neonate associated with intravenous administration of calcium gluconatePediatrics197555802-6
Laegeler WLTio JMStability of certain amino acids in a parenteral nutrition solutionAm J Hosp Pharm197431776-9
Kleinman LMTangrea JAGallelli JFStability of solutions of essential amino acidsAm J Hosp Pharm1973301054-7
Rowlands DACompatibility of calcium and phosphate in amino acids solutionAm J Hosp Pharm197532360
Saudek EC (The Upjohn Company): Personal communication; 1973 Jan 3
Rowlands DAWilkinson WRStorage stability of mixed hyperalimentation solutionsAm J Hosp Pharm197330436-8
Aro R (Senior Clinical Research Associate, Fujisawa USA): Personal communication, February 22, 1994
Rodriguez Penin IYanez Gonzalez ACamba Rodriguez AEstabilidad de la mezcla morfina-midazolam en un dispositivo de infusion continuaFarm Hosp199115407-9
Nahata MCZingarelli JRDurrell DEStability of caffeine injection in intravenous admixtures and parenteral nutrition solutionsDICP198923466-7
Hull RLUse of trace elements in intravenous hyperalimentation solutionsAm J Hosp Pharm197431759-61
Johnson CCloyd JParenteral hyperalimentationDrug Intell Clin Pharm19759493-9
Hankins DARiella MCScribner BHWhole blood trace element concentrations during total parenteral nutritionSurgery197679674-7
Hamann MATrace element requirements in hyperalimentationAm J Hosp Pharm1974311035
Hull RLTrace element requirements in hyperalimentationAm J Hosp Pharm1974311038
Heird WCWinters RWTotal intravenous alimentation in pediatric patientsSouth Med J1975681173-6
Baker JAKirkman HWoodley CComputer-assisted pediatric hyperalimentationAm J Hosp Pharm197431752-8
Parish RHyperalimentation proceduresAm J Hosp Pharm1974311160
Pomerance HHRader RECrystal formation: a new complication of total parenteral nutritionPediatrics197352864-6
Bohart RDOgawa GAn observation on the stability of cis-dichlorodiammineplatinum (II): a caution regarding its administrationCancer Treat Rep1979632117-8
Prestayko AWCadiz MIncompatibility of aluminum-containing iv administration equipment with cis-dichlorodiammineplatinum (II) administrationCancer Treat Rep1979632118-9
Shils MEMinerals in total parenteral nutritionDrug Intell Clin Pharm19726385-93
Flack HLGans JASerlick SEThe current status of parenteral hyperalimentationAm J Hosp Pharm197128326-35
McRae MPKing JCCompatibility of antineoplastic, antibiotic, and corticosteroid drugs in intravenous admixturesAm J Hosp Pharm1976331010-3
Warren ESynder RJThompson COStability of ampicillin in intravenous solutionsMayo Clin Proc19724734-5
Raffanti EFKing JCEffect of pH on the stability of sodium ampicillin solutionsAm J Hosp Pharm197431745-51
Savello DRShangraw RFStability of sodium ampicillin solutions in the frozen and liquid statesAm J Hosp Pharm197128754-9
Jacobs JNathan ISuperstine EAmpicillin and carbenicillin stability in commonly used infusion solutionsDrug Intell Clin Pharm19704204-8
Hiranaka PFrazier AGStability of sodium ampicillin in aqueous solutionsAm J Hosp Pharm197229321-2
Stratton MSandmann BJStability studies of ampicillin sodium in intravenous fluids using optical activityBull Parenter Drug Assoc197529286-95
Pincock REKiovsky TEKinetics of reactions in frozen solutionsJ Chem Educ196643358-60
Hou JPPoole JWKinetics and mechanism of degradation of ampicillin in solutionJ Pharm Sci196958447-54
Shils MEWright WLTurnbull ALong-term parenteral nutrition through an external arteriovenous shuntN Engl J Med1970283341-4
Zia HTehrani MKinetics of carbenicillin degradation in aqueous solutionsCan J Pharm Sci19749112-7
Riff LJJackson GGLaboratory and clinical conditions for gentamicin inactivation by carbenicillinArch Intern Med1972130887-91
McLaughlin JEReeves DSClinical and laboratory evidence for inactivation of gentamicin by carbenicillinLancet19711261-4
Klastersky JCarbenicillin plus gentamicinLancet19711653-4
Levison MEKaye DCarbenicillin plus gentamicinLancet1971245-6
Eykyn SPhillips IGentamicin plus carbenicillinLancet19711545-6
Riff LJackson GGGentamicin plus carbenicillinLancet19711592
Zost EDYanchick VAStability of gentamicin in combination with carbenicillinAm J Hosp Pharm197229388-90
Jacoby GACarbenicillin and gentamicinN Engl J Med19712841096-8
Kleinberg ML (Professional Services, Immunex, Seattle, WA): Personal communication; 1993 Jun 14
Baldini JT (Professional Services, Schering Laboratories, Kenilworth, NJ): Personal communication; 1972 Feb 11
Koup JRGerbracht LCombined use of heparin and gentamicin in peritoneal dialysis solutionsDrug Intell Clin Pharm19759388
Reeves DSBywater MJWise RAvailability of three antibiotics after intramuscular injection into thigh and buttockLancet197421421-2
Jackson GGGentamicinPractitioner1967198855-66
Preskey DKayes JBStability of sulfadiazine sodium as used in admixture with intravenous infusion fluidsJ Clin Pharm1976139-48
Physicians’ desk reference. 49th ed. Oradell, NJ: Medical Economics Company; 1995
Larsen SSJensen VGStudies on stability of drugs in frozen systems. II. The stabilities of hexobarbital sodium and phenobarbital sodium in frozen aqueous solutionsDan Tidsskr Farm19704421-31
NCI investigational drugs pharmaceutical data. Bethesda, MD: National Cancer Institute; 1988, 1990, 1994
Halpern NAColucci RDAlicea MThe compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injectionInt J Clin Pharmacol Ther Toxicol198927250-4
AnonKidney toxicity—main source of methotrexate complicationsJ Am Med Assoc19752231036-7
Baker MBC Hospital Products Division, Abbott Laboratories, Abbott Park, Illinois: Personal Communication; 2003 Aug 27
Hoeprich PDHuston ACStability of four antifungal antimicrobics in vitroJ Infect Dis197813787-93
Selam JLLord Pvan Antwerp WPHeparin addition to insulin in implantable pumps to prevent catheter obstructionDiabetes Care19891238-9
Wang DPStability of procaine in aqueous systemsAnalyst1983108851-6
Lapidas BCautions regarding the preparation of high-dose methotrexate infusionsAm J Hosp Pharm197633760
Pelsor FRCautions regarding the preparation of high-dose methotrexate infusionsAm J Hosp Pharm197633760
Pritchard JStability of heparin solutionsJ Pharm Pharmacol196416487-9
Turco SJI.V. drug incompatibilities—heparin sodium USPAm J IV Ther1976316-9
Kakkar VVCorrigan TPPrevention of fatal postoperative pulmonary embolism by low doses of heparin: an international multicentre trialLancet1975245-51
Sherry SLow-dose heparin prophylaxis for postoperative venous thromboembolismN Engl J Med1975293300-2
Gallus ASHirsch JO’Brien SEPrevention of venous thrombosis with small, subcutaneous doses of heparinJAMA19762351980-2
Hopefl AWLow-dose heparin for the prevention of venous thromboembolismHosp Pharm197611223
Wessler SHeparin as an antithrombotic agent. Low-dose prophylaxisJAMA1976236389-91
Erdi AKakkar VVThomas DPEffect of low-dose subcutaneous heparin on whole-blood viscosityLancet19762342-4
Hadgraft JWAdding drugs to intravenous infusionsLancet197021254
Stock SLWarner NHeparin in acid solutionsBr Med J19713307
Chessells JMBraithwaite TADextrose and sorbitol as diluents for continuous intravenous heparin infusionBr Med J1972281-2
Mitchell JFBarger RCHeparin stability in 5% dextrose and 0.9% sodium chlorideAm J Hosp Pharm197633540-2
Thomas RBSalter FJHeparin locks: their advantages and disadvantagesHosp Formul197510536-8
Deeb ENDiMattia PEThe key question: how much heparin in the lock?Am J IV Ther1976322-6
DeFina EHow we use heparin locksAm J IV Ther33 (Dec-Jan) 1976327
Hanson RLGrant AMHeparin-lock maintenance with ten units of sodium heparin in one milliliter of normal saline solutionSurg Gynecol Obstet1976142373-6
Rebagay TDeLuca PPResidues in antibiotic preparations, ii: effect of pH on the nature and level of particulate matter in sodium cephalothin intravenous solutionsAm J Hosp Pharm197633443-8
Albano D (Manager Drug Information, Wyeth-Ayerst). Personal Communication; 1994 Jan 5
Hopefl AWRoom temperature stability of drug productsAm J Hosp Pharm1975321084
Barger RCRoom temperature stability of drug productsAm J Hosp Pharm1975321089
Rosenbloom ALAdvances in commercial insulin preparationsAm J Dis Child1974128631-3
Rosenberg JMSimon WASangkachand PMixing insulin preparationsHosp Pharm197611186
Shainfeld FJErrors in insulin doses due to the design of insulin syringesPediatrics197556302-3
Weisenfeld SPodolsky SGoldsmith LAdsorption of insulin to infusion bottles and tubingDiabetes196817766-71
Petty CCunningham NLInsulin adsorption by glass infusion bottles, polyvinylchloride infusion containers, and intravenous tubingAnesthesiology197440400-4
Kraegen EWLazarus LMeler HCarrier solutions for low-level intravenous insulin infusionBr Med J19753464-6
Semple PRatcliffe JGCarrier solutions for low-level intravenous insulin infusionBr Med J19754228-9
Hays DPMehl BI.V. drug incompatibilities—insulinAm J IV Ther1976330-2
Owen JAThe insulin revolutionHosp Formul197611343
Galloway JA (Medical Research Division, Eli Lilly and Company, Indianapolis, IN): Personal communication; 1967 Aug 29
Rubin JHumphries JSmith GAntibiotic activity in peritoneal dialysateAm J Kidney Dis19833205-8
De Vroe CDe Muynck CRemon JPThe availability of diltiazem: a study on the sorption by intravenous delivery systems and on the stability of the drugJ Pharm Pharmacol198941273-5
Kochevar MFry LKInsulin and dead space volumeDrug Intell Clin Pharm1974833-4
Bornstein MThomas PNColeman DLStability of parenteral solutions of cefazolin sodiumAm J Hosp Pharm197431296-98
Carone SMBornstein MColeman DLStability of frozen solutions of cefazolin sodiumAm J Hosp Pharm197633639-41
Royston DA (Consumer Technical Services, Eli Lilly and Company, Indianapolis, IN): Personal communication; 1976 Feb 19
Brudney NEustace BTSome formulations and compatibility problems with dimenhydrinate (Gravol)Can Pharm J196396470-1
Acred PBrown DMKnudsen ETNew semi-synthetic penicillin active against pseudomonas pyocyaneaNature (London)196721525-30
Schwartz MABuckwalter FHPharmaceutics of penicillinJ Pharm Sci1962511119-28
Thur MP (Parenteral Products, Travenol Laboratories, Deerfield, IL): Personal communication; 1976 Sep 20
Hospira, Inc. Calcium chloride injection prescribing information. Lake Forest, IL; 2018 Jan.
Yamana TTsuji AComparative stability of cephalosporins in aqueous solution: kinetics and mechanisms of degradationJ Pharm Sci1976651563-74
Kleinman LMDavignon JPCradock JCInvestigational drug informationDrug Intell Clin Pharm19761048-9
Chang SYEvans TLThe stability of melphalan in the presence of chloride ionJ Pharm Pharmacol197931853-4
Mitenko PAOgilvie RIRational intravenous doses of theophyllineN Engl J Med1973289600-3
Simons FERPierson WECurrent status of the use of intravenously administered aminophyllineSouth Med J197568802-4
Weinberger MWMatthay RAGinchansky EJIntravenous aminophylline dosage. Use of serum theophylline measurement for guidanceJAMA19762352110-3
Nedich RLVitamin A absorption from plastic IV bagsJAMA19732241531-2
Kaplan MACoppola WPNunning BCPharmaceutical properties and stability of amikacin, part iCurr Ther Res Clin Exp197620352-8
Nunning BCGranatek APPhysical compatibility and chemical stability of amikacin sulfate in large-volume parenteral solutions, part iiCurr Ther Res Clin Exp197620359-68
Nunning BCGranatek APPhysical compatibility and chemical stability of amikacin sulfate in combination with antibiotics in large-volume parenteral solutions, part iiiCurr Ther Res Clin Exp197620369-416
Nunning BCGranatek APPhysical compatibility and chemical stability of amikacin sulfate in combination with non-antibiotic drugs in large-volume parenteral solutions, part ivCurr Ther Res Clin Exp197620417-91
Koup JRGerbracht LReduction in heparin activity by gentamicinDrug Intell Clin Pharm19759568
McKinley JD (M.D. Anderson Hospital and Tumor Institute, Houston, TX): Personal communication; 1976 Aug 23
Weiner BMcNeely DJKluge RMStability of gentamicin sulfate injection following unit dose repackagingAm J Hosp Pharm1976331254-9
Dinel BAAyotte DLBehme RJComparative stability of antibiotic admixtures in minibags and minibottlesDrug Intell Clin Pharm197711226-39
Dinel BAAyotte DLBehme RJStability of antibiotic admixtures frozen in minibagsDrug Intell Clin Pharm197711542-8
Lynn BPharmaceutics of the semi-synthetic penicillinsChem Drug1967187157-60
Stanaszek WFPan IHAnalysis of hydroxyzine hydrochloride, meperidine hydrochloride and atropine sulfate in glass and plastic syringesAm J Hosp Pharm1978351084-7
Fraser GLIncompatibility of magnesium sulfate and hydrocortisone sodium succinateAm J Hosp Pharm197835783
Kresel JJMcDermott JSHuffer LMStability of carbenicillin and oxacillin frozen in syringesAm J Hosp Pharm197835310-2
Manning REPredicted expiration times for penicillin G in combination with multivitamin injectionsAm J Hosp Pharm197633870
Cloyd JCBosch DEConcentration-time profile of phenytoin after admixture with small volumes of intravenous fluidsAm J Hosp Pharm19783545-8
Bauman JLSiepler JKPhenytoin crystallization in intravenous fluidsDrug Intell Clin Pharm197711646-9
Ashwin JLynn BAmpicillin stability in saline or dextrose infusionsPharm J1975214487-9
O’Brien MJPortnoff JBCefoxitin sodium compatibility with intravenous infusions and additivesAm J Hosp Pharm19793633-8
American Regent, Inc. Calcium chloride injection prescribing information. Shirley, NY; 2017 Jul.
Petrick RJWolleben JEStability of frozen solutions of doxycycline hyclate for injectionAm J Hosp Pharm1978351386-7
Melberg SGHavelund SVillumsen JInsulin compatibility with polymer materials used in external pump infusion systemsDiabet Med19885243-7
Gardella LAKesler HAmann AIntropin (dopamine hydrochloride) intravenous admixture compatibility, part 3: stability with miscellaneous additivesAm J Hosp Pharm197835581-4
Schuetz DHKing JCCompatibility and stability of electrolytes, vitamins and antibiotics in combination with 8% amino acids solutionAm J Hosp Pharm19783533-44
El-Nakeeb MASouccar NInactivation of various antibiotics by some vitaminsCan J Pharm Sci19761185-9
Dixon FWWeshalek JPhysical compatibility of nine drugs in various intavenous solutionsAm J Hosp Pharm197229822-3
Earhart RHInstability of cis-dichlorodiammineplatinum in dextrose solutionCancer Treat Rep1978621105-6
Greene RFChatterji DCHiranaka PKStability of cisplatin in aqueous solutionAm J Hosp Pharm19793638-43
Morrison RAOseekey KB5-Fluorouracil and methotrexate sodium: an admixture incompatibility?Am J Hosp Pharm19783515
King JC5-Fluorouracil and methotrexate sodium: an admixture incompatibility?Am J Hosp Pharm19783518
Rusmin SWelton SDeLuca PEffect of inline filtration on the potency of drugs administered intravenouslyAm J Hosp Pharm1977341071-4
Morris MECompatibility and stability of diazepam injection following dilution with intravenous fluidsAm J Hosp Pharm197835669-72
Allen LVLevinson RSCompatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration setsAm J Hosp Pharm197734939-43
Arnold TREder JCompatibility of primary-piggyback solution combinationsAm J Hosp Pharm197835249-50
Jansen JRVolume control sets and incompatibilitiesAm J Hosp Pharm1975321225
Aisenstein AKahn SStudy of the stability of some frozen antibioticsHosp Pharm1969417-21
Parker WAPhysical compatibilities of preanesthetic medicationsCan J Hosp Pharm19762991-2
Cradock JCKleinman LMEvaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinateAm J Hosp Pharm197835402-6
Sarubbi FAWilson BLee MNosocomial meningitis and bacteremia due to contaminated amphotericin BJAMA1978239416-8
The Upjohn Company. Solu-Medrol IV admixture, dilution, and compatibility information. 1978 Aug
Parker WAMorris MEIncompatibility of diazepam injection in plastic intravenous bagsAm J Hosp Pharm197936505-7
Ingallinera TKapadia AJHagman DCompatibility of glycopyrrolate injection with commonly used infusion solutions and additivesAm J Hosp Pharm197936508-10
Bateman NEGraham MDSolubility of an ephedrine-phenobarbitone complex in waterAustralas J Pharm196748S68-9
Chang CHAshford WRIves DAJStability of oxytocin in various infusion solutionsCan J Hosp Pharm197225152
Lynn BAdministration of carbenicillin and ticarcillin—pharmaceutical aspectsEur J Cancer19739425-33
Block ERBennett JEStability of amphotericin B in infusion bottlesAntimicrob Agents Chemother19734648-9
Gupta VDStewart KRQuantitation of carbenicillin disodium, cefazolin sodium, cephalothin sodium, nafcillin sodium, and ticarcillin disodium by high-pressure liquid chromatographyJ Pharm Sci1980691264-7
AnonLabel changes on albumin—a reminderFDA Drug Bull1978832
Knoppert DCFreeman DWebb DStability of ceftizoxime in 5 percent dextrose and 0.9 percent sodium chlorideCan J Hosp Pharm19934613-6
Koup JRSchentag JJVance JWSystem for clinical pharmacokinetic monitoring of theophylline therapyAm J Hosp Pharm197633949-56
Jusko WJKoup JRVance JWIntravenous theophylline therapy: nomogram guidelinesAnn Intern Med197786400-4
Travenol Laboratories. Product information on Travasol. Deerfield, IL; 1994 Jan
McGaw Laboratories. Product information on FreAmine III. Irvine, CA; 1991 Sep
Odne MALLee SCRationale for adding trace elements to total parenteral nutrient solutions—a brief reviewAm J Hosp Pharm1978351057-9
Jeejeebhoy KNLanger BTsallas GTotal parenteral nutrition at home: studies in patients surviving 4 months to 5 yearsGastroenterology1976Dec943-53
Hull RLCassidy DTrace element deficiencies during total parenteral nutritionDrug Intell Clin Pharm197711536-41
Shils MEMore on trace elements in total parenteral nutrition solutionsAm J Hosp Pharm197532141-2
Okada ATakagi YItakura TSkin lesions during intravenous hyperalimentation: zinc deficiencySurgery197680629-35
Matoi JRJeffreys LPFormulation of a trace element solution for long-term parenteral nutritionAm J Hosp Pharm197835165-8
Athanikar NBoyer BDeamer RVisual compatibility of 30 additives with a parenteral nutrient solutionAm J Hosp Pharm197936511-3
Finlayson JSThe birth and demise of “salt-poor” albuminAm J Hosp Pharm197835898-900
Winsnes MJeppsson RDiazepam adsorption to infusion sets and plastic syringesActa Anaesthesiol Scand19812593-6
Bonner DPMechlinski W, Schaffner CPStability studies with amphotericin B and amphotericin B methyl esterJ Antibiot197528132-5
Shadomy SBrummer DLLight sensitivity of prepared solutions of amphotericin BAm Rev Resp Dis1973107303-4
Fields BT JrBates JH, Abernathy RSEffect of rapid intravenous infusion on serum concentrations of amphotericin BAppl Microbiol197122615-7
Janknegt Rvan den Berg Tde Jong MCompatibility study with midazolamZiekenhuisfarmacie1986245-8
Arbuthnot RDullea AControlling thrombophlebitis from amphotericin BAm J Hosp Pharm197835129
Rosch JMPazin GMannitol and amphotericin BJAMA197723727
Moore DESithipitaks VPhotolytic degradation of frusemideJ Pharm Pharmacol198335489-93
Roberts JRCutaneous and subcutaneous complications of calcium infusionsJACEP1977616-20
Smith Kline & French Laboratories. Product information on Tagamet. Philadelphia, PA; 1978 Oct
Winters REChow AWHecht RHCombined use of gentamicin and carbenicillinAnn Intern Med197175925-7
Waitz JADrube CGMoss ELBiological aspects of the interaction between gentamicin and carbenicillinJ Antibiot197225219-25
Ervin FRBullock WEInactivation of gentamicin by penicillins in patients with renal failureAntimicrob Agents Chemother197691004-11
Peterson CDKaatz BLTicarcillin and carbenicillinDrug Intell Clin Pharm197711482-6
Davies MMorgan JRInteractions of carbenicillin and ticarcillin with gentamicinAntimicrob Agents Chemother19757431-4
Weibert RKeane WShapiro FCarbenicillin inactivation of aminoglycosides in patients with severe renal failureTrans Am Soc Artif Int Organs197622439-43
Weibert RTKeane WFCarbenicillin-gentamicin interaction in acute renal failureAm J Hosp Pharm1977341137-9
Bodey GPFeld Rß-Lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patientsAm J Med Sci1976271179-86
Schimpff SSatterlee WYoung UMEmpiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopeniaN Engl J Med19712841061-5
Hendeles L. Are carbenicillin and gentamicin synergists or antagonists? Hosp Pharm. 1972; (Sep)7:297-8
Kole-James AElectrolyte content of common intravenous solutions and antibioticsHosp Pharm197712394
Donnelly RFTirona RGStability of citrated caffeine injectable solution in glass vialsAm J Hosp Pharm199451512-4
Turco SJHasan IComparison of features of Kefzol and AncefHosp Pharm197611482
Vukovich RASugerman AAEffect of 2% procaine hydrochloride solution on the bioavailability of cephradine after intramuscular injectionCurr Ther Res Clin Exp197518711-9
Stennett DJSimonson WEffect of membrane filtration on 10-mg/mL cefazolin admixturesAm J Hosp Pharm197936657-60
Klink PR, Frable RA, Bornstein M. Stability of mandol in parenteral fluids, frozen solutions and admixtures containing other drugs. Presented at 13th annual ASHP midyear clinical meeting. San Antonio, TX: 1978 Dec
Henney JEVon Hoff DDRozencweig MThrombophlebitic potential of intravenous cytotoxic agentsDrug Intell Clin Pharm197711266-7
Sillers BRIrritant properties of diazepamBr Dent J1968124295
Roche Products LtdIrritant properties of diazepam—replyBr Dent J1968124295
Friedenberg WBarker JD JrIntravenous diazepam administrationJAMA1973224901-2
Jusko WJGretch M, Gassett RPrecipitation of diazepam from intravenous preparationsiJAMA1973225176
Kortilla KSothman APolyethylene glycol as a solvent for diazepam: bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutionsActa Pharmacol Toxicol (Copenh)197639104-17
Hillestad LHansen TMelsome HDiazepam metabolism in normal man I. Serum concentrations and clinical effects after intravenous, intramuscular and oral administrationClin Pharmacol Ther197416479-84
Assaf RADundee JW, Gamble JAThe influence of the route of administration on the clinical action of diazepamAnaesthesia197530152-8
Baxter MTMcKenzie DDDilution of diazepam in intravenous fluidsAm J Hosp Pharm197734124
Thong YHAbramson DCContinuous infusion of diazepam in infants with severe recurrent convulsionsMed Ann DC19744363-5
Khalid MSSchultz HTreatment and management of emergency status epilepticusEpilepsia19761773-6
Gibberd FBDiseases of the central nervous system—epilepsyBr Med J19754270-2
Kawathekar PAnusuya SRSriniwas PDiazepam (Calmpose) in eclampsia: a preliminary report of 16 casesCurr Ther Res Clin Exp197315845-55
Baskett TFBradford CRActive management of severe pre-eclampsiaCan Med Assoc J19731091209-11
Prensky ALRaff MCMoore MJIntravenous diazepam in the treatment of prolonged seizure activityN Engl J Med1967276779-84
Tehrani JBCavanaugh ADiazepam infusion in the treatment of tetanusDrug Intell Clin Pharm197711491
McLean WNSafety of diazepam infusion questionedDrug Intell Clin Pharm197711690
Trissel LAKleinman LMDavignon JPInvestigational drug information—daunorubicin hydrochloride and streptozotocinDrug Intell Clin Pharm197812404-6
Elsberry VAGrangeia JMGiorgianni SJThe lipid phase in TPNAm J IV Ther1977422-8
Belin RPBivins BAJona JZFat overload with a 10% soybean oil emulsionArch Surg19761111391-3
McNiff BLClinical use of 10% soybean oil emulsionAm J Hosp Pharm1977341080-6
Roche Laboratories, Nutley, NJ: Personal communication
McGaw Laboratories. McGaw compatibility studies: a preliminary report. Irvine, CA; 1978
Bundgaard HNorgaard TNielsen NMPhotodegradation and hydrolysis of furosemide and furosemide esters in aqueous solutionsInt J Pharm198842217-24
Kresel JJSmith ALStability of gentamicin in plastic syringesAm J Hosp Pharm197734570
McNeely DJWeiner BStewart RBStability of gentamicin in plastic syringesAm J Hosp Pharm197734570
Chrai SSAmbrosio TJGentamicin sulfate injection repackaging in syringesAm J Hosp Pharm197734920
Davis SM (Medical Information Manager, Astra Zeneca, Wilmington, Delaware): Personal communication; 2003 Aug 21.
Sohn CCupit GCConcentration of heparin in heparin-locksDrug Intell Clin Pharm197812112
Okuno TNelson CAAnticoagulant activity of heparin in intravenous fluidsJ Clin Pathol197528494-7
Joy RTHyneck MLBerardi RREffect of pH on the stability of heparin in 5% dextrose solutionsAm J Hosp Pharm197936618-21
Brown JStead KAnti-human lymphocyte globulin-heparin precipitateDrug Intell Clin Pharm197610654
Raab WPWindisch JAntagonism of neomycin by heparin. Further observations on the anaphylactoid activity of neomycinArzneimittelforschung1973231326-8
Stella VJA case for prodrugs: FosphenytoinAdv Drug Del Rev199619311-30
Dupuis LLWong BStability of propafenone hydrochloride in i.v. solutionsAm J Health-Syst Pharm1997541293-5
Dupuis LLTrope AGiesbrecht ECompatibility and stability of propafenone hydrochloride with five critical-care medicationsCan J Hosp Pharm19985155-7
Storvick WOHenry HJEffect of storage temperature on stability of commercial insulin preparationsDiabetes196817499-502
Jackson RLStorvick WOHollinden CSNeutral regular insulinDiabetes197221235-45
Page MMAlberti KGMMGreenwood RTreatment of diabetic coma with continuous low-dose infusion of insulinBr Med J19742687-90
Kidson WCasey JKraegen ETreatment of severe diabetes mellitus by insulin infusionBr Med J19742691-94
Semple PFWhite CContinuous intravenous infusion of small doses of insulin in treatment of diabetic ketoacidosisBr Med J19742694-8
Campbell LVLazarus LCasey JHRoutine use of low-dose intravenous insulin infusion in severe hyperglycaemiaMed J Aust19762519-22
Martin MMMartin ALAContinuous low-dose infusion of insulin in the treatment of diabetic ketoacidosis in childrenJ Pediatr197689560-4
Drop SLSDuval-Arnould BJMGober AELow-dose intravenous insulin infusion versus subcutaneous insulin injection: A controlled comparative study of diabetic ketoacidosisPediatrics197759733-8
Fisher JNShahshahani MNDiabetic ketoacidosis: low-dose insulin therapy by various routesN Engl J Med1977297238-41
Goldberg NJLevin SRInsulin adsorption to an inline membrane filterN Engl J Med19782981480
Kristofferson JSkobba TJAdsorption of insulin to infusion equipmentNor Farm Tidsskr197785220-4
Hirsch JIFratkin MJWood JHClinical significance of insulin adsorption by polyvinyl chloride infusion systemsAm J Hosp Pharm197734583-8
Weber SSWood WAAvailability of insulin from parenteral nutrient solutionsAm J Hosp Pharm197734353-7
Whalen FJLeCain WKAvailability of insulin from continuous low-dose insulin infusionsAm J Hosp Pharm197936330-7
Clarke BFCampbell IWFraser DMDirect addition of small doses of insulin to intravenous infusion in severe uncontrolled diabetesBr Med J197721395-6
Peterson LCaldwell JInsulin adsorbance to polyvinyl chloride surfaces with implications for constant-infusion therapyDiabetes19762572-4
Sadeghi AMehrbanpour JBehmard SA trial of total dose infusion iron therapy as an outpatient procedure in rural Iranian villages (a three month follow-up)Curr Ther Res Clin Exp197619595-602
Leach JKStrickland RDMillis DLBiological activity of dilute isoproterenol solution stored for long periods in plastic bagsAm J Hosp Pharm197734709-12
Browning MLIM MgSO₄ ampuls for IV useHosp Pharm197611325
Epperson ENedich RLMannitol crystallization in plastic containersAm J Hosp Pharm1978351337
Chatterji DCGallelli JFThermal and photolytic decomposition of methotrexate in aqueous solutionsJ Pharm Sci197867526-31
Muller HJBerg JStabilitatsstudie zu tramadolhydrochlorid im PVC-infusionbeutelKrankenhauspharmazie19971875-9
Duttera MJGallelli JFKleinman LMIntrathecal methotrexateLancet19722540
Hospira, Inc. Demerol^® (meperidine hydrochloride injection) prescribing information. Lake Forest, IL; 2023 Dec.
Hikma Pharmaceuticals USA Inc. Meperidine hydrochloride injection prescribing information. Berkeley Heights, NJ; 2023 May.
Hartline JVZachman RDVitamin A delivery in total parenteral nutrition solutionPediatrics197658448-51
Sina AYoussef MKKassem AAStability of oxytetracycline in solutions and injectionsCan J Pharm Sci1974944-9
Colding HAnderson GEStability of antibiotics and amino acids in two synthetic L-amino acid solutions commonly used for total parenteral nutrition in childrenAntimicrob Agents Chemother197813555-8
Schneider E (Knoll AG, Milan, Italy): Personal communication; 2000 Feb 25
Perrier DRapp RYoung BMaintenance of therapeutic phenytoin plasma levels via intramuscular administrationAnn Intern Med197685318-21
Sellers EMKalant HAlcohol intoxication and withdrawalN Engl J Med1976294757-62
Nahata MCFormulation of caffeine injection for i.v. administrationAm J Hosp Pharm1987441308, 1312
AnonIntravenous phenytoinN Engl J Med19762951078
AnonIntravenous phenytoinN Engl J Med19762951078
Frank JTAuthor’s responseDrug Intell Clin Pharm19737419
Woo EGreenblatt DJChoosing the right phenytoin dosageDrug Ther19777131-9
Bighley LDWille JMixing of additives in glass and plastic intravenous fluid containersAm J Hosp Pharm197431736-9
Schondelmeyer SGatlin LIntravenous phenytoin (concluded)N Engl J Med1977296111
Bauman JLSiepler JKIntravenous phenytoin (concluded)N Engl J Med1977296111
Sistare FGreene RPhenytoin crystallization in intravenous fluidsDrug Intell Clin Pharm197812120
Biberdorf RISpurbeck GHPhenytoin in IV fluids: results endorsedDrug Intell Clin Pharm197812300-1
Williams RHPPotassium overdosage: a potential hazard of non-rigid parenteral fluid containersBr Med J19731714-5
Woodside WKing JAAddition of potassium to non-rigid plastic intravenous infusion containers: a potential hazardJ Hosp Pharm197331192-4
Lankton JWSiler JNHyperkalemia after administration of potassium from nonrigid parenteral-fluid containersAnesthesiology197339660-1
Vrabel RBAmerson ABReconstitution of sodium nitroprussideAm J Hosp Pharm197532140-1
Challen RGStability of sodium nitroprusside solutionsAustralas J Pharm196748S110
Martin TPatel JADetermination of sodium nitroprusside in aqueous solutionAm J Hosp Pharm19692651-3
Frank MJJohnson JBSpectrophotometric determination of sodium nitroprusside and its photodegradation productsJ Pharm Sci19766544-8
Ammar HOStability of injection solutions of vitamin B₁Pharmazie197631373-4
AnonCorrection: sodium in ticarcillin and carbenicillinMed Lett Drugs Ther19771928
Yamaji AYasuko FOkuda HPhotodegradation of vitamin K¹ and vitamin K² injections in preservation and in intravenous admixturesJ Nippon Hosp Pharm Assoc Sci Ed197847-11
Kobayashi NHKing JCCompatibility of common additives in protein hydrolysate/dextrose solutionsAm J Hosp Pharm197734589-94
Humphreys AMarty JJGooey SLStability of methotrexate in an intravenous fluidAust J Hosp Pharm1978866-7
Clayton SKStability of intravenous additive preparations; studies on hydralazine as an additiveJ Clin Pharm19782247-56
AnonMixing chlorpromazine and morphineBr Med J19743681
Crapper JBMixing chlorpromazine and morphineBr Med J1975133
Baird GMWilloughby MLNPhotodegradation of dacarbazineLancet19782681
Georget SVigneron JBlaise NStability of refrigerated and frozen solutions of tropisetron in either polyvinylchloride or polyolefin infusion bagsJ Clin Pharm Ther199722257-60
Bergman HDCefamandoleDrug Intell Clin Pharm197913144-9
Indelicato JMWilham WLConversion of cefamandole nafate to cefamandole sodiumJ Pharm Sci1976651175-8
Palmer MAFraterrigo CCProduction of carbon dioxide gas after reconstitution of cefamandole nafateAm J Hosp Pharm197936596-7
Klink PRMcKeechan CWProduction of carbon dioxide gas after reconstitution of cefamandole nafateAm J Hosp Pharm197936597
Bornstein MKlink PRFarrell BTStability of frozen solutions of cefamandole nafateAm J Hosp Pharm,19803798-101
Buckles JWalters VStability of amitriptyline hydrochloride in aqueous solutionJ Clin Pharm19761107-12
Enever RPPo ALWMillard BJDecomposition of amitriptyline hydrochloride in aqueous solution: identification of decomposition productsJ Pharm Sci1975641497-9
Enever RPPo ALWFactors influencing decomposition rate of amitriptyline hydrochloride in aqueous solutionJ Pharm Sci1977661087-9
Holman BLDewanjee MKPotential pH incompatibility of pharmacological and isotopic adjuncts to arteriographyRadiology1974110722-3
Kawilarang CRTGeorghiou KThe effect of additives on the physical properties of a phospholipid-stabilized soybean oil emulsionJ Clin Hosp Pharm19805151-60
Bristol Laboratories. Stadol Q&A. Syracuse, NY; 1978 Nov:7
Jacobs RSCalcitonin-SalmonDrug Intell Clin Pharm19759557-9
Nahata MCZingarelli JDurrell DEStability of caffeine citrate injection in intravenous admixtures and parenteral nutrition solutionsJ Clin Pharm Ther19891453-5
Davignon JPYang KWWood HBFormulation of three nitrosoureas for intravenous useCancer Chemother Rep 31973437-11
Buckles JWalters VStability of imipramine hydrochloride solutionsJ Clin Pharm19761113-8
Bowmed Ibisqus Limited. Summary of product characteristics: Clarithromycin 500 mg powder for solution. Chirk, Wrexham, United Kingdom; 2023 Oct 4.
Smith JLCanham JEWells PAEffect of phototherapy light, sodium bisulfite, and pH on vitamin stability in total parenteral nutrition admixturesJ Parenter Enteral Nutr198812394-402
Lauper RDLeucovorin calcium administration and preparationAm J Hosp Pharm197835377
Tavoloni NGuarino AMPhotolytic degradation of adriamycinJ Pharm Pharmacol198032860-2
Black CDPopovich NGStability of intravenous fat emulsionsArch Surg1980115891
Bacon LA review of two safety factors in the use of paraldehydeJ R Coll Gen Pract198030622-4
Horton JKStevens MFGSearch for drug interactions between the antitumor agent DTIC and other cytotoxic agentsJ Pharm Pharmacol197931Suppl64P
Zaccardelli DSKrcmarik CSWolk RStability of imipenem and cilastatin sodium in total parenteral nutrient solutionJPEN J Parenter Enteral Nutr199014306-309
Kuehnle CMoore TDSodium chloride residue provides potential for drug incompatibilitiesAm J Hosp Pharm197936881
Trissel LAKleinman LMCradock JCInvestigational drug information—ifosfamide and semustineDrug Intell Clin Pharm197913340-3
Horton JKStevens MFGA new light on the photo-decomposition of the antitumour drug DTICJ Pharm Pharmacol198133808-11
Earp CMBarriere SLThe lack of inactivation of tobramycin by cefazolin, cefamandole, and moxalactam in vitroDrug Intell Clin Pharm198519677-9
Elliott TSJEley ACowlishaw AStability of tobramycin in combination with selected new beta-lactam antibioticsJ Antimicrob Chemother198617680-1
Gu LChiang HSBecker AKinetics and mechanisms of the autoxidation of ketorolac tromethamine in aqueous solutionInt J Pharm19884195-104
Brown AFHarvey DAHoddinott DJFreeze thaw stability of ceftazidimeBr J Parenter Ther1985643-5
Viatris Limited. New Zealand data sheet for Klacid^®, Klacid^® IV. Auckland, New Zealand; 2022 Sep 12.
Vieth RLedermann SEKooh SWLosses of calcitrol to peritoneal dialysis bags and tubingPeritoneal Dial Int19899277-80
McNiff BLMcNiff EFPotency and stability of extemporaneous nitroglycerin infusionsAm J Hosp Pharm197936173-7
Giamarellou HMavroudis KPetrikkos GIn vitro and in vivo interactions of recent cephalosporins with gentamicin and amikacinChemioterapia19843183-7
Milano GEtienne MCCassuto-Viguier ELong-term stability of 5-fluorouracil and folinic acid admixturesEur J Cancer199329A129-32
Sturek JKSokolski TDWinsley WTStability of nitroglycerin injection determined by gas chromatographyAm J Hosp Pharm197835537-41
Fung HLPotency and stability of extemporaneously prepared nitroglycerin intravenous solutions (editorial)Am J Hosp Pharm197835528-9
Grouthamel WGDorsch B, Shangraw RLoss of nitroglycerin from plastic intravenous bagsN Engl J Med1978299262
Cossum PAGalbraith AJRoberts MSLoss of nitroglycerin from intravenous infusion setsLancet19782349-50
Boylan JCRobison RLStability of nitroglycerin solutions in Viaflex plastic containersAm J Hosp Pharm1978351031
Ludwig DJUeda CTApparent stability of nitroglycerin in dextrose 5% in waterAm J Hosp Pharm197835541-4
Brillaud AR. Interaction of platinol (cisplatin) and the metal aluminum. Syracuse, NY: Bristol Laboratories; 1979 Jul
Hospira, Inc. 10% LMD in 5% Dextrose Injection (dextran 40 in dextrose injection) and 10% LMD in 0.9% sodium chloride injection (dextran 40 in sodium chloride injection) prescribing information.Lake Forest, IL; 2018 Oct.
USP. Metoprolol tartrate injection. In: USP-NF. Rockville, MD: USP; 2019 May 1. DOI: doi.org/10.31003/USPNF_M53526_04_01
Sewell DLGolper TAStability of antimicrobial agents in peritoneal dialysateAntimicrob Agents Chemother198221528-9
El-Mallakh RIncompatibilities with cimetidine hydrochloride injectionAm J Hosp Pharm1979361024
Cutie MRLettersHosp Formul198015502-3
Tung ECGurwich ELSula JAStability of five antibiotics in plastic intravenous solution containers of dextrose and sodium chlorideDrug Intell Clin Pharm198014848-50
Benvenuto JAAnderson RWKerkof KStability and compatibility of antitumor agents in glass and plastic containersAm J Hosp Pharm1981381914-8
Jhunjhunwala VPBhalla HLCompatibility of mephentermine sulfate with hydrocortisone sodium succinate or aminophylline in 5% dextrose injectionAm J Hosp Pharm1981381922-4
Jhunjhunwala VPBhalla HLCompatibility of aminophylline with hydrocortisone sodium succinate or dexamethasone sodium phosphate in 5% dextrose injectionAm J Hosp Pharm198138900-1
Lee YCMalick AWAmann AHBretylium tosylate intravenous admixture compatibility. II. Dopamine, lidocaine, procainamide and nitroglycerinAm J Hosp Pharm198138183-7
Colvin MHartner JStability of carmustine in the presence of sodium bicarbonateAm J Hosp Pharm198037677-8
Dorr RTIncompatibilities with parenteral anticancer drugsAm J IV Ther45, 46, 52 (Feb-Mar) 1979642
Das Gupta VStewart KRStability of cefamandole nafate and cefoxitin sodium solutionsAm J Hosp Pharm198138875-9
Poochikian GKCradock JCStability of anthracycline antitumor agents in four infusion fluidsAm J Hosp Pharm198138483-6
Newton DWFung EYYStability of five catecholamines and terbutaline sulfate in 5% dextrose injection in the absence and presence of aminophyllineAm J Hosp Pharm1981381314-9
Neil JMA rational approach to intravenous additivesProc Guild197973-33
Otterman GESamuelson DWIncompatibility between carbenicillin injection and promethazine injectionAm J Hosp Pharm1979361156
Marshall TRLing ITFollis GPharmacological incompatibility of contrast media with various drugs and agentsRadiology196584536-9
Monder CStability of corticosteroids in aqueous solutionsEndocrinology196882318-26
Kleinberg MLStauffer GLPrior RBStability of antibiotics frozen and stored in disposable hypodermic syringesAm J Hosp Pharm1980371087-8
Butler LDMunson JMEffect of inline filtration on the potency of low-dose drugsAm J Hosp Pharm198037935-41
Allen LVStiles MLCompatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2Am J Hosp Pharm198138380-1
KleinbergMLStauffer GLStability of five liquid drug products after unit dose repackagingAm J Hosp Pharm198037680-2
Kowaluk EARoberts MSBlackburn HDInteractions between drugs and polyvinyl chloride infusion bagsAm J Hosp Pharm1981381308-14
Zatz LSethia PStability of refrigerated aminophylline in 5% dextrose in water: a 96-hour studyHosp Pharm198116548
Scott KRBell AFDrug interactions I: Folic acid and calcium gluconateJ Pharm Sci198069234
Jurgens RWDeLuca PPCompatibility of amphotericin B with certain large-volume parenteralsAm J Hosp Pharm198138377-8
Gotz VPMar DDCompatibility of amphotericin B with drugs used to reduce adverse reactionsAm J Hosp Pharm198138378-9
Lee YCBaaske DMAmann AHBretylium tosylate intravenous admixture compatibility. I. Stability in common large-volume parenteral solutionsAm J Hosp Pharm198037803-8
Yuhas EMLofton FTBaldinus JGCimetidine hydrochloride compatibility with preoperative medicationsAm J Hosp Pharm1981381173-4
Smith FMNuessle NOStability of lidocaine hydrochloride in 5% dextrose injection in plastic bagsAm J Hosp Pharm1981381745-7
Finch MESodium thiopental in 5% dextrose in lactated Ringer’s precipitateHosp Pharm197914559-60
Kirschenbaum HLLesko LJMendes RWStability of procainamide in 0.9% sodium chloride or dextrose 5% in waterAm J Hosp Pharm1979361464-5
Baaske DMMalick AWStability of procainamide hydrochloride in dextrose solutionsAm J Hosp Pharm1980371050-2
Jeglum ELWinter ENafcillin sodium incompatibility with acidic solutionsAm J Hosp Pharm198138462
Cutie MRLordi NGCompatibility of verapamil hydrochloride injection in commonly used large-volume parenteralsAm J Hosp Pharm198037675-6
Rosenberg HADougherty JTMayron DCimetidine hydrochloride compatibility I: Chemical aspects and room temperature stability in intravenous infusion fluidsAm J Hosp Pharm198037390-3
Yuhas EMLofton FTMayron DCimetidine hydrochloride compatibility II: Room temperature stability in intravenous infusion fluidsAm J Hosp Pharm198138879-81
Yuhas EMLofton FTRosenberg HACimetidine hydrochloride compatibility III: Room temperature stability in drug admixturesAm J Hosp Pharm1981381919-22
Dahlin PAParedes SMVisual compatibility of dobutamine with seven parenteral drug productsAm J Hosp Pharm198037460
Lesko LJMarion AEricson JStability of trimethoprim-sulfamethoxazole injection in two infusion fluidsAm J Hosp Pharm1981381004-6
Holmes CJAusman RKWalter CWActivity of antibiotic admixtures subjected to different freeze-thaw treatmentsDrug Intell Clin Pharm198014353-7
Holmes CJAusman RKKundsin RBEffect of freezing and microwave thawing on the stability of six antibiotic admixtures in plastic bagsAm J Hosp Pharm198239104-8
Boddapati SYang KPhysiochemical properties of aminophylline-dextrose injection admixturesAm J Hosp Pharm198239108-12
Canton EMBaluch WMEffect of freezing on particle formation in three antibiotic injectionsAm J Hosp Pharm198239124-5
Chaudry IABruey KPHurlburt LECompatibility of netilmicin sulfate injection with commonly used intravenous injections and additivesAm J Hosp Pharm1981381737-42
Cutie MREffects of cold and freezing temperatures on pharmaceutical dosage formsUS Pharmacist1979438-40
Gove LWalls ADFMixing parenteral nutrition productsPharm J1979223587
Lauder ADMixing parenteral nutrition productsPharm J1979223587
Hardin TCClibon UStability of 5-fluorouracil in a crystalline amino acid solutionAm J IV Ther Clin Nutr1982939-40
Yamaji AFujii YKurata YStability of pyridoxine hydrochloride in infusion solution under practical circumstances in wardsYakuzaigaku198040143-50
Dony JDevleeschouwer MJEtude de la degradation photochimique de macrolides en presence de riboflavineJ Pharm Belg197631479-84
Parker WAShearer CAMetoclopramide compatibilityCan J Hosp Pharm19793238
Parker WACompatibility of perphenazine and butorphanol admixturesCan J Hosp Pharm198033152
Stiles MLAllen LVRetention of drugs during inline filtration of parenteral solutionsInfusion1979367-9
Somani PLeathem WD, Barlow ALSafflower oil emulsion: single and multiple infusions with or without added heparin in normal human volunteersJPEN J Parenter Enteral Nutr19804307-11
Rubin MBilik RGruenewald ZUse of 5-micron filter in administering ‘all-in-one’ mixtures for total parenteral nutritionClin Nutr19854163-8
Moore RAFeldman STreuting JCimetidine and parenteral nutritionJPEN J Parenter Enteral Nutr1981561-3
Das Gupta VStewart KRStability of haloperidol in 5% dextrose injectionAm J Hosp Pharm198239292-4
Cutie MRWaranis RCompatibility of hydromorphone hydrochloride in large-volume parenteralsAm J Hosp Pharm198239307-8
Mirtallo JMCaryer KSchneider PJGrowth of bacteria and fungi in parenteral nutrition solutions containing albuminAm J Hosp Pharm1981381907-10
Holt HABroughall JMMcCarthy MMInteractions between aminoglycoside antibiotics and carbenicillin or ticarcillinInfection19764107-9
Pickering LKGearhart PEffect of time and concentration upon interaction between gentamicin, tobramycin, netilmicin, or amikacin and carbenicillin or ticarcillinAntimicrob Agents Chemother197915592-6
Pieper JAVidal RAAnimal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactionsAntimicrob Agents Chemother198018604-9
Sturgeon RJAthanikar NKHenry RSTitratable acidities of crystalline amino acid admixturesAm J Hosp Pharm198037388-90
Ausman RKKerkhof KHolmes CJFrozen storage and microwave thawing of parenteral nutrition solutions in plastic containersDrug Intell Clin Pharm198115440-3
Tortorici MPFearing DInman MPhotoreaction involving essential amino acid injectionAm J Hosp Pharm1978351030
West KRSansom LNCosh DGSome aspects of the stability of parenteral nutrition solutionsPharm Acta Helv197651119-22
Jurgens RWHenry RSAmino acid stability in a mixed parenteral nutrition solutionAm J Hosp Pharm1981381358-9
Mirtallo JMRogers KRJohnson JAStability of amino acids and the availability of acid in total parenteral nutrition solutions containing hydrochloric acidAm J Hosp Pharm1981381729-31
Rusho WJStandish RA comparison of crystalline amino acid solutions for total parenteral nutritionHosp Formul19811629-33
AnonGuidelines for essential trace element preparations for parenteral use. A statement by an expert panel. AMA Department of Foods and NutritionJAMA.19792412051-54
Freund HAtamian S, Fischer JEChromium deficiency during total parenteral nutritionJAMA1979241496-8
Heller RMKirchner SGO’Neill JASkeletal changes of copper deficiency in infants receiving prolonged total parenteral nutritionJ Pediatr197892947-9
Moran DMRusso JZinc deficiency dermatitis accompanying parenteral nutrition supplemented with trace elementsClin Pharm19821169-76
Askari ALong CL, Blakemore WSZinc, copper, and parenteral nutrition in cancer. A reviewJPEN J Parenter Enteral Nutr19804561-71
Wolman SLAnderson GHMarliss EBZinc in total parenteral nutrition: requirements and metabolic effectsGastroenterology197976458-67
Fliss DMLamy PPTrace elements and total parenteral nutritionHosp Formul197914698-717
Schneider PJTotal parenteral nutrition: Part II: What goes into parenteral nutrition solutions?J Postgrad Pharm (Hosp Ed)1979118-27
Isaacs JWMillikan WJStackhouse JParenteral nutrition of adults with a 900 milliosmolar solution via peripheral veinsAm J Clin Nutr197730552-9
Romankiewicz JAMcManus JGotz VPMedications not to be refrigeratedAm J Hosp Pharm1979361541-5
Swerling RDilution of oral and intravenous aminophylline preparationsAm J Hosp Pharm1981381359-60
Alcorn BTBarnes SGPharmacy-initiated intravenous infusion guidelinesHosp Pharm19821760-76
Bowtle WJHeasman MJPrince APCompatibility of the cephalosporin, cefamandole nafate, with injectionsInt J Pharm19804263-5
AnonI.V. dosage guidelines for theophylline productsFDA Drug Bull1980104-5
Tipple MShadomy SAvailability of active amphotericin B after filtration through membrane filtersAm Rev Resp Dis1977115879-81
Maddux MSBarriere SLA review of complications of amphotericin B therapy: recommendations for prevention and managementDrug Intell Clin Pharm198014177-81
Lufter CHBall WDActivity of amphotericin B after filtrationDrug Intell Clin Pharm198014719
Kuchinskas EJLevy GNComparative stabilities of ampicillin and hetacillin in aqueous solutionsJ Pharm Sci197261727-9
Schwartz MAHayton WLRelative stability of hetacillin and ampicillin in solutionJ Pharm Sci197261906-9
Bundgaard HPolymerization of penicillins: kinetics and mechanism of di- and polymerization of ampicillin in aqueous solutionActa Pharm Suec1976139-26
Stjernstrom GOlson OTNyqvist HStudies on the stability and compatibility of drugs in infusion fluids 6. Factors affecting the stability of ampicillinActa Pharm Suec19781533-50
Johnson CAPorter WACompatibility of azathioprine sodium with intravenous fluidsAm J Hosp Pharm198138871-5
Kowaluk EARoberts MSInteractions between drugs and intravenous delivery systemsAm J Hosp Pharm198239460-7
Bryan CKDarby MHBretylium tosylate: a reviewAm J Hosp Pharm1979361189-92
Henry RSJurgens RWSturgeon RCompatibility of calcium chloride and calcium gluconate with sodium phosphate in a mixed TPN solutionAm J Hosp Pharm198037673-4
Eggert LDRusho WJMacKay MWCalcium and phosphorus compatibility in parenteral nutrition solutions for neonatesAm J Hosp Pharm19823949-53
Robinson LAWright BTCentral venous catheter occlusion caused by body-heat-mediated calcium phosphate precipitationAm J Hosp Pharm198239120-1
Tuttle CBGuidelines for phenytoin infusionsCan J Hosp Pharm198437137-9
Stewart PLourwood DGuidelines for the administration of a phenytoin loading dose via IVPBHosp Pharm1986211003-4
Goldschmied SAn evaluation of the stability and safety of phenytoin infusionNY State J Pharm1987745-7
Kradjan WABurger RIn vivo inactivation of gentamicin by carbenicillin and ticarcillinArch Intern Med19801401668-70
Young LSDecker GInactivation of gentamicin by carbenicillin in the urinary tractChemotherapy197420212-20
Henderson JLPolk REIn vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillinAm J Hosp Pharm1981381167-70
Flournoy DJInactivation of netilmicin by carbenicillinInfection19786241
Russo MEPenicillin-aminoglycoside inactivation: another possible mechanism of interactionAm J Hosp Pharm198037702-4
Laskar PAAyres JWDegradation of carmustine in aqueous mediaJ Pharm Sci1977661073-6
Cardi VWillcox GSReconstituting cefamandole and protecting from lightAm J Hosp Pharm198037334
Kaiser GVGorman MCefamandole—a review of chemistry and microbiologyJ Infect Dis1978137S10-S16
Wold JSJoost RRBlack HRHydrolysis of cefamandole nafate to cefamandole in vivoJ Infect Dis1978137S17-S24
Palmer MAFraterrigo CCClarification of “explosive-like’’ reaction occurring when reconstituted cefamandole nafate was stored in syringesAm J Hosp Pharm1979361025
Fites ALReconstituting cefamandole and protecting from lightAm J Hosp Pharm198037334
Foster TSShrewsbury RP, Coonrod JDBioavailability and pain study of cefamandole nafateJ Clin Pharmacol198020526-33
Indelicato JMStewart BAFormylation of glucose by cefamandole nafate at alkaline pHJ Pharm Sci1980691183-8
Tomecko GWKleinberg MLLatiolais CLStability of cefazolin sodium admixtures in plastic bags after thawing by microwave radiationAm J Hosp Pharm198037211-5
Janousek JPMinisci MPAn evaluation of cefazolin sodium injection in an IV piggyback bottleInfusion1978267-73
Stiles MLEffect of microwave radiation on the stability of frozen cefoxitin sodium solution in plastic bagsAm J Hosp Pharm1981381743-5
Oberholtzer ERBrenner GSCefoxitin sodium: solution and solid state chemical stability studiesJ Pharm Sci197968863-6
Bray RJDavies PAThe stability of preservative-free morphine in plastic syringesAnaesthesia198641294-5
Walker SEPaton TWFabian TMStability and sterility of cimetidine admixtures frozen in minibagsAm J Hosp Pharm198138881-3
Cohen MRError 148—More on cisplatin storageHosp Pharm198015158-9
LeRoy AFSome quantitative data on cis-dichlorodiammineplatinum (II) species in solutionCancer Treat Rep197963231-3
Hincal AALong DFCis-platin stability in aqueous parenteral vehiclesJ Parenter Drug Assoc197933107-16
Mariani EP, Southard BJ, Woolever JT, et al. Physical compatibility and chemical stability of cisplatin in various diluents and in large-volume parenteral solutions. In: Cisplatin current status and new developments. New York, NY: Academic Press; 1980:305-16
Repta AJLong DFcis-Dichlorodiammineplatinum (II) stability in aqueous vehiclesCancer Treat Rep197963229-30
Gamble JADundee JW, Assaf RAPlasma diazepam levels after single dose oral and intramuscular administrationAnaesthesia197530164-9
Langdon DEHarlan JR, Bailey RLThrombophlebitis with diazepam used intravenouslyJAMA1973223184-5
Dam MChristiansen JDiazepam: intravenous infusion in the treatment of status epilepticusActa Neurol Scand197654278-80
Huber JWRaymond GGAdditional conclusions on diazepam injectable precipitate: GC-MS confirmationClin Toxicol197914439-44
Raymond GHuber JWIdentification of injectable Valium precipitateDrug Intell Clin Pharm197913612
Newton DWDriscoll DFGoudreau JLSolubility characteristics of diazepam in aqueous admixture solutions: theory and practiceAm J Hosp Pharm198138179-82
Mason NACline SHyneck MLFactors affecting diazepam infusion: solubility, administration-set composition, and flow rateAm J Hosp Pharm1981381449-54
MacKichan JDuffner PKAdsorption of diazepam to plastic tubingN Engl J Med1979301332-3
Parker WAMacCara MECompatibility of diazepam with intravenous fluid containers and administration setsAm J Hosp Pharm198037496-500
Cloyd JCVezeau CAvailability of diazepam from plastic containersAm J Hosp Pharm198037492-6
Cloyd JCDiluting diazepam injectionAm J Hosp Pharm19813832
Dasta JFBrier KLoss of diazepam to drug delivery systemsAm J Hosp Pharm1980371176
Boatman JAJohnson JBA four-stage approach to new-drug developmentPharm Tech1981546-56
Martin CMChemical incompatibility of Renografin 76 and protamine sulfateAm Heart J197691675-7
Hoffman DMGrossano DDDamin LStability of refrigerated and frozen solutions of doxorubicin hydrochlorideAm J Hosp Pharm1979361536-8
Gardiner WAPossible incompatibility of doxorubicin hydrochloride with aluminumAm J Hosp Pharm1981381276
Pfaller MAGranich GGValdes RComparative study of the ability of four aminoglycoside assay techniques to detect the inactivation of aminoglycosides by beta-lactam antibioticsDiagn Microbiol Infect Dis1984293-100
Hospira Inc. Product information on Liposyn III 10%, 20%, and 30%. Lake Forest, IL; 2005 Aug/Sep
Black CDPopovich NGStudy of intravenous emulsion compatibility: effects of dextrose, amino acids and selected electrolytesDrug Intell Clin Pharm198115184-93
Black CDPopovich NGComment on intravenous emulsion compatibilityDrug Intell Clin Pharm198115908-9
Pelham LDRational use of intravenous fat emulsionsAm J Hosp Pharm198138198-208
Solussol CLong-term parenteral nutrition: an artificial gutInt Surg197661266-70
Wretlind A. Current status of intralipid and other fat emulsions. In: Fat emulsion in parenteral nutrition. Chicago, IL: American Medical Association; 1975:109-19
Higbee KCLamy PPUse of Intralipid in neonates and infantsHosp Formul(Feb) 198015117-9, 122, 127
Kleinberg MLStauffer GLEffect of microwave radiation on redissolving precipitated matter in fluorouracil injectionAm J Hosp Pharm198037678-9
Driessen OdeVos DAdsorption of fluorouracil on glass surfacesJ Pharm Sci1978671494-5
Ghanekar AGDas Gupta VStability of furosemide in aqueous systemsJ Pharm Sci197867808-11
McLaughlin JEReeves DSGentamicin plus carbenicillinLancet19711864-5
Young LSDecker GInactivation of gentamicin by carbenicillin in the urinary tractChemotherapy197420212-20
Murillo JStandiford HCSchimpff SCGentamicin and ticarcillin serum levelsJAMA19792412401-3
Storey PHill HHStLouis RH, et al. Subcutaneous infusions for control of cancer symptomsJ Pain Symptom Manag1990533-41
Edwards NDFletcher ACole JRCombined infusions of morphine and ketamine for postoperative pain in elderly patientsAnaesthesia199348124-7
Dormarunno CG (Associate Medical Information Scientist, Medical and Drug Information, Pharmacia Corp., Kalamazoo, MI): Personal communication; 2002 Mar 21.
Zydus Pharmaceuticals USA Inc. Indomethacin for injection prescribing information. Pennington, NJ; 2021 Apr.
Hayes DMReilly RMThe pharmaceutical stability of deferoxamine mesylateCan J Hosp Pharm1994479-14
Downie GMcRae NLeaching of plasticizers by fat emulsion from polyvinyl chlorideBr J Parenter Ther19856142-4
Anderson WHarthill JECouper IAHeparin stability in dextrose solutions [proceedings]J Pharm Pharmacol19772931P
Bowie HMHaylor VStability of heparin in sodium chloride solutionJ Clin Pharm19783211-4
Tunbridge LJLloyd JVPenhall RKStability of diluted heparin sodium stored in plastic syringesAm J Hosp Pharm1981381001-4
Deeb ENDiMattia PEStandardization of heparin-lock maintenance solutionN Engl J Med1976294448
Holford NHGVozeh SCoates PMore on heparin lockN Engl J Med19772961300-1
Lynch CLLinder GEFrequently asked questions about insulinHosp Pharm198015213-4
Graham DTPomeroy AREffects of freezing on commercial insulin suspensionsInt J Pharm19781315-22
Hill JBAdsorption of insulin to glassProc Soc Exp Biol Med195910275-7
Hill JBThe adsorption of I¹³¹-insulin to glassEndocrinology195965515-7
Wiseman RBaltz BEPrevention of insulin-I¹³¹ adsorption to glassEndocrinology196168354-6
Sonksen PHEllis JPLowy CQuantitative evaluation of the relative efficiency of gelatine and albumin in preventing insulin adsorption to glassDiabetologia19651208-10
Suess VFroesch ERZur therapie des coma diabeticum: quantitative bedeutung des insulinuerlusts am infusionsbesteckSchweizer Med Wochanschr19751051315-8
Okamoto HKikuchi TAdsorption of insulin to infusion bottles and plastic intravenous tubingYakuzaigaku197939107-11
Wingert TDLevin SRInsulin adsorption to an air-eliminating inline filterAm J Hosp Pharm198138382-3
Hirsch JIWood JHInsulin adsorption to polyolefin infusion bottles and polyvinyl chloride administration setsAm J Hosp Pharm198138995-7
Kerchner JCocaluca DMEffect of whole blood on insulin adsorption onto intravenous infusion systemsAm J Hosp Pharm1980371323-5
Galloway JABressler RInsulin treatment in diabetesMed Clin N Am197862663-80
AnonLetter: Carrier solutions for low-level intravenous insulin infusionBr Med J19761151-2
Wan KKTsallas GDilute iron dextran formulation for addition to parenteral nutrient solutionsAm J Hosp Pharm198037206-10
Bornstein MLo AYThomas PNMoxalactam disodium compatibility with intramuscular and intravenous diluentsAm J Hosp Pharm1982391495-8
Kleinberg MLLatiolais CJUse of a microwave oven to redissolve crystallized mannitol injection (25%) in ampulsHosp Pharm197914391-2
Hanson GGMicrowave oven explosionHosp Pharm197914612
Kleinberg MLLatiolais CJMicrowave oven explosionHosp Pharm197914612
Kana MJMicrowave oven explosionHosp Pharm198015104
Post REStephen SPA warming cabinet for storing mannitol ampulsHosp Pharm197510102-3
Scott KRBell AF, Thomas AJWarming kettle for storing mannitol injectionAm J Hosp Pharm19803716
Herring PKeeping mannitol in solutionHosp Pharm198015530-1
Church JJContinuous narcotic infusions for relief of postoperative painBr Med J19791977-9
Townsend RJPuchala AHStability of methylprednisolone sodium succinate in small volumes of 5% dextrose and 0.9% sodium chloride injectionsAm J Hosp Pharm1981381319-22
Knutsen CVEpps DRMcCormick DCTotal nutrient admixture guidelinesDrug Intell Clin Pharm198418253-4
Riggle MABrandt RBDecomposition of TPN solutionsJ Pediatr1982100670
Freund HR, Rimon B, Muggia-Sullam M, et al. The “All in one” system for TPN causes increased rates of catheter blockade. J Parenter Enteral Nutr. 1986; 10:543
Cohen MRHazard warning—Flagyl IV (metronidazole hydrochloride) product reconstitutionHosp Pharm198116398
Little GBBoylan JCI.V. Flagyl reacts with aluminumHosp Pharm198116627
Carmichael RRMahoney CDSolubility and stability of phenytoin sodium when mixed with intravenous solutionsAm J Hosp Pharm19803795-8
Salem RBYost RLTorosian GInvestigation of the crystallization of phenytoin in normal salineDrug Intell Clin Pharm198014605-8
Pfeifle CEAdler DSPhenytoin sodium solubility in three intravenous solutionsAm J Hosp Pharm198138358-2
Gilead Sciences, Inc. Veklury^® (remdesivir): Compatibility with alternative diluents. Updated 2024 Jan 4. From Gilead Medical Information website. Accessed 2024 Jan 17.
Gupta VDStewart KRStability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixturesJ Clin Hosp Pharm19861147-54
Newton DWKluza RBPrediction of phenytoin solubility in intravenous admixtures: physicochemical theoryAm J Hosp Pharm1980371647-51
Cohen MRMake sure your nurses mix drug additions to infusing I.V. solutionsHosp Pharm198116164
Schuna ANappi J, Kolstad JPotassium pooling in non-rigid parenteral fluid containersJ Parenter Drug Assoc197933184-6
McCloskey WWJeffrey LPRational ordering of phosphate supplementsHosp Pharm197914486-7
Herman JJPhosphate: its valence and methods of quantification in parenteral solutionsDrug Intell Clin Pharm197913579-85
Benderev KHypophosphatemia and phosphorus supplementationHosp Pharm198015611-3
Swerling RUse and preparation of cardioplegic solutions in cardiac surgeryHosp Pharm198015497-503
Loucas SPMehl BMaager PStability of procaine HCl in a buffered cardioplegia formulationAm J Hosp Pharm1981381924-8
Amann AHBaaske DMPlastic i.v. container for nitroglycerinAm J Hosp Pharm198037618
Cacace LGHarralson A, Clougherty TStability of NTGAm Heart J197997817-8
Yuen PHDenman SLSokoloski TDLoss of nitroglycerin from aqueous solution into plastic intravenous delivery systemsJ Pharm Sci1979681163-6
Baaske DMAmann AHWagenknecht DMNitroglycerin compatibility with intravenous fluid filters, containers, and administration setsAm J Hosp Pharm198037201-5
Roberts MSCossum PAGalbraith AJAvailability of nitroglycerin from parenteral solutionsJ Pharm Pharmacol198032237-44
Christiansen HSkobba TJAndersen RNitroglycerin infusion—factors influencing the concentration of nitroglycerin available to the patientJ Clin Hosp Pharm19805209-15
Sokoloski TDWu CCRapid adsorptive loss of nitroglycerin from aqueous solution to plasticInt J Pharm1980663-76
Baaske DMAmann AHKarnatz NNAdministration set for use with intravenous nitroglycerinAm J Hosp Pharm198239121-2
Little LAHatheway GJProblems with administration devices for commercially available nitroglycerin injectionAm J Hosp Pharm198239400
Schad RFJennings RProblems with administration devices for commercially available nitroglycerin injectionAm J Hosp Pharm198239400
Turco SJProblems with administration devices for commercially available nitroglycerin injectionAm J Hosp Pharm198239977
Vesey CJBatistoni GADetermination and stability of sodium nitroprusside in aqueous solutions (determination and stability of SNP)J Clin Pharm19772105-7
Milewski BJones DPhotodecompositionHosp Pharm198116178
Nolly RJStach PELatiolais CJStability of thiamine hydrochloride repackaged in disposable syringesAm J Hosp Pharm198239471-4
Polk REKline BJMail order tobramycin serum levels: low values caused by ticarcillinAm J Hosp Pharm198037920
Seitz DJArchambault JRKresel JJStability of tobramycin sulfate in plastic syringesAm J Hosp Pharm1980371614-5
Levison MEKnight RIn vitro evaluation of tobramycin, a new aminoglycoside antibioticAntimicrob Agents Chemother19721381-4
Svensson LAStressed oxidative degradation of terbutaline in aqueous solution. Identification of the degradation productsActa Pharm Suec19729141-6
Cutie MRCompatibility of verapamil with other additivesAm J Hosp Pharm198138231
Lederle Laboratories. Hospital formulary monograph—Pipracil. Wayne, NJ; 1981 Nov
Chan KKGiannini DDStaroscik JA5-Azacytidine hydrolysis kinetics measured by high-pressure liquid chromatography and ¹³C-NMR spectroscopyJ Pharm Sci197968807-12
Rubin MBilik RAserin ACatheter obstruction: analysis of filter content of total nutrient admixtureJ Parenter Enteral Nutr198913641-3
Flora KPSmith SLApplication of a simple high-performance liquid chromatographic method for the determination of melphalan in the presence of its hydrolysis productsJ Chromatogr197917791-7
Palmer AJSewell GJRowland CGQualitative studies on;ga-interferon-2b in prolonged continuous infusion regimes using gradient elution high-performance liquid chromatographyJ Clin Pharm Ther198813225-31
Morris MEParker WACompatibility of chlordiazepoxide HCl injection following dilutionCan J Pharm Sci19811643-5
Cummings DSPark MKCompatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containersAm J Hosp Pharm1982391685-7
Deans KWLang JRStability of trimethoprim-sulfamethoxazole injection in five infusion fluidsAm J Hosp Pharm1982391681-4
Munson JWKubiak EJCytosine arabinoside stability in intravenous admixtures with sodium bicarbonate and in plastic syringesDrug Intell Clin Pharm198216765-7
Kirschenbaum HLAronoff WPerentesis GPStability of dobutamine hydrochloride in selected large-volume parenteralsAm J Hosp Pharm1982391923-5
Ray JBNewton DWNye MTDroperidol stability in intravenous admixturesAm J Hosp Pharm19834094-7
Das Gupta VStewart KRStability of cefotaxime sodium and moxalactam disodium in 5% dextrose and 0.9% sodium chloride injectionsAm J IV Ther Clin Nutr27-9 (Jan) 19831020
Jett SEng SSProchlorperazine edisylate incompatibilityAm J Hosp Pharm198340210
Porter WRJohnson CACohon MSCompatibility and stability of clindamycin phosphate with intravenous fluidsAm J Hosp Pharm19834091-4
Hittel WPIafrate RPKarnes HTStability of pentobarbital sodium in 5% dextrose injection and 0.9% sodium chloride injectionAm J Hosp Pharm198340294-6
Niemiec PWVanderveen TWHohenwarter MWStability of aminophylline injection in three parenteral nutrition solutionsAm J Hosp Pharm198340428-32
Perentesis GPPiltz GWKirschenbaum HLStability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additivesAm J Hosp Pharm1983401010-2
Yuen PCTaddei CRWyka BECompatibility and stability of labetalol hydrochloride in commonly used intravenous solutionsAm J Hosp Pharm1983401007-9
Pyter RAHsu LCCStability of methylprednisolone sodium succinate in 5% dextrose and 0.9% sodium chloride injectionAm J Hosp Pharm1983401329-33
Gannon PMSesin GPStability of cytarabine following repackaging in plastic syringes and glass containersAm J IV Ther Clin Nutr19831011-6
Sesin GPMillette LAStability study of 5-fluorouracil following repackaging in plastic disposable syringes and multidose vialsAm J IV Ther Clin Nutr29-30 (Sep) 1982923-5
Parker WACompatibility of perphenazine and butorphanol admixturesCan J Hosp Pharm19813438
Jump WGPlaza VMCompatibility of nalbuphine hydrochloride with other preoperative medicationsAm J Hosp Pharm198239841-3
Dorr RTPeng YMAlberts DSBleomycin compatibility with selected intravenous medicationsJ Med198213(1-2):121-30
Cutie MRCompatibility of verapamil hydrochloride injection with commonly used additivesAm J Hosp Pharm1983401205-7
Shively CDRedford AFlagyl I.V., drug-drug physical compatibilityAm J IV Ther Clin Nutr198189-16
Souney PFSteele LEffect of vitamin B complex and ascorbic acid on the antimicrobial activity of cefazolin sodiumAm J Hosp Pharm198239840-1
Keller JHEnsminger WDStability of cancer chemotherapeutic agents in a totally implanted drug delivery systemAm J Hosp Pharm1982391321-3
Rodanelli RComelli MPascale WClinical pharmacology of some antibiotics: problems relating to their intravenous use in hospitalsFarmaco Ed Prat198237185-8
Kowaluk EARoberts MSDrug loss in polyolefin infusion systemsAm J Hosp Pharm198340118-9
Illum LBundgaard HSorption of drugs by plastic infusion bagsInt J Pharm198210339-51
Pfizer Laboratories. Vistaril IM, table of physical compatibilities. New York, NY; 1979 Jul
Abbott Laboratories. Package insert on Neut. North Chicago, IL; 1988 Oct
Jhunjhuowala VPBhalla HLSodium ampicillin: its stability in some large volume parenteral solutionsIndian J Hosp Pharm1981855-7
Scheiner JMAraujo MMThiamine destruction by sodium bisulfite in infusion solutionsAm J Hosp Pharm1981381911-3
Kirschenbaum HLAronoff WPerentesis GPStability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drug additivesAm J Hosp Pharm1982391013-5
Lackner TEBaldus DButler CDLidocaine stability in cardioplegic solution stored in glass bottles and polyvinyl chloride bagsAm J Hosp Pharm19834097-101
Russell WJMeyer-Witting MThe stability of atracurium in clinical practiceAnaesth Intens Care199018550-2
Shank WACoupal JJStability of digoxin in common large-volume injectionsAm J Hosp Pharm198239844-6
Solomon DANasinnyk KKCompatibility of haloperidol lactate and heparin sodiumAm J Hosp Pharm198239843-4
Elliott GTMcKenzie MWCurry SHStability of cimetidine hydrochloride in admixtures after microwave thawingAm J Hosp Pharm1983401002-6
Tsallas GAllen LCStability of cimetidine hydrochloride in parenteral nutrition solutionsAm J Hosp Pharm198239484-5
Roberts MSCossum PAKowaluk EAPlastic syringes and intravenous infusionsMed J Aust19812580-1
Das Gupta VStewart KREffect of tobramycin on the stability of carbenicillin disodiumAm J Hosp Pharm1983401013-6
Simmons AAllwood MCSorption to plastic syringes of drugs administered by syringe pumpJ Clin Hosp Pharm1981671-3
Nicholas EHess GDegradation of penicillin, ticarcillin and carbenicillin resulting from storage of unit dosesN Engl J Med1982306547-8
Carpenter JPGomez EAAdministration of lorazepam injection through intravenous tubingAm J Hosp Pharm1981381514-6
Newton DWNarducci WALeet WALorazepam solubility in and sorption from intravenous admixture solutionsAm J Hosp Pharm198340424-7
Frable RAKlink PREngel GLStability of cefamandole nafate injection with parenteral solutions and additivesAm J Hosp Pharm198239622-7
Kirschenbaum HLAronoff WPiltz GWCompatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additivesAm J Hosp Pharm1983401690-1
Bosch EHvan Doorne HBrouwers JRBJVermindering van het sufentanilgehalte bij de bereiding en tijdens het gebruik van een epidurale toedieningsvorm. Een orienterend onderzoekZiekenhuisfarmacie1993997-101
Cairns CJIncompatibility of amiodaronePharm J198623668
Roney JV (Scientific Services, Hoechst-Roussel Pharmaceuinticals, Somerville, NJ): Personal communication; 1983 Dec 4
Berge SMHenderson NLKinetics and mechanism of degradation of cefotaxime sodium in aqueous solutionJ Pharm Sci19837259-63
Smith FMNuessle NOStability of diazepam injection repackaged in glass unit-dose syringesAm J Hosp Pharm1982391687-90
Cossum PARoberts MSAvailability of isosorbide dinitrate, diazepam and chlormethiazole from I.V. delivery systemsEur J Clin Pharmacol198119181-5
Smith ABird GCompatibility of diazepam with infusion fluids and their containersJ Clin Hosp Pharm19827181-6
Yliruusi JKSothmann AGLaine RHSorptive loss of diazepam and nitroglycerin from solutions to three types of containersAm J Hosp Pharm1982391018-21
Kuhlman JAbshagen UCleavage of glycosidic bonds of digoxin and derivatives as function of pH and timeNaunyn Schmiedebergs Arch Pharmacol1973276149-56
Gault MHCharles JDSugden DLHydrolysis of digoxin by acidJ Pharm Pharmacol19772927-32
Sternson LAShaffer RDKinetics of digoxin stability in aqueous solutionJ Pharm Sci197867327-30
Khalil SAEl-Masry SInstability of digoxin in acid medium using a nonisotopic methodJ Pharm Sci1978671358-60
Fagerman KEDean REDaily digoxin administration in parenteral nutrition solutionAm J Hosp Pharm1981381955
Patterson MJTjokrosetio RStability of adrenaline injection BP following resterilizationAust J Hosp Pharm19811121-2
Nazeravich DROtlen NHHEffect of inline filtration on delivery of gentamicin at a slow infusion rateAm J Hosp Pharm1983401961-4
Zell MPaone RPStability of insulin in plastic syringesAm J Hosp Pharm198340637-8
Benvenuto JAErrors in oncolytic agent stability studyAm J Hosp Pharm1983401628
Bisaillon SSarrazin RCompatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusionJ Parenter Sci Technol198337129-132
Gove LAntibiotic interactionsPharm J1983231233
Ennis CEMerritt RJ, Neff DNIn vitro study of in line filtration of medications commonly administered to pediatric cancer patientsJPEN J Parenter Enteral Nutr19837156-8
Buxton PCConduit SMStability of parentrovite in infusion fluidsBr J IV Ther198345
Das Gupta VStewart KRStability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5% dextrose injectionsAm J Hosp Pharm198441686-9
Hasegawa GREder JFVisual compatibility of dobutamine hydrochloride with other injectable drugsAm J Hosp Pharm198441949-51
Souney PFColucci RDMariani GCompatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injectionAm J Hosp Pharm198441323-4
Lundergan FSLombardi TPNeilan GEStability of tobramycin sulfate mixed with oxacillin sodium and nafcillin sodium in human serumAm J Hosp Pharm198441144-5
Parker WAPhysical compatibility update of preoperative medicationsHosp Pharm198419475-8
Hale DCJenkins RIn-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillinAm J Clin Pathol198074316-9
Rank DMPacker AMIn vitro inactivation of tobramycin by penicillinsAm J Hosp Pharm1984411187-8
Karlsen JThonnesen HHOlsen IRStability of cytotoxic intravenous solutions subjected to freeze-thaw treatmentNor Pharm Acta19834561-7
Cheung YWVishnuvajjala BRStability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixturesAm J Hosp Pharm1984411802-6
Bundgaard HLarsen CInfluence of carbohydrates and polyhydric alcohols on the stability of cephalosporins in aqueous solutionInt J Pharm198316319-25
Hamilton GAdverse reactions to intravenous pyelography contrast agentsCan Med Assoc J1983129405-6
Miller BPesko LEffect of freezing on particulate matter concentrations in five antibiotic solutionsAm J IV Ther Clin Nutr19841119-22
Wagman GHBailey JVBinding of aminoglycoside antibiotics to filtration materialsAntimicrob Agents Chemother19757316-319
Tindula RJAmbrose PJAminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoringDrug Intell Clin Pharm198317906-8
Gillies IRPhysical stability of Intralipid following drug additionAust J Hosp Pharm198010118-20
Hardin TCClibon UPage CPCompatibility of 5-fluorouracil and total parenteral nutrition solutionsJPEN J Parenter Enteral Nutr19826163-5
Gaj ESesin GPEvaluation of growth of five microorganisms in doxorubicin and floxuridine mediaPharm Manufacturing1984152-3
Gaj EGriffin REEvaluation of growth of six microorganisms in fluorouracil, bacteriostatic sodium chloride 0.9% and sodium chloride 0.9% mediaHosp Pharm198318348-9
Turco SJDrug adsorption to membrane filtersAm J IV Ther Clin Nutr198296
Robinson WAKrebs LUThe “real stuff” for intrathecal injection during leukaemia therapyLancet19821283
Frear RSCefoperazone-aminoglycoside incompatibilityAm J Hosp Pharm198340564
O’Bey KAJim LKGee JPTemperature dependence of the stability of tobramycin mixed with penicillins in human serumAm J Hosp Pharm1982391005-8
Bhatia JMims LCEffect of phototherapy on amino acid solutions containing multivitaminsJ Pediatr198096284-6
Koshiro AFujita TInteraction of penicillins with the components of plasma expandersDrug Intell Clin Pharm198317351-6
Szucsova SSlana MStability of infusion mixtures of 5% glucose solution with injection solutionsFarm Obzor198352209-13
Gillis JJones G, Pencharz PDelivery of vitamins A, D, and E in total parenteral nutrition solutionsJPEN J Parenter Enteral Nutr1983711-4
Farago SCompatibility of antibiotics and other drugs in total parenteral nutrition solutionsCan J Hosp Pharm19833643-51
Gaj ESesin GPCompatibility of doxorubicin hydrochloride and vinblastine sulfate—stability of a solution stored in Cormed reservoir bags or Monoject plastic syringesAm J IV Ther Clin Nutr13-14, 19-20 (May) 1984118-9
Bar-Or DKulig KMarx JAPrecipitation of verapamilAnn Intern Med198297619
Tucker RGentile JFPrecipitation of verapamil with nafcillinAm J Hosp Pharm1984412588
Hasegawa GREder JFDobutamine-heparin mixture inadvisableAm J Hosp Pharm1984412588
Chen MFBoyce HW, Triplett LStability of the B vitamins in mixed parenteral nutrition solutionJPEN J Parenter Enteral Nutr19837462-4
Bowman BBNguyen PStability of thiamin in parenteral nutrition solutionsJPEN J Parenter Enteral Nutr19837567-8
Newton DWPhysicochemical determinants of incompatibility and instability in injectable drug solutions and admixturesAm J Hosp Pharm1978351213-22
Newton DW. Physicochemical determinants of incompatibility and instability of drugs for injection and infusion. In: Trissel LA. Handbook on injectable drugs. 3rd ed. Bethesda, MD: American Society of Hospital Pharmacists; 1983:XI-XXI
Raymond GDay PSodium content of commonly administered intravenous drugsHosp Pharm198217560-1
Rich DSRecent information about inactivation of aminoglycosides by carbenicillin and ticarcillin: clinical implicationsHosp Pharm19831841-3
Lawrence RIFlukes WKRust VJTotal parenteral nutrition using a combined nutrient solutionAust J Hosp Pharm198111540-2
Davis SSGalloway MTotal parenteral nutritionPharm J19836 (Jan 1 & 8):230
Travenol Laboratories. 3-in-1 admixture guide from Travenol. 1983 Nov
Chan JCMalekzadeh M, Hurley HpH and titratable acidity of amino acid mixtures used in hyperalimentationJAMA19722201119-20
Kirk BSprake JMStability of aminophyllineBr J IV Ther(Nov) 198234, 6, 8
Vogenberg FRSouney PFStability guidelines for routinely refrigerated drug productsAm J Hosp Pharm198340101-2
Niemiec PWVanderveen TWCompatibility considerations in parenteral nutrient solutionsAm J Hosp Pharm198441893-911
Irving JDReynolds PVDisposable syringe dangerLancet19661362
Salter F (Bristol-Myers Squibb, Princeton, NJ): Personal communication; 1991 Feb 27
Hopefl AWClinical use of intravenous acyclovirDrug Intell Clin Pharm198317623-8
Larsen CBundgaard HPolymerization of penicillins VI. Time-course of formation of antigenic di- and polymerization products in aqueous ampicillin sodium solutionsArch Pharm Chemi Sci Ed19775201-9
Carthy BJHill GTSome aspects of the analysis and stability of atracurium besylateAnal Proc198320177-9
D’Arcy PFComment on handling of anticancer drugsDrug Intell Clin Pharm198418417
Adams JWilson JPInstability of bleomycin in plastic containersAm J Hosp Pharm1982391636
Levin VAZackheim HSStability of carmustine for topical applicationArch Dermatol1982118450-1
Chan KKZackheim HSStability of nitrosourea solutionsArch Dermatol1973107298
Teil SMArwood LLStability of gentamicin and cefamandole in serumAm J Hosp Pharm198239485-6
Portnoff JBHenley MWDevelopment of sodium cefoxitin as a dosage formJ Parenter Sci Technol198337180-5
Vaughan LMPoon CYStability of ceftazidime and vancomycin alone and in combination in heparinized and nonheparinized peritoneal dialysis solutionAnn Pharmacother199428572-6
Muller RHHeinemann SFat emulsions for parenteral nutrition. IV. Lipofundin MCT/LCT regimens for total parenteral nutrition (TPN) with high electrolyte loadInt J Pharm1994107121-32
Sorkin EMDarvey DCReview of cimetidine drug interactionsDrug Intell Clin Pharm198317110-20
Raymond GDay PMultiple sources of sodium in injectable drugsDrug Intell Clin Pharm198216703
Eshaque MMcKay MJD-Mannitol platinum complexesWadley Med Bull19777338-48
Ferguson DEDegradation of clindamycin in frozen admixturesAm J Hosp Pharm1982391156
Ausman RKHolmes CJKundsin RBDegradation of clindamycin in frozen admixturesAm J Hosp Pharm1982391156
Cairns CJRobertson JIncompatibility of ceftazidime and vancomycinPharm J1987238577
Sandoz. Sandimmune—pharmacy fact sheet. East Hanover, NJ; 1983 Nov
Senholzi CSKerus MPCrystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injectionAm J Hosp Pharm198542129-30
Thompson DFAllen LVDesai SRCompatibility of furosemide with aminoglycoside admixturesAm J Hosp Pharm198542116-9
Geary TGAkood MA, Jensen JBCharacteristics of chloroquine binding to glass and plasticAm J Trop Med Hyg19833219-23
Yayon AGinsburg AA method for the measurement of chloroquin uptake in erythrocytesAnal Biochem1980107332-6
D’Arcy PFDrug interactions with medical plasticsDrug Intell Clin Pharm198317726-31
Kowaluk EARoberts MSFactors affecting the availability of diazepam stored in plastic bags and administered through intravenous setsAm J Hosp Pharm198340417-23
Kasahara KRuiz-Torres AEinwirkung der verdauungssafe auf die bestandigkeit des digoxin-und digitoxin-molekulsKlin Wochenschr1969471109-11
Berman WWhitman VMarks KHInadvertent overadministration of digoxin to low-birth-weight infantsJ Pediatr1978921024-5
Berman WDubynsky OWhitman VDigoxin therapy in low-birth-weight infants with patent ductus arteriosusJ Pediatr197893652-5
Hajratwala BRStability of prostaglandinsAust J Pharm Sci1975NS5Jun39-41
Roseman TJSims BStability of prostaglandinsAm J Hosp Pharm197330236-9
Gupta VDStewart KRStability of cefsulodin in aqueous buffered solutions and some intravenous admixturesJ Clin Hosp Pharm1984921-7
Williamson MJLuce JKDoxorubicin hydrochloride-aluminum interactionAm J Hosp Pharm198340214
Chin TH (Professional Services, Miles Inc., West Haven, CT): Personal communication; 1993 Dec 3
Hausrani PKDavis SSPreparation and properties of sterile intravenous emulsionsJ Parenter Sci Technol198337145-50
Gray MSSingleton WSCreaming of phosphatide stabilized fat emulsions by electrolyte solutionsJ Pharm Sci1967561429-31
Knutsen CMiller PCompatibility, stability, and effect of mixing 10% fat emulsion in TPN solutionsJPEN J Parenter Enteral Nutr19815579
Burnham WRHansrani PKKnott CEStability of a fat emulsion based intravenous feeding mixtureInt J Pharm1983139-22
Hardin TCComplex parenteral nutrition solutions: II. Addition of fat emulsionsNutr Supp Serv1983350-51
Quebbeman EJHamid AARHoffman NEStability of fluorouracil in plastic containers used for continuous infusion at homeAm J Hosp Pharm1984411153-6
Barker AHebron BSBeck PRFolic acid and total parenteral nutritionJPEN J Parenter Enteral Nutr198483-8
Louie NStennett DJStability of folic acid in 25% dextrose, 3.5% amino acids, and multivitamin solutionJPEN J Parenter Enteral Nutr19848421-6
Koshiro AOie SHarima YCompatibility of gentamicin sulfate injection in parenteral solutionsJap J Hosp Pharm19827377-80
Godefroid RJIntravenous gentamicin dilution requirementsAm J Hosp Pharm1982391457
Godefroid RJComment on IV guidelinesDrug Intell Clin Pharm198418925
Matthews HHeparin anticoagulant activity in intravenous fluids utilising a chromagenic substrate assay methodAust J Hosp Pharm198212S17-S22
Turco SJHeparin locksAm J IV Ther Clin Nutr1983109
Swerling R: Normal saline or dilute heparin for heparin lock flush? Infusion. 1982; 6:123-124
Epperson ELEfficacy of 0.9% sodium chloride injection with and without heparin for maintaining indwelling intermittent injection sitesClin Pharm19843626-9
Kanke MEubanks JLBinding of selected drugs to a “treated” inline filterAm J Hosp Pharm1983401323-8
Anderson WHarthill JEAnticoagulant activity of heparins in dextrose solutionsJ Pharm Pharmacol19823490-6
Enderlin GDiscoloration of hydralazine injectionAm J Hosp Pharm198441634
Pingel MVolund AStability of insulin preparationsDiabetes197221805-13
Weber SSWood WAInsulin adsorption controversyDrug Intell Clin Pharm197610232-3
Schildt BAhlgren TBerghem LAdsorption of insulin by infusion materialsActa Anaesthesiol Scand197822556-62
Mitrano FPNewton DWFactors affecting insulin adherence to type I glass bottlesAm J Hosp Pharm1982391491-5
Twardowski ZJNolph KDMcGary TJInsulin binding to plastic bags: a methodologic studyAm J Hosp Pharm198340575-9
Twardowski ZJNolph KDMcGary TJNature of insulin binding to plastic bagsAm J Hosp Pharm198340579-82
Twardowski ZJNolph KDMcGary TJInfluence of temperature and time on insulin adsorption to plastic bagsAm J Hosp Pharm198340583-6
Sato SEbert CDPrevention of insulin self-association and surface adsorptionJ Pharm Sci198372228-32
Phillips NCLauper RDReview of etoposideClin Pharm19832112-9
McCollam PLGarrison TJEtoposide: A new chemotherapeutic agentAm J IV Ther Clin Nutr27-28 (Mar) 19841124
Stroup JWMighton-Eryou LMExpiry date guidelines for a centralized IV admixture serviceCan J Hosp Pharm19863957-9
Bishop BGAdsorption of iron-dextran on membrane filtersNZ Pharm1981149
Reed MDBertino JSUse of intravenous iron dextran injection in children receiving total parenteral nutritionAm J Dis Child1981135829-31
Halpin TCUse of intravenous iron dextran in sick patients receiving TPNNutr Supp Serv1982219-20
Shimada AAdverse reactions to total-dose infusion of iron dextranClin Pharm19821248-9
Thompson DFShimanek MStability of sterility study with magnesium sulfate admixturesInfusion86 (May-June) 1983783
Akorn, Inc. Hydralazine hydrochloride injection prescribing information. Lake Forest, IL; 2021 Apr.
A.H. Robins Pharmaceutical Division. Compatibility chart for reglan injectable 5 mg/mL. Richmond, VA; 1983 Oct
Bonati MGaspari FD’Aranno VPhysicochemical and analytical characteristics of amiodaroneJ Pharm Sci198473829-31
Feroz RM, Puppala S, Chaudhry MA, et al. Compatibility of M.V.C. 9+3 (multivitamin concentrate for infusion) in different large volume parenteral solutions. LyphoMed, Inc., 1984
Alam ASIdentification of labetalol precipitateAm J Hosp Pharm19844174
Wagenknecht DMBaaske DMAlam ASStability of nitroglycerin solutions in polyolefin and glass containersAm J Hosp Pharm1984411807-11
Klamerus KJUeda CTStability of nitroglycerin in intravenous admixturesAm J Hosp Pharm198441303-5
Scheife AHGrisafe JAStability of intravenous nitroglycerin solutionsJ Pharm Sci19827155-9
Ingram JKMiller JDPlastic absorption adsorption of nitroglycerin solutionAnesthesiology197951S132
Mathot FBonnard JHans PLes perfusions de nitroglycerine: Etude de l’absorption par differents materiaux plastiquesJ Pharm Belg198035389-93
Sokoloski TDWu CCNitroglycerin stability: effects on bioavailability, assay and biological dissolutionJ Clin Hosp Pharm19816227-32
Cawello VWBonn RBioverfugbarkeitseinflusse durch die wahl des infusionsmaterials bei der therapie mit nitroglycerinArzneimittelforschung198333595-7
Rock CMGull JReducing IV-nitroglycerin loss to an intravenous administration set by preliminary preparationAm J IV Ther Clin Nutr40-42 (Oct) 1982936
Nix DETharpe WNEffects of presaturation on nitroglycerin delivery by polyvinyl chloride infusion setsAm J Hosp Pharm1984411835-7
Jacobi JDasta JFReilley TELoss of nitroglycerin to pulmonary artery delivery systemsAm J Hosp Pharm1983401980-2
Jacobi JDasta JFWu LSLoss of nitroglycerin to central venous pressure catheterDrug Intell Clin Pharm198216331-2
Dasta JFJacobi JSokolowski TDLoss of nitroglycerin to cardiopulmonary bypass apparatusCrit Care Med19831150-2
Dasta JFJacobi JSokoloski TDExtraction of nitroglycerin by a membrane oxygenatorJ Extra-Corp Tech198315101-3
St. Peter JVCochran TGNitroglycerin loss from intravenous solutions administered with a volumetric infusion pumpAm J Hosp Pharm1982391328-30
Hola ETLoss of nitroglycerin during microinfusionAm J Hosp Pharm198441142-4
Yacobi AAmann AHPharmaceutical considerations of nitroglycerinDrug Intell Clin Pharm198317255-63
Malick AWAmann AHBaaske DMLoss of nitroglycerin from solutions to intravenous plastic containers: a theoretical treatmentJ Pharm Sci198170798-800
Amann AHBaaske DMLoss of nitroglycerin from intravenous administration sets during infusion: a theoretical treatmentJ Pharm Sci198271473-4
Neftel KAWalti MSpengler HEffect of storage of penicillin G solutions on sensitization to penicillin G after intravenous administrationLancet19821986-8
Salem RBWilder BJYost RLRapid infusion of phenytoin sodium loading dosesAm J Hosp Pharm198138354-7
Gannaway WLWilding DCSiepler JKClinical use of intravenous phenytoin sodium infusionsClin Pharm19832135-8
Boike SCRybak MJTintinalli JEEvaluation of a method for intravenous phenytoin infusionClin Pharm19832444-6
Earnest MPMarx JA, Drury LRComplications of intravenous phenytoin for acute treatment of seizuresJAMA1983249762-5
Giacona NBauman JLCrystallization of three phenytoin preparations in intravenous solutionsAm J Hosp Pharm198239630-4
Lau ALee MFlascha SEffect of piperacillin on tobramycin pharmacokinetics in patients with normal renal functionAntimicrob Agents Chemother198324533-7
Autian JDhorda CNEvaluation of disposable plastic syringes as to physical incompatibilities with parenteral productsAm J Hosp Pharm195916176-9
Addy DPAlesbury PParaldehyde and plastic syringesBr Med J197821434
Fenton-May VLee FParaldehyde and plastic syringesBr Med J197821166
Evans RJEffect of paraldehyde on disposable syringes and needlesLancet196121451
Johnson CEVigoreaux JACompatibility of paraldehyde with plastic syringes and needle hubsAm J Hosp Pharm198441306-8
Mahony CBrown JEStarget WWIn vitro stability of sodium nitroprusside solutions for intravenous administrationJ Pharm Sci198473838-9
Fricker MPSwerling RSodium nitroprusside reconstitution and administrationInfusion1981556
Boehm JJDutton DMShelf life of unrefrigerated succinylcholine chloride injectionAm J Hosp Pharm198441300-2
Roach MIV tetracyclinePharm J1978220143
Chow MSQwintiliani R, Nightingale CHIn vivo inactivation of tobramycin by ticarcillin. A case reportJAMA1982247658-9
Baumgartner TGRussell WLIntravenous trimethoprim-sulfamethoxazole administration alertAm J IV Ther Clin Nutr19831014-5
Hiskey CFBullock ESpectrophotometric study of aqueous solutions of warfarin sodiumJ Pharm Sci19625143-6
Nahata MCStability of ceftriaxone sodium in intravenous solutionsAm J Hosp Pharm1983402193-4
Smith BREffect of storage temperature and time on stability of cefmenoxime, ceftriaxone, and cefotetan in 5% dextrose injectionAm J Hosp Pharm1983401024-5
Vishnuvajjala BRCradock JCCompatibility of plastic infusion devices with diluted N-methylformamide and N,N-dimethylacetamideAm J Hosp Pharm1984411160-3
Godefroid RJVindesine: A new antineoplastic drugCancer Chemother Update198424-7
Cheung YWVishnuvajjala BRMorris NLStability of azacitidine in infusion fluidsAm J Hosp Pharm1984411156-9
Bosanquet AGStability of melphalan solutions during preparation and storageJ Pharm Sci198574348-51
Tabibi SECradock JCStability of melphalan in infusion fluidsAm J Hosp Pharm1984411380-2
Teresi MAllison JInteraction between vancomycin and ticarcillinAm J Hosp Pharm1985422420
Jorgensen JHCrawford SASelective inactivation of aminoglycosides by newer beta-lactam antibioticsCurr Ther Res Clin Exp19823225-35
Bhatia JStegink LD, Ziegler EERiboflavin enhances photo-oxidation of amino acids under simulated clinical conditionsJPEN J Parenter Enteral Nutr19837277-9
Smith GHasson KEffects of ascorbic acid and disodium edetate on the stability of isoprenaline hydrochloride injectionJ Clin Hosp Pharm19849209-15
Hutchinson SMHeparin and aminoglycosides instabilityDrug Intell Clin Pharm198620886
Johnston-Early AMcKenzie MAKrasnow SHDrug trapping in intravenous infusion side armsJAMA19842522392
Parker WAPhysical compatibility of ranitidine HCl with preoperative injectable medicationsCan J Hosp Pharm198538160-1
Das Gupta VStewart KRChemical stabilities of cefamandole nafate and metronidazole when mixed together for intravenous infusionJ Clin Hosp Pharm198510379-83
Cohen MHJohnston-Early AHood MADrug precipitation within iv tubing: a potential hazard of chemotherapy administrationCancer Treat Rep1985691325-6
Marble DABosso JACompatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditionsDrug Intell Clin Pharm198620960-3
Gove LFGordon NHMiller JPre-filled syringes for self-administration of epidural opiatesPharm J1985234378-9
Bosso JATownsend RJStability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutionsAm J Hosp Pharm1985422211-4
Nahata MCDurrell DEStability of tobramycin sulfate in admixtures with calcium gluconateAm J Hosp Pharm1985421987-8
Baker DEYost GSCraig VLCompatibility of heparin sodium and morphine sulfateAm J Hosp Pharm1985421352-5
Carlson GHMatzke GRParticle formation of third-generation cephalosporin injectionsAm J Hosp Pharm1985421578-9
Nieves-Cordero ALLuciw HMCompatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injectionAm J Hosp Pharm1985421108-9
Ogawa GSYoung RDispensing-pin problemsAm J Hosp Pharm1985421042
Conklin CAKerege JFStability of an analgesic-sedative combination in glass and plastic single-dose syringesAm J Hosp Pharm198542339-42
Thompson MSmith MGragg RStability of nitroglycerin and dobutamine in 5% dextrose and 0.9% sodium chloride injectionAm J Hosp Pharm198542361-2
Rhodes RSRhodes PJStability of meperidine hydrochloride, promethazine hydrochloride, and atropine sulfate in plastic syringesAm J Hosp Pharm198542112-5
Kiel DConnolly BJVisual compatibility of amrinone lactate with various i.v. secondary additivesParenterals (May-June) 198531, 5-6
Das Gupta VStewart KRChemical stabilities of hydrocortisone sodium succinate and several antibiotics when mixed with metronidazole injection for intravenous infusionJ Parenter Sci Technol198539145-8
Foley PTBosso JABair JNCompatibility of clindamycin phosphate with cefotaxime sodium or netilmicin sulfate in small-volume admixturesAm J Hosp Pharm198542839-43
Mansur JMAbramowitz PWLerner SAStability and cost analysis of clindamycin-gentamicin admixtures given every eight hoursAm J Hosp Pharm198542332-5
Quock JRSakai RIStability of cytarabine in a parenteral nutrient solutionAm J Hosp Pharm198542592-4
Hospira, Inc. Nalbuphine hydrochloride injection prescribing information. Lake Forest, IL; 2023 Nov.
Baptista RJPalumbo JDTahan SRStability of cimetidine hydrochloride in a total nutrient admixtureAm J Hosp Pharm1985422208-10
Das Gupta VStewart KRpH-Dependent effect of magnesium sulfate on the stability of penicillin G potassium solutionAm J Hosp Pharm198542598-602
Macias JMMartin WJStability of morphine sulfate and meperidine hydrochloride in a parenteral nutrient formulationAm J Hosp Pharm1985421087-94
James MJRiley CMStability of intravenous admixtures of aztreonam and ampicillinAm J Hosp Pharm1985421095-110
James MJRiley CMStability of intravenous admixtures of aztreonam and clindamycin phosphateAm J Hosp Pharm1985421984-6
Thompson DFThompson GDEffect of inline filtration on pediatric doses of gentamicin and tobramycinInfusion1984831-2
Alexander SRArena RPredicting calcium phosphate precipitation in premature infant parenteral nutrition solutionsHosp Pharm198520656-8
Spruill WJMcCall CYIn vitro inactivation of tobramycin by cephalosporinsAm J Hosp Pharm1985422506-9
Stevenson JGPatriarca CIncompatibility of morphine sulfate and prochlorperazine edisylate in syringesAm J Hosp Pharm1985422651
Beijnen JHRosing HdeVries PAStability of anthracycline antitumor agents in infusion fluidsJ Parenter Sci Technol198539220-2
Baptista RJLawrence RWCompatibility of total nutrient admixtures and secondary antibiotic infusionsAm J Hosp Pharm198542362-3
Baptista RJDumas GJBistrian BRCompatibility of total nutrient admixtures and secondary cardiovascular medicationsAm J Hosp Pharm198542777-8
Avet Pharmaceuticals, Inc. Prochlorperazine edisylate injection prescribing information. East Brunswick, NJ; 2020 Dec.
Henann NEJacks TTCompatibility and availability of sodium bicarbonate in total parenteral nutrient solutionsAm J Hosp Pharm1985422718-20
Watson DPiggyback compatibility of antibiotics with pediatric parenteral nutrition solutionsJPEN J Parenter Enteral Nutr19859220-4
Turner SAStability and clinical use of intravenous admixtures containing lipid emulsionPharm J1985234799-800
El Eini DKnott CEStability of iv lipid emulsionsPharm J1985235170
Hobbiss JHStability of iv lipid emulsionsPharm J1985235170
Allwood MCDrop size of infusions containing fat emulsionBr J Parenter Ther19845113-4
Iliano LDelanghe Mvan Den Baviere HEffect of electrolytes in the presence of some trace elements on the stability of all-in-one emulsion mixtures for total parenteral nutritionJ Clin Hosp Pharm1984987-93
Whateley TLSteele GUrwin JParticle size stability of Intralipid and mixed total parenteral nutrition mixturesJ Clin Hosp Pharm19849113-26
Harrie KRJacob MMcCormick DComparison of total nutrient admixture stability using two intravenous fat emulsions, Soyacal and Intralipid 20%JPEN J Parenter Enteral Nutr198610381-7
Riley CMJames MJStability of intravenous admixtures containing aztreonam and cefazolinAm J Hosp Pharm198643925-7
Kuhn RJNahata MCStability of netilmicin sulfate in admixtures with calcium gluconate and aminophyllineAm J Hosp Pharm1986431241-2
Johnson CECohen IACraft DACompatibility of aminophylline and methylprednisolone sodium succinate intravenous admixturesAm J Hosp Pharm1986431482-5
Bell RGLipford LCMassanari MJStability of intravenous admixtures of aztreonam and cefoxitin, gentamicin, metronidazole, or tobramycinAm J Hosp Pharm1986431444-53
Fitzgerald KAMacKay MWCalcium and phosphate solubility in neonatal parenteral nutrient solutions containing TrophAmineAm J Hosp Pharm19864388-93
Sayeed FAJohnson HWSukumaran KBStability of Liposyn II fat emulsion in total nutrient admixturesAm J Hosp Pharm1986431230-5
Marble DABosso JAStability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutionsAm J Hosp Pharm1986431732-6
Lee MGSorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration setsAm J Hosp Pharm1986431945-50
Riley CMLipford LCInteraction of aztreonam with nafcillin in intravenous admixturesAm J Hosp Pharm1986432221-4
Walker PCKaufmann RECompatibility of cefazolin and gentamicin in peritoneal dialysis solutionsDrug Intell Clin Pharm198620697-700
Beijnen JHNeef CMenwissen OJATStability of intravenous admixtures of doxorubicin and vincristineAm J Hosp Pharm1986433022-7
Campbell SNolan PEBliss MStability of amiodarone hydrochloride in admixtures with other injectable drugsAm J Hosp Pharm198643917-21
Hasegawa GREder JFVisual compatibility of amiodarone hydrochloride injection with other injectable drugsAm J Hosp Pharm1984411379-80
Allwood MCSorption of drugs to intravenous delivery systemsPharm Int1983483-5
Khue NVJung LStudy of the retention of child-dose drugs on cellulose ester membranes during inline intravenous filtrationS-T-P-Pharma19851201-7
Das Gupta VShah KAStability of ampicillin sodium and penicillin G potassium solutions using high-pressure liquid chromatographyCan J Pharm Sci19811661-5
Janknegt RNeil MJLEDe verenigbaarheid van antimicrobiele middelen in infusievloeistoffenPharm Weekbl1985120638-40
Bouma JBeijnen JHBult AAnthracycline antitumor agents, a review of physicochemical, analytical and stability propertiesPharm Weekbl [Sci]19868109-33
Howard LChu RFeman SVitamin A deficiency from long-term parenteral nutritionAnn Intern Med198093576-7
Shenai JPStahlman MTVitamin A delivery from parenteral alimentation solutionJ Pediatr198199661-3
Kishi HYamaji AKataoka KVitamin A and E requirements during total parenteral nutritionJPEN J Parenter Enteral Nutr19815420-3
Knight PHeer D, Abdenour GCaxP and Ca/P in the parenteral feeding of preterm infantsJPEN J Parenter Enteral Nutr19837110-4
Poole RKRupp CA, Kerner JA JrCalcium and phosphorus in neonatal parenteral nutrition solutionsJPEN J Parenter Enteral Nutr19837358-60
Ritschel WAAlcorn GJStreng WHCimetidine-theophylline complex formationMethods Find Exp Clin Pharmacol1983555-8
Glew RHPavuk RAStability of vancomycin and aminoglycoside antibiotics in peritoneal dialysis concentrateNephron198128241-3
Kamen BAGunther NSowinsky NAnalysis of antibiotic stability in a parenteral nutrition solutionPediatr Infect Dis19854387-9
Baumgartner TGSitren HSHall JStability of urokinase in parenteral nutrition solutionsNutr Supp Serv1985541-3
Allwood MCInfluence of light on vitamin A degradation during administrationClin Nutr1982163-70
Allwood MCPlane JHDegradation of vitamin A exposed to ultraviolet radiationInt J Pharm198419207-13
Riggle MABrandt RBDecrease of available vitamin A in parenteral nutrition solutionsJPEN J Parenter Enteral Nutr198610388-92
McKenna MCBieri JCLoss of vitamin A from total parenteral nutrition (TPN) solutionsFed Proc198039561
Bryant CANeufeld NJDifferences in vitamin A content of enteral feeding solutions following exposure to a polyvinyl chloride enteral feeding systemJPEN J Parenter Enteral Nutr19826403-5
Riff LJThomason JLComparative aminoglycoside inactivation by beta-lactam antibiotics—effect of cephalosporin and six penicillins on five aminoglycosidesJ Antibiot (Tokyo)198235850-7
Schutz VHSchroder FHeparin-natrium kompatibilitat bei gleichzeitiger applikation anderer pharmakaKrankenhauspharmazie198567-11
Wermeling DPRapp RPDeLuca PPOsmolality of small-volume intravenous admixturesAm J Hosp Pharm1985421739-44
Johnston SJStability of tryptophan in total parenteral nutrient solutionsAm J Hosp Pharm1986431424
Allwood MCFactors influencing the stability of ascorbic acid in total parenteral nutrition infusionsJ Clin Hosp Pharm1984975-85
Parr MDBertch KEAmino acid stability and microbial growth in total parenteral nutrient solutionsAm J Hosp Pharm1985422688-91
Nordfjeld KRasmussen MStorage of mixtures for total parenteral nutrition: long-term stability of a total parenteral nutrition mixtureJ Clin Hosp Pharm19838265-74
Nordfjeld KPedersen JLRasmussen MStorage of mixtures for total parenteral nutrition III. Stability of vitamins in TPN mixturesJ Clin Hosp Pharm19849293-301
Das Gupta VStability of vitamins in total parenteral nutrient solutionsAm J Hosp Pharm1986432132
Allwood MCStability of vitamins in total parenteral nutrient solutionsAm J Hosp Pharm1986432138
Louie NStability of vitamins in total parenteral nutrient solutionsAm J Hosp Pharm1986432138
Shine BFarwell JAStability and compatibility in parenteral nutrition solutionsBr J Parenter Ther44-46, 50 (Mar) 198454
Pamperl HKleinberger GStability of intravenous fat emulsionsArch Surg1982117859-860
Hardy G, Cotter R, Dawe R. The stability and comparative clearance of TPN mixtures with lipid. In: Johnson ID, ed. Advances in Clinical Nutrition: Selected Proceedings of the 2nd International Symposium. Lancaster, England: MTP Press; 1983:241-60
Hardy GKlim RAStability studies of parenteral nutrition mixtures with lipidsJPEN J Parenter Enteral Nutr19815569
Jeppsson RISjoberg BCompatibility of parenteral nutrition solutions when mixed in a plastic bagClin Nutr19842149-58
Parry VAHarrie KREffect of various nutrient ratios on the emulsion stability of total nutrient admixturesAm J Hosp Pharm1986433017-22
Bettner FSStennett DJEffects of pH, temperature, concentration, and time on particle counts in lipid-containing total parenteral nutrition admixturesJPEN J Parenter Enteral Nutr198610375-80
Schneider PJThree-in-one TPN formulationsInfusion(May-June) 1984894-5, 101
Ernst JAWilliams JMGlick MROsmolality of substances used in the intensive care nurseryPediatrics198372347-52
Connors KA, Amidon GL, Stella VJ. Chemical stability of pharmaceuticals: a handbook for pharmacists. New York: John Wiley & Sons; 1986
Bosanquet AGStability of solutions of antineoplastic agents during preparation and storage for in vitro assays II. Assay methods, adriamycin and the other antitumor antibioticsCancer Chemother Pharmacol1986171-10
Grant AM (Medical Affairs, Abbott Laboratories, Abbott Park, IL): Personal communication; 1987 Mar 23
Bornstein MTempleton RJCrystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injectionAm J Hosp Pharm1985422436
White JRCampbell RKGuide to mixing insulinsHosp Pharm1991261046-48
Das Gupta VStability of cefotaxime sodium as determined by high-performance liquid chromatographyJ Pharm Sci198473565-7
Carlson GHMatzke GRParticle formation of ceftizoxime sodium injectionsAm J Hosp Pharm1985422651-2
Swenson EGooch WMVisual compatibility of ceftizoxime sodium in four electrolyte injectionsAm J Hosp Pharm1986432242-4
Barbero JRMarino ELAccelerated stability studies on Rocephin by high-efficiency liquid chromatographyInt J Pharm198419199-206
Smith RCOverfill in cefuroxime sodium vialsAm J Hosp Pharm1985421045-6
Smith RCNo more overfill in cefuroxime sodium vialsAm J Hosp Pharm1986432154
DeVane CLWailand LAStability of chlorpromazine in five milliliter vialsCan J Hosp Pharm1984379
Mu-Chow KJBaptista RJCost-effectiveness of parenteral nutrient solutions containing cimetidine hydrochlorideAm J Hosp Pharm1984411321
Parasrampuria JDas Gupta VStability of acetazolamide sodium in 5% dextrose or 0.9% sodium chloride injectionAm J Hosp Pharm198744358-60
Zuber DECompatibility of morphine sulfate injections and prochlorperazine edisylate injectionsAm J Hosp Pharm19874467
Cheung YWCradock JCVishnuvajjala BRStability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous infusion solutionsAm J Hosp Pharm198744124-30
LaFollette JMArbus MHStability of cisplatin admixtures in polyvinyl chloride bagsAm J Hosp Pharm1985422652
Hussain AAHaddadin MReaction of cis-platinum with sodium bisulfiteJ Pharm Sci198069364
Kirk BMelia CDWilson JVChemical stability of cyclophosphamide injectionBr J Parenter Ther1984590-7
Ptachcinski RJLogue LWBurckart GJStability and availability of cyclosporine in 5% dextrose injection or 0.9% sodium chloride injectionAm J Hosp Pharm19864394-7
Venkataramanan RBurckart GJPtachcinski RJLeaching of diethylhexyl phthalate from polyvinyl chloride bags into intravenous cyclosporine solutionAm J Hosp Pharm1986432800-2
Stevens MFPeatey LPhotodegradation of solutions of the antitumour drug DTIC [proceedings]J Pharm Pharmacol197830Suppl47P
Williams BATritton TRPhotoinactivation of anthracyclinesPhotochem Photobiol198134131-4
Maloney TJDilution of diazepam injection prior to intravenous administrationAust J Hosp Pharm19831379
Hancock BGBlack CDEffect of polyethylene-lined administration set on the availability of diazepam injectionAm J Hosp Pharm198542335-9
Yliruusi JKUotila JAEffect of tubing length on adsorption of diazepam to polyvinyl chloride administration setsAm J Hosp Pharm1986432789-94
Yliruusi JKUotila JAEffect of flow rate and type of i.v. container on adsorption of diazepam to i.v. administration systemsAm J Hosp Pharm1986432795-9
Bell HEBertino JSConstant diazepam infusion in the treatment of continuous seizure activityDrug Intell Clin Pharm198418965-70
Dandurand KRStennett DJStability of dopamine hydrochloride exposed to blue-light phototherapyAm J Hosp Pharm198542595-7
Pluta PLMorgan PKStability of erythromycin in intravenous admixturesAm J Hosp Pharm1986432732
Deitel MFaksa MKaminsky VMGrowth of microorganisms in soybean oil emulsion and clinical implicationsInt Surg19796427-32
Keammerer DMayhall CGHall GOMicrobial growth patterns in intravenous fat emulsionsAm J Hosp Pharm1983401650-3
Kim CHLewis DEBacterial and fungal growth in intravenous fat emulsionsAm J Hosp Pharm1983402159-61
Allwood MCRelease of DEHP plasticizer into fat emulsion from iv administration setsPharm J1985235600
Driscoll DFBaptista RJBistrian BRPractical considerations regarding the use of total nutrient admixturesAm J Hosp Pharm198643416-9
Morgan DEBergdale SEffect of syringe-pump position on infusion of fat emulsion with a primary solutionAm J Hosp Pharm1985421110-1
Neil JMFell AFEvaluation of the stability of frusemide in intravenous infusions by reversed-phase high-performance liquid chromatographyInt J Pharm198422105-26
Dean TRidley PUse of 0.9% sodium chloride injection without heparin for maintaining indwelling intermittent injection sitesClin Pharm19854488
Chantelau EABerger MPollution of insulin with silicone oil, a hazard of disposable plastic syringesLancet198511459
Furberg HJensen AKEffect of pretreatment with 0.9% sodium chloride or insulin solutions on the delivery of insulin from an infusion systemAm J Hosp Pharm1986432209-13
Kane MJay MBinding of insulin to a continuous ambulatory peritoneal dialysis systemAm J Hosp Pharm19864381-8
Hutchinson KGAssessment of gelling in insulin solutions for infusion pumpsJ Pharm Pharmacol198537528-31
Kamerman BDissolving mannitol crystalsHosp Pharm198520360
Cano SBGlogiewicz FLStorage requirements for metronidazole injectionAm J Hosp Pharm1986432983
Schell KHCopland JRMetronidazole hydrochloride-aluminum interactionAm J Hosp Pharm1985421040
Struthers BJParr RJClarifying the metronidazole hydrochloride-aluminum interactionAm J Hosp Pharm1985422660
Quebbeman EJHoffman NEAusman RKStability of mitomycin admixturesAm J Hosp Pharm1985421750-4
Edwards DSelkirk ABDetermination of the stability of mitomycin C by high-performance liquid chromatographyInt J Pharm1979421-6
Young JBPratt CMFarmer JASpecialized delivery systems for intravenous nitroglycerin. Are they necessary?Am J Med19847627-37
Nix DETharpe WNIntravenous nitroglycerin delivery: dynamics and cost considerationsHosp Pharm198520230-2
Schaber DEUden DLNitroglycerin adsorption to a combination polyvinyl chloride, polyethylene intravenous administration setDrug Intell Clin Pharm198519572-5
Mendel SGreen JAComment: Nitroglycerin iv tubing adsorptionDrug Intell Clin Pharm198519946-7
Tarr BDCampbell RKStability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 daysAm J Hosp Pharm1991482631-4
Rayani SFakhreddin JStability of penicillin G sodium in 5% dextrose in water minibags after freezingCan J Hosp Pharm198538162-3
Das Gupta VDavis DDStability of piperacillin sodium in dextrose 5% and sodium chloride 0.9% injectionsAm J IV Ther Clin Nutr(Feb) 19841114-5, 18-19
Deardorff DLSchmidt CNMixing additives by squeezing plastic bagsAm J Hosp Pharm198542533-4
Synave RVergote AStability of procaine hydrochloride in a cardioplegic solution containing bicarbonateJ Clin Hosp Pharm198510385-8
Raymond GDeGennaro MEffect of Neut on the pH of some commercially available intravenous solutionsInfusion19859144-6
Sewell GJForbes DRStability of sodium nitroprusside infusion during the administration by motorized syringe-pumpJ Clin Hosp Pharm198510351-60
Baaske DMSmith MDKarnatz NHigh-performance liquid chromatographic determination of sodium nitroprussideJ Chromatogr1981212339-46
Elenbaas JKLander RDEffect of inline filtration on tobramycin deliveryDrug Intell Clin Pharm198519122-5
Mehta JSearcy CJStability of terbutaline sulfate admixtures stored in polyvinyl chloride bagsAm J Hosp Pharm1986431760-2
Das Gupta VStewart KRStability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injectionsAm J Hosp Pharm1986431729-31
Hazlet TKTankersley DLPossible incompatibilities with immune globulin for i.v. useAm J Hosp Pharm199350654, 659-60
Richardson BLWoodford JDAndrews GDPharmacy of ceftazidimeJ Antimicrob Chemother19818233-6
Cox MERoesner MProduction of carbon dioxide gas after reconstitution of ceftazidimeAm J Hosp Pharm1986431422
Fites ALProduction of carbon dioxide gas after reconstitution of ceftazidimeAm J Hosp Pharm1986431422-3
Marwaha RKJohnson BFSimple stability-indicating assay for histamine solutionsAm J Hosp Pharm1985421568-71
Marwaha RKJohnson BFLong-term stability study of histamine in sterile bronchoprovocation solutionsAm J Hosp Pharm198643380-3
Bigley FPForsyth RJCompatibility of imipenem-cilastatin sodium with commonly used intravenous solutionsAm J Hosp Pharm1986432803-9
De NCAlam ASStability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injectionsAm J Hosp Pharm1986431486-8
Fresenius Kabi USA, LLC. Propranolol hydrochloride injection prescribing information. Lake Zurich, IL; 2022 Nov.
Gralla RJTyson LBKris MGManagement of chemotherapy-induced nausea and vomitingMed Clinics N Am198771289-301
Forman JKSouney PFVisual compatibility of midazolam hydrochloride with common preoperative injectable medicationsAm J Hosp Pharm1987442298-9
Thompson DFThompson GDVisual compatibility of esmolol hydrochloride and furosemide in 5% dextrose or 0.9% sodium chloride injectionsAm J Hosp Pharm1987442740
Ahmed IDay PStability of cefazolin sodium in various artificial tear solutions and aqueous vehiclesAm J Hosp Pharm1987442287-90
McSherry TJIncompatibility between chlorpromazine and metacresolAm J Hosp Pharm1987441574
Tebbett IRMelrose EStability of promazine as an intravenous infusionPharm J1986237172
Hospira, Inc. Erythrocin^® lactobionate - IV (erythromycin lactobionate for injection) prescribing information. Lake Forest, IL; 2022 Nov.
Hospira, Inc. Erythrocin^® lactobionate - IV (erythromycin lactobionate for injection) single-dose ADD-Vantage vials prescribing information. Lake Forest, IL; 2020 Mar.
Navarro JNAznar MTRuiz MDStability of 5-fluorouracil in large volume intravenous solutionsRev Assoc Esp Farm Hosp1985969-72
Biondi LNairn JGStability of 5-fluorouracil and flucytosine in parenteral solutionsCan J Hosp Pharm19863960-3
Parr MDBarton SDHaver VMCyclosporine binding to components in medication administration setsDrug Intell Clin Pharm198822173-4
Gasca MFanikos JVisual compatibility of perphenazine with various antimicrobials during simulated Y-site injectionAm J Hosp Pharm198744574-5
Nolte MSPoon VGrodsky GMReduced solubility of short-acting soluble insulins when mixed with longer-acting insulinsDiabetes1983321177-81
Forman JKLachs JRVisual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injectionAm J Hosp Pharm1987441408-9
Nelson RWYoung RVisual incompatibility of dacarbazine and heparinAm J Hosp Pharm1987442028
Zbrozek ASMarble DABosso JACompatibility and stability of clindamycin phosphate-aminoglycoside combinations within polypropylene syringesDrug Intell Clin Pharm198721806-10
Perry MKhalidi NStability of penicillins in total parenteral nutrient solutionAm J Hosp Pharm1987441625-8
Tu YHAllen LVStability of papaverine hydrochloride and phentolamine mesylate in injectable mixturesAm J Hosp Pharm1987442524-7
Seargeant LEKobrinsky NLSus CJIn vitro stability and compatibility of daunorubicin, cytarabine, and etoposideCancer Treat Rep1987711189-92
Baumgartner TGKnudsen AKDunn AJNorepinephrine stability in saline solutionsHosp Pharm (Jan) 19882344, 49, 59
Marble DABosso JACompatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottlesDrug Intell Clin Pharm19882254-7
Welty TECloyd JCDelivery of paraldehyde in 5% dextrose and 0.9% sodium chloride injections through polyvinyl chloride i.v. sets and burettesAm J Hosp Pharm198845131-5
Thompson DFStiles MLAllen LVCompatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injectionAm J Hosp Pharm198845142-5
Pesko LJArend KAHagman DEPhysical compatibility and stability of metoclopramide injectionParenterals(Dec-Jan) 198851-3, 6-8
Karnatz NNWong JKesler HCompatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administrationAm J Hosp Pharm198845368-71
Colucci RDCobuzzi LEVisual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injectionAm J Hosp Pharm198845630-2
Schilling CGCompatibility of drugs with a heparin-containing neonatal total parenteral nutrient solutionAm J Hosp Pharm198845313-4
Colucci RDCobuzzi LEVisual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injectionAm J Hosp Pharm1988451357-8
Hikma Pharmaceuticals USA Inc. Glycopyrrolate injection prescribing information. Berkeley Heights, NJ; 2020 Dec.
Excela Pharma Sciences, LLC. GLYRX^®-PF (glycopyrrolate injection) prescribing information. Lenoir, NC; 2018 Aug.
Morgan GJMcClellan JDStability of a heparin urokinase mixtureBr J Parenter Ther1987889
Garren KWRepta AJIncompatibility of cisplatin and Reglan injectableInt J Pharm19852491-9
Sanburg ALLyndon RCEffects of freezing, long-term storage and microwave thawing on the stability of three antibiotics reconstituted in minibagsAust J Hosp Pharm19871731-4
Murase SOchiai KAoki MStudy on compatibility of dopram with other drugsJap J Hosp Pharm198713244-60
Borst DLSesin GPStability of selected beta-lactam antibiotics stored in plastic syringesNITA198710368-72
Roberts DECross MDThomas PHAzlocillin-aminoglycoside combinations in CAPD fluidBr J Pharm Pract1987998-9
Robinson DCCookson TLConcentration guidelines for parenteral antibiotics in fluid-restricted patientsDrug Intell Clin Pharm198721985-9
Sterchele JAUpdate on stability guidelines for routinely refrigerated drug productsAm J Hosp Pharm1987442698
Dahl JMRoche VFVisual compatibility of cibenzoline succinate with commonly used acute care medicationsAm J Hosp Pharm1987441123-5
Sagent Pharmaceuticals, Inc. Vinorelbine injection prescribing information. Schaumburg, IL; 2020 Apr.
Jimenez MDVisual compatibility of nalbuphine hydrochloride and promethazine hydrochlorideAm J Hosp Pharm1988451278
Pereira-Rosario RUtamura TInteraction of heparin sodium and dopamine hydrochloride in admixtures studied by microcalorimetryAm J Hosp Pharm1988451350-2
Baptista RJMitrano FPStability and compatibility of cimetidine hydrochloride and aminophylline in dextrose 5% in water injectionDrug Intell Clin Pharm198822592-3
Holmes CJKubey WYViability of microorganisms in fluorouracil and cisplatin small-volume injectionsAm J Hosp Pharm1988451089-91
Jay GTFanikos JVisual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injectionAm J Hosp Pharm1988451556-7
Tucker DRSieradzan RVisual compatibility of ciprofloxacin lactate with five broad-spectrum antimicrobial agents during simulated Y-site injectionAm J Hosp Pharm1988451910-1
Marquardt EDVisual compatibility of hydroxyzine hydrochloride with various antineoplastic agentsAm J Hosp Pharm1988452127
Riley CMStability of milrinone and digoxin, furosemide, procainamide hydrochloride, propranolol hydrochloride, quinidine gluconate, or verapamil hydrochloride in 5% dextrose injectionAm J Hosp Pharm1988452079-91
Awang DVGraham KCMicrowave thawing of frozen drug solutionsAm J Hosp Pharm1987442256
Bashaw EDAmantea MAMinor JRVisual compatibility of zidovudine with other injectable drugs during simulated Y-site administrationAm J Hosp Pharm1988452532-3
Souney PFFanikos JCompatibility of cyclophosphamide solution with antibiotics during simulated Y-site injectionParenterals(Aug-Sep) 198861, 2, 8
Beijnen JHVendrig DEMMStability of Vinca alkaloid anticancer drugs in three commonly used infusion fluidsJ Parenter Sci Technol19894384-7
Fong PAWard JVisual compatibility of intravenous famotidine with selected drugsAm J Hosp Pharm198946125-6
Karnatz NNWong JBaaske DMStability of esmolol hydrochloride and sodium nitroprusside in intravenous admixturesAm J Hosp Pharm198946101-4
Johnson CELloyd CWMesaros JLCompatibility of aminophylline and verapamil in intravenous admixturesAm J Hosp Pharm19894697-100
Parti RWolf WCaveats with respect to storage of cisplatin and fluorouracil admixturesAm J Hosp Pharm198946259
Johnson EGJanosik JEManufacturer’s recommendations for handling spilled antineoplastic agentsAm J Hosp Pharm198946318-9
Jarosinski PFKennedy PFStability of concentrated trimethoprim-sulfamethoxazole admixturesAm J Hosp Pharm198946732-7
Bosanquet AGStability of solutions of antineoplastic agents during preparation and storage for in vitro assays III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agentsCancer Chemother Pharmacol198923197-207
Beijnen JHUnderberg WJMDegradation of mitomycin C in acidic solutionInt J Pharm198524219-29
Beijnen JHden Hartigh JQuantitative aspects of the degradation of mitomycin C in alkaline solutionJ Pharm Biomed Anal1985359-69
Beijnen JHRosing HStability of mitomycins in infusion fluidsArch Pharm Chemi Sci Ed19851358-66
Janssen MJHCrommelin DJAStorm GDoxorubicin decomposition on storage. Effect of pH, type of buffer and liposome encapsulationInt J Pharm1985231-11
Beijnen JH, van der Houwen OAGJ, Voskuilen MCH, et al. Aspects of the degradation kinetics of daunorubicin in aqueous solution. In: Beijnen JH, ed. Chemical stability of mitomycin and anthracycline antineoplastic drugs. Utrecht, The Netherlands: Drukkerij Elkinkwijk BV; 1986:245-60
Beijnen JHvan der Houwen OAGJAspects of the degradation kinetics of doxorubicin in aqueous solutionInt J Pharm198632123-31
Fritz BLLockhart HEChemical stability of selected pharmaceuticals repackaged in glass and plasticPharm Tech(Nov) 19881244, 46, 48, 50-2
Venkataraman PSBrissie EOStability of calcium and phosphorus in neonatal parenteral nutrition solutionsJ Pediatr Gastroenterol Nutr19832640-3
Fitzgerald KAMacKay MWCalcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn PFAm J Hosp Pharm1987441396-1400
Mikrut BACalcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn PF or TrophAmineAm J Hosp Pharm1987442702-4
Lenz GTMikrut BACalcium and phosphate solubility in neonatal parenteral nutrient solutions containing Aminosyn-PF or TrophAmineAm J Hosp Pharm1988452367-71
Raupp Pvon Kries RSchmidt EIncompatibility between fat emulsion and calcium plus heparin in parenteral nutrition of premature babiesLancet19881700
Waller DJSmith SRUse of infusion devices with total nutrient admixturesAm J Hosp Pharm1987441570
Gilbert MGallagher SCEads MMicrobial growth patterns in a total parenteral nutrition formulation containing lipid emulsionJPEN J Parenter Enteral Nutr198610494-7
Barat ACHarrie KJacob MEffect of amino acid solutions on total nutrient admixture stabilityJPEN J Parenter Enteral Nutr198711384-8
Cripps ALStability studies on total parenteral nutrition mixtures containing fat emulsionsBr J Pharm Pract19846187-95
Davis SSGalloway MStudies on fat emulsions in combined nutrition solutionsJ Clin Hosp Pharm19861133-45
Ang SDCanham JE, Daly JMParenteral infusion with an admixture of amino acids, dextrose, and fat emulsion solution: compatibility and clinical safetyJPEN J Parenter Enteral Nutr19871123-7
du Plessis JVan Wyk CJThe stability of parenteral fat emulsions in nutrition admixturesJ Clin Pharm Ther198712307-18
Sayeed FATripp MGSukumaran KBStability of total nutrient admixtures using various intravenous fat emulsionsAm J Hosp Pharm1987442271-80
Sayeed FATripp MGSukumaran KBStability of various total nutrient admixture formulations using Liposyn II and Aminosyn IIAm J Hosp Pharm1987442280-6
McGee CDMascarenhas MGOstro MJSelenium and vitamin E stability in parenteral solutionsJPEN J Parenter Enteral Nutr19859568-70
Dahl GBJeppsson RIVitamin stability in a TPN mixture stored in an EVA plastic bagJ Clin Hosp Pharm198611271-9
Shenkin AFraser WDMcLelland AJMaintenance of vitamin and trace element status in intravenous nutrition using a complete nutritive mixtureJPEN J Parenter Enteral Nutr198711238-42
Yamaoka KNakajima YOkinaga SVariation by combination of hyperalimentation with fat emulsionJap J Hosp Pharm198713211-5
Sewell DLGolper TABrown SDStability of single and combination antimicrobial agents in various peritoneal dialysates in the presence of insulin and heparinAm J Kidney Dis19833209-12
Nance KSMatzke GRStability of gentamicin and tobramycin in concentrate solutions for automated peritoneal dialysisAm J Nephrol19844240-3
Das Gupta VParasrampuria JQuantitation of acetazolamide in pharmaceutical dosage forms using high-performance liquid chromatographyDrug Dev Ind Pharm198713147-57
Boak LRAminophylline stabilityCan J Hosp Pharm198740155
Moore BRTindula RIncompatibility between amphotericin B and evacuated i.v. containersAm J Hosp Pharm1987441312
Bretschneider HOsmolalities of commercially supplied drugs often used in anesthesiaAnaesth Analg198766361-2
Odgers CDrug/nutrient interactions and incompatibilities complicating TPNN.Z. Pharm1986664-8
Kedzierewicz FFinance CNicolas AEtude comparative de la stabilite de solutions de carbenicilline en fonction de la temperature. Interet du cycle congelation-decongelation au four a micro-ondesPharm Acta Helv198762109-15
Arbus MHRoom temperature stability guidelines for carmustineAm J Hosp Pharm198845531
Frederiksson KLundgren PStability of carmustine—kinetics and compatibility during administrationActa Pharm Suec198623115-24
Sewell GJRiley CMThe stability of carboplatin in ambulatory continuous infusion regimesJ Clin Pharm Ther198712427-32
Ross MBAdditional stability guidelines for routinely refrigerated drug productsAm J Hosp Pharm1988451498-9
Goodell JAHarry DJ, Low JRMore on production of a carbon dioxide gas after reconstitution of ceftazidimeAm J Hosp Pharm198744510
Savello DRMore on production of carbon dioxide gas after reconstitution of ceftazidimeAm J Hosp Pharm198744512
Rovers JPMenielly GSouney PFThe use of stability-indicating assays to determine the in vitro compatibility and stability of metronidazole/gentamicin admixturesCan J Hosp Pharm198942143-6
Walker SEDranitsaris GStability of reconstituted ceftriaxone in dextrose and saline solutionsCan J Hosp Pharm198740161-6
Martinez-Pancheco RVila-Jato JLEffect of different factors on stability of ceftriaxone in solutionFarmaco Ed Prat198742131-7
Kedzierewicz FFinance CNicolas AStability of parenteral ceftriaxone disodium solutions in frozen and liquid states: effect of freezing and microwave thawingJ Pharm Sci19897873-7
Kristjansson FSternson LAAn investigation on possible oligomer formation in pharmaceutical formulations of cisplatinInt J Pharm19884167-74
AnonHigh-dose Maxolon mixes with cisplatinPharm J1985234593
Kirk BThe evaluation of a light-protective giving set. The photosensitivity of intravenous dacarbazine solutionsBr J Parenter Ther(May-June) 1987878, 81-2, 85-6
Bosanquet AGStability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agentsCancer Chemother Pharmacol19851483-95
Beijnen JHPotman RPvan Ooijen RDStructure elucidation and characterization of daunorubicin degradation productsInt J Pharm198734247-57
Haronikova KPikulikova ZKral LSorption of diazepam on the surface of the plastic infusion unit, part 2Farm Obz198655485-94
Mathot FBonnard JParis PInfluence des materiaux de perfusion sur les solutions de diazepamJ Pharm Belg198237153-6
Murphy AMaltby SDissolution time, on reconstitution, of a new parenteral formulation of doxorubicin (Doxorubicin Rapid Dissolution)Int J Pharm198738257-9
Baumann TJSmythe MAKaufmann KDissolution times of Adriamycin and Adriamycin RDFAm J Hosp Pharm1988451667
Vogelzang NJRuane MPhase I trial of an implanted battery-powered, programmable drug delivery system for continuous doxorubicin administrationJ Clin Oncol19853407-14
Keusters LStolk LMLUmans RStability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20 °C and thawing by microwave radiationPharm Weekbl [Sci]19868194-7
Williamson MLuce JKMicrowave thawing of doxorubicin hydrochloride admixtures not recommendedAm J Hosp Pharm198744505
Adams SFernandez FIntravenous use of haloperidolHosp Pharm198722306-7
Thoma KStruve MUntersuchungen zur photo- und thermostabilitat von adrenalin-losungenPharm Acta Helv1986612-9
David LMPhlebitis with intravenous erythromycinAm J Hosp Pharm198744732
Schwinghammer TLReilly MCracking of ABS plastic devices used to infuse undiluted etoposide injectionAm J Hosp Pharm1988451277
Beijnen JHHolthuis JJMKerkdijk HGDegradation kinetics of etoposide in aqueous solutionInt J Pharm198841169-78
Brown DHSimkover RAMaximum hang times for i.v. fat emulsionsAm J Hosp Pharm198744282
Allwood MCThe release of phthalate ester plasticizer from intravenous administration sets into fat emulsionInt J Pharm198629233-6
Nahata MCHipple TFStability of gentamicin diluted in 0.9% sodium chloride injection in glass syringesHosp Pharm1987221131-2
Dunn DLLenihan SFThe case for the saline flushAm J Nurs1987877989
Shearer JNormal saline flush versus dilute heparin flush. A study of peripheral intermittent I.V. devicesNITA198710425-7
Hamilton RAPlis JMClay CHeparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devicesClin Pharm19887439-43
Lombardi TPGundersen BZammett LOEfficacy of 0.9% sodium chloride injection with or without heparin sodium for maintaining patency of intravenous catheters in childrenClin Pharm19887832-6
Cyganski JMDonahue JMThe case for the heparin flushAm J Nurs198787796-7
Bullock LS, Fitzgerald JF, Glick MRStability of famotidine in minibags refrigerated and/or frozenDICP198923132-5
Swanson DJDeAngelis CSmith ILDegradation kinetics of imipenem in normal saline and human serumAntimicrob Agents Chemother198629936-7
Smith GBSchoenewaldt EFStability of N-formimidoylthienamycin in aqueous solutionJ Pharm Sci198170272-6
McElnay JCElliott DSBinding of human insulin to burette administration setsInt J Pharm198736199-203
Adams PSHaines-Nutt RFStability of insulin mixtures in disposable plastic insulin syringesJ Pharm Pharmacol198739158-63
Mozzi GConegliani BLomi RStabilita del calcio folinato in soluzioni acquose in funzione del pH e delta temperaturaBoll Chim Farm1986125424-8
Powell MFStability of lidocaine in aqueous solution: effect of temperature, pH, buffer, and metal ions on amide hydrolysisPharm Res1987442-5
Das Gupta VStewart KRChemical stabilities of lignocaine hydrochloride and phenylephrine hydrochloride in aqueous solutionJ Clin Hosp Pharm198611449-52
Clinigen, Inc. Ethyol^® (amifostine) for injection prescribing information. Yardley, PA; 2019 Dec.
Wright MPNewton JMStability of methotrexate injection in prefilled, plastic disposable syringesInt J Pharm198845237-44
Dyvik OGrislingaas ALTonnesen HHMethotrexate in infusion solutions—a stability test for the hospital pharmacyJ Clin Hosp Pharm198611343-8
Cabeza Barrera JBautista Paloma JGarcia de Pesquera FDisminucion de la adsorcion de insulina a los envases de nutricion parenteralRev Assoc Esp Farm Hosp198812251-4
Beijnen JHFokkens RHRosing HDegradation of mitomycin C in acid phosphate and acetate buffer solutionsInt J Pharm198632111-21
Beijnen JHLingeman HVan Munster HAMitomycin antitumor agents: a review of their physico-chemical and analytical properties and stabilityJ Pharm Biomed Anal19864275-95
Stolk LMLFruijtier AStability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical usePharm Weekbl [Sci]19868286-8
Depiero DRekhi GSSouney PFStability of morphine sulfate solutions frozen in polyvinyl chloride intravenous bagsPharm Pract News (Oct) 1987141, 39-40
Hung CTYoung MStability of morphine solutions in plastic syringes determined by reversed-phase ion-pair liquid chromatographyJ Pharm Sci198877719-23
Visor GCLin LHJackson SEStability of ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride injectionsAm J Hosp Pharm1986432810-2
Behme RJBrooke DKensler TTIncompatibility of ifosfamide with benzyl-alcohol-preserved bacteriostatic water for injectionAm J Hosp Pharm198845627-8
Rowland CGBradford EAdams PInfusion of ifosfamide plus mesnaLancet19842468
Bristol-Myers Oncology Division. Product information on Mesnex (Mesna). Evansville, IN; 1989 Jun
Dorr RT. Mesnex dosing and administration guide. Evansville, IN: Bristol-Myers Company; 1989
Lederle Laboratories, American Cyanamid Company. Product information on Novantrone. Pearl River, NY; 1988
Nahata MCHipple TFStability of phenobarbital sodium diluted in 0.9% sodium chloride injectionAm J Hosp Pharm198643384-5
Dela Cruz FGKanter MZFischer JHEfficacy of individualized phenytoin sodium loading doses administered by intravenous infusionClin Pharm19887219-24
Davidson SWLyall DSodium nitroprusside stability in light-protective administration setsPharm J1987239599-601
Saunders AStability and light sensitivity of sodium nitroprusside infusionsAust J Hosp Pharm19861655-6
Glascock JCDiPiro JTCadwallader DEStability of terbutaline sulfate repackaged in disposable plastic syringesAm J Hosp Pharm1987442291-3
Raymond GGStability of terbutaline sulfate injection stored in plastic tuberculin syringesDrug Intell Clin Pharm198822303-5
Das Gupta VGardner SNJalowsky CMChemical stability of thiopental sodium injection in disposable plastic syringesJ Clin Pharm Ther198712339-42
Nahata MCMiller MAStability of vancomycin hydrochloride in various concentrations of dextrose injectionAm J Hosp Pharm198744802-4
Greenberg RNSaeed AMKKennedy DJInstability of vancomycin in Infusaid drug pump model 100Antimicrob Agents Chemother198731610-1
Tucker RGentile JFPrecipitation of verapamil in an intravenous lineAnn Intern Med1984101880
Patel SDYalkowsky SHDevelopment of an intravenous formulation for the antiviral drug 9-(beta-D-arabinofuranosyl)-adenineJ Parenter Sci Technol19874115-20
Stolk LMLHuisman WNordemann HDFormulation of a stable vidarabine infusion fluidPharm Weekbl [Sci]1983557-60
Black JBuechter DDStability of vinblastine sulfate when exposed to lightDrug Intell Clin Pharm198822634-6
Vendrig DEMMSmeets BPGHBeijnen JHDegradation kinetics of vinblastine sulphate in aqueous solutionsInt J Pharm198843131-8
Cartwight-Shamoon JMMcElnay JCExamination of sorption and photodegradation of amsacrine during storage in intravenous burette administration setsInt J Pharm19884241-6
Milano GEtienne MCCassuto-Viguier ELong-term stability of 5-fluorouracil and folinic acid admixturesEur J Cancer199229A129-32
Kraynak MAPharmaceutical aspects of docetaxelAm J Health-Syst Pharm199754S7-S10
Leigh PHBuddle GCPentamidine infusion stabilityBr J Pharm Pract19881022-3
Roos PJGlerum JH, Meilink JWStability of morphine hydrochloride in a portable pump reservoirPharm Weekbl Sci19921423-6
Wohlford JGFowler MDVisual compatibility of hetastarch with injectable critical-care drugsAm J Hosp Pharm198946995-6
Wohlford JGClarification of visual compatibility of hetastarch and ranitidine hydrochlorideAm J Hosp Pharm1989461772
Wohlford JGWright JCMore information on the visual compatibility of hetastarch with injectable critical-care drugsAm J Hosp Pharm199047297-8
Dasta JFHale KNStauffer GLComparison of visual and turbidimetric methods for determining short-term compatibility of intravenous critical-care drugsAm J Hosp Pharm1988452361-6
Smith JAMorris ADuafala MEStability of floxuridine and leucovorin calcium admixtures for intraperitoneal administrationAm J Hosp Pharm198946985-9
Perrin JHPereira-Rosario RThe interaction of dobutamine hydrochloride and heparin sodium in parenteral fluidsDrug Dev Indust Pharm1988141617-22
Lesko ABSesin GPCeftizoxime stability in iv solutionsDICP, Ann Pharmacother617-618 (July-Aug) 198923615
Mitrano FPBaptista RJStability of cimetidine HCl and copper sulfate in a TPN solutionDICP, Ann Pharmacother198923429-30
Schilling CGWatson DMMcCoy HGStability and delivery of vancomycin hydrochloride when admixed in a total parenteral nutrition solutionJPEN J Parenter Enteral Nutr19891363-4
Strong DKHo WVisual compatibility of vancomycin and heparin in peritoneal dialysis solutionsAm J Hosp Pharm1989461832-3
Chilvers MRLysne JMVisual compatibility of ranitidine hydrochloride with commonly used critical-care medicationsAm J Hosp Pharm1989462057-8
Bullock LClark JHFitzgerald JFThe stability of amikacin, gentamicin, and tobramycin in total nutrient admixturesJPEN J Parenter Enteral Nutr198913505-9
Nahata MCStability of vancomycin hydrochloride in total parenteral nutrient solutionsAm J Hosp Pharm1989462055-7
Fox ASBoyer KMAntibiotic stability in a pediatric parenteral alimentation solutionJ Pediatr1988112813-7
Raymond GGReed MTTeagarden JRStability of procainamide hydrochloride in neutralized 5% dextrose injectionAm J Hosp Pharm1988452513-7
Zbrozek ASMarble DACompatibility and stability of cefazolin sodium, clindamycin phosphate, and gentamicin sulfate in two intravenous solutionsDrug Intell Clin Pharm198822873-5
Stewart CFHampton EMStability of cisplatin and etoposide in intravenous admixturesAm J Hosp Pharm1989461400-4
Shea BFPtachcinski RJO’Neill SStability of cyclosporine in 5% dextrose injectionAm J Hosp Pharm1989462053-5
Bullock LFitzgerald JFGlick MRStability of famotidine 20 and 40 mg/L and amino acids in total parenteral nutrient solutionsAm J Hosp Pharm1989462321-5
Bullock LFitzgerald JFStability of famotidine 20 and 50 mg/L in total nutrient admixturesAm J Hosp Pharm1989462326-9
Montoro JBPou LSalvador PStability of famotidine 20 and 40 mg/L in total nutrient admixturesAm J Hosp Pharm1989462329-32
DiStefano JEMitrano FPBaptista RJLong-term stability of famotidine 20 mg/L in a total parenteral nutrient solutionAm J Hosp Pharm1989462333-5
Lor ETakagi JVisual compatibility of foscarnet with other injectable drugsAm J Hosp Pharm199047157-9
Scott SMIncompatibility of cefoperazone and promethazineAm J Hosp Pharm199047519
Savitsky MEVisual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injectionAm J Hosp Pharm199047820-1
Smythe MAPatel MAVisual compatibility of narcotic analgesics with selected intravenous admixturesAm J Hosp Pharm199047819-20
Stewart CFFleming RACompatibility of cisplatin and fluorouracil in 0.9% sodium chloride injectionAm J Hosp Pharm1990471373-7
Lee CYMauro VFVisual and spectrophotometric determination of compatibility of alteplase and streptokinase with other injectable drugsAm J Hosp Pharm199047606-8
Gupta VDBethea CChemical stabilities of cefoperazone sodium and ceftazidime in 5% dextrose and 0.9% sodium chloride injectionsJ Clin Pharm Ther198813199-205
Gupta VDParasrampuria JChemical stabilities of famotidine and ranitidine hydrochloride in intravenous admixturesJ Clin Pharm Ther198813329-34
Gupta VDPramar YStability of acyclovir sodium in dextrose and sodium chloride injectionsJ Clin Pharm Ther198914451-6
Underberg WJMKoomen JMStability of famotidine in commonly used nutritional infusion fluidsJ Parenter Sci Technol19884294-7
Messerschmidt WPharmazeutische kompatibilitat von ceftazidim und metronidazolPharm Ztg199013536-8
Messerschmidt WKompatibilitat von ciprofloxacin und metronidazol in mischinfusionenPharm Ztg198813326
Murdoch JMGarner STCalcium gluconate compatibilityPharm J1989242634
Stoberski PZakrzewski ZBandanie stabilnosci furosemidu i soli sodowej hemibursztynianu hydrokortyzonu metoda RP-HPLC w wybranych plynach infuzyjnychFarm Pol198844398-401
Vecchio MWalker SEIazzetta JThe stability of morphine intravenous infusion solutionsCan J Hosp Pharm1988415-9
Fosun Pharma USA Inc. Calcitriol injection prescribing information. Princeton, NJ; 2023 May.
Gupta VDParasrampuria JBethea CStability of clindamycin phosphate in dextrose and saline solutionsCan J Hosp Pharm198942109-12
Walker SEIazzetta JLau DWCFamotidine stability in total parenteral nutrient solutionsCan J Hosp Pharm19894297-103
Walker SEDranitsaris GCeftazidime stability in normal saline and dextrose 5% in waterCan J Hosp Pharm19884165-71
Walker SEBirkhans BStability of intravenous vancomycinCan J Hosp Pharm198841233-8
Halpern NAColucci RDAlicea MVisual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injectionInt J Clin Pharmacol Ther Toxicol198927294-7
Allen LV JrStiles MLStability of fentanyl citrate in 0.9% sodium chloride solution in portable infusion pumpsAm J Hosp Pharm1990471572-4
Kowalski SRGourlay GKStability of fentanyl citrate in glass and plastic containers and in a patient-controlled delivery systemAm J Hosp Pharm1990471584-7
Schaaf LJRobinson DHVogel GJStability of esmolol hydrochloride in the presence of aminophylline, bretylium tosylate, heparin sodium, and procainamide hydrochlorideAm J Hosp Pharm1990471567-71
Rosenberg LSHostetler CKWagenknecht DMAn accurate prediction of the pH change due to degradation: correction for a “produced” secondary buffering systemPharm Res19885514-7
Hospira, Inc. Aminocaproic acid injection prescribing information. Lake Forest, IL; 2018 Jun.
American Regent, Inc. Aminocaproic acid injection prescribing information. Shirley, NY; 2020 May.
Hospira, Inc. Nipent^® (pentostatin for injection) prescribing information. Lake Forest, IL; 2019 Oct.
Marquardt EDVisual compatibility of tolazoline hydrochloride with various medications during simulated Y-site injectionAm J Hosp Pharm1990471802-3
Chandler SWFolstad JAztreonam-vancomycin incompatibilityAm J Hosp Pharm1990471970
Trissel LATramonte SMVisual compatibility of ondansetron hydrochloride with other selected drugs during simulated Y-site injectionAm J Hosp Pharm199148988-92
Leak REWoodford JDPharmaceutical development of ondansetron injectionEur J Cancer Clin Oncol198925Suppl 1S67-S69
Mackinnon JWCollin DTThe chemistry of ondansetronEur J Cancer Clin Oncol198925Suppl 1S61
Adria Laboratories. Idamycin—hospital formulary product information form. Columbus, OH; 1990 Oct 19
Allwood M, Stanley A, Wright P. The cytotoxics handbook. 4th ed. Oxford, England: Radcliffe Medical Press; 2002.
Genentech, Inc. Avastin^® (bevacizumab) injection prescribing information. South San Francisco, CA; 2019 Jun.
Sandoz Laboratories. Sandostatin—compatibility between octreotide in the infusion and the giving set/container. Basle, Switzerland; 1986 Apr 3
Bakri SJSnyder MRPulido JSSix-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezingRetina2006 May-Jun26519-22
Marchiarullo M. Stability of octreotide in various infusion supplies. East Hanover, NJ: Sandoz Pharmaceuticals Corporation; 1990 Mar 20
Beijnen JHBeijnen-Bandhoe AUDubbelman ACChemical and physical stability of etoposide and teniposide in commonly used infusion fluidsJ Parenter Sci Technol199145108-12
Santiero MLSagraves ROsmolality of small-volume i.v. admixtures for pediatric patientsAm J Hosp Pharm1990471359-64
Messerschmidt WKompatibilitat von cefuroxim mit metronidazoleKrankenhauspharmazie1987845-7
Rosen GHPotential incompatibility of insulin and octreotide in total parenteral nutrient solutionsAm J Hosp Pharm1989461128
McElnay JCElliott DSCartwright-Shamoon JStability of methotrexate and vinblastine in burette administration setsInt J Pharm198847239-47
Williams DA. Stability and compatibility of admixtures of antineoplastic drugs. In: Lokich JJ, ed. Cancer chemotherapy by infusion. 2nd ed. Chicago, IL: Precept Press; 1990:52-73
Baaske DMDeMay JFLatona CAStability of nicardipine hydrochloride in intravenous solutionsAm J Health-Syst Pharm1996531701-5
Trissel LAChandler SWVisual compatibility of amsacrine with selected drugs during simulated Y-site injectionAm J Hosp Pharm1990472525-8
Townsend RSIn vitro inactivation of gentamicin by ampicillinAm J Hosp Pharm1989462250-1
Vaughn LMSmall CIncompatibility of iron dextran and a total nutrient admixtureAm J Hosp Pharm1990471745-6
Cutie MRVerapamil precipitationAnn Intern Med198398672
Garner SSWiest DBCompatibility of drugs separated by a fluid barrier in a retrograde intravenous infusion systemAm J Hosp Pharm199047604-6
Lokich JAnderson NBern MCombined floxuridine and cisplatin in a 14-day infusionCancer1988622309-12
Anderson NLokich JBern MA phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusionCancer198963233-7
Lokich JAnderson NBern MEtoposide admixed with cisplatinCancer198963818-21
Lokich JBern MAnderson NCyclophosphamide, methotrexate, and 5-fluorouracil in a three-drug admixtureCancer198963822-4
Anderson NLokich JBern MCombined 5-fluorouracil and floxuridine administered as a 14-day infusionCancer198963825-7
Stiles MLTu YHStability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirsAm J Hosp Pharm1989461408-12
Martens HJDe Goede PNSorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containersAm J Hosp Pharm199047369-73
Baltz JKKennedy PMinor JRVisual compatibility of foscarnet with other injectable drugs during simulated Y-site administrationAm J Hosp Pharm1990472075-7
Walker SECoons CMatte DHydromorphone and morphine stability in portable infusion pump casettes and minibagsCan J Hosp Pharm198841177-82
Smythe MMalouf EVisual compatibility of insulin with secondary intravenous drugs in admixturesAm J Hosp Pharm199148125-6
Tu YHStiles MLStability of fentanyl citrate and bupivacaine hydrochloride in portable pump reservoirsAm J Hosp Pharm1990472037-40
Pugh CBPabis DJVisual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injectionAm J Hosp Pharm199148123-5
Pritts DHancock DIncompatibility of ceftriaxone with vancomycinAm J Hosp Pharm19914877
DeMuynck CDe Vroe CRemon JPBinding of drugs to end-line filters: a study of four commonly administered drugs in intensive care unitsJ Clin Pharm Ther198813335-40
Aki HSawai NYamamoto KStructural confirmation of ampicillin polymers formed in aqueous solutionPharm Res19918119-22
Bonhomme LPostaire ETouratier SChemical stability of lignocaine (lidocaine) and adrenaline (epinephrine) in pH-adjusted parenteral solutionsJ Clin Pharm Ther198813257-61
Lee DKTLee ACompatibility of cefoperazone sodium and furosemide in 5% dextrose injectionAm J Hosp Pharm199148108-10
Lee DKTWang DPCompatibility of cefoperazone sodium and cimetidine hydrochloride in 5% dextrose injectionAm J Hosp Pharm199148111-3
Kirkpatrick AEHolcome BJEffect of retrograde aminophylline administration on calcium and phosphate solubility in neonatal total parenteral nutrient solutionsAm J Hosp Pharm1989462496-500
Seay RBostrom BApparent compatibility of methotrexate and vancomycinAm J Hosp Pharm1990472656
Johnson OLWashington CDavis SSThe destabilization of parenteral feeding emulsions by heparinInt J Pharm198953237-40
Lor ESheybani TVisual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administrationAm J Hosp Pharm199148744-6
Tol AQuik RFPAdsorption of human and porcine insulins to intravenous administration setsPharm Weekbl [Sci]198810213-6
Thompson DFAllen LV JrVisual compatibility of enalaprilat with selected intravenous medications during simulated Y-site injectionAm J Hosp Pharm1990472530-1
Wilson TDForde MDStability of milrinone and epinephrine, atropine sulfate, lidocaine hydrochloride, or morphine sulfate injectionAm J Hosp Pharm1990472504-7
Lam NPKennedy PEJarosinski PFStability of zidovudine in 5% dextrose injection and 0.9% sodium chloride injectionAm J Hosp Pharm199148280-2
Horrow JCDigregorio GJBarbieri EJIntravenous infusions of nitroprusside, dobutamine, and nitroglycerin are compatibleCrit Care Med199018858-61
Halstead DCGuzzo JGiardina JAIn vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluidsAntimicrob Agents Chemother1989331553-6
Drake JMMyre SAStaneck JLAntimicrobial activity of vancomycin, gentamicin, and tobramycin in peritoneal dialysis solutionAm J Hosp Pharm1990471604-6
Pavlik EJvan Nagell JRHanson MBSensitivity to anticancer agents in vitro: standardizing the cytotoxic response and characterizing the sensitivities of a reference cell lineGynecol Oncol198214243-61
Pavlik EJKenady DEvan Nagell JRProperties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivityCancer Chemother Pharmacol1983118-15
Gora MLSeth SVisconti JAStability of dobutamine hydrochloride in peritoneal dialysis solutionsAm J Hosp Pharm1991481234-7
Strom JG JrMiller SWStability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injectionAm J Hosp Pharm1991481237-41
Riley CMJunkin PStability of amrinone and digoxin, procainamide hydrochloride, propranolol hydrochloride, sodium bicarbonate, potassium chloride, or verapamil hydrochloride in intravenous admixturesAm J Hosp Pharm1991481245-52
Pennell ATAllington DREffect of ceftazidime, cefotaxime, and cefoperazone on serum tobramycin concentrationsAm J Hosp Pharm199148520-2
Collins JLLutz RJIn vitro study of simultaneous infusion of incompatible drugs in multilumen cathetersHeart Lung199120271-7
Gupta VDComplexation of procainamide with dextroseJ Pharm Sci198271994-6
Gupta VDComplexation of procainamide with hydroxide-containing compoundsJ Pharm Sci198372205-7
Parasrampuria JGupta VDPreformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stabilityJ Pharm Sci198978855-7
Frazin BSMaximal dilution of activaseAm J Hosp Pharm1990471016
Tripp MGAutomated 3-in-1 admixture compounding: a comparative study of simultaneous versus sequential pumping of core substrates on admixture stabilityHosp Pharm1990251090-3
Knowles JBCusson GSmith MPulmonary deposition of calcium phosphate crystals as a complication of home total parenteral nutritionJPEN J Parenter Enteral Nutr198913209-13
Knight PJBuchanan SCalcium and phosphate requirements of preterm infants who require prolonged hyperalimentationJ Am Med Assoc19802431244-6
Stennett DJGerwick WHEgging PKPrecipitate analysis from an indwelling total parenteral nutrition catheterJPEN J Parenter Enteral Nutr19881288-92
Mazur HIStennett DJ, Egging PKExtraction of diethylhexylphthalate from total nutrient solution-containing polyvinyl chloride bagsJPEN J Parenter Enteral Nutr19891359-62
Smith JLCanham JEKirkland WDEffect of Intralipid, amino acids, container, temperature, and duration of storage on vitamin stability in total parenteral nutrition admixturesJPEN J Parenter Enteral Nutr198812478-83
Tripp MGMenon SKStability of total nutrient admixtures in a dual-chamber flexible containerAm J Hosp Pharm1990472496-503
Dalton-Bunnow MFHalvacks FJUpdate on room-temperature stability of drug products labeled for refrigerated storageAm J Hosp Pharm1990472522-4
Kintzel PEKennedy PEStability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous lineAm J Hosp Pharm199148283-5
Rice JKVisual compatibility of amphotericin B and flush solutionsAm J Hosp Pharm1989462461
Trissel LABready BBKwan JWThe visual compatibility of sargramostim with selected chemotherapeutic drugs, anti-infectives, and other drugs during simulated Y-site injectionAm J Hosp Pharm199249402-6
Fresenius Kabi USA, LLC. Fluphenazine hydrochloride prescribing information. Lake Zurich, IL; 2016 Nov.
Irving HDBurbridge BEIncompatibility of contrast agents with intravascular medicationsRadiology198917391-2
Trissel LAParks NPTVisual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injectionAm J Hosp Pharm1991482186-9
Tidy PJSewell GJJeffries TMMicrowave freeze-thaw studies on azlocillin infusionPharm J1988241R22-R23
Koberda MZieske PARaghavan NVStability of bleomycin sulfate reconstituted in 5% dextrose injection or 0.9% sodium chloride injection stored in glass vials or polyvinyl chloride containersAm J Hosp Pharm1990472528-9
Datapharm Publications Ltd. ABPI compendium of data sheets and summaries of product characteristics 1999/2000. London, England; 1999
Weir SJSzucs Myers VABengston KDSorption of amiodarone to polyvinyl chloride infusion bags and administration setsAm J Hosp Pharm1985422679-83
Benedict MKRoche VFBanakar UVVisual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injectionAm J Hosp Pharm1988451117-8
Capps PARobertson ALInfluence of amiodarone injection on delivery rate of intravenous fluidsPharm J198523414-5
Tsuei SENation RLSorption of chlormethiazole by intravenous infusion giving setsEur J Clin Pharmacol198018333-8
Lingam SBertwistle HElliston HMProblems with intravenous chlormethiazole (Heminevrin) in status epilepticusBr Med J1980280155-6
Beaumont IMStability study of aqueous solutions of diamorphine and morphine using HPLCPharm J198222939-41
Kleinberg MLDuafala MENacov CStability of heroin hydrochloride in infusion devices and containers for intravenous administrationAm J Hosp Pharm199047377-81
Jones VAHanks GWNew portable infusion pump for prolonged subcutaneous administration of opiod analgesics in patients with advanced cancerBMJ19862921496
Jones VA, Hoskin PJ, Omar OA, et al. Diamorphine stability in aqueous solution for subcutaneous infusion. Abs Br Soc Pharmacol Meet. 1986; 66(Dec)
Omar OAHoskin PJJohnston ADiamorphine stability in aqueous solution for subcutaneous infusionJ Pharm Pharmacol198941275-7
Al-Razzak LABenedetti AEWaugh WNChemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressive agentPharm Res19907452-60
Allwood MCDiamorphine mixed with antiemetic drugs in plastic syringesBr J Pharm Prac1984688-90
Regnard CPashley SAnti-emetic/diamorphine mixture compatibility in infusion pumpsBr J Pharm Pract19868218-20
Collins AJAbathell JAHolmes SGStability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administrationJ Pharm Pharmacol198638S51P
Page JHudson SADiamorphine hydrochloride compatibility with salinePharm J1982228238-9
Kirk BHain WRDiamorphine injection BP incompatibilityPharm J1985235171
Jones VMurphy ASolubility of diamorphinePharm J1985235426
Wood MJIrwin WJ, Scott DKStability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibagsJ Clin Pharm Ther199015279-89
Targett PLKeefe PAStability of two concentrations of morphine tartrate in 10 mL polypropylene syringesAust J Hosp Pharm199727452-4
Keusters LStolk LMLUmans RStability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20 °C and thawing by microwave radiationPharm Weekbl [Sci]19868194-7
Wood MJIrwin WJPhotodegradation of doxorubicin, daunorubicin, and epirubicin measured by high-performance liquid chromatographyJ Clin Pharm Ther199035291-300
Lee MGFenton-May VAbsorption of isosorbide dinitrate by PVC infusion bags and administration setsJ Clin Hosp Pharm19816209-11
DeMuynck CRemon JPColardyn FThe sorption of isosorbide dinitrate to intravenous delivery systemsJ Pharm Pharmacol198840601-4
Struhar MMandak MHeinrich JSorption of isosorbide dinitrate on infusion setsFarm Obz198958443-6
Allwood MCSorption of parenteral nitrates during administration with a syringe pump and extension setInt J Pharm198739183-6
Wilson TDForde isoMDCrain AVRStability of milrinone in 0.45% sodium chloride, 0.9% sodium chloride, or 5% dextrose injectionsAm J Hosp Pharm1986432218-20
Cook BHill SAThe stability of amoxycillin sodium in intravenous infusion fluidsJ Clin Hosp Pharm19827245-50
Concannon JLovitt HRamage MStability of aqueous solutions of amoxicillin sodium in the frozen and liquid statesAm J Hosp Pharm1986433027-30
McDonald CSunderland VBLau HThe stability of amoxicillin sodium in normal saline and glucose (5%) solutions in the liquid and frozen statesJ Clin Pharm Ther19891445-52
McDonald CSunderland VBMarshall CAFreezing rates of 50-mL infusion bags and some implications for drug stability as shown with amoxycillinAust J Hosp Pharm198919194-7
Janknegt RSchrouff GGMHooymans PMQuinolones and penicillins incompatibilityDICP, Ann Pharmacother19892391-2
Ashwin JLynn BStability and administration of intravenous AugmentinPharm J1987238116-8
Lynn BThe stability and administration of intravenous penicillinsBr J IV Ther1981222-39
Landersjo LKallstrand GStudies on the stability and compatibility of drugs in infusion fluids III. Factors affecting the stability of cloxacillinActa Pharm Suec197411563-80
Bundgaard HIlver KKinetics of degradation of cloxacillin sodium in aqueous solutionDansk Tidsskr Farm197044365-80
Brown AFHarvey DAHoddinott DJFreeze-thaw stability of antibiotics used in an IV additive serviceBr J Parenter Ther1986742-4
Beatson CTaylor AA physical compatibility study of frusemide and flucloxacillin injectionsBr J Pharm Pract19879223-6
Nahata MCAhalt PAStability of cefazolin sodium in peritoneal dialysis solutionsAm J Hosp Pharm199148291-2
Paap CMNahata MCStability of cefotaxime in two peritoneal dialysis solutionsAm J Hosp Pharm199047147-50
Mehta ACMcCarty MThe chemical stability of cephradine injection solutionsIntensive Ther Clin Monit19889195-6
Lyall DBlythe JCiprofloxacin lactate infusionPharm J1987238290
Veljkovic VBLazic MLStability of bottled dextran solutions with respect to insoluble particle formations: a reviewPharmazie198944305-10
Veljkovic VBLazic MLMechanism of insoluble particle formation in bottled dextran solutionsPharmazie198843840-2
Shea BFSouney PFStability of famotidine frozen in polypropylene syringesAm J Hosp Pharm1990472073-4
Bullock LSFitzgerald JFStability of intravenous famotidine stored in polyvinyl-chloride syringesDICP, Ann Pharmacother198923588-90
Thomas SMBStability of Intralipid in a parenteral nutrition solutionAust J Hosp Pharm198717115-7
Stiles MLAllen LV JrStability of fluorouracil administered through four portable infusion pumpsAm J Hosp Pharm1989462036-40
Tu YHStiles MLAllen LV JrStability study of gentamicin sulfate administered via Pharmacia Deltec CADD-VT pumpHosp Pharm199025843-5
Parkinson RWilson JVRoss MStability of low-dosage heparin in pre-filled syringesBr J Pharm Pract19891134
Menzies ARBenoliel DMThe effects of autoclaving on the physical properties and biological activity of parenteral heparin preparationsJ Pharm Pharmacol198941512-6
Farmitalia Carlo Erba. Stability of 4-demethoxydaunorubicin hydrochloride reconstituted solutions with water for injections, sodium chloride, dextrose, and sodium chloride with dextrose injections. Milan, Italy; 1986 Jun
Radford JAMargison JMSwindell RThe stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pumpCancer Chemother Pharmacol199026144-6
Shaw ICRose JWPInfusion of ifosfamide plus mesnaLancet198411353-4
Bristol-Myers Oncology. Product information on IFEX (ifosfamide). Evansville, IN; 1990 Feb
Doglietto GBBellantone RBossola MInsulin adsorption to three-liter ethylen vinyl acetate bags during 24-hour infusionJPEN J Parenter Enteral Nutr198913539-41
Donnelly RFImmune globulin solubility in 5% dextrose injectionAm J Hosp Pharm1990471976
Prouix SMReconstitution of intravenous immunoglobulinsHosp Pharm1987221133-4
Denson DDCrews JCGrummich KWStability of methadone hydrochloride in 0.9% sodium chloride injection in single-dose plastic containersAm J Hosp Pharm199148515-7
Anderson BDTaphouse VInitial rate studies of hydrolysis and acyl migration in methylprednisolone 21-hemisuccinate and 17-hemisuccinateJ Pharm Sci198170181-6
USP. Amifostine for Injection Monograph. In: USP-NF. Rockville, MD: USP; May 1, 2022. DOI: https://doi.org/10.31003/USPNF_M2603_05_01.
Beijnen JHvan Gijn RChemical stability of the antitumor drug mitomycin C in solutions for intravesical installationJ Parenter Sci Technol199044332-5
Duafala MEKleinberg MLNacov CStability of morphine sulfate in infusion devices and containers for intravenous administrationAm J Hosp Pharm199047143-6
Walker SEIazetta JStability of sulfite free high potency morphine sulfate solutions in portable infusion pump casettesCan J Hosp Pharm (Oct) 198942195-200, 218-9
Altman LHopkins RJAhmed SStability of morphine sulfate in Cormed III (Kalex) intravenous bagsAm J Hosp Pharm1990472040-2
Stiles MLTu YHStability of morphine sulfate in portable pump reservoirs during storage and simulated administrationAm J Hosp Pharm1989461404-7
Caute BMonsarrat BLazorthes YThe stability of morphine in isobaric and hyperbaric solutions in a drug delivery systemJ Pharm Pharmacol198840644-5
Martens HJStabilitat wasserloslicher vitamine in verschiedenen infusionsbentelnKrankenhauspharmazie198910359-61
Tracy TSBowman LNitroglycerin delivery through a polyethylene-lined intravenous administration setAm J Hosp Pharm1989462031-5
Loucas SPMaager PMehl BEffect of vehicle ionic strength on sorption on nitroglycerin to a polyvinyl chloride administration setAm J Hosp Pharm1990471559-62
DeRudder DRemon JPThe sorption of nitroglycerin by infusion setsJ Pharm Pharmacol198739556-8
Jarosinski PFHirschfield SPrecipitation of ondansetron in alkaline solutionsN Engl J Med19913251315-6
Markowsky SJKohls PREhresman DCompatibility and pH variability of four injectable phenytoin sodium productsAm J Hosp Pharm199148510-4
Hikma Pharmaceuticals USA Inc. Phenergan^® injection (promethazine hydrochloride injection) prescribing information. Berkeley Heights, NJ; 2020 May.
XGen Pharmaceuticals DJB, Inc. Promethazine hydrochloride injection prescribing information. Big Flats, NY; 2023 Dec.
Thibault LStreptokinase flocculation in evacuated glass bottlesAm J Hosp Pharm198542278
Lerebours E, Ducable G, Francheschi A, et al. Catheter obstruction during prolonged parenteral alimentation. Are lipids responsible? Clin Nutr. 1985; 4:135-8
Den Hartigh JBrandenburg HCRStability of azacitidine in lactated Ringer’s injection frozen in polypropylene syringesAm J Hosp Pharm1989462500-5
Waugh WNTrissel LAStability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containersAm J Hosp Pharm1991481520-4
Strong DKMorris LAPrecipitation of teniposide during infusionAm J Hosp Pharm199047512
Outman WRMitrano FPVisual compatibility of ganciclovir sodium and total parenteral nutrient solution during simulated Y-site injectionAm J Hosp Pharm1991481538-9
Outman WRMonolakis JVisual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injectionAm J Hosp Pharm1991481539-41
Neels JTCompatibility of hydromorphone hydrochloride and tetracaine hydrochlorideAm J Hosp Pharm1991481682-83
Turowski RCDurthaler JMVisual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injectionAm J Hosp Pharm1991482181-4
Woloschuk DMMWermeling JRStability and compatibility of fluorouracil and mannitol during simulated Y-site administrationAm J Hosp Pharm1991482158-60
Ishisaka DYvan Fleet JVisual compatibility of indomethacin sodium trihydrate with drugs given to neonates by continuous infusionAm J Hosp Pharm1991482442-3
Trissel LABready BBTurbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injectionAm J Hosp Pharm1992491716-9
DiStefano JEOutman WRAdditional data on visual compatibility of foscarnet sodium with morphine sulfateAm J Hosp Pharm1992491672
Zanetti LAVisual compatibility of diltiazem with commonly used injectable drugs during simulated Y-site administrationAm J Hosp Pharm1992491911
Martin KM. (Product Information Services, Lederle Laboratories, Pearl River, NY): Personal communication; 1992 Jan 14
Walker SEDeAngelis CStability and compatibility of combinations of hydromorphone and a second drugCan J Hosp Pharm199144289-95
Raineri DLCwik MJRodvold KAStability of nizatidine in commonly used intravenous fluids and containersAm J Hosp Pharm1988451523-9
Hatton JHolstad SGRosenbloom ADStability of nizatidine in total nutrient admixturesAm J Hosp Pharm1991481507-10
Wade CSLampasona VMullins REStability of ceftazidime and amino acids in parenteral nutrient solutionsAm J Hosp Pharm1991481515-9
Patel JPTran LTSinai WJActivity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringesAm J Hosp Pharm1991481511-4
Kintzel PEKennedy PEStability of amphotericin B in 5% dextrose injection at 25 °CAm J Hosp Pharm1991481681
Stiles MLAllen LVStability of doxorubicin hydrochloride in portable pump reservoirsAm J Hosp Pharm1991481976-7
Sarkar MARogers EReinhard MStability of clindamycin phosphate, ranitidine hydrochloride, and piperacillin sodium in polyolefin containersAm J Hosp Pharm1991482184-6
Ritchie DJHolstad SGWestrich TJActivity of octreotide acetate in a total nutrient admixtureAm J Hosp Pharm1991482172-5
Goodwin SDNix DEHeyd ACompatibility of ciprofloxacin injection with selected drugs and solutionsAm J Hosp Pharm1991482166-71
Walker SEDeAngelis CIazzetta JCompatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochlorideAm J Hosp Pharm1991482161-6
Harkness BJWilliams DStewart MCChange needed for i.v. rifampin preparation instructionsAm J Hosp Pharm1991482127-8
Wiest DBMaish WAGarner SSStability of amphotericin B in four concentrations of dextrose injectionAm J Hosp Pharm1991482430-3
Silvestri APMitrano FPBaptista RJStability and compatibility of ganciclovir sodium in 5% dextrose injection over 35 daysAm J Hosp Pharm1991482641-3
Mitrano FPOutman WRBaptista RJChemical and visual stability of amphotericin B in 5% dextrose injection stored at 4 °C for 35 daysAm J Hosp Pharm1991482635-7
Rivers TEMcBride HAStability of cefotaxime sodium and metronidazole in an i.v. admixture at 8 °CAm J Hosp Pharm1991482638-40
Rochard EBBarthes DMCStability of fluorouracil, cytarabine, or doxorubicin hydrochloride in ethylene vinyl acetate portable infusion-pump reservoirsAm J Hosp Pharm199249619-23
Letourneau MMilot LVisual compatibility of magnesium sulfate with narcotic analgesicsAm J Hosp Pharm199249838-9
Thompson DFHeflin NRIncompatibility of injectable indomethacin with gentamicin sulfate or tobramycin sulfateAm J Hosp Pharm199249836
Munoz MGirona VPujol MStability of ifosfamide in 0.9% sodium chloride solution or water for injection in a portable i.v. pump cassetteAm J Hosp Pharm1992491137-9
Anderson PMRogosheske JRRamsay NKCBiological activity of recombinant interleukin-2 in intravenous admixtures containing antibiotic, morphine sulfate, or total parenteral nutrient solutionAm J Hosp Pharm199249608-12
Stiles MLAllen LVStability of ondansetron hydrochloride in portable infusion-pump reservoirsAm J Hosp Pharm1992491471-3
Couch PJacobson PStability of fluconazole and amino acids in parenteral nutrient solutionsAm J Hosp Pharm1992491459-62
McDonald CFaridahSolubilities of trimethoprim and sulfamethoxazole at various pH values and crystallization of trimethoprim from infusion fluidsJ Parenter Sci Technol199145147-51
Trissel LAMartinez JFTurbidimetric assessment of the compatibility of taxol with 42 drugs during simulated Y-site injectionAm J Hosp Pharm199350300-4
Trissel LAMartinez JFPhysical compatibility of melphalan with selected drugs during simulated Y-site administrationAm J Hosp Pharm1993502359-63
Trissel LAMartinez JFVisual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injectionAm J Hosp Pharm199451495-9
Pearson SDTrissel LAStability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at various temperaturesAm J Hosp Pharm199350698-702
Graham CLDukes GEKao CFStability of ondansetron in large-volume parenteral solutionsAnn Pharmacother199226768-71
Halasi SNairn JGStability of hydralazine hydrochloride in parenteral solutionsCan J Hosp Pharm199043237-41
Speaker TJTurco SJNardone DAA study of the interaction of selected drugs and plastic syringesJ Parenter Sci Technol199145212-7
Hospira, Inc. Aminophylline injection prescribing information. Lake Forest, IL; 2018 Mar.
Adams PSHaines-Nutt RFBradford EPharmaceutical aspects of home infusion therapy for cancer patientsPharm J1987238476-8
Barnes ARChemical stabilities of cefuroxime sodium and metronidazole in an admixture for intravenous infusionJ Clin Pharm Ther199015187-96
Weir PJIreland DSChemical stability of cytarabine and vinblastine injectionsBr J Pharm Pract(Feb) 19901253, 54, 60
Vincke BJVerstraeten AEEl Eini DIDExtended stability of 5-fluorouracil and methotrexate solutions in PVC containersInt J Pharm198954181-9
Stevens RFWilkins KMUse of cytotoxic drugs with an end-line filter—a study of four drugs commonly administered to paediatric patientsJ Clin Pharm Ther198914475-9
Garner STMurdoch JMDopamine dilutionsPharm J1990244218
Schroder FSchutz HKompatibilitat von heparin und gentamicin sulfatPharm Ztg198913424-6
Adams PSHaines-Nutt RFThe stability of aminophylline intravenous infusion solutionsProc Guild19882541-4
Schaaf LJTremel LCWulf BGCompatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride, and nitroprussideJ Clin Pharm Ther199015371-6
Kern JWLee KJMartinoff JTThe in vivo availability of gentamicin when admixed with total nutrient solutions: a comparative studyJPEN J Parenter Enteral Nutr199014523-6
Montoro JBGalard RCatalan RStability of somatostatin in total parenteral nutritionPharm Weekbl [Sci]199012240-2
Sauer HAufbewahrung von zytostatika-losungenKrankenhauspharmazie199011373-5
Shea BFSouney PFStability of famotidine in a 3-in-1 total nutrient admixtureDICP199024232-5
De Vroe CDe Muynck CRemon JPA study on the stability of three antineoplastic drugs and on their sorption by i.v. delivery systems and end-line filtersInt J Pharm19906549-56
Raymond GGDavis RLPhysical compatibility and chemical stability of amphotericin B in combination with magnesium sulfate in 5% dextrose injectionDICP199125123-6
Pramar YGupta VDGardner SNStabilities of dobutamine, dopamine, nitroglycerin, and sodium nitroprusside in disposable plastic syringesJ Clin Pharm Ther199116203-7
Stewart JTWarren FWJohnson SMStability of ceftazidime in plastic syringes and glass vials under various storage conditionsAm J Hosp Pharm1992492765-8
Stiles MLAllen LV JrStability of ceftazidime (with arginine) and cefuroxime sodium in infusion-pump reservoirsAm J Hosp Pharm1992492761-4
Kaufman MBScavone JMStability of undiluted trimethoprim-sulfamethoxazole for injection in plastic syringesAm J Hosp Pharm1992492782-3
Nahata MCMorosco RSStability of morphine sulfate in bacteriostatic 0.9% sodium chloride injection stored in glass vials at two temperaturesAm J Hosp Pharm1992492785-6
Nahata MCMorosco RSStability of ceftazidime (with arginine) stored in plastic syringes at three temperaturesAm J Hosp Pharm1992492954-6
Mawhinney WMAdair CGGorman SPStability of ciprofloxacin in peritoneal dialysis solutionsAm J Hosp Pharm1992492956-9
Nahata MCMorosco RSStability of aminophylline in bacteriostatic water for injection stored in plastic syringes at two temperaturesAm J Hosp Pharm1992492962-3
Allwood MCThe influence of buffering on the stability of erythromycin injection in small-volume infusionsInt J Pharm199280R7-R9
Toki NGlass adsorption of highly purified urokinaseThromb Haemost19804367
Zimmerman RSchoffel GUrokinase therapy: dose reduction by administration in plastic materialThromb Haemost198145296
Walker SEIazzetta JCompatibility and stability of pentobarbital infusionsAnesthesiology198155487-9
Walker SEIazzetta JCefotetan stability in normal saline and five percent dextrose in waterCan J Hosp Pharm(1) 1992459-13, 37
Nahata MCStability of ceftriaxone sodium in peritoneal dialysis solutionsDICP199125741-2
Walker SELau DWCDeAngelis CMitoxantrone stability in syringes and glass vials and evaluation of chemical contaminationCan J Hosp Pharm199144143-51
Walker SLau DDeAngelis CDoxorubicin stability in syringes and glass vials and evaluation of chemical contaminationCan J Hosp Pharm19914471-78
Peterson GMKhoo BHCGalloway JGA preliminary study of the stability of midazolam in polypropylene syringesAust J Hosp Pharm199121115-8
Lecompte DBousselet MGayrard DStability study of reconstituted and diluted solutions of calcium folinatePharm Ind19915390-4
Allwood MCThe stability of erythromycin injection in small-volume infusionsInt J Pharm199062R1-R3
Gupta VDPramar YOdom CChemical stability of cefotetan disodium in 5% dextrose and 0.9% sodium chloride injectionsJ Clin Pharm Ther199015109-14
Poggi GLCompatibility of morphine tartrate admixtures in polypropylene syringesAust J Hosp Pharm199121316
McLaughlin JPSimpson CThe stability of reconstituted aztreonamBr J Pharm Pract(Oct) 199012328, 330, 334
Biejnen JHvan Gijn RHorenblas SChemical stability of suramin in commonly used infusion fluidsDICP1990241056-8
Patel JPUrokinase: stability studies in solution and lyophilized formulationsDrug Dev Ind Pharm1990162613-26
Driver AGWorden JP JrIntravenous streptomycinDICP199024826-8
Bosso JAClindamycin stabilityDICP1990241008-9
Theuer HScherbel GDistler FCisplatin-injektionslosungKrankenhauspharmazie199011288-91
Bluhm DPSummers RSLowes MMJInfluence of container on vitamin A stability in TPN admixturesInt J Pharm199168281-3
Bluhm DPSummers RSLowes MMJLipid emulsion content and vitamin A stability in TPN admixturesInt J Pharm199168277-80
Beijnen JKoks CHWVisual compatibility of ondansetron and dexamethasoneDICP199125869
Lawson WALongmore RBMcDonald CStability of hyoscine in mixtures with morphine for continuous subcutaneous administrationAust J Hosp Pharm199121395-6
Allwood MCThe stability of four catecholamines in 5% glucose infusionsJ Clin Pharm Ther199116337-40
Van Asten PGlerum JHSpaanderman ERCompatibility of bupivacaine and iohexol in two mixtures for paediatric regional anaesthesiaPharm Weekbl Sci199113254-6
Sewell GJPalmer AJThe chemical and physical stability of three intravenous infusions subjected to frozen storage and microwave thawingInt J Pharm19917257-63
Janknegt RStratermans TCilissen JOfloxacin intravenous—compatibility with other antibacterial agentsPharm Weekbl Sci199113207-9
Dunham BMarcuard SKhazanie PGThe solubility of calcium and phosphorus in neonatal total parenteral nutrition solutionsJPEN J Parenter Enteral Nutr199115608-11
Delaney RAMikkelsen SLEffects of heat treatment on selected plasma therapeutic drug concentrationsAnn Pharmacother199226338-40
McLeod HLMcGuire TRStability of cyclosporine in dextrose 5%, NaCl 0.9%, dextrose/amino acid solution, and lipid emulsionAnn Pharmacother199226172-5
Andreu ACardona DPastor CIntravenous aminophylline: in vitro stability in fat-containing TPNAnn Pharmacother199226127-8
Matsuura GVisual compatibility of sargramostim (GM-CSF) during simulated Y-site administration with selected agentsHosp Pharm(Mar) 199227200, 202, 209
De Muynck CColardyn FRemon JPInfluence of intravenous administration set composition on the sorption of isosorbide dinitrateJ Pharm Pharmacol199143601-4
Bullock LFitzgerald JF, Walter WVEmulsion stability in total nutrient admixtures containing a pediatric amino acid formulationJPEN J Parenter Enteral Nutr19921664-8
Olbrich AWeichmacher als problematische bestandteile von mischinfusionenKrankenhauspharmazie199112192-4
Cano SMMontoro JBPastor CStability of cimetidine in total parenteral nutritionJ Clin Nutr Gastroenter1987240-3
Loeppky CTarka ECompatibility of cephalosporins and aminoglycosides in peritoneal dialysis fluidPerit Dial Bull19833128-9
Bhatt-Mehta VRosen DAKing RSStability of midazolam hydrochloride in parenteral nutrient solutionsAm J Hosp Pharm199350285-8
Jacobson PAMaksym CJLandvay ACompatibility of cyclosporine with fat emulsionAm J Hosp Pharm199350687-90
Johnson CEJacobson PAPillen HAStability and compatibility of fluconazole and aminophylline in intravenous admixturesAm J Hosp Pharm199350703-6
Allen LV JrStiles MLWang DPStability of bupivacaine hydrochloride, epinephrine hydrochloride, and fentanyl citrate in portable infusion-pump reservoirsAm J Hosp Pharm199350714-5
Percy LARho JPVisual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injectionAm J Hosp Pharm199350715-6
Nieforth KAShea BFSouney PFStability of cyclosporine with magnesium sulfate in 5% dextrose injectionAm J Hosp Pharm199350470-2
Min DIBrown TVisual compatibility of tacrolimus with commonly used drugs during simulated Y-site injectionAm J Hosp Pharm1992492964-6
Dine TLuyckx MCazin JCStability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bagsInt J Pharm199177279-85
Fresenium Kabi USA, LLC. Glycopyrrolate injection prescribing information. Lake Zurich, IL; 2020 Sep.
Mitra AKNarurkar MMKinetics of azathioprine degradation in aqueous solutionInt J Pharm198635165-71
Snyder RLFilter clogging caused by albumin in i.v. nutrient solutionAm J Hosp Pharm19935063-4
Feldman FBergman GFilter clogging caused by albumin in i.v. nutrient solutionAm J Hosp Pharm19935064
Bornstein MKao SHMercorelli MStability of an ofloxacin injection in various infusion fluidsAm J Hosp Pharm1992492756-60
Heni JRekonstituierte ganciclovirlosungKrankenhauspharmazie199112342-4
Theuer HScherbel GStabilitatsuntersuchungen von fentanylcitrat i.v.Krankenhauspharmazie199112233-45
Burger DM, Brandjes DP, Koks CH, et al. Heparine in het heparineslot? Pharm Weekbl. 1991; 126:624-7
Witmer DRHeparin lock flush solution versus 0.9% sodium chloride injection for maintaining patencyAm J Hosp Pharm199350241
Weber DR. Is heparin really necessary in the lock and, if so, how much? DICP. 1991; 25:399-407
Bosso JAPrince RAStability of ondansetron hydrochloride in injectable solutions at -20, 5, and 25 °CAm J Hosp Pharm1992492223-5
Parasrampuria JLi LCStelmach AHStability of ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection over 35 daysAm J Hosp Pharm199249116-8
Guo-jie JLCompatibility of bumetanide injection and dextrose injectionYaoxue Tongbao19892486-7
Buck GWWolfe KRInteraction of sodium ascorbate with stainless steel particulate-filter needlesAm J Hosp Pharm1991481191
Floy BJRoyko CGCompatibility of ketorolac tromethamine injection with common infusion fluids and administration setsAm J Hosp Pharm1990471097-100
Zieske PAKoberda MHines JLCharacterization of cisplatin degradation as affected by pH and lightAm J Hosp Pharm1991481500-6
Tu YHKnox NLBiringer JMCompatibility of iron dextran with total nutrient admixturesAm J Hosp Pharm1992492233-5
Rivers TEMcBride HA, Trang JMStability of cefazolin sodium and metronidazole at 8 °C for use as an i.v. admixtureJ Parenter Sci Technol199347135-7
Helbock HJMotchnik PAToxic hydroperoxides in intravenous lipid emulsions used in preterm infantsPediatrics19939183-7
Washington CSizer TStability of TPN mixtures compounded from Lipofundin S and Aminoplex amino-acid solutions: comparison of laser diffraction and Coulter counter droplet size analysisInt J Pharm199283227-31
Mason NAJohnson CEStability of ceftazidime and tobramycin sulfate in peritoneal dialysis solutionAm J Hosp Pharm1992491139-42
Brawley VBhatia JHydrogen peroxide generation in a model paediatric parenteral amino acid solutionClin Sci199385709-12
Mawhinney WMAdair CGGorman SPStability of vancomycin hydrochloride in peritoneal dialysis solutionAm J Hosp Pharm199249137-9
Cervenka PDeJong DJButler BLVisual compatibility of injectable ciprofloxacin lactate with selected injectable drugs during simulated Y-site administrationHosp Pharm(Nov) 199227957-8, 961-2
Garrelts JCLaRocca JAst DComparison of heparin and 0.9% sodium chloride injection in the maintenance of indwelling intermittent i.v. devicesClin Pharm1989834-9
Lewis JSJustification for use of 1.2 micron end-line filters on total nutrient admixturesHosp Pharm199328656-8
Benvenuto JA, Adams SC, Vyas HM, et al. Pharmaceutical issues in infusion chemotherapy stability and compatibility. In: Lokich JJ, ed. Cancer chemotherapy by infusion. Chicago, IL: Precept Press; 1987:100-13
Briceland LLFudin JEvaluation of microbial growth in select inoculated antineoplastic solutionsHosp Pharm199025338-40
Neels JTCompatibility of bupivacaine hydrochloride with hydromorphone hydrochloride or morphine sulfateAm J Hosp Pharm1992492149
Hauser ARTrissel LAOndansetron compatible with sodium acetateJ Clin Oncol199311197
Pecosky DAParasrampuria JLi LCStability and sorption of calcitriol in plastic tuberculin syringesAm J Hosp Pharm1992491463-6
Gregory REdwards SDemonstration of insulin transformation products in insulin vials by high-performance liquid chromatographyDiabetes Care19911442-8
Seres DSInsulin adsorption to parenteral infusion systems: case report and review of the literatureNutr Clin Pract19905111-7
Lazorova LHaronikova KStudium sorpcie inzulinu v priebehu infuznej terapieFarm Obz199059157-64
Stolk LMLChandi LSStabiliteit van fluorouracil (0,55 mg) in polypropyleen spuiten bij -20 °CZiekenhuisfarmacie1991712-3
de Vogel EMHendrikx MMPvan Dellen RTAdsorptie van sufentanil aan bacteriefiltersZiekenhuisfarmacie1991765-70
Hehenberger HFettemulsionen kompatibilitat wahrend der bypass-infusionKrankenhauspharmazie198910513-8
Carstens GCalcium-folinat uberlegungen zur stabilitat und zum einsatz verschiedener zubereitungenKrankenhauspharmazie198910478-82
Washington CThe stability of intravenous fat emulsions in total parenteral nutrition mixturesInt J Pharm1990661-21
Allwood MCBrown PWThe effect of buffering on the stability of reconstituted benzylpenicillin injectionInt J Pharm Pract19921242-4
Allwood MCThe stability of diamorphine alone and in combination with anti-emetics in plastic syringesPalliative Med19915330-3
ViiV Healthcare. Retrovir^® (zidovudine) capsules, oral solution, and injection prescribing information. Durham, NC; 2023 Jun.
Jahns BEBakst CMExtension of expiration time for lorazepam injection at room temperatureAm J Hosp Pharm1993501134
Trissel LAMartinez JFIdarubicin hydrochloride turbidity versus incompatibilityAm J Hosp Pharm1993501134
Hunt-Fugate AKHennessey CKStability of fluconazole injectable solutionsAm J Hosp Pharm1993501186-7
Inagaki KTakagi JLor EStability of fluconazole in commonly used intravenous antibiotic solutionsAm J Hosp Pharm1993501206-8
Liao EFox JLInline filtration of ondansetron hydrochloride during simulated i.v. administrationAm J Hosp Pharm199350906
Belliveau PPShea BFStability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injectionAm J Hosp Pharm199350950-2
Ringwood MA. Stability of cefepime for injection for IM or IV use following constitution/dilution. Syracuse, NY: Bristol-Myers Company; 1990 Aug 16
Ringwood MA, Vance VH. Cefepime IM, IV, and compatibility studies for U.S. registrational filing. Syracuse, NY: Bristol-Myers Company; 1992 May 13
Vance VH. Stability of cefepime admixed with vancomycin, metronidazole, ampicillin, clindamycin, tobramycin, netilmicin, TPN solution, and PD solution. Syracuse, NY: Bristol-Myers Company; 1992 Oct 14
Pearson SDTrissel LALeaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation componentsAm J Hosp Pharm1993501405-9
Trissel LAPearson SDStorage of lorazepam in three injectable solutions in polyvinyl chloride and polyolefin bagsAm J Hosp Pharm199451368-72
Gilead Sciences, Inc. Veklury^®(remdesivir): pH of the final solution. Updated 2023 Dec 13. From Gilead Medical Information website. Accessed 2024 Jan 18.
Trissel LAMartinez JFCompatibility of allopurinol sodium with selected drugs during simulated Y-site administrationAm J Hosp Pharm1994511792-9
Trissel LAMartinez JFCompatibility of filgrastim with selected drugs during simulated Y-site administrationAm J Hosp Pharm1994511907-13
Trissel LAMartinez JFCompatibility of piperacillin sodium plus tazobactam sodium with selected drugs during simulated Y-site injectionAm J Hosp Pharm199451672-8
Gilead Sciences, Inc. Veklury^® (remdesivir): Lyophilized powder storage and stability. Updated 2023 Nov 9. From Gilead Medical Information website. Accessed 2024 Jan 18
Trissel LAXu QMartinez JFCompatibility and stability of ondansetron hydrochloride with morphine sulfate and hydromorphone hydrochloride in 0.9% sodium chloride injection at various temperaturesAm J Hosp Pharm1994512138-42
Belliveau PPNightingale CHStability of aztreonam and ampicillin/sulbactam in 0.9% saline for injectionAm J Hosp Pharm199451901-4
Fisher DMCanfell CStability of atracurium administered by infusionAnesthesiology198461347-8
Harper NJPollard BJEdwards DStability of atracurium in dilute solutionsBr J Anaesth198860344P-345P
Talton MA (Drug Information, Burroughs Wellcome Company, Research Triangle Park, NC): Personal communication; 1993 Jun 11
Perrone RKKaplan MAExtent of cisplatin formation in carboplatin admixturesAm J Hosp Pharm198946258-9
Northcott MAllsopp MAPowell HThe stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged “in-use” conditionsJ Clin Pharm Ther199116123-9
Ahmed STParkinson RThe stability of drugs in pre-filled syringes: flucloxacillin, ampicillin, cefuroxime, cefotaxime, and ceftazidimeHosp Pharm Pract19922285-9
Faouzi MADine TLuyckx MStability and compatibility studies of pefloxacin, ofloxacin and ciprofloxacin with PVC infusion bagsInt J Pharm199389125-31
Stiles MLAllen LV JrGas production of three brands of ceftazidimeAm J Hosp Pharm1991481727-9
Dine TCazin JCGressier BStability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin, and pirarubicin with PVC infusion bagsPharm Weekbl [Sci]199214365-9
Trissel LAMartinez JFSargramostim incompatibilityHosp Pharm199227929
Trissel LAAlternative interpretation for dataAm J Hosp Pharm199249570
Knapp AJMauro VFIncompatibility of ketorolac tromethamine with selected postoperative drugsAm J Hosp Pharm1992492960-2
Teva Pharmaceuticals, Inc. Zanosar^® (streptozocin sterile powder) prescribing information. Parsippany, NJ; 2023 Mar.
Cohon MS (Clinical Development and Medical Affairs, The Upjohn Company, Kalamazoo, MI): Personal communication; 1993 Dec 6
Chandler SWTrissel LA, Weinstein SMCombined administration of opioids with selected drugs to manage pain and other cancer symptoms: initial safety screening for compatibilityJ Pain Symptom Manage199612168-71
Nation RLHackett LPUptake of clonazepam by plastic intravenous infusion bags and administration setsAm J Hosp Pharm1983401692-3
Hooymans PMJanknegt RComparison of clonazepam sorption to polyvinyl chloride-coated and polyethylene-coated tubingsPharm Weekbl [Sci]199012188-9
McLaughlin JPSimpson CThe stability of reconstituted diethanolamine fusidate in a 5% dextrose infusionHosp Pharm Pract1992259-62
Olsen KMGurley BJDavis GAStability of flumazenil with selected drugs in 5% dextrose injectionAm J Hosp Pharm1993501907-12
Food and Drug Administration. Center for Drug Evaluation and Research. Application number: 20-9401Orig1s000: Multi-Discipline Review. From FDA website.
Larson PORagi GSwandby MStability of buffered lidocaine and epinephrine used for local anesthesiaJ Dermatol Surg Oncol199117411-4
Stewart JHCole GWNeutralized lidocaine with epinephrine for local anesthesiaJ Dermatol Surg Oncol1989151081-3
Nahata MCMorosco RSStability of cimetidine hydrochloride and of clindamycin phosphate in water for injection stored in glass vials at two temperaturesAm J Hosp Pharm1993502559-61
Zeisler JAlagna CIncompatibility of labetalol hydrochloride and furosemideAm J Hosp Pharm1993502521-2
Pfeifer RWHale KNPrecipitation of paclitaxel during infusion by pumpAm J Hosp Pharm1993502518
Hagan RLJacobs LFPimsler MStability of midazolam hydrochloride in 5% dextrose injection or 0.9% sodium chloride injection over 30 daysAm J Hosp Pharm1993502379-81
Jones JWDavis ATStability of bupivacaine hydrochloride in polypropylene syringesAm J Hosp Pharm1993502364-5
Vogt CSkipper PMCompatibility of magnesium sulfate and morphine sulfate in 0.9% sodium chloride injectionAm J Hosp Pharm1993502311
Bailey LCTang KTStability of ceftriaxone sodium in infusion-pump syringesAm J Hosp Pharm1993502092-4
Szof CWalker PCIncompatibility of cefotaxime sodium and vancomycin sulfate during Y-site administrationAm J Hosp Pharm1993502054
Jhee SSJeong EWChin AStability of ondansetron hydrochloride stored in a disposable, elastomeric infusion device at 4 °CAm J Hosp Pharm1993501918-20
Bartfield JMHomer PJFord DTBuffered lidocaine as a local anesthetic: an investigation of shelf lifeAnn Emerg Med19922116-9
Peterfreund RADatta SpH adjustment of local anesthetic solutions with sodium bicarbonate: laboratory evaluation of alkalinization and precipitationReg Anesth198914265-70
Accord BioPharma Inc. Mutamycin^® (mitomycin) for injection prescribing information. Durham, NC; 2016 Sep.
Woods KSteinman WBruns LStability of foscarnet sodium in 0.9% sodium chloride injectionAm J Hosp Pharm19945188-90
Parrish MABailey LCStability of ceftriaxone sodium and aminophylline or theophylline in intravenous admixturesAm J Hosp Pharm19945192-4
Lee MDHess MMBoucher BAStability of amphotericin B in 5% dextrose injection stored at 4 or 25 °C for 120 hoursAm J Hosp Pharm199451394-6
Dukes MNG (ed). Meyler's side effects of drugs. Vol 8. Amsterdam, Holland: Excerpta Medica; 1975:745.
Novartis Pharmaceuticals Corporation. Hycamtin^® (topotecan) for injection prescribing information. East Hanover, NJ; 2019 Oct.
Wolff DJKline SSStability of amikacin, gentamicin, or tobramycin in 10% dextrose injectionAm J Hosp Pharm199451518-9
Bosso JAPrince RACompatibility of ondansetron hydrochloride with fluconazole, ceftazidime, aztreonam, and cefazolin sodium under simulated Y-site conditionsAm J Hosp Pharm199451389-91
Stiles MLAllen LV JrPrince SJStability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirsAm J Hosp Pharm199451514-7
Messerschmidt WKompatibilitat von ofloxacin mit ampicillinKrankenhauspharmazie199415337-40
Messerschmidt WKompatibilitat von cefotaxim mit ofloxacinPharmazie199113642-4
Wyeth Laboratories Inc. Cyanocobalamin (vitamin B₁₂) injection prescribing information. Philadelphia, PA; 1984 Jan.
Messerschmidt WKompatibilitat von cefotiam mit metronidazolKrankenhauspharmazie19867263-5
Messerschmidt WPharmazeutische kompatibilitat der kombination cefotiam und ampicillinKrankenhauspharmazie19921398-100
Cronquist SEDaniels MPrecipitation of paclitaxel during infusion by pumpAm J Hosp Pharm1993502521
Fraser GLRiker RRVisual compatibility of haloperidol lactate with injectable solutionsAm J Hosp Pharm199451905-6
Burm JPJhee SSChin AStability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administrationAm J Hosp Pharm1994511201-4
Mulye NVTurco SJStability of ganciclovir sodium in an infusion-pump syringeAm J Hosp Pharm1994511348-9
Bonhomme LBenhamou DComoy EStability of adrenaline pH-adjusted solutions of local anaestheticsJ Pharm Biomed Anal19919497-9
Johnson CEJacobson PAStability of ganciclovir sodium and amino acids in parenteral nutrient solutionsAm J Hosp Pharm199451503-8
Abubakar AAMustapha AAn in vitro chemical interaction between promethazine hydrochloride and chloroquine phosphateInt J Pharm1993714-9
Xu QTrissel LAStability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32 °CAm J Hosp Pharm1994513058-60
Kearney ASPatel KPreformulation studies to aid in the development of a ready-to-use injectable solution of the antitumor agent, topotecanInt J Pharm1996127229-37
Cilissen JHooymans PMIndicatie van de stabiliteit van een mengsel van piperacilline en flucloxacilline in een reservoir voor een draagbare infusiepompZiekenhuisfarmacie19941010-1
Banerjee PSGhosh LKStudies on the effects of some additives on the stability of injectable formulations of diazepamIndian Drugs199229361-4
Lorillon PCorbel JCMordelet MFPhotosensibilite du 5-fluoro-uracile et du methotrexate dans des perfuseurs translucides ou opaquesJ Pharm Clin199211285-95
Brouwers JRBJvan Doorne HMeevis RFStability of sufentanil citrate and sufentanil citrate/bupivacaine mixture in portable infusion pump reservoirsEur Hosp Pharm1995112-4
Chung KCMoon YSKChin ACompatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administrationAm J Health-Syst Pharm1995521554-6
Erickson SHUlici DIncompatibility of cefotetan disodium and promethazine hydrochlorideAm J Health-Syst Pharm1995521347
Belliveau PPNightingale CHStability of cefotaxime sodium and metronidazole in 0.9% sodium chloride injection or in ready-to-use metronidazole bagsAm J Health-Syst Pharm1995521561-3
Roos PJGlerum JHStability of sufentanil citrate in a portable pump reservoir, a glass container and a polyethylene containerPharm Weekbl [Sci]199214196-200
Roos PJGlerum JH, Schroeders MJEffect of glucose 5% solution and bupivacaine hydrochloride on absorption of sufentanil citrate in a portable pump reservoir during storage and simulated infusion by an epidural catheterPharm World Sci199315269-75
Benaji BDine TLuyckx MStability and compatibility of cisplatin and carboplatin with PVC infusion bagsJ Clin Pharm Ther19941995-100
Trissel LAMartinez JFCompatibility of aztreonam with selected drugs during simulated Y-site administrationAm J Health-Syst Pharm1995521086-90
Choi JSBurm JPJhee SSStability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administrationAm J Hosp Pharm1994512273-6
Ishisaka DYVisual compatibility of fluconazole with drugs given by continuous infusionAm J Hosp Pharm1994512290
Fawcett JPWoods DJMunasiri BCompatibility of cyclizine lactate and haloperidol lactateAm J Hosp Pharm1994512292
Hassan ELeslie JStability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injectionAm J Hosp Pharm1994512143-5
Wang DPChang LCWong CYStability of cefazolin sodium-famotidine admixtureAm J Hosp Pharm1994512205
Singh RFCorelli RLSterility of unit dose syringes of filgrastim and sargramostimAm J Hosp Pharm1994512811-2
Kleinberg MLSterility of repackaged filgrastim and sargramostimAm J Health-Syst Pharm1995521101
Kirkham JCRutherford ETCunningham GNStability of ondansetron hydrochloride in a total parenteral nutrient admixtureAm J Health-Syst Pharm1995521557-8
Gilbar PJGroves CFVisual compatibility of total parenteral nutrition solution (Synthamin 17 premix) with selected drugs during simulated Y-site injectionAust J Hosp Pharm199424167-70
Moon YSKChung KCChin AStability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibagsAm J Health-Syst Pharm199552999-1001
Lumpkin MMBurlington DBSafety alert: hazards of precipitation associated with parenteral nutritionAm J Hosp Pharm1994511427-8
Hasegawa GRCaring about stability and compatibilityAm J Hosp Pharm1994511533-4
Trissel LACompounding our problemsAm J Hosp Pharm1994511534
Mirtallo JMThe complexity of mixing calcium and phosphateAm J Hosp Pharm1994511535-6
Koorenhof MJCTimmer JGStability of total parenteral nutrition supplied as “all-in-one” for children with chemotherapy-linked hyperhydrationPharm Weekbl [Sci]19921450-4
Picard CBrazier MHary LStabilite de quatre solutions de penicillines dans des poches et tubulures de perfusion en PVC plastifieJ Pharm Clin199211302-5
Szucsova SSykora JStablita injekcneho pripravku celaskon v infuznych zmesiachFarm Obzor199261109-12
Walker SEIazzetta JDe Angelis CStability and compatibility of combinations of hydromorphone and dimenhydrinate, lorazepam or prochlorperazineCan J Hosp Pharm.19934661-5
Maswoswe JJOkpara AUAn old nemesis: calcium and phosphate interaction in TPN admixturesHosp Pharm(July) 199530579-80, 582-6
Deardorff DLSchmidt CN, Wiley RAEffect of preparation techniques on mixing of additives in intravenous fluids in nonrigid containersHosp Pharm(Apr) 199328306, 309-10, 312-3
Stiles MLAllen LV JrStability of various antibiotics kept in an insulated pouch during administration via portable infusion pumpAm J Health-Syst Pharm19955270-4
Wang DPChang LCLee DKTStability of fluorouracil-metoclopramide hydrochloride admixtureAm J Health-Syst Pharm19955298-9
Jackson CWCunningham KCompatibility of haloperidol lactate with benztropine mesylateAm J Hosp Pharm1994512962-3
Mirtallo JM. Should the use of total nutrient admixtures be limited? Am J Hosp Pharm. 1994; 51(22):2831-4
Driscoll DFNewton DWPrecipitation of calcium phosphate from parenteral nutrient fluidsAm J Hosp Pharm1994512834-6
Gibler BKim MSVisual compatibility of neuroleptics with anticholinergics or antihistamines in polyethylene syringesAm J Hosp Pharm1994512709-10
Huang EAnderson RPCompatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamineAm J Hosp Pharm1994512963
Mendenhall AHoyt DBIncompatibility of ketorolac tromethamine with haloperidol lactate and thiethylperazine maleateAm J Hosp Pharm1994512964
Harraki BGuiraud PRochat MHInfluence of copper, iron, and zinc on the physicochemical properties of parenteral admixtureJ Parenter Sci Technol199347199-204
Aujoulat PCoze CBraguer DCompatibilite physico-chimique du methotrexate avec les medicaments co-administres dans les protocols de chimiotherapieJ Pharm Clin19931231-5
Johnson CEBhatt-Mehta VMancari SCStability of midazolam hydrochloride and morphine sulfate during simulated intravenous coadministrationAm J Hosp Pharm1994512812-3
Burm JPChoi JSJhee SSStability of paclitaxel and fluconazole during simulated Y-site administrationAm J Hosp Pharm1994512704-6
Grassby PFRoberts DEStability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bagsInt J Pharm Pract19953174-7
Allwood MCBrown PWStability of injections containing diamorphine and midazolam in plastic syringesInt J Pharm Pract1994357-9
Kershaw BPMonnier HL, Mason JHVisual compatibility of premixed theophylline or heparin with selected drugs for i.v. administrationAm J Hosp Pharm1362-3 (July) 1993501360
Trissel LA. Were the bubbles evolved or entrained? Am J Health-Syst Pharm. 1995; 52(7):757
Francomb MMFord JLAdsorption of vincristine, doxorubicin and mitoxantrone to in-line intravenous filtersInt J Pharm199410387-92
Salomies HEMHeinonen RMSorptive loss of diazepam, nitroglycerin and warfarin sodium to polypropylene-lined infusion bags (Softbags)Int J Pharm1994110197-201
Chen YHWu PCShiea JEvaluation of the sterility, stability, and efficacy of bevacizumab stored in multiple-dose vials for 6 monthsJ Ocul Pharmacol Ther20092565-9
Bianchi CAiraudo CBSorption studies of dipotassium clorazepate salt (Tranxene) and midazolam hydrochloride (Hypnovel) in polyvinyl chloride and glass infusion containersJ Clin Pharm Ther199217223-7
Sautou VChopineau JGremeau ICompatibility with medical plastics and stability of continuously and simultaneously infused isosorbide dinitrate and heparinInt J Pharm1994107111-19
Mitchell CL (Leo Pharmaceuticals, Buckinghamshire, United Kingdom): Personal communication; 1998 Sep 11
Hadzija BWLubarsky DACompatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesiaAm J Health-Syst Pharm199552997-9
Stewart JTWarren FWStability of ranitidine hydrochloride and seven medicationsAm J Hosp Pharm1994511802-7
Palmquist KLQuattrocchi FPCompatibility of furosemide with 20% mannitolAm J Health-Syst Pharm199552648
Trissel LAMartinez JFCompatibility of granisetron hydrochloride with selected alkaline drugsAm J Health-Syst Pharm199552208
Bhatt-Mehta VPaglia REStability of propofol with parenteral nutrient solutions during simulated Y-site injectionAm J Health-Syst Pharm199552192-6
Hagan RLCarr-Lopez SMStability of nafcillin sodium in the presence of lidocaine hydrochlorideAm J Health-Syst Pharm199552521-3
Gayed AAKeshary PRVisual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injectionAm J Health-Syst Pharm199552516-20
Trissel LAAmphotericin B does not mix with fat emulsionAm J Health-Syst Pharm1995521463-4
Kirsch RGoldstein RTarloff JAn emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasisJ Infect Dis19881581065-70
Chavenet PYGarry ICharlier NTrial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasisBMJ1992305921-5
Caillot DCasanova OSolary EEfficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patientsJ Antimicrob Chemother199331161-9
Fleming RAOlsen DJSavage PDStability of ondansetron hydrochloride and cyclophosphamide in injectable solutionsAm J Health-Syst Pharm199552514-6
Driscoll DFTotal nutrient admixtures: theory and practiceNutr Clin Pract199510114-9
Driscoll DFBhargava HNLi LPhysicochemical stability of total nutrient admixturesAm J Health-Syst Pharm199552623-34
Pettei MJIsrael D, Levine JSerum vitamin K concentration in pediatric patients receiving total parenteral nutritionionJPEN J Parenter Enteral Nutr199317465-7
Trissel LAMartinez JFIncompatibility of fluorouracil with leucovorin calcium or levoleucovorin calciumAm J Health-Syst Pharm199552710-5
Montoya Garcia-Reol CSevilla Azzati ENegro Vega EEstudio de la estabilidad de la mezcla fluorouracilo/folinato calcico en fluidos intravenososFarm Hosp19931799-103
Ward GHYalkowsky SHStudies in phlebitis VI: dilution-induced precipitation of amiodarone HClJ Parenter Sci Technol199347161-5
Ward GHYalkowsky SHStudies in phlebitis IV: injection rate and amiodarone-induced phlebitisJ Parenter Sci Technol19934740-3
Allwood MCBrown PWStability of ampicillin infusions in unbuffered and buffered salineInt J Pharm199397219-22
Lauper RD (Professional Services, Cetus Oncology Corporation, Emeryville, CA): Personal communication; 1993 Dec 20
Allen LVPlasminogen activatorUS Pharmacist19921764-5, 70-1
Rochard EBarthes DStability and compatibility of carboplatin with three portable infusion pump reservoirsInt J Pharm1994101257-62
Bailey LCCappel KMStability of ceftriaxone sodium in injectable solutions stored frozen in syringesAm J Hosp Pharm1994512159-61
Mazzo DJNguyen-Huu JJPagniez SCompatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materialsAm J Health-Syst Pharm199754566-9
Kane MPBailie GRMoon DGStability of ciprofloxacin injection in peritoneal dialysis solutionsAm J Hosp Pharm199451373-7
Rochard EBarthes DStability of cisplatin in ethylene vinylacetate portable infusion-pump reservoirsJ Clin Pharm Ther199217315-8
Pujol Cubells MPrat Aixela JGirona Brumos VStability of cisplatin in sodium chloride 0.9% intravenous solution related to the container’s materialPharm World Sci19931534-6
Islam MSAsker AFPhotostabilization of dacarbazine with reduced glutathioneJ Pharm Sci Technol19944838-40
Wiest DBGarner SSStability of esmolol hydrochloride in 5% dextrose injectionAm J Health-Syst Pharm199552716-8
Baaske DMDykstra SDWagenknecht DMStability of esmolol hydrochloride in intravenous solutionsAm J Hosp Pharm1994512693-6
Woloschuk DMMNazeravich DREtoposide precipitationCan J Hosp Pharm199245136
Barthes DMCRochard EBPouliquen IJStability and compatibility of etoposide in 0.9% sodium chloride injection in three containersAm J Hosp Pharm1994512706-9
Mathew MGupta VDStability of foscarnet sodium in 5% dextrose and 0.9% sodium chloride injectionsJ Clin Pharm Ther19941935-6
Stolk LMHendrikse HAutoclave and long-term sterility of foscarnet sodium admixturesAm J Health-Syst Pharm199552103
Phaypradith SVigneron JPerrin AStabilite des solutions diluees de ganciclovir sodique (Cymevan) en seringues polypropylene et en poches PVC pour perfusionsJ Pharm Belg199247494-8
Chung KCChin AStability of granisetron hydrochloride in a disposable elastomeric infusion deviceAm J Health-Syst Pharm1995521541-3
Flahive E (Medical Information, Ortho-McNeil, Raritan, NJ): Personal communication; 1995 Apr 6.
AnonASHP therapeutic position statement on the institutional use of 0.9% sodium chloride injection to maintain patency of peripheral indwelling intermittent infusion devicesAm J Hosp Pharm1994511572-4
Nahata MCMorosco RSStability of lorazepam diluted in bacteriostatic water for injection at two temperaturesJ Clin Pharm Ther19931869-71
Pinguet FMartel PRouanet PEffect of sodium chloride concentration and temperature on melphalan stability during storage and useAm J Hosp Pharm1994512701-4
Chin ARamakrishnan RRYoshimura NNPaclitaxel stability and compatibility in polyolefin containersAnn Pharmacother19942835-6
Trissel LAXu QKwan JCompatibility of paclitaxel injection vehicle with intravenous administration and extension setsAm J Hosp Pharm1994512804-10
McLaughlin JP, Simpson C, Taylor RA. When is flucloxacillin stable? Hosp Pharm Pract. 1993; 553-6
Trissel LAMartinez JFCompatibility of amifostine with selected drugs during simulated Y-site administrationAm J Health-Syst Pharm1995522208-12
Henry DWMarshall JLNazzaro DStability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusionAm J Health-Syst Pharm1995522570-3
Mantong MLMarquardt EDVisual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injectionAm J Health-Syst Pharm1995522567-8
Trissel LAXu QACompatibility and stability of aztreonam and vancomycin hydrochlorideAm J Health-Syst Pharm1995522560-4
Rivers TEWebster AAStability of ceftizoxime sodium, ceftriaxone sodium, and ceftazidime with metronidazole in ready-to-use metronidazole bagsAm J Health-Syst Pharm1995522568-70
Wulf HGleim MThe stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromesJ Pain Symptom Manage19949308-11
Korth-Bradley JMLudwig SIncompatibility of amiodarone hydrochloride and sodium bicarbonate injectionsAm J Health-Syst Pharm1995522340
Bhatt-Mehta VJohnson CELeininger NStability of fentanyl citrate and midazolam hydrochloride during simulated intravenous coadministrationAm J Health-Syst Pharm199552511-3
Matuschka PRSmith WRCompatibility of mannitol and sodium bicarbonate in injectable fluidsAm J Health-Syst Pharm199552320-1
Ku YMMin DIKumar VCompatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injectionAm J Health-Syst Pharm1995522024-5
Swart ELMooren RAGCompatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administrationAm J Health-Syst Pharm1995522020-2
Lam XMWard CAStability and activity of alteplase with injectable drugs commonly used in cardiac therapyAm J Health-Syst Pharm1995521904-9
Alex SGupta SLMinor JRCompatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: evaluation of three methodsAm J Health-Syst Pharm1995522423-6
Mancano MABoullata JIGelone SPAvailability of lorazepam after simulated administration from glass and polyvinyl chloride containersAm J Health-Syst Pharm1995522213-6
McMullin STBurns Schaif RAStability of midazolam hydrochloride in polyvinyl chloride bags under fluorescent lightAm J Health-Syst Pharm1995522018-20
Bednar DAKlutman NEHenry DWStability of ceftazidime (with arginine) in an elastomeric infusion deviceAm J Health-Syst Pharm1995521912-4
Trissel LAMartinez JFCompatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administrationAm J Health-Syst Pharm1996531041-5
Xu QATrissel LACompatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administrationAnn Pharmacother1995291106-9
Bleasel MDPeterson GMStability of midazolam in sodium chloride infusion packsAust J Hosp Pharm199323260-2
Taormina DAbdallah HYVenkataramanan RStability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containersAm J Hosp Pharm199249119-22
Hikma Pharmaceuticals USA Inc. Robaxin^® Injectable (methocarbamol injection) prescribing information. Berkeley Heights, NJ; 2023 Feb.
Dorr RTLiddil JDStability of mitomycin C in different infusion fluids: compatibility with heparin and glucocorticoidsJ Oncol Pharm Pract1995119-24
Benaji BDine TGoudaliez FCompatibility study of methotrexate with PVC bags after repackaging into two types of infusion admixturesInt J Pharm199410583-7
Sanchez Alcaraz AQuintana Vergara BEstabilidad del midazolam en soluciones intravenosas gran volumenFarm Hosp199216393-8
Trissel LAConcentration-dependent precipitation of sodium bicarbonate with ciprofloxacin lactateAm J Health-Syst Pharm19965384-5
Christen CJohnson CEStability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministrationAm J Health-Syst Pharm199653170-3
Mewborn ALKessler JMCompatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hoursAm J Health-Syst Pharm199653167-9
Ericsson OHallmen ACAmphotericin B incompatible with lipid emulsionAnn Pharmacother199630298
Hoey LLVance-Bryan KClarens DMLorazepam stability in parenteral solutions for continuous intravenous administrationAnn Pharmacother199630343-6
Nyhammar EKJohansson SGStability of doxorubicin hydrochloride and vincristine sulfate in two portable infusion-pump reservoirsAm J Health-Syst Pharm1996531171-3
Chin AMoon YSKChung KCStability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 daysAm J Health-Syst Pharm1996531174-6
Stewart JTWarren FWKing DTStability of ondansetron hydrochloride and five antineoplastic medicationsAm J Health-Syst Pharm1996531297-300
Yamashita SKWalker SEChoudhury TCompatibility of selected critical care drugs during simulated Y-site administrationAm J Health-Syst Pharm1996531048-51
Ohls RKChristensen RDStability of human recombinant epoetin alfa in commonly used neonatal intravenous solutionsAnn Pharmacother199630466-8
Nahata MCEdmonds JJStability of metronidazole and ceftizoxime sodium in ready-to-use metronidazole bags stored at 4 and 25°CAm J Health-Syst Pharm1996531046-8
Lewis JDEl-Gendy ACephalosporin-pentamidine isethionate incompatibilitiesAm J Health-Syst Pharm1996531461-2
Tanque NUeda HMoriyama YCompatibility of irinotecan hydrochloride injection with other injectionsJpn J Hosp Pharm199622457-65
Hagan RLMallett MSStability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 daysAm J Health-Syst Pharm1996531431-5
Mayron DGennaro ARStability and compatibility of granisetron hydrochloride in i.v. solutions and oral liquids and during simulated Y-site injection with selected drugsAm J Health-Syst Pharm199653294-304
Pinguet FRouanet PMartel PCompatibility and stability of granisetron, dexamethasone, and methylprednisolone in injectable solutionsJ Pharm Sci199584267-8
Lindsay CADang KAdams JMStability and activity of intravenous immunoglobulin with neonatal dextrose and total parenteral nutrient solutionsAnn Pharmacother1994281014-7
Ukhun IACompatibility of haloperidol and diphenhydramine in a hypodermic syringeAnn Pharmacother1995291168-9
Melonakos TKCiprofloxacin-ampicillin sulbactam incompatibilityAnn Pharmacother19963087
Digel SCefamandolnafat und metronidazolKrankenhauspharmazie1995169-12
Heni JStrehl EKompatibilitat von cefotiamKrankenhauspharmazie199415187-92
Tham A (Medical Affairs, Chiron Therapeutics, Emeryville, CA): Personal communication; 1999 Nov 1
Mathew MGupta VDStability of ciprofloxacin in 5% dextrose and normal saline injectionsJ Clin Pharm Ther199419261-2
Pramar YVMoniz DChemical stability and adsorption of succinylcholine chloride injections in disposable plastic syringesJ Clin Pharm Ther199419195-8
Wood MJLund RStability of vancomycin in plastic syringes measured by high-performance liquid chromatographyJ Clin Pharm Ther199520319-25
Strong MLSchaaf LJPankaskie MCShelf-lives and factors affecting the stability of morphine sulphate and meperidine (pethidine) hydrochloride in plastic syringes for use in patient-controlled analgesic devicesJ Clin Pharm Ther199419361-9
Giordano FBettinetti GCursano RA physicochemical approach to the investigation of the stability of trimethoprim-sulfamethoxazole (co-trimoxazole) mixtures for injectablesJ Pharm Sci1995841254-8
Sianipar AParkin JEChemical incompatibility between procainamide hydrochloride and glucose following intravenous admixtureJ Pharm Pharmacol199446951-5
Lau DWCLaw SWalker SEDexamethasone phosphate stability and contamination of solutions stored in syringesPDA J Pharm Sci Technol199650261-7
Ambados FIncompatibility between aminophylline and elemental zinc injectionsAust J Hosp Pharm199626370-1
Ambados FCompatibility of morphine and ketamine for subcutaneous infusionAust J Hosp Pharm199525352
Boldu SPCubells MPBrumos VGStability study of azlocillin sodium in glass bottles and PVC bags containing intravenous admixturesBoll Chim Farm1995134467-71
LeBelle MJSavard CCompatibility of morphine and midazolam or haloperidol in parenteral admixturesCan J Hosp Pharm199548155-60
Donnelly RFYen MEpinephrine stability in plastic syringes and glass vialsCan J Hosp Pharm19964962-5
Sadjak AWintersteiger RCompatibility of morphine, baclofen, floxuridine and fluorouracil in an implantable medication pumpArzneim Forsch19954593-8
Donnelly RFFarncombe MCompatibility of morphine or hydromorphone with salbutamol in a syringeCan J Hosp Pharm199447252
Corbo DCSuddith RLSharma BStability, potency, and preservative effectiveness of epoetin alfa after addition of a bacteriostatic diluentAm J Hosp Pharm1992491455-8
Lane GWaite NErythropoietin stabilityCan J Hosp Pharm199447182
Walker SELau DWCCompatibility and stability of hyaluronidase and hydromorphoneCan J Hosp Pharm199245187-92
Sastre Gervas IFerrandiz Gosalbez JREstabilidad fisica y quimica del sulfate magnesico combinado con heparina sodica en solucion salina al 0,9 por 100Farm Hosp19951938-40
Medicure International Inc. Aggrastat^® (tirofiban hydrochloride) injection. Princeton, NJ; 2023 Jan.
Gila Azanedo JAMengual Sendra AFernandez Barral CEstudio de la estabilidad de una solucion de clorhidrato de morfina mas anestesicos locales en solucion salina 0,9 por 100 sin conservantes para uso epiduralFarm Hosp199418261-4
Sitaram BRTsui MRawicki HBStability and compatibility of baclofen and morphine admixtures for use in an implantable infusion pumpInt J Pharm1995118181-9
Allwood MCMartin HJLong-term stability of cimetidine in total parenteral nutritionJ Clin Pharm Ther19962119-21
Jacolot AArnaud PLecompte DStability and compatibility of 2.5 mg/mL methotrexate solution in plastic syringes over 7 daysInt J Pharm1996128283-6
Wright AHecker JLong term stability of heparin in dextrose-saline intravenous fluidsInt J Pharm Pract19953253-5
Kawano KMatsunaga ATerada KLoss of diltiazem hydrochloride in solutions in polyvinyl chloride containers or intravenous administration set—hydrolysis and sorptionJpn J Hosp Pharm199420537-41
Metras JISwenson CFMcDermott MPStability of procainamide hydrochloride in an extemporaneously compounded oral liquidAm J Hosp Pharm19924917,20-4
Kawano KTakamatsu SYamashita JEffect of pH on the sorption of in-solution diazepam into the ethylene-vinylacetate copolymer membraneJpn J Hosp Pharm199420404-9
Picard CBrazier MBou PStabilite de quatre solutions de penicillines dans les poches de perfusion multicouchesJ Pharm Clin19941345-9
Theuer HScherbel GBalzulat SHerstellung und stabilitatuntersuchungen von carboplatin i.vKrankenhauspharmazie199415120-30
Strehl EHeni JAmoxicillin, clavulansaure und metronidazol in kombinationKrankenhauspharmazie199415592-5
Hatton JLuer MHirsch JHistamine receptor antagonists and lipid stability in total nutrient admixturesJPEN J Parenter Enteral Nutr199418308-12
Ku YMMin DIKumar VStability of tacrolimus injection in total parenteral nutrition solutionJ Pharm Technol19961258-61
Martinelli EMuhlebach SKunststoffumbeutel als lichtschutz fur infusionenKrankenhauspharmazie199516286-9
Teraoka KMinakuchi KTsuchiya KCompatibility of ciprofloxacin infusion with other injectionsJpn J Hosp Pharm199521541-50
Asahara KGoda YShimomura YStability of thiamine in intravenous hyperalimentation containing multivitaminJpn J Hosp Pharm19952115-21
Namika YFujiwara AKihara NFactors affecting tautomeric phenomenon of a novel potent immunosuppressant (FK506) on the design for injectable formulationDrug Dev Ind Pharm199521809-22
Antipas ASVander Velde DFactors affecting the deamidation of vancomycin in aqueous solutionsInt J Pharm1994109261-9
King ADStewart JTStability of cefmetazole-doxycycline mixtures in sodium chloride and dextrose injectionsJ Clin Pharm Ther199419317-25
Hughes IESmith JAThe stability of noradrenaline in physiologic saline solutionsJ Pharm Pharmacol197830124-6
AnonInfections linked to lax handling of propofolAm J Health-Syst Pharm1995522061
Ordovas Baines JPRonchera Oms CLJimenez Torres NVMezclas iv binarias de metronidazol y aminoglycosidosRevista AEFH198812119-23
Nitescu PHultman EAppelgren LBacteriology, drug stability and exchange of percutaneous delivery systems and antibacterial filters in long-term intrathecal infusion of opioid drugs and bupivacaine in “refractory” painClin J Pain19928324-37
Yao JDArkin CF, Karchmer AWVancomycin stability in heparin and total parenteral nutrition solutions: novel approach to therapy of central venous catheter-related infectionsJPEN J Parenter Enteral Nutr199216268-74
Jim LKPhysical and chemical compatibility of intravenous ciprofloxacin with other drugsAnn Pharmacother199327704-7
Paesen JKhan KRoets EStudy of the stability of erythromycin in neutral and alkaline solutions by liquid chromatography on poly(styrene-divinylbenzene)Int J Pharm1994113215-22
Keyi XGagnon NBisson CStability of famotidine in polyvinyl chloride minibags and polypropylene syringes and compatibility of famotidine with selected drugsAnn Pharmacother199327422-6
Pleasants RAVaughan LMWilliams DMCompatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusionAnn Pharmacother1992261221-6
Nahata MCMorosco RSStability of diluted methylprednisolone sodium succinate injection at two temperaturesAm J Hosp Pharm1994512157-9
Nixon ARO’Hare MCBThe stability of morphine sulphate and metoclopramide hydrochloride in various delivery presentationsPharm J1995254153-5
Lugo RANahata MCStability of diluted dexamethasone sodium phosphate injection at two temperaturesAnn Pharmacother1994281018-9
Hanff PAJMVan den Biggelaar JPFAStabiliteitsonderzoek van nitroglycerine-oplossingen voor parenteraal gebruikZiekenhuisfarmacie199410134-8
Forte FJCaravone DCoyne MJAlbumin dilution as a cause of hemolysis during plasmapheresisAm J Health-Syst Pharm199552207
Little G (Drug Information, Wyeth-Ayerst Laboratories, Philadelphia, PA): Personal communication; 1996 Mar 25
Andersin RTammilehto SPhotochemical decomposition of midazolam, part iv: study of pH-dependent stability by high-performance liquid chromatographyInt J Pharm1995123229-35
Boullata JIGelone SPMancano MAPrecipitation of lorazepam infusionAnn Pharmacother1996301037-8
Taylor RBRichards RMELow ASChemical stability of polymyxin B in aqueous solutionInt J Pharm1994102201-6
Neuzil JDarlow BAInder TEOxidation of parenteral lipid emulsion by ambient and phototherapy lights: potential toxicity of routine parenteral feedingJ Pediatr1995126785-90
Katakam MBanga AKAggregation of insulin and its prevention by carbohydrate excipientsPDA J Pharm Sci Technol199549160-5
Woloschuk DMDrug precipitation and peristaltic pumpsAm J Hosp Pharm1994511473
Hehenberger HPrednisolon-21-hemisuccinat-natriumKrankenhauspharmazie19867128-32
Driscoll DFBacon MProvost PSAutomated compounders for parenteral nutrition admixturesJPEN J Parenter Enteral Nutr199418385-6
Mehta ACKay EAAdmixtures’ storage is extendedPharm Pract19966113-4
Faouzi MADine TLuyckx MStability and compatibility studies of cephaloridine, cefuroxime and ceftazidime with PVC infusion bagsPharmazie199449425-9
Williams DALokich JA review of the stability and compatibility of antineoplastic drugs for multiple-drug infusionsCancer Chemother Pharmacol199231171-81
Chevrier RSautou VPinon VStability and compatibility of a mixture of the anti-cancer drugs etoposide, cytarabine and daunorubicine for infusionPharm Acta Helv199570141-8
Christie JMJones CWChemical compatibility of regional anesthetic drug combinationsAnn Pharmacother1992261078-80
Abdel-Moety EMAl-Rashood KARauf APhotostability-indicating HPLC method for determination of trifluoperazine in bulk form and pharmaceutical formulationsJ Pharm Biomed Anal1996141639-44
Poochikian GKCradock JCHeroin: stability and formulation approachesInt J Pharm198313219-26
Kamitomo VOlson KUsing normal saline to lock peripheral intravenous catheters in ambulatory cancer patientsJ Intraven Nurs19961975-8
Burnakis TGInsulin syringes: more than a one-shot dealHosp Pharm199631410
Sautou-Miranda VGremeau IChamard IStability of dopamine hydrochloride and of dobutamine hydrochloride in plastic syringes and administration setsAm J Health-Syst Pharm199653186
Murthey SSBrittain HGStability of revex, nalmefene hydrochloride injection, in injectable solutionsJ Pharm Biomed Anal199615221-6
Yuan LCSamuels GJStability of cidofovir in 0.9% sodium chloride injection and in 5% dextrose injectionAm J Health-Syst Pharm1996531939-43
Leader WGIncompatibility between ceftriaxone sodium and labetalol hydrochlorideAm J Health-Syst Pharm1996532639
West-Ward Pharmaceuticals Corp. Phentolamine mesylate for injection prescribing information. Eatontown, NJ; 2015 Nov.
Lee DKTWong CYWang DPStability of cefazolin sodium and meperidine hydrochlorideAm J Health-Syst Pharm199653131608, 1610
Stiles MLAllen LV JrStability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringesAm J Health-Syst Pharm1996531583-8
Quercia RAZhang JFan CStability of granisetron hydrochloride in polypropylene syringesAm J Health-Syst Pharm1996532744-6
Trissel LAMartinez JFScreening cladribine for Y-site physical compatibility with selected drugsHosp Pharm1996311425-8
Allen LV JrStiles MLPrince SJStability of 14 drugs in the latex reservoir of an elastomeric infusion deviceAm J Health-Syst Pharm1996532740-3
Benjamin BECiprofloxacin and sodium phosphates not compatible during actual Y-site injectionAm J Health-Syst Pharm1996531850-1
Trissel LAEverything in a compatibility study is importantAm J Health-Syst Pharm1996532990
Matuschka PRHill LJMore on the compatibility of mannitol and sodium bicarbonate in injectable fluidsAm J Health-Syst Pharm1996532639
Veltri MLee CKKCompatibility of neonatal parenteral nutrient solutions with selected intravenous drugsAm J Health-Syst Pharm1996532611-3
Ritter HTrissel LAAnderson RWElectronic balance as quality assurance for cytotoxic drug admixturesAm J Health-Syst Pharm1996532318-20
Zhang YXu QATrissel LAPhysical and chemical stability of methotrexate sodium, cytarabine, and hydrocortisone sodium succinate in Elliott’s B solutionHosp Pharm199631965-70
Xu QATrissel LAStability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochlorideAnn Pharmacother199630756-61
Kohut J IIITrissel LADon’t ignore the details of drug-compatibility reportsAm J Health-Syst Pharm1996532339
Grillo JABarie PSPrecipitation of lorazepam during infusion by volumetric pumpAm J Health-Syst Pharm1996531850
Volles DFMore on usability of lorazepam admixtures for continuous infusionAm J Health-Syst Pharm1996532753-4
Boullata JIGelone SPMore on usability of lorazepam admixtures for continuous infusionAm J Health-Syst Pharm1996532754
Strozyk WRWilliamson RIncompatibility of amiodarone hydrochloride and evacuated glass bottlesAm J Health-Syst Pharm199653184
Baud-Camus FCrauste-Manciet SKlein EStability of fluorouracil in polypropylene syringes and ethylene vinyl acetate infusion-pump reservoirsAm J Health-Syst Pharm1996531457
Chernin ELStewart JTStability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°CAm J Health-Syst Pharm1996531576-9
Prankerd RJJones RDPhysicochemical compatibility of propofol with thiopental sodiumAm J Health-Syst Pharm1996532606-10
Williams NABornstein MStability of levofloxacin in intravenous solutions in polyvinyl chloride bagsAm J Health-Syst Pharm1996532309-13
Cleary JDAmphotericin B formulated in a lipid emulsionAnn Pharmacother199630409-12
Lopez RMAyestaran APou LStability of amphotericin B in an extemporaneously prepared i.v. fat emulsionAm J Health-Syst Pharm1996532724-7
Manduru MFariello AWhite RLStability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solutionAm J Health-Syst Pharm1996532731-4
Plumridge RJRieck AMAnnus TPStability of ceftriaxone sodium in polypropylene syringes at -20, 4, and 20°CAm J Health-Syst Pharm1996532320-3
Plumridge RJRieck AMAnnus TPStability of ceftriaxone sodium reconstituted with lidocaine hydrochloride and stored in polypropylene syringesAm J Health-Syst Pharm1996532323-5
Henderson F21-Day compatibility of hydromorphone hydrochloride and promethazine hydrochloride in a casetteAm J Health-Syst Pharm1996532338-9
Lima HALennon JSesterhenn KStability of dextrose and sodium chloride in injectable solutions stored in an elastomeric infusion deviceAm J Health-Syst Pharm199653794-5
Patel PRCompatibility of meropenem with commonly used injectable drugsAm J Health-Syst Pharm1996532853-5
Lougheed WDAlbisser AMMartindale HMPhysical stability of insulin formulationsDiabetes198332424-32
Gupta VDQuantitation of papaverine hydrochloride in a discoloured injectionDrug Stability19961132-4
Akimoto KKawai AOhya KPhotodegradation reactions of CPT-11, a derivative of camptothecin, part i: chemical structure of main degradation products in aqueous solutionDrug Stability19961118-22
Akimoto KKawai APhotodegradation reactions of CPT-11, a derivative of camptothecin, part ii: photodegradation behaviour of CPT-11 in aqueous solutionDrug Stability19961141-6
O’Connell CSabra KStability of reconstituted ceftriaxone solution in polypropylene syringesEur Hosp Pharm1996247-8
Trissel LAGilbert DLCompatibility of granisetron hydrochloride with selected drugs during simulated Y-site administrationAm J Health-Syst Pharm19975456-60
Zhang YTrissel LAMartinez JFStability of metoclopramide hydrochloride in plastic syringesAm J Health-Syst Pharm1996531300-2
Kaijser GPAalbers TBeijnen JHChemical stability of cyclophosphamide, trofosfamide, and 2- and 3-dechloroethylfosfamide in aqueous solutionsJ Oncol Pharm Pract1996215-21
Nelson TJGraves SM0.9% Sodium chloride injection with and without heparin for maintaining peripheral indwelling intermittent-infusion devices in infantsAm J Health-Syst Pharm199855570-3
Martel PPetit IPinguet FLong-term stability of 5-fluorouracil stored in PVC bags and in ambulatory pump reservoirsJ Pharm Biomed Anal199614395-9
Hospira, Inc. Ketorolac tromethamine injection prescribing information. Lake Forest, IL; 2022 Nov.
Erkkila DM (Professional Services, Immunex Corporation): Personal communication; 1996 Mar 6
Xu QATrissel LAZhang YStability of thiotepa (lyophilized) in 5% dextrose injection at 4 and 23°CAm J Health-Syst Pharm1996532728-30
van Doorne HBernaards JCeftazidime degradation rates for predicting stability in a portable infusion-pump reservoirAm J Health-Syst Pharm1996531302-5
Celesk RA (Medical Services, Bayer Pharmaceutical Division): Personal communication; 1996 May 7
Grandison D (Worldwide Medical Affairs, Du Pont Pharma): Personal communication; 1995 Dec 4
Martinez JFTrissel LACompatibility of warfarin sodium with selected drugs and large-volume parenteral solutionsInt J Pharm Compound19971356-8
Williams DAZwitterions and pH-dependent solubilityAm J Health-Syst Pharm1996531732
Ariano REKassum DAMeatherhill RCLack of in vitro inactivation of tobramycin by imipenem/cilastatinAnn Pharmacother1992261075-7
Jenke DRDrug binding by reservoirs in elastomeric devicesPharm Res199411984-9
McCollom RALange BBryson SMPolyvinylchloride containers do not influence the hemodynamic response to intravenous nitroglycerinCan J Hosp Pharm199346165-70
Altavela JLHaas CENowak DRClinical response to intravenous nitroglycerin infused through polyethylene or polyvinyl chloride tubingAm J Hosp Pharm199451490-94
McCullough JMSprentall-Nankervis EPotcova CARecovery and biological activity of filgrastim after injection through silicone rubber cathetersAm J Health-Syst Pharm199552186-8
Park TWLe-Bui LPKChung KCStability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutionsAm J Health-Syst Pharm1995522022-4
Gilead Sciences, Inc. Veklury^® (remdesivir): Flushing IV line. Updated 2023 Feb 7. From Gilead Medical Information website. Accessed 2024 Jan 18.
Stiles MLAllen LV JrResztak KEStability of octreotide acetate in polypropylene syringesAm J Hosp Pharm1993502356-8
Ripley RGRitchie DJStability of octreotide acetate in polypropylene syringes at 5 and -20°CAm J Health-Syst Pharm1995521910-1
Schepart BSBurns BAEvans SLong-term stability of interferon alfa-2b diluted to 2 million units/mLAm J Health-Syst Pharm1995522128-30
Ikeda SFrank PASchweiss JFIn vitro cyanide release from sodium nitroprusside in various intravenous solutionsAnesth Analg198867360-2
Webster LKCrinis NADavis JRConversion of etoposide phosphate to etoposide under ambulatory infusion conditionsJ Oncol Pharm Pract1995133-6
Hensrud DDBurritt MF, Hall LGStability of heparin anticoagulant activity over time in parenteral nutrition solutionsJPEN J Parenter Enteral Nutr199620219-21
Gutcher GRLax AAVitamin A losses to plastic intravenous infusion devices and an improved method of deliveryAm J Clin Nutr1984408-13
Greene HLPhillips BLFranck LPersistently low blood retinol levels during and after parenteral feeding of very low birth weight infants: examination of losses into intravenous administration sets and a method of prevention by addition to a lipid emulsionPediatrics198779894-900
Henton DHMerrott RJVitamin A sorption to polyvinyl and polyolefin intravenous tubingJPEN J Parenter Enteral Nutr19901479-81
Washington CFerguson JAComputational prediction of the stability of lipid emulsions in total nutrient admixturesJ Pharm Sci199382808-12
Li LCSampogna TPA factorial design study on the physical stability of 3-in-1 admixturesJ Pharm Pharmacol199345985-7
Foresta KUse of total nutrient admixtures should not be limitedAm J Health-Syst Pharm199552893
Driscoll DFUse of total nutrient admixtures should not be limitedAm J Health-Syst Pharm199552893-4
Mirtallo JMUse of total nutrient admixtures should not be limitedAm J Health-Syst Pharm199552894-5
Trissel LAUse of total nutrient admixtures should not be limitedAm J Health-Syst Pharm199552895
Driscoll DFDebate on total nutrient admixtures continuesAm J Health-Syst Pharm1995521921-2
Trissel LADebate on total nutrient admixtures continuesAm J Health-Syst Pharm1995521921-2
Hill SEHeldman LSGoo EDFatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solutionJPEN J Parenter Enteral Nutr19962081-7
MacKay MWFitzgerald KA, Jackson DThe solubility of calcium and phosphate in two specialty amino acid solutionsJPEN J Parenter Enteral Nutr19962063-6
Shatsky FMcFeely EJA table for estimating calcium and phosphorus compatibility in parenteral nutrition formulas that contain Trophamine plus cysteineHosp Pharm199530690-2
Grassby PFHutchings LFactors affecting the physical and chemical stability of morphine sulphate solutions stored in syringesInt J Pharm Pract1993239-43
Ritter HTrissel LAAnderson RWElectronic balance as quality assurance for cytotoxic drug admixturesAm J Health-Syst Pharm1996532318-20
Roos PJGlerum JHMeilink JWEffect of pH on absorption of sufentanil citrate in a portable pump reservoir during storage and administration under simulated epidural conditionsPharm World Sci199315139-44
Bristol Laboratories. Sodium bicarbonate injection prescribing information. Syracuse, NY; 1980 Apr.
Allen LV JrStiles MLPrince SJStability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injectionAm J Health-Syst Pharm1995522427-33
Bureau ALahet JJD’Athis PCompatibilite PVC-psychotropes au cours d’une perfusionJ Pharm Clin19951426-30
Streng WHBrake NWDextrose adduct formation in aqueous teicoplanin solutionsPharm Res198961032-8
Hixt UL-Alanyl-L-glutamine dipeptide for parenteral nutritionEur Hosp Pharm1996272-6
Tivnann HGaines-Gas RThorpe RAn evaluation of the stability of granulocyte colony stimulating factor on the short-term storage and delivery from an elastomeric infusion systemJ Oncol Pharm Pract19962107-12
Billion-Rey FGuillaumont MFrederich AStability of fat-soluble vitamins A (retinol palmitate), E (tocopherol acetate), and K1 (phylloquinone) in total parenteral nutrition at homeJPEN J Parenter Enteral Nutr19931756-60
Dahl GBSvensson LKinnander NJStability of vitamins in soybean oil fat emulsion under conditions simulating intravenous feeding of neonates and childrenJPEN J Parenter Enteral Nutr199418234-9
Henry DWLacerte JAKlutman NEIrreversibility of procainamide-dextrose complex in plasma in vitroAm J Hosp Pharm1991482426-9
Martin MBepko RPaclitaxel diluent and the case of the slippery spikeAm J Hosp Pharm1994513078
AstraZeneca. Nexium^® (esomeprazole magnesium) I.V. for HCPs website. Updated 2022 Nov. Accessed 2024 Jan 8. www.purplepill.com/hcp/nexium-iv.html.
Haas CENowak DREffect of using a standard polyvinyl chloride intravenous infusion set on patient response to nitroglycerinAm J Hosp Pharm1992491135-7
Driver PSJarvi EJStability of nitroglycerin as nitroglycerin concentrate for injection stored in plastic syringesAm J Hosp Pharm1993502561-3
Casto DTStability of ondansetron stored in polypropylene syringesAnn Pharmacother199428712-4
Bailey LCTang KTEffect of syringe filter and i.v. administration set on delivery of propofol emulsionAm J Hosp Pharm1991482627-30
Johnson CEChristen CPerez MMCompatibility of bupivacaine hydrochloride and morphine sulfateAm J Health-Syst Pharm19975461-4
Ambados FCompatibility of ketamine hydrochloride and meperidine hydrochlorideAm J Health-Syst Pharm199754205
Hall PDYui DLyons SCompatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administrationAm J Health-Syst Pharm199754185-9
Fausel CANewton DWDriscoll DFEffect of fat emulsion and supersaturation on calcium phosphate solubility in parenteral nutrient admixturesInt J Pharm Compound1997154-9
Chiu MFSchwartz MLVisual compatibility of injectable drugs used in the intensive care unitAm J Health-Syst Pharm19975464-5
Najari ZRusho WJCompatibility of commonly used bone marrow transplant drugs during Y-site deliveryAm J Health-Syst Pharm199754181-4
Xu QATrissel LARapid loss of fentanyl citrate admixed with fluorouracil in polyvinyl chloride containersAnn Pharmacother199731297-302
Gilbert DL JrTrissel LACompatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administrationAm J Health-Syst Pharm1997541193-5
Trissel LAGilbert DLCompatibility of propofol injectable emulsion with selected drugs during simulated Y-site administrationAm J Health-Syst Pharm1997541287-92
Asker AFFerdous AJPhotodegradation of furosemide solutionsPDA J Pharm Sci Technol199650158-62
Compatibility of meropenem with commonly used injectable drugs. AJHP. 1996; 53:2853-5. [Correction: Am J Health-Syst Pharm. 1998; 55:735.]
Schobelock MJ (Medical Affairs Department, Roxane Laboratories, Inc.): Personal communication; 1997 Nov 4
Barnes ARNash SStability of bupivacaine hydrochloride and diamorphine hydrochloride in an epidural infusionPharm World Sci19951787-92
Grassby PFHutchings LDrug combinations in syringe drivers: the compatibility and stability of diamorphine with cyclizine and haloperidolPalliat Med199711217-24
Cohen MRVolume limitations for IV drug infusions when sterile water for injection is used as a diluentHosp Pharm199833274-7
Pierce LRGaines AVarricchio FHemolysis and renal failure associated with use of sterile water for injection to dilute 25% human albumin solutionAm J Health-Syst Pharm199855101057, 1062, 1070
Trissel LAMartinez JFCompatibility of cisatracurium besylate with selected drugs during simulated Y-site administrationAm J Health-Syst Pharm1997541735-41
Trissel LAGilbert DLMartinez JFCompatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administrationAm J Health-Syst Pharm1997542192-6
Ennis RDDahl TCStability of cidofovir in 0.9% sodium chloride injection for five daysAm J Health-Syst Pharm199754192204-6
Murray KMErkkila DGombotz WRStability of thiotepa (lyophilized) in 0.9% sodium chloride injectionAm J Health-Syst Pharm1997542588-91
Bahal SMLee TJMcGinnes MVisual compatibility of warfarin sodium injection with selected medications and solutionsAm J Health-Syst Pharm1997542599-600
Nolan PEHoyer GLLeDoux JHStability of ranitidine hydrochloride and human insulin in 0.9% sodium chloride injectionAm J Health-Syst Pharm1997541304-6
Stiles MLAllen LVStability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium, and tobramycin sulfate in polyvinyl chloride drug reservoirsAm J Health-Syst Pharm1997541068-70
Pujol MMunoz MPrat JStability study of epirubicin in NaCl 0.9% injectionAnn Pharmacother199731992-5
Walker SEDeAngelis CStability and compatibility of combinations of hydromorphone and a second drugCan J Hosp Pharm199144289-95
Fischer JHCwik MJLuer MSStability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringesAnn Pharmacother199731553-9
Evrard BCeccato AGaspard OStability of ondansetron hydrochloride and dexamethasone sodium phosphate in 0.9% sodium chloride injection and in 5% dextrose injectionAm J Health-Syst Pharm1997541065-8
Peddicord TEOlsen KMZumBrunnen TLStability of high-concentration dopamine hydrochloride, norepinephrine bitartrate, epinephrine hydrochloride, and nitroglycerin in 5% dextrose injectionAm J Health-Syst Pharm1997541417-9
Walker SEMeinders AStability and compatibility of reconstituted sterile hydromorphone with midazolamCan J Hosp Pharm199649290-8
Trissel LAGilbert DLCompatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administrationAm J Health-Syst Pharm1997542708-13
Pramar YVLoucas VAStability of midazolam hydrochloride in syringes and i.v. fluidsAm J Health-Syst Pharm199754913-5
Patel PRCook SEStability of meropenem in intravenous solutionsAm J Health-Syst Pharm199754412-21
Cornish LAMontgomery PAStability of bumetanide in 5% dextrose injectionAm J Health-Syst Pharm199754422-3
Bailey LCOrosz STStability of ceftriaxone sodium and metronidazole hydrochlorideAm J Health-Syst Pharm199754424-7
Stewart JTWarren FWKing DTStability of ondansetron hydrochloride, doxorubicin hydrochloride, and dacarbazine or vincristine sulfate in elastomeric portable infusion devices and polyvinyl chloride bagsAm J Health-Syst Pharm199754915-20
Owens DFleming RARestino MSStability of amphotericin B 0.05 and 0.5 mg/mL in 20% fat emulsionAm J Health-Syst Pharm199754683-6
Zhang YXu QATrissel LACompatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutionsAnn Pharmcother1997311465-70
Gupta VDMaswoswe JStability of ketorolac tromethamine in 5% dextrose injection and 0.9% sodium chloride injectionsInt J Pharm Compound19971206-7
Zhang YPTrissel LAStability of aminocaproic acid injection admixtures in 5% dextrose injection and 0.9% sodium chloride injectionInt J Pharm Compound19971132-4
Allen LVStiles MLStability of vancomycin hydrochloride in medication cassette reservoirsInt J Pharm Compound19971123-4
Zhang YPTrissel LAMartinez JFStability of acyclovir sodium 1, 7, and 10 mg/mL in 5% dextrose injection and 0.9% sodium chloride injectionAm J Health-Syst Pharm199855574-7
Amador FDAzzati ESStability of carboplatin in polyvinyl chloride bagsAm J Health-Syst Pharm199855602
Gupta VDMaswoswe JStability of cefmetazole sodium in 5% dextrose injection and 0.9% sodium chloride injectionInt J Pharm Compound19971208-9
Gupta VDMaswoswe JStability of ceftriaxone sodium when mixed with metronidazole injectionInt J Pharm Compound19971280-1
Gupta VDMaswoswe JStability of cefepime hydrochloride in 5% dextrose injection and 0.9% sodium chloride injectionInt J Pharm Compound19971435-6
Mayhew SLQuick MWCompatibility of iron dextran with neonatal parenteral nutrient solutionsAm J Health-Syst Pharm199754570-1
Moshfeghi MCiuffo JDVisual compatibility of fentanyl citrate with parenteral nutrient solutionsAm J Health-Syst Pharm1998551194
Gupta VDMaswoswe JStability of indomethacin in 0.9% sodium chloride injectionInt J Pharm Compound19982170-1
Wong FGill MAStability of milrinone lactate 200 mcg/mL in 5% dextrose injection and 0.9% sodium chloride injectionInt J Pharm Compound19982168-9
Nguyen DGill MAStability of milrinone lactate in 5% dextrose injection and 0.9% sodium chloride injection at concentrations of 400, 600, and 800 mcg/mLInt J Pharm Compound19982246-8
Montgomery PACornish LAJohnson CEStability of torsemide in 5% dextrose injectionAm J Health-Syst Pharm1998551042-3
Trissel LAGilbert DLMartinez JFCompatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administrationAm J Health-Syst Pharm1997541295-1300
Pramar YVChemical stability of amiodarone hydrochloride in intravenous fluidsInt J Pharm Compound19971347-8
Wang DPWang MTWong CYCompatibility of vancomycin hydrochloride and famotidine in 5% dextrose injectionInt J Pharm Compound19971354-5
Bhatt-Mehta VHirata SPhysical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusionInt J Pharm Compound1998279-82
Stendal TLKlem WTonnesen HHDrug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion deviceAm J Health-Syst Pharm199855683-5
Ketkar VAKolling WMNardviriyakul NStability of undiluted and diluted adenosine at three temperatures in syringes and bagsAm J Health-Syst Pharm199855466-0
Naud CMarti BFernandez CStability of adenosine 6 mcg/mL in 0.9% sodium chloride solutionAm J Health-Syst Pharm1998551161-4
Xu QAZhang YPTrissel LAStability of cisatracurium besylate in vials, syringes, and infusion admixturesAm J Health-Syst Pharm1998551037-41
Das TVolety SAhsan SMSafety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumabClin Exp Ophthalmol201543466-73
Allwood MCMartin JHow does storage affect propofol? The stability of propofol in plastic syringesPharm Pract1997715-6
Harris MC, Como JA. Heparin flush solutions: how much is enough? South J Health-Syst Pharm. 1997; 2:10-4
Meyer BALittle CJThorp JAHeparin versus normal saline as a peripheral line flush in maintenance of intermittent intravenous lines in obstetric patientsObstet Gynecol199585433-6
Danek GDNoris EMPediatric i.v. catheters: efficacy of saline flushPediatr Nurs199218111-3
Hook MLReuling JLuettgen MLComparison of the patency of arterial lines maintained with heparinized and nonheparinized infusions. The Cardiovascular Intensive Care Unit Nursing Research Committee of St. Luke’s HospitalHeart Lung198716693-9
Kulkarni MElsner COuellet DHeparinized saline versus normal saline in maintaining patency of the radial artery catheterCan J Surg19943737-42
Clifton GDBranson PKelly HJComparison of normal saline and heparin solutions for maintenance of arterial catheter patencyHeart Lung199120115-8
Butt WShann FMcDonnell GEffect of heparin concentration and infusion rate on the patency of arterial cathetersCrit Care Med198715230-2
Smith S, Dawson S, Hennessey R, et al. Maintenance of the patency of indwelling central venous catheters: is heparin necessary? Am J Pediatr Hematol Oncol. 1991; 13(2):141-3
O’Neill TJTierney LM Jr, Proulx RJHeparin lock-induced alterations in the activated partial thromboplastin timeJAMA19742271297-8
Passannante AMacik BGCase report: the heparin flush syndrome: a cause of iatrogenic hemorrhageAm J Med Sci198829671-3
Heeger PSBackstrom JTHeparin flushes and thrombocytopeniaAnn Intern Med1986105143
Laster JCikrit DWalker NThe heparin-induced thrombocytopenia syndrome: an updateSurgery1987102763-70
Rizzoni WEMiller KRick MHeparin-induced thrombocytopenia and thromboembolism in the postoperative periodSurgery1988103470-6
Doty JRAlving BMMcDonnell DEHeparin-associated thrombocytopenia in the neurosurgical patientNeurosurgery19861969-72
Mehta ACKay EAStorage time can be extendedPharm Pract(June) 19977305, 306, 308
Brittain HGLafferty LBousserski PStability of Revex, nalmefene hydrochloride injectionPDA J Pharm Sci Technol19965035-9
McKinnon BTFDA Safety Alert: hazards of precipitation associated with parenteral nutritionNutr Clin Pract19961159-65
Seidner DLSpeerhas RCan octreotide be added to parenteral nutrition? Point-counterpointNutr Clin Pract19981384-8
Dodds HMCraik DJPhotodegradation of irinotecan (CPT-11) in aqueous solutions: identification of fluorescent products and influence of solution compositionJ Pharm Sci1997861410-6
Gremeau ISautou-miranda VPicq FInfluence de la nature de la membrane sur le passage du nitrate d’isosorbide et de son metabolite actif au cours d’une dialyseJ Pharm Clin19971619-23
Graham AESpeicher EAnalysis of gentamicin sulfate and a study of its degradation in dextrose solutionJ Pharm Biomed Anal199715537-43
Craig SBBhatt UHStability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containersJ Pharm Biomed Anal199716199-205
Pramar YVLoucas VAChemical stability and adsorption of atracurium besylate injections in disposable plastic syringesJ Clin Pharm Ther199621173-5
Galanti LMHecq JDVanbeckbergen DLong-term stability of cefuroxime and cefazolin sodium in intravenous infusionsJ Clin Pharm Ther199621185-9
Kawano KTakamatsu SMochizuku CLoss of isosorbide dinitrate or nitroglycerin solution content in practice injection or precision continuous drip infusionJpn J Hosp Pharm199622167-72
Yoshida HTakaba DUchida YResearch for the crystal material produced in the continuous infusion line of midazloam (Dormicium) and butorphanol (Stadol)Jpn J Hosp Pharm199723531-8
Mawhinney WMAdair CGGorman SPLong-term stability of teicoplanin in dialysis fluid: implications for the home-treatment of CAPD peritonitisInt J Pharm Pract1991190-3
Allwood MCMartin HThe extraction of diethylhexylphthalate (DEHP) from polyvinyl chloride components of intravenous infusion containers and administration sets by paclitaxel injectionInt J Pharm199612765-71
Valiere CArnaud PCaroff EStability and compatibility study of a carboplatin solution in syringes for continuous ambulatory infusionInt J Pharm1996138125-8
Khalfi FDine TGressier BCompatibility and stability of vancomycin hydrochloride with PVC infusion material in various conditions using stability-indicating high-performance liquid chromatographic assayInt J Pharm1996139243-7
Hourcade FSautou-Miranda VNormand BCompatibility of granisetron towards glass and plastics and its stability under various storage conditionsInt J Pharm199715495-102
Rabouan-Guyon SMGuet AFCourtois PYStability study of cefepime in different infusion solutionsInt J Pharm1997154185-90
AnonHow I survived a direct injection of potassium chlorideHosp Pharm199732298-300
Kramer IStability of meropenem in elastomeric portable infusion devicesEur Hosp Pharm19973168-71
Uges DRARuige MVancomycin adsorption to teflon tubingEur Hosp Pharm1996238
Daouphars MVigneron JPerrin AStability of cladribine in either polyethylene containers or polyvinyl chloride bagsEurop Hosp Pharm19973154-6
Girona VPrat JPujol MStability of vinblastine sulphate in 0.9% sodium chloride in polypropylene syringesBoll Chim Farm1996135413-4
Smith BAHilmi SCMcDonald CThe stability of foscarnet in the presence of potassiumAust J Hosp Pharm199626560-1
Jaffe GJGreen GDJStability of recombinant tissue plasminogen activatorAm J Ophthal198910890-1
Ward CWeck SDilution and storage of recombinant tissue plasminogen activator (Activase) in balanced salt solutionsAm J Ophthal199010998-9
Grewing RMester U, Low MClinical experience with tissue plasminogen activator stored at -20°COphthalmic Surg199223780-1
Kramer IViability of microorganisms in novel antineoplastic and antiviral drug solutionsJ Oncol Pharm Pract1998432-7
Schneider JJWilson KMA study of the osmolality and pH of subcutaneous drug infusion solutionsAust J Hosp Pharm19972729-31
Vermeire ARemon JPThe solubility of morphine and the stability of concentrated morphine solutions in glass, polypropylene syringes and PVC containersInt J Pharm1997146213-23
Kearney MCJAllwood MCMartin HThe influence of amino acid source on the stability of ascorbic acid in TPN mixturesNutrition199814173-8
Casasin Edo TRoca Massa MSistema de distribucion de medicamentos utilizados en anestesia mediante jeringas precargadas. Estudio de estabilidadFarm Hosp19962055-9
Malcomson CZilka SSaum JInvestigations into the compatibility of teicoplanin with heparinEur J Parenter Sci1997251-5
Walker SEWalshaw PRImipenem stability and staining of teethCan J Hosp Pharm19975061-7
Liu LAmmar DARoss LASilicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandlingInvest Ophthalmol Vis Sci2011521023-34
Burm JPStability of ondansetron and fluconazole in 5% dextrose injection and normal saline during Y-site administrationArch Pharm Res199720171-5
Truelle-Hugon BTourrette GCouineaux BEtude de stabilite du chlorhydrate de morphine Lavoisier dans differents systemes actifs pour perfusion apres reconstitution dans divers solventsAnn Pharm Fr199755216-23
Sitaram BRTsui MRawicki HBStability and compatibility of intrathecal admixtures containing baclofen and high concentrations of morphineInt J Pharm199715313-24
Trinkle RCompatibility of hydromorphone and prochlorperazine, and irritation due to subcutaneous prochlorperazine infusionAnn Pharmacother199731789-90
Guchelar HJHartog MEDe stabiliteit van clonazepaminjectievloeistofZiekenhuisfarmacie19971321-3
Leboucher GCharpiat BIncompatibilite physico-chimique entre l’omeprazole et la vancomycinePharm Hosp Fr1997121124
Taylor AReview of clarithromycin mixturesPharm Pract(Oct) 19977473, 474, 476
Farhang-Asnafi SCallaert SBarre JInfluence du solvant de dilution sur la stabilite de la nouvelle forme de 5-fluorouracile en perfusionJ Pharm Clin19971645-8
Oustric-Mendes ACHuart BLe Hoang MDStudy protocol: stability of morphine injected without preservative, delivered with a disposable infusion deviceJ Clin Pharm Ther199722283-90
Schoffski PFreund MWunder RSafety and toxicity of amphotericin B in glucose 5% or Intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised studyBMJ1998317379-84
Heinemann VKahny BJehn USerum pharmacology of amphotericin B applied in lipid emulsionsAntimicrob Agents Chemother199741728-32
Gupta VDMaswoswe JStability of mitomycin aqueous solution when stored in tuberculin syringesInt J Pharm Compound19971282-3
Targett PLKeefe PACompatibility and stability of drug adjuvants and morphine tartrate in 10 mL polypropylene syringesAust J Hosp Pharm199727207-12
Goren MPLyman BAThe stability of mesna in beverages and syrup for oral administrationCancer Chemother Pharmacol199128298-301
Xu QATrissel LACompatibility of paclitaxel in 5% glucose and 0.9% sodium chloride injections with EVA minibagsAust J Hosp Pharm199828156-9
Xu QAZhang YPTrissel LAStability of busulfan injection admixtures in 5% dextrose injection and 0.9% sodium chloride injectionJ Oncol Pharm Pract19962101-5
Sarver JGPryka RAlexander KSStability of magnesium sulfate in 0.9% sodium chloride and lactated Ringer’s solutionsInt J Pharm Compound19982385-8
Jobet-Hermelin IMallvais MLJacquot CProposition d’une concentration limite acceptable du plastifiant librere par le poly(chlorure de vinyle) dans les solutions injectables aqueusesJ Pharm Clin199615132-6
Jacobson PAWest NJSpadoni VSterility of filgrastim (G-CSF) in syringesAnn Pharmacother1996301238-42
Trissel LASpadoni VTComment: filgrastim sterility in syringesAnn Pharmacother199731500-1
Appenheimer MMSchepart BSPoleon GPStability of albumin-free interferon alfa-2b for 42 daysAm J Health-Syst Pharm1998551602-5
Trissel LAGilbert DLConcentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administrationHosp Pharm1998331515-22
McLaughlin JPSimpson CHow stable is acyclovir in PVC bags? The stability of reconstituted acyclovir sodium in a 0.9% w/v sodium chloride infusion when stored at room temperaturePharm Pract1995553-8
Mehta ACKay EAHow stable is alfentanil? Stability of alfentanil hydrochloride in 5% dextrose stored in syringesPharm Pract19955303-4
McLaughlin JPSimpson CHow stable are Zinacef & Metrovex? The stability of cefuroxime sodium and metronidazole infusion when stored in a refrigeratorPharm Pract19955100-6
Bonferoni MCMellerio GGiunchedi PPhotostability evaluation of nicardipine HCl solutionsInt J Pharm199280109-17
Erdman SHMcElwee CLKramer JMCentral line occlusion with three-in-one nutrition admixtures administered at homeJPEN J Parenter Enteral Nutr199418177-81
GE Healthcare Inc. Visipaque^® (iodixanol) injection prescribing information. Marlborough, MA; 2023 Apr.
Hoie EBNarducci WALaser particle analysis of calcium phosphate precipitate in neonatal TPN admixturesJ Ped Pharm Pract19961163-7
Ambados FBrealey JIncompatibilities with trace elements during TPN solution admixtureAust J Hosp Pharm199828112-4
Xu QATrissel LACompatibility of paclitaxel injection diluent with two reduced-phthalate administration sets for the Acclaim pumpInt J Pharm Compound19982382-4
Stewart JTWarren FWKing DTStability of ondansetron hydrochloride and 12 medications in plastic syringesAm J Health-Syst Pharm1998552630-4
Donnelly RFBushfield TLChemical stability of meperidine hydrochloride in polypropylene syringesInt J Pharm Compound19982463-5
Jappinen ALKokki HRasi ASStability of sufentanil in a syringe pump under simulated epidural infusionInt J Pharm Compound19982466-8
Wilson KMSchneider JJStability of midazolam and fentanyl in infusion solutionsJ Pain Symptom Manage19981652-8
Gupta VDPramar YStability of lorazepam in 5% dextrose injectionInt J Pharm Compound19982322-4
Heide PEPrecipitation of amphotericin B from i.v. fat emulsionAm J Health-Syst Pharm1997541449
Heide PEHehenberger HTensiometrische und konduktometrische stabilitatuntersuchungen von amphotericin B in fettmulsionenOesterreichische Krankenhaus Pharmazie19961036-43
To TPGarrett MKStability of flucloxacillin in a hospital in the home programAust J Hosp Pharm199828289-90
Levanda MNoticeable difference in admixtures prepared from lorazepam 2 and 4 mg/mLAm J Health-Syst Pharm1998552305
Share MJHarrison RDFolstad JStability of lorazepam 1 and 2 mg/mL in glass bottles and polypropylene syringesAm J Health-Syst Pharm1998552013-5
Inagaki KKambara MMizuno MCompatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated Y-site administrationInt J Pharm Compound19982318-21
Ray LRChen DAStability of somatropin stored in plastic syringes for 28 daysAm J Health-Syst Pharm1998551508-11
Patel KCraig SBMcBride MGMicrobial inhibitory properties and stability of topotecan hydrochloride injectionAm J Health-Syst Pharm1998551584-7
English BARiggs RMWebster AAY-site stability of fosphenytoin and sodium phenobarbitalInt J Pharm Compound1999364-6
Lieu CLChin AFive-day stability of vinorelbine in 5% dextrose injection and in 0.9% sodium chloride injection at room temperatureInt J Pharm Compound1999367-8
Akkerman SRZhang HMullins REStability of milrinone lactate in the presence of 29 critical care drugs and 4 i.v. solutionsAm J Health-Syst Pharm19995663-8
Trissel LAGilbert DLMartinez JFCompatibility of medications with 3-in-1 parenteral nutrition admixturesJPEN J Parenter Enteral Nutr19992367-74
Johnson CEvandenBussche HLChio CCStability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministrationAm J Health-Syst Pharm199956164-9
Stamatakis MKLeader WGStability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutionsAm J Health-Syst Pharm199956246-8
Trissel LAMartinez JFCompatibility of etoposide phosphate with selected drugs during simulated Y-site injectionJ Am Pharm Assoc199939141-5
Zhang YTrissel LAPhysical and chemical stability of etoposide phosphate solutionsJ Am Pharm Assoc199939146-50
Stewart JTWarren FWStability of cefepime hydrochloride injection in polypropylene syringes at -20°C, 4°C, and 22-24°CAm J Health Syst Pharm199956457-9
Stewart JTMaddox FCStability of cefepime hydrochloride in polypropylene syringesAm J Health-Syst Pharm1999561134
Burkiewicz JSIncompatibility of ceftriaxone sodium with lactated Ringer’s injectionAm J Health-Syst Pharm199956384
Riggs RMEnglish BAWebster AAFosphenytoin Y-site stability studies with lorazepam and midazolam hydrochlorideInt J Pharm Compound19993235-8
Trissel LAGilbert DLCompatibility of docetaxel with selected drugs during simulated Y-site administrationInt J Pharm Compound19993241-4
Johnson CETruong NMStability and compatibility of tacrolimus and fluconazole in 0.9% sodium chlorideJ Am Pharm Assoc199939505-8
Trissel LAMartinez JFCompatibility of gemcitabine hydrochloride with 107 selected drugs during simulated Y-site injectionJ Am Pharm Assoc199939514-8
Xu QZhang YPhysical and chemical stability of gemcitabine hydrochloride solutionsJ Am Pharm Assoc199939509-13
Walker SEGray SStability of reconstituted indomethacin sodium trihydrate in original vials and polypropylene syringesAm J Health-Syst Pharm199855154-8
Schlatter JSaulnier JLInline filtration of ranitidine hydrochloride solutionsAm J Health-Syst Pharm199855840
Zhang YTrissel LAPaclitaxel compatibility with a triple-lumen polyurethane central catheterHosp Pharm199833547-51
Xu QATrissel LAPaclitaxel compatibility with the IV Express filter unitInt J Pharm Compound19982243-5
Xu QATrissel LAPaclitaxel compatibility with a TOTM-plasticized PVC administration setHosp Pharm1997321635-8
Saltsman CLTom CMMitchell ACompatibility of levofloxacin with 34 medications during simulated Y-site administrationAm J Health-Syst Pharm1999561458-9
Trissel LAGilbert DLCompatibility screening of gatifloxacin during simulated Y-site administration with other drugsHosp Pharm1999341409-16
Voytilla KLRusho WJCompatibility of alatrofloxacin mesylate with commonly used drugs during Y-site deliveryAm J Health-Syst Pharm2000571437-9
Johnson CETruong NMStability and compatibility of tacrolimus and fluconazole in 0.9% sodium chlorideJ Am Pharm Assoc199939505-8
Paul MVieillard VRoumi ELong-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administrationAnn Pharm Fr201270139-54
Balthasar JPConcentration-dependent incompatibility of vinorelbine tartrate and heparin sodiumAm J Health-Syst Pharm1999561891
Wolfe JLThoma LADu CCompatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injectionAm J Health-Syst Pharm199956985-9
Peek BTWebster KDStability and compatibility of promethazine hydrochloride and dihydroergotamine mesylate in combinationAm J Health-Syst Pharm1999561835-8
Webster AAEnglish BAMcGuire JMStability of dobutamine hydrochloride 4 mg/mL in 5% dextrose injection at 5 and 23 (CInt J Pharmaceut Compound19993412-4
Thiesen JKramer IPhysico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containersPharm World Sci199921137-41
Kramer IThiesen JStability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devicesJ Oncol Pharm Pract1999575-82
Hecq JDEvrard JMGillet PEtude de stabilite visuelle du chlorydrate de chlorpromazine, du chlorure de potassium, de la furosemide et de l’heparine sodique en perfusion continuePharmakon1998116145-8
Mayron DGennaro ARStability and compatibility of topotecan hydrochloride with selected drugsAm J Health-Syst Pharm199956875-81
Harvey SCToussaint CPCoe SEStability of meperidine in an implantable infusion pump using capillary gas chromatography-mass spectrometry and a deuterated internal standardJ Pharm Biomed Anal199921577-83
Trissel LAXu QACompatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutionsAnn Pharmacother1998321013-6
Rogers CH, Soine TO, Wilson CO. A text-book of inorganic pharmaceutical chemistry. 4th ed. Philadelphia: Lea and Febiger; 1948: 152.
Bergquist PAZimmerman JKenney RRStability of tirofiban hydrochloride in three commonly used i.v. solutions and polyvinyl chloride administration setsAm J Health-Syst Pharm1999561627-9
Bergquist PAHunke WAReed RACompatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administrationJ Clin Pharm Ther199924125-32
McLaughlin JP, Simpson C. How stable is ganciclovir? Pharm Pract. 1998; 8:329-30, 332
Galanti LMHecq JDVanbeckbergen DLong-term stability of vancomycin hydrochloride in intravenous infusionsJ Clin Pharm Ther199722353-6
Hor MMSChan SYYow KLStability of admixtures of pethidine and metoclopramide in aqueous solution, 5% dextrose and 0.9% sodium chlorideJ Clin Pharm Ther199722339-45
Hor MMChan SYYow KLStability of morphine sulphate in saline under simulated patient administration conditionsJ Clin Pharm Ther199722405-10
Mittner AVincze ZStability of cyclophosphamide containing infusionsPharmazie199954224-5
Mittner AVincze ZStability of vinblastine sulphate containing infusionsPharmazie199954625-6
Schrijvers DTai-Apin CDe Smet MCDetermination of compatibility and stability of drugs used in palliative careJ Clin Pharm Ther199823311-4
Kopelent-Frank HSchimper AHPTLC-based stability assay for the determination of amiodarone in intravenous admixturesPharmazie199954542-4
Inagaki KMiyamoto YKurata NStability of ranitidine hydrochloride with cefazolin sodium, cefbuperazone sodium, cefoxitin sodium, and cephalothin sodium during simulated Y-site administrationInt J Pharmaceut Compound20004150-3
Roy JJHildgen PStability of morphine-ketamine mixtures in 0.9% sodium chloride injection packaged in syringes, plastic bags and Medication Cassette reservoirsInt J Pharmaceut Compound20004225-8
Grant EMZhong MKAmbrose PGStability of meropenem in a portable infusion device in a cold pouchAm J Health-Syst Pharm200057992-5
Xu QATrissel LACompatibility and stability of linezolid injection admixed with three cephalosporin antibioticsJ Am Pharm Assoc200040509-14
Zhang YXu QATrissel LACompatibility and stability of linezolid injection admixed with aztreonam or piperacillin sodiumJ Am Pharm Assoc200040520-4
Trissel LAWilliams KYCompatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutionsJ Am Pharm Assoc200040515-9
Zhang YXu QATrissel LAPhysical compatibility of calcium acetate and potassium phosphates in parenteral nutrition solutions containing Aminosyn IIInt J Pharmaceut Compound19993415-20
Ambados FBrealey JPrecipitation of potassium sulphate during TPN solution admixtureAust J Hosp Pharm199828444
Ambados FDestabilization of fat emulsion in total nutrient admixtures by concentrated albumin 20% infusionAust J Hosp Pharm199929210-2
Peterson GMMiller KAGalloway JGCompatibility and stability of fentanyl admixtures in polypropylene syringes J Clin Pharm Ther199823167-72
Picard CHary LBou PStability of three aminoglycoside solutions in PVC and multilayer infusion bagsPharmazie199954854-6
Shella CHow to shake insulinHosp Pharm199934518
Bjorkman SRoth BChemical compatibility of mitoxantrone and etoposide (VP-16)Acta Pharm Nord19913251
Charland SLDavis DDActivity of enoxaparin sodium in tuberculin syringes for 10 daysAm J Health-Syst Pharm1998551296-8
Couldry RSanborn MKlutman NEContinuous infusion of ceftazidime with an elastomeric infusion deviceAm J Health-Syst Pharm199855145-9
Tanoue NKishita SShiotsu KCompatibility of irinotecan hydrochloride injection with other injectionsJpn J Hosp Pharm199824420-8
Stiles MLAllen LV JrStability of two concentrations of heparin sodium prefilled in CADD-Micro pump syringesInt J Pharmaceut Compound19971433-4
Nii LJChin ACao TMStability of sumatriptan succinate in polypropylene syringesAm J Health-Syst Pharm199956983-5
Proot PVan Schepdael ARaymakers AAStability of adenosine in infusionJ Pharm Biomed Anal199817415-8
Biellmann-Berlaud VWillemin JCStabilite de la vancomycine en poches de polyolefine ou polychlorure de vinyle et en flacons de verre J Pharm Clin1998173145-8
Mylan Institutional LLC. Ascorbic acid injection prescribing information. Rockford, IL; 2016 Dec.
Demange CVailleau JLWacquier SEtude de photosensibilite et fixation de la chlorpromazine sur le chlorure de polyvinyle pour administration en perfusion intraveineuseJ Pharm Clin19981777-82
Saito HTanida NInukai KStability of iphosphamide and mesna in mixed infusion solutionsJpn J Hosp Pharm19982496-99
Silvers KMDarlow BA, Winterbourn CCPharmacologic levels of heparin do not destabilize neonatal parenteral nutritionJPEN J Parenter Enteral Nutr199822311-4
Williamson JCVolles DFLynch PLMStability of cefepime in peritoneal dialysis solutionAnn Pharmacother199933906-9
Kramer IMaas BCompatibility of amsacrine (Amsidyl) concentrate for infusion with polypropylene syringesPharmazie199954538-41
Farina APorra RCotichini VStability of reconstituted solutions of ceftazidime for injections: an HPLC and CE approachJ Pharm Biomed Anal199920521-30
Yokoyama HAoyama TMatsuyama TThe cause of polyurethane catheter cracking during constant infusion of etoposide (VP-16) injectionYakugaku Zasshi1998118581-8
Torres-Bondia FICarmona-Ibanez GGuevara-Serrano JEstabilidad del valproate sodico en fluidos intravenososFarm Hosp199923320-2
Priston MJSewell GJStability of three cytotoxic drug infusions in the Graseby 9000 ambulatory infusion pumpJ Oncol Pharm Pract19984143-9
Zeidler CDettmering DSchrammel WCompatibility of various drugs used in intensive care medicine in polyethylene, PVC, and glass infusion containersEurop Hosp Pharm19995106-10
Goettner K (Scientific Affairs, Janssen, Horsham, PA): Personal communication; 2016 Apr 29.
Shay DKFann LMRespiratory distress and sudden death associated with receipt of a peripheral parenteral nutrition admixtureInfect Control Hosp Epidemiol199718814-7
Zhan XYin GImproved stability of 25% vitamin C parenteral formulationInt J Pharm199817343-9
Mittner AVincze ZStability of cisplatin containing infusionsPharmazie199853490-2
Carleton BCPrimmett DRLevine MSterility of unit-dosing filgrastim (G-CSF) J Ped Pharm Pract1999468-74
Oliva ASantovena ALlabres MStability study of human albumin pharmaceutical preparationsJ Pharm Pharmacol199951385-92
Stephens DBares DRobinson DDetermination of amylose/particulate relationship in hydroxyethylstarchPDA J Pharm Sci Technol199953181-5
Parsons TJUpton RNMartinez AMNo loss of undiluted propofol by sorption into administration systemsPharm Pharmacol Commun19995377-81
Brigas FSautou-Miranda VNormand BCompatibility of tropisetron with glass and plastics. Stability under different storage conditionsJ Pharm Pharmacol1998504407-11
Tse CST, Abdullah, RDissolving phenytoin precipitate in central venous access deviceAnn Intern Med19981281049
Akinwande KIKeehn DMDissolution of phenytoin precipitate with sodium bicarbonate in an occluded central venous access deviceAnn Pharmacother199529707-9
Fuloria MFriedberg MADuRant RHEffect of flow rate and insulin priming on the recovery of insulin from microbore infusion tubingPediatrics19981021401-6
Muller HJFrank CStabilitatstudie zu pentoxifyllin im PVC-infusionsbeutelKrankenhauspharmazie199819469-72
Stahlmann SAFrey ORStabilitatstudie zu fosfomycin-dinatrium (Fosfocin p.i. 5,0) in applikationfertigen perfusorspritzenKrankenhauspharmazie199819553-7
Muller HJFrank CStabilitatstudie zu alizaprid im PVC-infusionsbeutelKrankenhauspharmazie19992055-8
Sattler AJage JPhysico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocainePharmazie199853386-91
Laborie SLavoie JCPineault MProtecting solutions of parenteral nutrition from peroxidation JPEN J Parenter Enteral Nutr1999232104-8
Wakiya YSaiki AKondou NStability of vitamins in the TPN mixture at a clinical siteJpn J Hosp Pharm19992540-7
Pertkkiewicz MKnyt AMajewska KBadania stabilnosci mieszanin odzywczych z aminomel 10%E i aminomel 12,5%E oraz emulsja tluszczowa ivelip 10% i 20% Farm Polska19995516756-63
Brawley VBhatia JEffect of sodium metabisulfite on hydrogen peroxide production in light-exposed pediatric parenteral amino acid solutionsAm J Health-Syst Pharm1998551288-92
Brawley VBhatia JHydrogen peroxide generation in a model paediatric parenteral amino acid solutionClin Sci199385709-12
McGuff Pharmaceuticals, Inc. Ascor^® (ascorbic acid) injection prescribing information. Santa Ana, CA; 2017 Oct.
Malesker MAMalone PMCingle CMExtravasation of i.v. promethazineAm J Health-Syst Pharm1999561742-3
Boersma HHGroothuijsen HJGStolk LMLGoed loudbaar onder normale omstandighedenPharmaceut Weekblad19991341444-8
Akorn, Inc. Ephedrine sulfate injection for IM, IV, or SC use prescribing information. Lake Forest, IL; 2012 Dec.
Khalfi FDine TGressier BCompatibility of cefpirome and cephalothin with PVC bags during simulated infusion and storagePharmazie199853112-6
Laborie SLavoie JCPineault MContribution of multivitamins, air, and light in the generation of peroxides in adult and neonatal parenteral nutrition solutionsAnn Pharmacother200034440-5
Laborie SLavoie JCParadoxical role of ascorbic acid and riboflavin in solutions of total parenteral nutrition: implication in photoinduced peroxide generationPediat Res199843601-6
Rhoney DHCoplin WMUrokinase activity after freezing: implications for thrombolysis in intraventricular hemorrhageAm J Health-Syst Pharm1999562047-51
Hrubisko MMcGown ATPrendiville JASuitability of cisplatin solutions for 14-day continuous infusion by ambulatory pumpCancer Chemother Pharmacol199229252-5
Dine TKhalfi FGressier BStability study of fotemustine in PVC infusion bags and sets under various conditions using a stability-indicating high-performance liquid chromatographic assayJ Pharm Biomed Anal199818373-81
Hadfield JAMcGown ATDawson MJThe suitability of carboplatin solutions for 14-day continuous infusion by ambulatory pump: an HPLC-dynamic FAB studyJ Pharm Biomed Anal199311723-7
Frey ORMaier LPolyethylene vials of calcium gluconate reduce aluminum contamination of TPNAnn Pharmacother200034811-12
Louie SChin AActivity of dalteparin sodium in polypropylene syringesAm J Health-Syst Pharm200057760-2
Stewart JTMaddox FCStability of cefepime hydrochloride injection and metronidazole in polyvinyl chloride bags at 4°C and 22°C-24°CHosp Pharm2000351057-64
Ling JGupta VDStability of nafcillin sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric useInt J Pharmaceut Compound20004480-1
Gupta VDStability of levothyroxine sodium injection in polypropylene syringesInt J Pharmaceut Compound20004482-3
Davis SNVermeulen LBanton JActivity and dosage of alteplase dilution for clearing occlusions of venous-access devicesAm J Health-Syst Pharm2000571039-45
Generali JCada DJAlteplase (t-PA) bolus: occluded cathetersHosp Pharm20013693-103
Phelps KCVerzino KCAlternatives to urokinase for the management of central venous catheter occlusionHosp Pharm200136265-74
Haire WDHerbst SLUse of alteplase (t-PA) for the management of thrombotic catheter dysfunction: guidelines from a consensus conference of the National Association of Vascular Access Networks (NAVAN)Nutr Clin Pract200015265-75
Gupta VDLing JStability of hydrocortisone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric useInt J Pharmaceut Compound20004396-7
Xu QATrissel LAZhang YCompatibility and stability of linezolid injection admixed with gentamicin sulfate and tobramycin sulfateInt J Pharmaceut Compound20004476-9
Trissel LAZhang YIncompatibility of erythromycin lactobionate and sulfamethoxazole/trimethoprim with linezolid injectionHosp Pharm2000351192-6
Zhang YXu QATrissel LACompatibility and stability of linezolid injection admixed with three quinolone antibioticsAnn Pharmacother200034996-1001
Xu QAZhang YTrissel LAAdequacy of a new chlorhexidine-bearing polyurethane central catheter for administration of 82 selected parenteral drugsAnn Pharmacother2000341109-16
Trissel LADrug compatibility differences with propofol injectable emulsion productsCrit Care Med200129466-8
Favier MDe Cazanove FCoste AStability of carmustine in polyvinyl chloride bags and polyethylene-lined trilayer plastic containersAm J Health-Syst Pharm2001583238-41
Zhang YTrissel LACompatibility of linezolid injection with intravenous administration setsJ Am Pharm Assoc200141285-6
Trissel LAWilliams KYCompatibility screening of Hextend during simulated Y-site administration with other drugsInt J Pharmaceut Compound2001569-73
Gupta VDChemical stability of methylprednisolone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringesInt J Pharmaceut Compound20015148-50
Ling JGupta VDStability of cefepime hydrochloride after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric useInt J Pharmaceut Compound20015151-2
Sterling JIntralipids and tubing changesHosp Pharm200136258-9
Yuan PGrimes GJShankman SECompatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injectionAm J Health-Syst Pharm200158594-8
Baker MTYellowing of metabisulfite-containing propofol emulsionAm J Health-Syst Pharm2001581042
Gupta VDLing JStability of piperacillin sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric useInt J Pharmaceut Compound20015230-1
Bethune KAllwood MGrainger CUse of filters during the preparation and administration of parenteral nutrition: position paper and guidelines prepared by a British Pharmaceutical Nutrition Group Working PartyNutrition200117403-8
Gellis CSautou-Miranda VArvouet AStability of methylprednisolone sodium succinate in pediatric parenteral nutrition mixturesAm J Health-Syst Pharm2001581139-42
Redhead HMJones CBPharmaceutical and antimicrobial differences between propofol emulsion productsAm J Health-Syst Pharm2000571174
Mirejovsky DGhosh MPharmaceutical and antimicrobial differences between propofol emulsion productsAm J Health-Syst Pharm2000571176-7
Trissel LAZhang YThe stability of diluted vincristine sulfate used as a deterrent to inadvertent intrathecal injectionHosp Pharm200136740-5
Thoma LAJohnson-Singh AWood GCPhysical compatibility of 10% alcohol in 5% dextrose injection with selected drugs during simulated Y-site administrationAm J Health-Syst Pharm2000572286-7
Chalmers JRBobek MBMilitello MAVisual compatibility of amiodarone hydrochloride injection with various intravenous drugsAm J Health-Syst Pharm200158504-6
Gupta VDBailey REStability of alatrofloxacin mesylate in 5% dextrose injection and 0.45% sodium-chloride injectionInt J Pharmaceut Compound2000466-8
Gupta VD. Stability of levothyroxine sodium injection in polypropylene syringes, Int J Pharmaceut Compound. 2000; 4:482-3
Garabito MJJimenez LBautista FJStability of tirofiban hydrochloride in 0.9% sodium chloride injection for 30 daysAm J Health-Syst Pharm2001581850-1
Bergquist PAManas DHunke WAStability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugsAm J Health-Syst Pharm2001581218-23
Seto WTrope ACarfrae LVisual compatibility of sodium nitroprusside with other injectable medications given to pediatric patientsAm J Health-Syst Pharm2001581422-6
Zhang YTrissel LAStability of piperacillin and ticarcillin in AutoDose infusion system bagsAnn Pharmacother2001351360-3
Godwin DAKim NHZuniga RStability of baclofen and clonidine hydrochloride admixture for intrathecal administrationHosp Pharm200136950-4
Quay ITan ECompatibility and stability of potassium chloride and magnesium sulfate in 0.9% sodium chloride injection and 5% dextrose injection solutionsInt J Pharmaceut Compound20015323-4
Vega ESola NQuantitative analysis of metronidazole in intravenous admixture with ciprofloxacin by first derivative spectrophotometryJ Pharm Biomed Anal200125523-30
Inagaki KMiyamoto YKurata NStability of ranitidine hydrochloride with cefazolin sodium, cefbuperazone sodium, cefoxitin sodium and cephalothin sodium during simulated Y-site administrationInt J Pharmaceut Compound20004150-3
Trissel LAXu QAZhang YStability of ciprofloxacin and vancomycin hydrochloride in AutoDose infusion system bagsHosp Pharm2001361170-3
Galanti LMHecq JDJeuniau PAssessment of the stability of teicoplanin in intravenous infusionsInt J Pharmaceut Compound20015397-400
Storms MLStewart JTWarren FWStability of ephedrine sulfate at ambient temperature and 4;dgC in polypropylene syringesInt J Pharmaceut Compound20015394-6
Faouzi MAKhalfi FDine TStability, compatibility and plasticizer extraction of quinine injection added to infusion solutions and stored in polyvinyl chloride (PVC) containersJ Pharmaceut Biomed Anal199921923-30
della Cuno FSR, Mella M, Magistrali G, et al. Stability and compatibility of methylprednisolone acetate and ropivacaine hydrochloride in polypropylene syringes for epidural administration, Am J Health-Syst Pharm. 2001; 58:1753-6
Voytilla KLTyler LSRusho WJVisual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site deliveryAm J Health-Syst Pharm200259853-5
Trissel LAZhang YBaker MBStability of fenoldopam mesylate in two infusion solutionsAm J Health-Syst Pharm200259846-8
Xu QA, Trissel LA, Saenz CA, et al. Stability of three cephalosporin antibiotics in AutoDose infusion system bags, J Am Pharm Assoc. 2002; 42:428-31
Gupta VDStability of cefotaxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric useInt J Pharmaceut Compound20026234-6
Walker SEDufour AIazzetta JConcentration and solution dependent stability of cloxacillin intravenous solutionsCan J Hosp Pharm19985113-9
Trissel LASaenz CACompatibility screening of bivalirudin during simulated Y-site administration with other drugsInt J Pharmaceut Compound20026311-4
GE Healthcare Inc. Visipaque^® (iodixanol) injection pharmacy bulk package prescribing information. Marlborough, MA; 2023 Apr.
Li WYKoda RTStability of irinotecan hydrochloride in aqueous solutionsAm J Health-Syst Pharm200259539-44
Trissel LAXu QAPham LPhysical and chemical stability of morphine sulfate 5 mg/mL and 50 mg/mL packaged in plastic syringesInt J Pharmaceut Compound2002662-5
Trissel LAXu QAPham LPhysical and chemical stability of hydromorphone hydrochloride 1.5 mg/mL and 80 mg/mL packaged in plastic syringesInt J Pharmaceut Compound2002674-6
Trissel LAXu QAPham LPhysical and chemical stability of low and high concentrations of morphine sulfate with bupivacaine hydrochloride packaged in plastic syringesInt J Pharmaceut Compound2002670-3
Xu QATrissel LASaenz CAStability of gentamicin sulfate and tobramycin sulfate in AutoDose infusion system bagsInt J Pharmaceut Compound20026152-4
Xu QATrissel LAPham LPhysical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringesInt J Pharmaceut Compound2002666-9
Veltri MAConner KGPhysical compatibility of milrinone lactate injection with intravenous drugs commonly used in the pediatric intensive care unitAm J Health-Syst Pharm200259452-4
Elwell RJSpencer APBarnes JFStability of furosemide in human albumin solutionAnn Pharmacother200236423-6
Trissel LASaenz CAIngram DSCompatibility screening of Precedex during simulated Y-site administration with other drugsInt J Pharmaceut Compound20026230-3
Zhang YTrissel LAStability of ampicillin sodium, nafcillin sodium, and oxacillin sodium in AutoDose infusion system bagsInt J Pharmaceut Compound20026226-9
Stewart JTStorms MLWarren FWStability of tubocurarine chloride injection at ambient temperature and 4;dgC in polypropylene syringesInt J Pharmaceut Compound20026308-10
El Aatmani MPoujol SAstre CStability of dacarbazine in amber glass vials and polyvinyl chloride bagsAm J Health-Syst Pharm2002591351-6
Jappinen AKokki HNaaranlahti TpH stability of injectable fentanyl, bupivacaine, or clonidine solution or a ternary mixture in 0.9% sodium chloride in two types of propylene syringesInt J Pharmaceut Compound20026471-4
Wu CCWand DPWong CYStability of cefazolin in heparinized and nonheparinized peritoneal dialysis solutionsAm J Health-Syst Pharm2002591537-8
Donnelly RFChemical stability of furosemide in minibags and polypropylene syringesInt J Pharmaceut Compound20026468-70
Schlesser VHecq JDVanbeckbergen DEffect of freezing, long-term storage, and microwave thawing of the stability of cefepime in 5% dextrose infusion in polyvinyl chloride bagsInt J Pharmaceut Compound20026391-4
Hartman CABaroletti SAChurchill WWVisual compatibility of argatroban with selected drugsAm J Health-Syst Pharm2002591784-5
Gupta VDChemical stability of dexamethasone sodium phosphate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringesInt J Pharmaceut Compound20026395-7
Trissel LAZhang YStability of methylprednisolone sodium succinate in AutoDose infusion system bagsJ Am Pharm Assoc200242868-70
Certain EBeteta FGoudou-Sinha CStability of i.v. mycophenolate mofetil in 5% dextrose injection in polyvinyl chloride infusion bagsAm J Health-Syst Pharm2002592434-9
Beijnen JHvan Gijn RChemical stability of the cardioprotective agent ICRF-187 in infusion fluidsJ Parenter Sci Technol199347166-71
Fatou A, Denis P, Conrath G, et al. Campto 20 mg/mL concentrate for infusion, stability during infusion, stability of the diluted parenteral solution prepared ahead of time in glass bottles and PVC bags
Bobineau V, Nguyen-Huu JJ. CPT-11 (RP 64174A) 20 mg/mL solution for injection, study of the stability of infusion solutions reconstituted in glass bottles or PVC infusion bags after 24 hours’ storage at room temperature
Stolk LML, Chandi LS. Stabiliteit van cladribine in natriumchloride-oplossing 0,9% voor infusie, Ziekenhuisfarmacie. 1994; 10:138-9
Tiefenbacher EMHaen EPrzybilla BPhotodegradation of some quinolones used as antimicrobial therapeuticsJ Pharm Sci199483463-7
Calis KACullinane AMHorne MKBioactivity of cryopreserved alteplase solutionsAm J Health-Syst Pharm1999562056-7
Kaijser GPBeijnen JHBult AA systematic study on the chemical stability of ifosfamideJ Pharmaceut Biomed Anal199191061-7
Lau DWCWalker SEFremes SEAdenosine stability in cardioplegic solutionsCan J Hosp Pharm199548167-71
Muller HJ, Berg J. Stabilitatstude zu apomorphine-hydrochlorid im PVC-infusionsbeutel, Krankenhauspharmazie. 1997; 18:468-73
Andrisano VGotti RLeoni APhotodegradation studies on atenolol by liquid chromatographyJ Pharmaceut Biomed Anal199921851-7
Blaise NVigeron JPerrin AStability of refrigerated and frozen solutions of ondansetron hydrochlorideEur J Hosp Pharm1994412-3
Lougheed WDWoulfe-Flanagan HClement JRInsulin aggregation in artificial delivery systemsDiabetologia1980191-9
Meyer GHenneman PLBuffered lidocaineAnn Emerg Med199120218-9
Murakami CSOdland PBRoss BKBuffered local anesthetics and epinephrine degradationJ Dermatol Surg Oncol199420192-5
Hinshaw KDFiscella RSugar JPreparation of pH-adjusted local anestheticsOphthalmol Surg199526194-9
Avelar MAWalker SEStability and compatibility of reconstituted hydromorphone with potassium chloride or heparinCan J Hosp Pharm199649140-5
Crowther JHrazdil JJolly DTGrowth of microorganisms in propofol, thiopental, and a 1:1 mixture of propofol and thiopentalAnesth Analg199682475-8
El-Yazigi AWahab FamAfrane BStability study and content uniformity of prochlorperazine in pharmaceutical preparations by liquid chromatographyJ Chromatog A199569071-6
Ekmore RLContois MEKelly KStability and compatibility of admixtures of intravenous ciprofloxacin and selected drugsClin Ther199618246-55
Luo DDong HTang XZStability of amphotericin B in 50 g/L dextrose injectionChin Pharm J199833220-2
Sewell GJAllsopp MCollinson MPStability studies on admixtures of 5-fluorouracil with carboplatin and 5-fluorouracil with heparin for administration in continuous infusion regimensJ Clin Pharm Ther199419127-33
Lugo RAMacKay MRucho WJStability of lorazepam 0.2 mg/L, 0.5 mg/mL, and 1 mg/mL in polypropylene syringesJ Pediatr Pharmacol Ther20016122-9
Zhao LYalkowsky SHStabilization of epitifibitide by cosolventsInt J Pharm200121843-56
Gupta VDLing JStability of piperacillin sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric useInt J Pharmaceut Compound20015 230-1
Thiesen JKramer IPhysicochemical stability of irinotecan injection concentrate and diluted infusion solutions in PVC bagsJ Oncol Pharm Pract20006115-21
Beitz CEinberger CWehling MStabilitat und Kompatibilitat von Zytostatika-Zubereitungen mit Infusionslosungsbehaltern aus PolyethyleneKrankenhauspharmazie199920121-5
Favetta PAllombert CBreysse CFortum stability in different disposable infusion devices by pyridine assayJ Pharmaceut Biomed Anal200227873-9
Orwa JAGovaerts CGevers KStudy of the stability of polymyxins B₁, E₁, and E₂ in aqueous solution using liquid chromatography and mass spectrometryJ Pharmaceut Biomed Anal200229203-12
Mayer MIWeickum RJSolimando DAStability of cisplatin, doxorubicin, and mitomycin combined with Iversol for chemoembolizationAnn Pharmacother2001351548-51
Loff SKabs FWitt KPolyvinylchloride infusion lines expose infants to large amounts of toxic plasticizersJ Ped Surg2000351775-81
Storms MLStewart JTWarren FWStability of neostigmine methylsulfate injection at ambient temperature and 4;dgC in polypropylene syringesInt J Pharmaceut Compound20026475-7
Ulsaker GTeien GDegradation of methylprednisolone sodium succinate in a diluent-containing vialAm J Health-Syst Pharm2002592456-7
Johnson TJVoss GContinuous infusion of undiluted lorazepam injectionAm J Health-Syst Pharm20025978-9
Storms MLStewart JTWarren FWStability of lidocaine hydrochloride injection at ambient temperature and 4;dgC in polypropylene syringesInt J Pharmaceut Compound20026388-90
Gupta VDStability of pentobarbital sodium after reconstitution in 0.9% sodium chloride injection and repackaged in glass and polypropylene syringesInt J Pharmaceut Compound20016482-4
Beitz CBertsch THannak DCompatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materialsInt J Pharm1999185113-21
Gupta VD: Stability of ketamine hydrochloride injection after reconstitution in water for injection and storage in 1-mL tuberculin polypropylene syringes for pediatric use. Int J Pharmaceut Compound. 2002; 6:316-7
Andrisano VHrelia PGotti RPhotostability and phototoxicity studies on diltiazemJ Pharmaceut Biomed Anal200125589-97
Svedberg KOMcKenzie EJLarrivee-Elkins CCompatibility of ropivacaine with morphine, sufentanil, fentanyl, or clonidineJ Clin Pharm Ther20022739-45
Servais HTulkens PMStability and compatibility of ceftazidime administered by continuous infusion to intensive care patientsAntimicrob Agents Chemother2001452643-7
Parti RMankarious SStability assessment of lyophilized intravenous immunoglobulin after reconstitution in glass containers and poly(vinyl chloride) bagsBiotechnol Appl Biochem19972313-8
Jappinen AKokki HNaaranlahti TJStability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solutionPharm World Sci199921272-4
Jappinen AKokki HNaaranlahti TJChemical stability of a mixture of fentanyl citrate, bupivacaine hydrochloride and clonidine hydrochloride in 0.9% sodium chloride injection stored in syringes and medication cassettesPharm World Sci Suppl1996A11119-21
Storms MLStewart JTWarren FWStability of succinylcholine chloride injection at ambient temperature and 4;dgC in polypropylene syringesInt J Pharmaceut Compound2003768-70
Storms MLStewart JTWarren FWStability of glycopyrrolate injection at ambient temperature and 4;dgC in polypropylene syringesInt J Pharmaceut Compound2003765-7
Mitchell ALGailey RACompatibility of caffeine citrate with other medications commonly used in a neonatal intensive care unitJ Pediatr Pharm Pract19994239-42
Wang DPLee DKTWang CNStability of sodium cefazolin and tenoxicam in 5% dextroseChin Pharmaceut J200153185-9
Shi AWalker SELaw SStability of ketorolac tromethamine in IV solutions and waste reductionCan J Hosp Pharm200053263-9
Yano RNakamura TAono HThe amount of the loss of cyclosporine A dose correlated with the amount of leaching di (2-ethylhexyl) phthalate from polyvinyl chloride infusion tubeYakugaku Zasshi2001121139-44
Micard SRieutord APrognon PStability and sterility of meglumine gadoterate injection repackaged in plastic syringesInt J Pharm200121293-9
Han HDavis SSWashington CPhysical properties and stability of two emulsion formulations of propofolInt J Pharm2001215207-20
Deitcher SRFesen MRKiproff PMSafety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trialJ Clin Oncol200220317-24
Demore DVigeron JPerrin ALeaching of diethylhexyl phthalate from polyvinyl chloride bags into intravenous etoposide solutionJ Clin Pharm Ther200227139-42
Sakazume SSasahara KKawada TThe adsorption of recombinant factor VIII (Kogenate) to infusion sets and inline filtersJpn J Pharm Health Care Sci200127143-7
Little G (Director, Drug Information, Wyeth-Ayerst Pharmaceuticals, Philadelphia, PA): Personal communication; 1999 Mar 5
Hecq JD, Lebrun J, Vanbeckbergen D, et al. Effect of freezing, long-term storage, and microwave thawing on the stability of ketorolac tromethamine and tramadol hydrochloride in 5% dextrose infusion
Nguyen-Huu JJ, Bousquet O, Bobee JM. Compatibility of taxotere infusion solution with intravenous administration/extension sets, Rhone Poulenc Rorer, 2002
Suzuki MTakamatsu SMuramatsu ELoss of tacrolimus solution content and leaching of di-2-ethylhexyl phthalate in practice injection of precision continuous drip infusionJpn J Hosp Pharm2000267-12
He YYu YCStudy on the stability of tetracaine hydrochloride injectionChin Pharm J20013633-5
Chikuma TShinoda TTaguchi KStability of morphine hydrochloride in a total parenteral nutrient solutionJpn J Hosp Pharm200026316-21
Farhang-Asnafi SBarre JCallaert SCompatibilite et stabilite du m;aaelange bupivacaine-sufentanil en pocheJ Pharm Clin200019248-51
Pereboom MBecker MLAmenchar MStability assessment of repackaged bevacizumab for intravitreal administrationInt J Pharm Compd2015 Jan-Feb1970-2
Khalili HSharma GFroome AStorage stability of bevacizumab in polycarbonate and polypropylene syringesEye (Lond)201529820-7
Ball PA. Particulate contamination in parenteral nutrition solutions: still a cause for concern? Nutrition. 2001; 17:926-9
Allwood MCMartin HJThe photodegradation of vitamin A and E in parenteral nutrition mixtures during infusionClin Nutr200019339-42
Sforzini ABersani GStancari AAnalysis of all-in-one parenteral nutrition admixtures by liquid chromatography and laser diffraction: study of stabilityJ Pharmaceut Biomed Anal2001241099-1109
Gibbons EAllwood MCNeal TDegradation of dehydroascorbic acid in parenteral nutrition mixturesJ Pharmaceut Biomed Anal200125605-11
Proot Pde Pourcq LRaymakes AAStability of ascorbic acid in a standard total parenteral nutrition mixtureClin Nutr199413273-9
Allwood MCBrown PWGhedini CThe stability of ascorbic acid in TPN mixtures stored in a multilayer bagClin Nutr199211284-8
Hak EBStorm MCHelms RAChromium and zinc contamination of parenteral nutrient solution components commonly used in infants and childrenAm J Health-Syst Pharm199855150-4
Mehta RCHead LFHazrati AMFat emulsion particle-size distribution in total nutrient admixturesAm J Hosp Pharm1992492749-55
Song YHBurgess DJHerson VCSolubility of calcium acetate (CaAce) and sodium phosphate (NaP) in pediatric parenteral nutrition (PN) solutionJ Parenter Enteral Nutr200024S22
Trissel LASaenz CAOgundele ABCompatibility of fenoldopam mesylate with other drugs during simulated Y-site administrationAm J Health-Syst Pharm20036080-5
Levadoux ESautou VBazin JEMedical plastics: compatibility of alfentanil and propofol alone or mixed. Stability of the alfentanil-propofol mixtureInt J Pharm1996127255-9
Trissel LAXu QZhang YUse of cysteine hydrochloride injection to increase the solubility of calcium and phosphates in FreAmine III-containing parenteral nutrition solutionsInt J Pharmaceut Compound2003771-3
Bell MSNolt DHVisual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nurseryAm J Health-Syst Pharm200360193-4
Trissel LAXu QAStability of Imipenem-cilastatin sodium in AutoDose infusion system bagsHosp Pharm200338130-4
Naughton CADuppong LMForbes KDStability of multidose, preserved formulation epoetin alfa in syringes for three and six weeksAm J Health-Syst Pharm200360464-8
Xu QA, Trissel LA. Stability of clindamycin phosphate in AutoDose infusion system bags, Int J Pharmaceut Compound. 2003; 7:149-51
Gupta VDChemical stability of cefazolin sodium after reconstituting in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric useInt J Pharmaceut Compound20037152-4
Zhang YTrissel LAStability of amikacin sulfate in AutoDose infusion system bagsInt J Pharmaceut Compound20037230-2
Phares KRWeiser WEMiller SPStability and preservative effectiveness of treprostinil sodium after dilution in common intravenous diluentsAm J Health-Syst Pharm200360916-22
Hildebrand KRElsberry DDHassenbusch SJStability and compatibility of morphine-clonidine admixtures in an implantable infusion systemJ Pain Symp Manage200325464-71
Feddema SRusho WJTyler LSPhysical compatibility of vasopressin with medications commonly used in cardiac arrestAm J Health-Syst Pharm2003601271-2
Trissel LAXu QAStability of cefepime hydrochloride in AutoDose infusion system bagsAnn Pharmacother200337804-7
Lin YFWu CCLin SHStability of cefazolin sodium in icodextrin-containing peritoneal dialysis solutionAm J Health-Syst Pharm2002592362-3
Cohen M (President, Institute for Safe Medication Practices, Huntingdon Valley, PA): Personal communication; 2003 Sep 5
Greenberg LErrors and near misses linked to i.v. administration of sterile water for injectionPharm Pract News20033024
Roberts SSewell GJStability and compatibility of 5-fluorouracil infusions in Braun EasypumpJ Oncol Pharm Pract20039109-12
Laposata MJohnson SMAssessment of the stability of dalteparin sodium in prepared syringes for up to thirty days: an in vitro studyClin Ther2003251219-25
Gupta VDChemical stability of cefuroxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric useInt J Pharmaceut Compound20037310-2
Menard CBourguignon CSchlatter JStability of cyclophosphamide and mesna admixtures in polyethylene infusion bagsAnn Pharmacother2003371789-92
McQuade MSVan Nostrand VSchariter JStability and compatibility of reconstituted ertapenem with commonly used i.v. infusion and coinfusion solutionsAm J Health-Syst Pharm20046138-45
Trissel LASaenz CAPhysical compatibility of antithymocyte globulin (rabbit) with heparin sodium and hydrocortisone sodium succinateAm J Health-Syst Pharm2003601650-2
Musami PStewart JTTaylor EWStability of zidovudine and dobutamine hydrochloride injections in 0.9% sodium chloride and 5% dextrose injections stored at ambient temperature (23 ± 2°C) and 4°C in 50-mL polyvinyl chloride bags up to 24 hoursInt J Pharmaceut Compound2004873-6
Masaki YTanaka MNishikawa TPhysicochemical compatibility of propofol-lidocaine mixtureAnesth Analg2003971646-51
Anderson PLMiller SBushman LRStability of zidovudine with oxytocin in a simulated Y-site injectionAm J Heath-Syst Pharm200461394-96
Walker SEVarrin SYannicelli DStability of meropenem in saline and dextrose solutions and compatibility with potassium chlorideCan J Hosp Pharm199851156-68
Berlage VHecq JDVanbeckbergen DLong term stability of procaine hydrochloride cardioplegic infusion in P.V.C. bags at 4°CPharmakon2003353-8
Kannan SIncompatibility of prochlorperazine and ketoprofenAnaesthesia200156920
Smith RPRJones MPrecipitation in Manchester:ketorolac/cyclizineAnaesthesia200156494-5
Akhtar MJKhan MAAhmad IIdentification of photoproducts of folic acid and its degradation pathways in aqueous solutionJ Pharmaceut Biomed Anal200331579-88
Tsui BCHCave DDiscoloration of parenteral ondansetronAnesth Analg2003961239
Hartmann MKnoth HKohler WStability of fentanyl/ropivacaine preparations for epidural applicationPharmazie200358434-5
Dager WEGosselin RCKing JHAnti-Xa stability of diluted enoxaparin for use in pediatricsAnn Pharmacother200438569-73
Manley HJMcClaran MLBedenbaugh ALinezolid stability in peritoneal dialysis solutionsPerit Dial Int200222419-22
Semba CPWeck SPatapoff TAlteplase: stability and bioactivity after dilution in normal saline solutionJ Vasc Interv Radiol20031499-102
Faouzi MADine TLuyckx MStability and compatibility studies of cephamandole nafate with PVC infusion bagsJ Pharmaceut Biomed Anal19941299-104
Diduk NPerez KGde la Munoz LEstabilidad de ciclosporina inyectable (50 mg/mL)Rev Mexicana Ciencias Farm20003119-22
Bruch HREsser MCatheter occlusion by calcium carbonate during simultaneous infusion of 5-FU and calcium folinateOnkologie200326469-72
Vehabovic MHadzovic SStambolic FStability of ranitidine in injectable solutionsInt J Pharm2003256109-15
Brodner GErmert TVan Aken HStability of sufentanil-ropivacaine mixture in glass and PVC reservoirEurop J Anesthesiol200219295-7
Lettner AZollner PVisuelle documentation der stabilitat der intravenosen losungen von omeprazole (Losec) und pantoprazole (Pantoloc)Wien Med Wechenschr2002152568-78
Bosso JATaylor AJWhite RLCompatibility of two concentrations of recombinant human interleukin-1 receptor antagonist with selected antimicromical agentsJ Infect Dis Pharmacother1995145-54
Nahata MCMorosco RSSabados BKStability and compatibility of anakinra with ceftriaxone sodium injection in 0.9% sodium chloride or 5% dextrose injectionJ Clin Pharm Ther199722167-9
Nahata MCMorosco RSSabados BKStability and compatibility of anakinra and clindamycin phosphate injections in 0.9% sodium chloride injectionJ App Ther Res1998287-9
Nahata MCMorosco RSSabados BKStability and compatibility of anakinra with cimetidine hydrochloride or famotidine in 0.9% sodium chloride injectionJ Clin Pharm Ther19952097-9
Nahata MCMorosco RSSabados BKStability and compatibility of anakinra with lorazepam injection in 0.9% sodium chloride injectionJ App Ther19961191-2
Baririan NChanteux HViaene EStability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care unitsJ Antimicrob Chemother200351651-8
Sprauten PFBeringer PMLouie SGStability and antibacterial activity of cefepime during continuous infusionAntimicrob Agents Chemother2003471991-4
Vercaigne LMSitar DSPenner SBAntibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheterPharmacother200020394-9
Vercaigne LMZhanel GGAntibiotic-heparin lock: in vitro confirmation of antibacterial activityCan J Hosp Pharm200053193-8
Sanchez del Aguila MJJones MFVohra APremixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on their long-term stabilityBr J Anaesthes200390179-82
Ranchere JYLatour JFFuhrman CAmphotericin B Intralipid formulation: stability and particle sizeJ Antimicrob Chemother1996371165-9
Hatem AMarton SCsoka GPreformulation studies of atenolol in oral liquid dosage form. I. Effect of pH and temperatureActa Pharmaceut Hung199666177-80
Wiernikowski JTCrowther MClase CMStability and sterility of recombinant tissue plasminogen activator at -30°CLancet20003552221
Barcia EReyes RLuz Azuara MCompatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative careSupport Care Cancer200311107-13
Dix JWeber RJFrye RFStability of atropine sulfate prepared for mass chemical terrorismJ Toxicol200341771-5
GE Healthcare Inc. Omnipaque^® (iohexol) injection prescribing information. Marlborough, MA; 2023 Apr.
Gupta VDChemical stability of phenylephrine hydrochloride after reconstitution in 0.9% sodium chloride injection for infusionInt J Pharmaceut Compound20048153-5
Norenburg JPAchusim LESteel THStability of lorazepam in 0.9% sodium chloride in polyolefin bagsAm J Health-Syst Pharm2004611039-41
Lebrun JHecq JDVanbeckbergen DEffect of freezing, long-term storage and microwave thawing on the stability of tramadol in 5% dextrose infusion in polyvinyl chloride bagsInt J Pharmaceut Compound20048156-9
Sharley NABurgess NGStability and compatibility of alfentanil hydrochloride and morphine sulfate in polypropylene syringesJ Pharm Pract Res200333279-81
Xu QATrissel LAPham L Physical and chemical stability of treprostinil sodium injection packaged in plastic syringe pump reservoirsInt J Pharmaceut Compound20048228-30
Trissel LASaenz CAWilliams KYIncompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministrationInt J Pharmaceut Compound20025314-9
Braeden JUStendal TLFagernaes CBStability of dopamine hydrochloride 0.5 mg/mL in polypropylene syringesJ Clin Pharm Ther200328471-4
Good PDSchneider JJRavenscroft PJThe compatibility and stability of midazolam and dexamethasone in infusion solutionsJ Pain Sympt Manag200427471-5
Jaruratanasirikul SSriwiriyajan SStability of meropenem in normal saline solution after storage at room temperatureSoutheast Asian J Trop Med Pub Health200334627-9
Xu QATrissel LAStability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administrationAm J Health-Syst Pharm2004611596-8
Sewell GJRigsby-Jones AEPriston MJStability of intravesical epirubicin infusion: a sequential temperature studyJ Clin Pharm Ther200328349-53
Trissel LAXu QAPhysical and chemical stability of palonosetron HCl in 4 infusion solutionsAnn Pharmacother2004381608-11
Curtis JMEdwards DJStability of trimethoprim in admixtures of trimethoprim-sulfamethoxazole prepared in polyvinyl chloride bags and glass bottlesCan J Hosp Pharm200255207-11
La Forgia SPSharley NABurgess NGStability and compatibility of morphine, midazolam, and bupivacaine combinations for intravenous infusionJ Pharm Pract Res20023265-8
Stecher ALMorgantetti de Deus PPolikarpov IStability of L-asparaginase: an enzyme used in leukemia treatmentPharm Acta Helv1999741-9
Arsene MFavetta PFavier BComparison of ceftazidime degradation in glass bottles and plastic bags under various conditionsJ Clin Pharm Ther200227205-9
Bennett JGross JNichols FThe chemical and physical stability of a 1:1 mixture of propofol and methohexitalAnesth Prog20014861-5
Lepage RWalker SEGodin JStability and compatibility of etoposide in normal salineCan J Hosp Pharm200053338-44
Mayer JLRPascale VJClyne LPStability of low-dose vancomycin hydrochloride in heparin sodium 100 IU/mLJ Pharm Tech19991513-7
Park JWPark ESChi SCThe effect of lidocaine on the globule size distribution of propofol emulsionsAnesth Analg200397769-71
Vincentelli JBraguer DGuillet PFormulation of a flush solution of heparin, vancomycin, and colistin for implantation access systems in oncologyJ Oncol Pharm Pract1997318-23
Westphal MHohage HBuerkle HAdsorption of sufentanil to epidural filters and cathetersEurop J Anesthes200320124-6
Hamilton MAStang LEtches WSStability of low molecular weight heparins stored in plastic syringesThromb Res20031121127-9
Vella-Brincat JWABegg EJGallagher KStability of benzylpenicillin during continuous home intravenous therapyJ Antimicrob Chemother200453675-7
Gill MAKislik AZGoree LStability of advanced life support drugs in the fieldAm J Health-Syst Pharm200461597-602
Boitquin LHecq JDEvrard JMLong-term stability of sufentanil citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion PVC bags at 4°CJ Pain Symptom Manage2004284-6
Jappinen ATurpeinen MKokki HStability of sufentanil and levobupivacaine solutions and a mixture in a 0.9% sodium chloride infusion stored in polypropylene syringesEurop J Pharm Sci20031931-6
Gupta VDChemical stability of terbutaline sulfate injection after diluting with 0.9% sodium chloride injection when stored at room temperature in polyvinyl chloride bagsInt J Pharmaceut Compound20048404-6
Trissel LAZhang YCompatibility and stability of Aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphateInt J Pharmaceut Compound20048398-403
Lai JJBrodeur SKPhysical and chemical compatibility of daptomycin with nine medicationsAnn Pharmacother2004381612-6
Smith DLBauer SMNicolau DPStability of meropenem in polyvinyl chloride bags and an elastomeric infusion deviceAm J Health-Syst Pharm2004611682-5
Gong YTian XXu QCompatibility of bumetanide injection combined with four kinds of injectionChina Pharm20036550-1
Ling JGupta VDStability of ethacrynate sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric useInt J Pharmaceut Compound2001573-5
Wang DPChiou HJLee DKTCompatibility and stability of ceftazidime sodium and tenoxicam in 5% dextrose injectionAm J Health-Syst Pharm2004611924-7
Ling JGupta VDStability of acyclovir sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric useInt J Pharmaceut Compound2001575-7
Xu XWDu XLLi DKStudy on the sorption of fifteen injectable drugs in three different kinds of intravenous solution containersChin Pharm J200439205-7
Murata AOkamoto YSasa YEffect of light and sodium bisulfite on the stability of thiamine in TPN fluids and integrated dose in period valuesJpn J Pharm Health Care Sci200430266-70
Dedrick SCRamirez-Rico JPotency and stability of frozen urokinase solutions in syringesAm J Health-Syst Pharm2004611586-9
Valenzuela TDCriss EAHammargen WMThermal stability of prehospital medicationsAnn Emerg Med198918173-6
Ambados FBrealey JCompatibility of ketamine hydrochloride and fentanyl citrate in polypropylene syringesAm J Health-Syst Pharm2004611438, 1445
Trissel LASaenz CAOgundele ABPhysical compatibility of pemetrexed disodium with other drugs during simulated Y-site administrationAm J Health-Syst Pharm2004612289-93
Alvarez JCde Mazancourt PChartier-Kastler EDrug stability testing to support clinical feasibility investigations for intrathecal baclofen-clonidine admixtureJ Pain Sympt Manage200428268-72
Trissel LASaenz CAIngram DSCompatibility screening of oxaliplatin during simulated Y-site administration with other drugsJ Oncol Pharm Pract2002833-7
White CMQuercia RStability of extemporaneously prepared sterile testosterone solution in 0.9% sodium chloride solution large-volume parenterals in plastic bagsInt J Pharmaceut19993156-7
Kuti JLNightingale CHKnauft RFPharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosisClin Ther200426493-501
Ferreira EForest JMHildgen PCompatibilite du dimenhydrinate injectable pour l’administration en YPharmactuel20043717-20
Fubara JONotari REInfluence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutionsJ Pharm Sci1998871572-6
Brustugun JKristensen SHjorth Tonnesen HPhotostability of epinephrine—the influence of bisulfite and degradation productsPharmazie200459457-63
Honisko MEFink JMMilitello MACompatibility of argatroban with selected cardiovascular agentsAm J Health-Syst Pharm2004612415-8
Dooley DPTyler JRWortham WGProlonged stability of antimicrobial activity in peritoneal dialysis solutionsPerit Dial Int20032358-62
Pere HChasse VForest JMCompatibilite du pantoprazole lors d’administration en YPharmactuel200437193-6
Baker MTGregerson MSMartin SMFree radical and drug oxidation products in an intensive care unit sedative: propofol with sulfiteCrit Care Med200331787-92
Zaloga GPMarik PSulfite-induced propofol oxidation: a cause for radical concernCrit Care Med200331981-3
Lasak M. (Medical Information, Fujisawa): Personal communication; 2003 Sep 19.
Boitquin LPHecq JDVanbeckbergen DStability of sufentanil citrate with levobupivacaine hydrochloride in NaCl 0.9% infusion after microwave freeze-thaw treatmentAnn Pharmacother2004381836-9
Trissel LAZhang YPhysical and chemical stability of palonosetron HCl with cisplatin, carboplatin, and oxaliplatin during simulated Y-site administrationJ Oncol Pharm Pract200410191-5
Sprandal KAStyrczula DEDeyo KStability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administrationAm J Health-Syst Pharm20056288-92
Trissel LAZhang YPalonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administrationAnn Pharmacother200539280-3
Lim SCBRoberts MJPaech MJStability of insulin aspart in normal saline infusionJ Pharm Pract Res20043411-3
Hildebrand KRElsberry DDDeer TRStability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery systemClin J Pain200117239-44
Hildebrand KRElsberry DEAnderson VCStability and compatibility of hydromorphone hydrochloride in an implantable infusion systemJ Pain Sympt Manag2001221042-7
Classen AMWmbish GHKupiec TCStability of admixture containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion systemJ Pain Sympt Manag200428603-10
Gupta VDChemical stability of metoclopramide hydrochloride injection diluted with 0.9% sodium chloride injection in polypropylene syringes at room temperatureInt J Pharmaceut Compound2005972-4
Bourdeaux DSautou-Miranda VBagel-Boithias SAnalysis by liquid chromatography and infrared spectrometry of di(2-ethylhexyl)phthalate released by multilayer infusion tubingJ Pharmaceut Biomed Anal20043557-64
Kambia KDine TGressier BEvaluation of childhood exposure to di(2-ethylhexyl)phthalate from perfusion kits during long-term parenteral nutritionInt J Pharm200326283-91
Driscoll DFDunbar JGMarmarou AFat-globule size in a propofol emulsion containing sodium metabisulfiteAm J Health-Syst Pharm2004611276-80
Turnbull KBielech MWalker SEStability of oxycodone hydrochloride for injection in dextrose and saline solutionsCan J Hosp Pharm200255272-7
Rigge DCJones MFShelf lives of aseptically prepared medicines—stability of netilmicin injection in polypropylene syringesJ Pharmaceut Biomed Anal2004351251-6
Hecq JDBoitquin LPVanbeckbergen DEffect of freezing and microwave thawing on the stability of cefuroxime in 5% dextrose infusion polyolefin bags at 4°CAnn Pharmacother2005391244-8
Rudich ZPeng PDunn EStability of clonidine in clonidine-hydromorphone mixture from implanted intrathecal infusion pumps in chronic pain patientsJ Pain Sympt Manag200428599-602
Oh JGwak HMoon HStability of roxatidine acetate in parenteral nutrient solutions containing different amino acid formulationsAm J Health-Syst Pharm200562289-91
Noppawinyoowong CSrisangchun JPongjanyakul TChemical stability of frozen ganciclovir intravitreal injectionsThai J Hosp Pharm200313213-8
Kim YHHeinze TMBeger RA kinetic study on the degradation of erythromycin A in aqueous solutionInt J Pharm200427163-76
Ambados FIncompatibility between calcium and sulfate ions in solutions for injectionJ Pharm Pract Res200232307-9
Tang WMXue PHStability of ceftriaxone sodium injectionsPharm Care Res20022171-3
Torne GRLuque AAPozo JFEstudio de la adsorcion de insulina en las bolsas de nutricion parenteral: influencia del tiempo de administracion y la temperaturaJ Clin Pharm20035565-9
Gardiner PRCompatibility of an injectable oxycodone formulation with typical diluents, syringes, tubings, infusion bags and drugs for potential co-administrationHosp Pharmacist200310358-61
Sugiura MNakajima KYamada YAdsorption of rhG-CSF (filgrastim) to extension tubeJpn J Pharm Health Care Sci200329173-7
Priano RMHocht COyola EEstabilidad de prostaglandina E1 fraccionada en jeringas de polipropilenoFarm Hosp200327304-7
Walker SEFau-Lun CWyllie APhysical compatibility of pantoprazole with selected medications during simulated Y-site administrationCan J Hosp Pharm20045790-7
Voges MFaict DLechien GStability of drug additives in peritoneal dialysis solutions in a new containerPerit Dial Int200424590-5
Bagel-Boithias SSautou-Miranda VBourseaux DLeaching of diethyl hexyl phthalate from multilayer tubing into etoposide infusion solutionsAm J Health-Syst Pharm200562182-8
Uebel RAWium CASchmidt ACStability evaluation of a prostaglandin E1 saline solution packed in insulin syringesInt J Impotence Res20011316-7
Hennere GHavard LBonan BStability of cidofovir in extemporaneously prepared syringesAm J Health-Syst Pharm200562506-9
Trissel LAXu QAPhysical and chemical stability of palonosetron hydrochloride with lorazepam and midazolam hydrochloride during simulated Y-site administrationInt J Pharmaceut Compound20059235-7
Trissel LAXu QAPhysical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administrationInt J Pharmaceut Compound20059238-41
Volonte MGValora PDCingolani AStability of ibuprofen in injection solutionsAm J Health-Syst Pharm200562630-3
Phares KRWade MWeiser WEImproved stability of treprostinil sodium with proper vial puncture technique and adapter useJ Pharm Technol200420270-5
He YYu YCStudy on the stability of tetracaine hydrochloride injectionChin Pharm J20013633-5
Priston MJHughes JMSantillo MStability of epidural analgesic admixture containing epinephrine, fentanyl, and bupivacaineAnaesthesia200459979-83
Hecq JDBerlage VVanbeckbergen DEffects of freezing, long-term storage, and microwave thawing on the stability of piperacillin plus tazobactam in 5% dextrose for infusionCan J Hosp Pharm200457276-82
Mann HJDemon SLBoelk DAPhysical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administrationAm J Health-Syst Pharm2004612664-71
Elwell RJVolino LRFrye RFStability of cefepime in icodextrin peritoneal dialysis solutionAnn Pharmacother2004382041-4
Trissel LAOgundele ABCompatibility of anidulafungin with other drugs during simulated Y-site administrationAm J Health-Syst Pharm200562834-7
Dupertuis YMMorch AFathi MPhysical characteristics of total parenteral nutrition bags significantly affect the stability of vitamins C and B1: A controlled prospective studyJ Parenter Enter Nutr2002261310-6
Driscoll DFNehne JPeters HPhysicochemical stability of intravenous lipid emulsions as all-in-one admixtures intended for the very youngClin Nutr20032489-95
McNearney TBajaj CBoyars MTotal parenteral nutrition associated crystalline precipitates resulting in pulmonary artery occlusions and alveolar granulomasDigestive Dis Sci2003481352-4
Lee MDYoon JKim SStability of total nutrient admixtures in reference to ambient temperaturesNutrition2003481352-4
Parikh MJDumas GSilvestri APhysical compatibility of neonatal total parenteral nutrient admixtures containing organic calcium and inorganic phosphate saltsAm J Health-Syst Pharm2005621177-83
Levi FMetzger GMassari COxaliplatin pharmacokinetics and chronopharmacological aspectsClin Pharmacokinet2000381-21
Hoppe-Tichy TWenzel SGehring AKStability of voriconazole concentrate and voriconazole in infusion bagsPharmazie20056077-8
Actavis Pharma, Inc. Fludarabine phosphate for injection prescribing information. Parsippany, NJ; 2014 Jun.
XGen Pharmaceuticals DJB, Inc. Amphotericin B for injection prescribing information. Big Flats, NY; 2020 Oct.
Trissel LAZhang YPhysical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administrationInt J Pharmaceut Compound20059320-2
Lee GSabra K Stability of morphine sulphate in ANAPA Plus ambulatory infusion device and PEGA infusion setsEurop J Hosp Pharm Sci20061276-80
Chin A Liu STing-Chan J Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injectionAm J Health-Syst Pharm2005621073-4
Patel K Hursting MJ Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administrationAm J Health-Syst Pharm2005621381-4
Wazny L Walker SMoist L Visual compatibility of gentamicin sulfate and 4% sodium citrate solutionsAm J Health-Syst Pharm2005621548, 1550
Barcia E Martin A Azuara ML Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stabilitySupport Care Cancer20071557-62
Laville IMercier LCachaty E Shelf-lives of morphine and pethidine solutions stored in patient-controlled analgesia devices: physico-chemical and microbiological stability study Pathol Biol (Paris)200553210-6
Barcia EReyes R Azuara ML Stability and compatibility of binary mixtures of morphine hydrochloride with hyoscine-n-butyl bromide Support Care Cancer200513239-45
Fink JMCapozzi DLShermock KM Alteplase for central catheter clearance: 1 mg/mL versus 2 mg/mL Ann Pharmacother200438351-2
Lian MH Shao MHYuan H Study on the stability of levofloxacin lactate for injection Chin J Antibiotics200429346-8
de Lemos M Vinorelbine and venous irritation: optimal parenteral administration J Oncol Pharm Pract20051179-81
DeFillippis MR Bell MAHeyob JA In vitro stability of insulin lispro in continuous subcutaneous insulin infusion Diabetes Tech Ther20068358-68
Paul MRazzouq NTixier G Stability of prostaglandin e₁ (pge₁) in aqueous solutions Europ J Hosp Pharm Sci20051131-6
Xu QATrissel LA Compatibility of palonosetron with cyclophosphamide and with ifosfamide during simulated Y-site administration Am J Health-Syst Pharm2005621998-2000
Barker BFeddema S Rusho WJ Visual compatibility of vasopressin with other injectable drugs Am J Health-Syst Pharm2005621969, 1975-6
Veggeland T Visual compatibility of clonidine with selected drugs Am J Health-Syst Pharm2005621968-9
Bougouin CThelcide CCrespin-Maillard F Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers Am J Health-Syst Pharm2005622001-5
Gupta VD Chemical stability of hydralazine hydrochloride after reconstitution in 0.9% sodium chloride injection or 5% dextrose injection for infusion Int J Pharmaceut Compound20059399-401
Hecq JD Boitquin LPVenbeckbergen DF Effect of freezing, long-term storage, and microwave thawing on the stability of ketorolac tromethamine Ann Pharmacother2005391654-8
Fresenius Kabi USA, LLC. Fludarabine phosphate injection prescribing information. Lake Zurich, IL; 2016 Sep.
Voges MDivino-Filho JCFaict D Compatibility of insulin over 24 hours in standard and bicarbonate-based peritoneal dialysis solutions contained in bags made of different materials Perit Dial Int200626498-502
Donnelly RFChemical stability of fentanyl in polypropylene syringes and polyvinyl chloride bags Int J Pharmaceut Compound20059482-3
Lewis BJarvi ECady P Atropine and ephedrine adsorption to syringe plastic AANA J199464257-60
Nornoo AO Elwell RJStability of vancomycin in icodextrin peritoneal dialysis solution Ann Pharmacother2006401950-4
Velpandian T Saluja VKumar Ravi A Evaluation of the stability of extemporaneously prepared ophthalmic formulation of mitomycin C J Ocular Pharmacol Ther200521217-22
Abanmy NOZaghloul IYRadwan MA Compatibility of tramadol hydrochloride injection with selected drugs and solutions Am J Health-Syst Pharm2005621299-302
Lee DKTWand DPHarsono R Compatibility of fentanyl citrate, ketamine hydrochloride, and droperidol in 0.9% sodium chloride injection stored in polyvinyl chloride bags Am J Health-Syst Pharm2005621190-2
Rigge DC Jones MF Shelf lives of aseptically prepared medicines—stability of hydrocortisone sodium succinate in PVC and non-PVC bags and in polypropylene syringes J Pharm Biomed Anal200538322-6
Robinson RFMorosco RSSmith CV Stability of cefazolin sodium in four heparinized and non-heparinized dialysate solutions at 38°C Perit Dial Int200626593-7
Johnson CE Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes Am J Health-Syst Pharm2005622410-2
Swart ELvan Reij EML Lee WC Visual compatibility of atosiban acetate with four drugs Am J Health-Syst Pharm2005622459, 2463
Thalhammer FMaier-Salamon AJager W Examination of stability and compatibility of flucloxacillin (Floxapen) and ceftazidime (Fortum) in two infusion media: relevance for clinical practice Wien Med Wochenschr2005155337-43
Han JWashington C Partition of antimicrobial additives in an intravenous emulsion and their effect on emulsion physical stability Int J Pharm2005288263-71
Trissel LAXu QABaker M Drug compatibility with new polyolefin infusion solution containers Am J Health-Syst Pharm2006632379-82
Rodenbach MPHecq JDVanbeckbergen D Stability of cefuroxime infusion: the brand-name drug versus a generic product Europ J Hosp Pharm Sci20061232-4
Cadrobbi JHecq JDLebrun C Long-term stability of voriconazole 4 mg/mL in dextrose 5% polyvinyl chloride bags at 4°C Europ J Hosp Pharm Sci20061257-9
Andre PCisternino SChiadmi F Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial Ann Pharmacother2005391462-6
Chan V Influence of temperature and drug concentration on nafcillin precipitation Am J Health-Syst Pharm2005621347-8
Nguyen-Xuan TGriffiths WKern C Stability of morphine sulfate in polypropylene infusion bags for use in patient-controlled analgesia pumps for postoperative pain management Int J Pharmaceut Compound20061069-73
Wang DP Stability of tetracaine in aqueous systems J Taiwan Pharm Assoc198335132-41
Rigge DCJones MF Shelf lives of aseptically prepared medicines—stability of piperacillin/tazobactam in PVC and non-PVC bags J Pharm Biomed Anal200539339-43
Weck SCheung SHiraoka-Sutow M Alteplase as a catheter locking solution: in vitro evaluation of biochemical stability and antimicrobial propertiesJ Vasc Interven Radiol200516379-83
Pourroy BBotta CSolas C Seventy-two-hour stability of Taxol in 5% dextrose or 0.9% sodium chloride in Viaflo, Freeflex, Ecoflac, and Macoflex N non-PVC bags J Clin Pharm Ther200530455-8
Ariz Ozdemir F Anilanmert BPekin M Spectrophotometric investigation of the chemical compatibility of the anticancer drugs irinotecan-HCl and epirubicin-HCl in the same infusion solution Cancer Chemother Pharmacol200556529-34
Trissel LA Zhang YDouglass K Extended stability of oxytocin in common infusion solutions Int J Pharmaceut Compound200610156-8
Negro S Martin AAzuara ML Stability of tramadol and haloperidol for continuous subcutaneous infusion at homeJ Pain Symptom Manage200530192-9
Sautou-Miranda V Brigas FVanheerswynghels S Compatibility of paclitaxel in 5% glucose solution with ECOFLAC low-density polyethylene containers—stability under different storage conditions Int J Pharm199917877-82
Trittler RStability of intravenous admixtures of doxorubicin and vincristine confirmed by LC-MS Europ J Hosp Pharm Sci20061210-2
XGen Pharmaceuticals DJB, Inc. Streptomycin for injection prescribing information. Big Flats, NY; 2022 Oct.
Zhang YTrissel LA Physical and chemical stability of pemetrexed solutions in plastic syringes Ann Pharmacother2005392026-8
Watson DGLin MMorton A Compatibility and stability of dexamethasone sodium phosphate and ketamine hydrochloride subcutaneous infusions in polypropylene syringes J Pain Symptom Manage20053080-6
Lee GSabra K Doyle L Stability of morphine sulphate in P.C.A.s Europ J Hosp Pharm Sci200381-9
Theou NHavard LMaestroni ML Leaching of di(2-ethylhexyl)phthalate from polyvinyl chloride medical devices: recommendations for taxanes infusion Europ J Hosp Pharm Sci20051155-61
Hartman CAFaria CEMago K Visual compatibility of bivalirudin with selected drugs Am J Health-Syst Pharm2004611774, 1776
Trissel LA Zhang YXu QA Physical and chemical stability of palonosetron hydrochloride with dacarbazine and with methylprednisolone sodium succinate during simulated Y-site administration Int J Pharmaceut Compound200610234-6
Rodenbach MP Hecq JDVanbeckbergen ED Effect of freezing, long-term storage and microwave thawing on the stability of vancomycin hydrochloride in 5% dextrose infusions Europ J Hosp Pharm Sci200511111-3
Trusley C Kupiec TCTrissel LA Compatibility of micafungin injection with other drugs during simulated Y-site co-administration Int J Pharmaceut Compound200610230-3
Robinson JLTawfik GSaxinger L Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy J Antimicrob Chemother200556951-3
Corvino TF Nahata MCAngelos MG Availability, stability, and sterility of pralidoxime for mass casualty use Ann Emerg Med200647272-7
Robinson RF Morosco RStability of ciprofloxacin in four heparinized and nonheparinized dialysate solutions at 38°CASHP Midyear Clinical Meeting PosterDec 200540P442E
Faria CE Fiumara KPatel N Visual compatibility of furosemide with phenylephrine and vasopressin Am J Health-Syst Pharm200663906, 908
Boothby LA Madabushi RKumar V Extended stability of oxytocin in Ringer’s lactate solution at 4° and 25°CHosp Pharm200641437-41
Zhang Y Trissel LA Physical and chemical stability of pemetrexed in infusion solutionsAnn Pharmacother2006401082-5
Driscoll DF Lipid injectable emulsions: pharmacopeial and safety issuesPharm Res2006231959-69
Anacardio R Bartolini S Gentile MM HPLC investigated physicochemical compatibility between artrosilene injectable solution and other pharmaceutical products frequently used for combined therapy into elastomeric Baxter LV5 infusion device Inter J Immunopath Pharmacol200518791-8
Gupta VD Chemical stability of pyridoxine hydrochloride 100-mg/mL injection, preservative free Int J Pharmaceut Compound200610318-9
Zhang Y Trissel LA Physical instability of frozen pemetrexed solutions in PVC bags Ann Pharmacother2006401289-92
Sahraoui LChiadmi FSchlatter J Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injection Am J Health-Syst Pharm2006631423-6
Hamada C Hayashi KShou IPharmacokinetics of calcitriol and maxacalcitol administered into peritoneal dialysate bags in peritoneal dialysis patients Perit Dial Int200525570-5
Carpenter JF McNulty MADusci LJStability of omeprazole sodium and pantoprazole sodium diluted for intravenous infusion J Pharm Technol20062295-8
Mendez ASL Dalomo J Steppe MStability and degradation kinetics of meropenem in powder for injection and reconstituted samples J Pharm Biomed Anal2006411363-6
Kumarvel V Gandhimani P Cundill GFrozen succinylcholine chlorideAnaesthesia200661202
Stone J Fawcett WA case of frozen succinylcholine chloride encountered during emergency Cesarean delivery Anesth Analg2002951465
Negro S Reyes R Azuara MLMorphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: compatibility and stability evaluation in terminal oncology patientsInt J Pharm2006307278-84
Negro S Azuara ML Sanchez YPhysical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care Support Care Cancer20021065-70
Shields D Montenegro R Ragusa MChemical stability of admixtures combining ziconotide with morphine or hydromorphone during simulated intrathecal administration Neuromodulation20054257-63
Shields D Montenegro RThe chemical stability of admixtures combining ziconotide and clonidine during simulated intrathecal administration7th Congress International Modulation Society PosterJun 2005
Shields D Montenegro R Aclan J The chemical stability of admixtures combining ziconotide and bupivacaine hydrochloride during simulated intrathecal administration7th Congress International Modulation Society PosterJun 2005
Huang L Effect of pH and temperature on the stability of 1% tetracaine hydrochloride injection Yaoxue Tongbao198217,208-9
Kambia NKLuyckx MDine T Stability and compatibility of paracetamol injection admixed with ketoprofen Europ J Hosp Pharm Sci20061281-4
Hecq JDBoitquin LLebrun C Freeze thaw treatment of ketorolac tromethamine in 5% dextrose infusion polyolefin bags: effect of drug concentration and microwave power on the long-term stability at 4°C Europ J Hosp Pharm Sci20061272-5
Donyai PSewell GJ Physical and chemical stability of paclitaxel infusions in different container types J Oncol Pharm Pract200612211-2
Fielding HKyaterekera NSkellern GG The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes Palliative Med200014205-7
Vranken JHvan Kan HJvan der Vegt MH Stability and compatibility of a meperidine-clonidine mixture in portable pump reservoirs for the management of cancer pain syndromes J Pain Symptom Manage200632297-9
Negro S Rendon ALAzuara ML Compatibility and stability of furosemide and dexamethasone combined in infusion solutionsArzneimittelforschung200656714-20
Fernandez-Varon EMarin PEspuny AStability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%) J Clin Pharm Ther200631641-3
Shields DAclan JSzatkowski AThe chemical stability of an admixture containing 25 mcg/mL ziconotide and 20 mg/mL morphine sulfate during simulated intrathecal administrationN Amer Neuromodulation Soc Poster2006
Ludwig SVencl-Joncic MGandhi PSimulated Y-site compatibility testing of various diluents and drug products with tigecycline, a first-in-class intravenous glycylcyclineASHP Summer Meeting Poster2006P62E
Carroll JAStability of flucloxacillin in elastomeric infusion devices J Pharm Pract Res20053590-2
Trusley CBen MKupiec TCPhysical and chemical stability of palonosetron with metoclopramide and promethazine during simulated Y-site administration Int J Pharmaceut Compound20071182-5
Chapalain-Pargrade S Laville IPaci AMicrobiological and physicochemical stability of fentanyl and sufentanil solutions for patient-controlled delivery systems J Pain Symptom Manage20063290-7
Dalle M Sautou-Miranda VBalayssac DCan solutions of docetaxel be conditioned in PVC bags?J Pharm Clin200625147-52
Chiesi USA, Inc. Retavase^® (reteplase) for injection prescribing information. Cary, NC; 2022 Apr.
Trissel LA Trusley CBen MPhysical and chemical stability of palonosetron hydrochloride with five opiate agonists during simulated Y-site administration Am J Health-Syst Pharm2007641209-13
Driscoll DF Sivestri APNehne J Physicochemical stability of highly concentrated total nutrient admixtures for fluid-restricted patients Am J Health-Syst Pharm20066379-85
Pietroski N (Associate Director, Medical Services, Merck & Co., North Wales, PA). Personal communication; 2007 Jun 15
Pietroski N (Associate Director, Medical Services, Merck & Co., North Wales, PA). Personal communication; 2007 Jun 29
Hecq JDEvrard JMVanbeckbergen DFEffect of freezing, long term storage and microwave thawing on the stability of ceftriaxone sodium in 5% dextrose infusion polyolefin bags at 2-8°CEurop J Hosp Pharm Sci20061252-6
Sudekum MJ (Manager, Clinical Pharmacy Services, Botsford Hospital, Farmington Hills, MI): Personal communication; 2007 Jun 6
Nolin TDLambert DAOwens RC JrStability of cefepime and metronidazole prepared for simplified administration as a single productDiag Microbiol Infect Dis200656179-84
Serrurier CChenot EDVigneron JAssessment of injectable drugs’ administration in two intensive care units and determination of potential physico-chemical incompatibilitiesEurop J Hosp Pharm Sci20061296-9
Kraft MDJohnson CEChung CStability of metoprolol tartrate injection 1 mg/mL undiluted and 0.5 mg/mL in 0.9% sodium chloride injection and 5% dextrose injectionAm J Health-Syst Pharm200865636-8
Kattige ALong-term physical and chemical stability of a generic paclitaxel infusion under simulated storage and clinical-use conditionsEurop J Hosp Pharm Sci200612129-34
Griffiths WFavet JIng HChemical stability and microbiological potency of intravenous vancomycin hydrochloride in polypropylene syringes for use in the neonatal intensive care unitEurop J Hosp Pharm Sci200612135-9
Anon. Rocephin (ceftriaxone sodium) for injection (posted 07/05/2007). FDA MedWatch 2007. www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm152863.htm
Vanneaux VProust VCheron MA physical and chemical stability study of amphotericin B lipid complexes (Abelcet) after dilution in dextrose 5%Europ J Hosp Pharm Sci20071310-3
Rondelot GSerrurier CVigneron JStability of pemetrexed 25 mg/mL in a glass vial and 5 mg/mL in a PVC container after storage for one month at 2-8°CEurop J Hosp Pharm Sci20071314-6
Food and Drug Administration. Information for healthcare professionals: colistimethate (marketed as Coly-Mycin M and generic products). 2007 Jun 28. FDA website. Accessed 2016 Apr 12. www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm152109.htm
Johnson CECober MPStability of vecuronium in sterile water for injection stored in polypropylene syringes for 21 daysAm J Health-Syst Pharm2007642356-8
Kondo MGenpei MWatanabe KY-site injection physical compatibility of remdesivir with select intravenous drugs used in palliative care and for treating coronavirus disease 2019J Nippon Med Sch202390381-386
Kiser THOldland ARFish DNStability of phenylephrine hydrochloride injection in polypropylene syringesAm J Health-Syst Pharm2007641092-5
Cochran BGSowinski KMFausel CPhysical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugsAm J Health-Syst Pharm2007641410-4
Karstens AKramer IChemical and physical stability of diluted busulfan infusion solutionsEurop J Hosp Pharm Sci20071340-7
Karstens AKramer IViability of micro-organisms in novel anticancer drug solutionsEurop J Hosp Pharm Sci20071327-32
Ponton JLMunoz CRey MThe stability of (lyophilized) gemcitabine in 0.9% sodium chloride injectionEurop J Hosp Pharm2002123-5
Adnet FLe Moyec LSmith CEStability of succinylcholine solutions stored at room temperature studied by nuclear magnetic resonance spectroscopyEmerg Med J200724168-9
GE Healthcare Inc. Omnipaque^® (iohexol) injection pharmacy bulk package prescribing information. Marlborough, MA; 2023 Apr.
Andre PCisternino SRoy ALStability of oxaliplatin in infusion bags containing 5% dextrose injectionAm J Health-Syst Pharm2007641950-4
Cohen VJellinek SPTeperikdis LRoom-temperature storage of medications labeled for refrigerationAm J Health-Syst Pharm2007641711-5
Dice JEPhysical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unitJ Pediatr Pharmacol Ther200611233-6
Negro SSalama ASanchez YCompatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patientsJ Clin Pharm Ther200732441-4
Parti RSchoppmann ALee HStability of lyophilized and reconstituted plasma/albumin-free recombinant human factor VIII (ADVATE rAHF-PFM)Haemophilia200511492-6
Ben MTrusley CKupiec TCPalonosetron hydrochloride compatibility and stability with three ß-lactam antibiotics during simulated Y-site administrationInt J Pharmaceut Compound200711520-4
Girbau J, Jane S. Diltiazem-HCl 1 mg/mL prediluted in normal saline and dextrose 5%: compounding with the Gri-Fill 3.0 system and stability study up to 90 days in Gri-Bag. November 2007
Shields DMontenegro RAclan JChemical stability of an admixture combining ziconotide and bupivacaine during simulated intrathecal administrationNeuromodulation200710S1-5
Shields DMontenegro RChemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administrationNeuromodulation200710S6-11
Shields DMontenegro RAclan JChemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administrationNeuromodulation200710S12-17
Avadel Legacy Pharmaceuticals, LLC. Akovaz^® (ephedrine sulfate) injection prescribing information. Chesterfield, MO; 2017 Apr.
Dura JVHinkle GHStability of a mixture of technetium Tc 99m sulfur colloid and lidocaine hydrochlorideAm J Health-Syst Pharm2007642477-9
Cober MPJohnson CEStability of 70% alcohol solutions in polypropylene syringes for use in ethanol-lock therapyAm J Health-Syst Pharm2007642480-2
Bracco Diagnostics Inc. Isovue^® 200. 250. 300. 370 (iopamidol injection) prescribing information. Monroe Township, NJ; 2023 Apr.
Chan PHealtherly KKupiec TCCompatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministrationInt J Pharmaceut Compound200812276-8
Kaiser JDVigneron JZenier HChemical and physical stability of dexrazoxane, diluted with Ringer’s lactate solution, in polyvinyl and polyethylene containersEurop J Hosp Pharm Sci20071355-9
Kupiec TCAloumanis VBen MPhysical and chemical stability of esomeprazole sodium solutionsAnn Pharmacother2008421247-51
Walker SEStability of docetaxel solution after dilution in ethanol and storage in vials and after dilution in normal saline and storage in bagsCan J Hosp Pharm200760231-7
Chan PBishop AKupiec TCCompatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administrationAm J Health-Syst Pharm2008651545-51
Roy JJBoismenu DMamer OARoom temperature stability of injectable succinylcholine dichlorideInt J Pharmaceut Compound20081283-5
Trusley CBen MKupiec TCCompatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administrationInt J Pharmaceut Compound200812156-60
Kupiec TCBen MTrusley CCompatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated Y-site administrationInt J Pharmaceut Compound200812170-3
Condie CKTyler LSBarker BVisual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site deliveryAm J Health-Syst Pharm200865454-7
Brousseau PNickerson JDobson GDexamethasone and ondansetron incompatibility in polypropylene syringesCan J Anesth200754953-4
Walker SEMilliken DLaw SStability of bortezomib reconstituted with 0.9% sodium chloride at 4°C and room temperature (23°C)Can J Hosp Pharm20086114-20
Chandler CGryniewicz CMPringle TInsulin temperature and stability under simulated transit conditionsAm J Health-Syst Pharm200865953-63
Walker SE, Law S. Physical [visual] Y-site compatibility of Voluven with 38 other intravenous medications. CSHP Annual Meeting Poster. Aug 2007
Kupiec TCTrusley CBen MPhysical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administrationAm J Health-Syst Pharm2008651735-9
Shields DEAclan JSzatkowski AChemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administrationInt J Pharmaceut Compound200812463-6
Ben MTrusley CKupiec TCPhysical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administrationInt J Pharmaceut Compound200812368-72
Goldenberg NAJacobson LHathaway HAnti-Xa stability of diluted dalteparin for pediatric useAnn Pharmacother200842511-5
Ben MKupiec TCTrusley CCompatibility and stability of palonosetron hydrochloride with lactated Ringer’s, hetastarch in lactated electrolyte, and mannitol injections during simulated Y-site administrationInt J Pharmaceut Compound200812460-2
Tremblay MLessard MRTrepanier CAStability of norepinephrine infusions prepared in dextrose and normal saline solutionsCan J Anesth200855163-7
Kaestner SSewell GA sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate “dose-banding”J Oncol Pharm Pract200713119-26
Newton DWDriscoll DFChemistry and safety of phosphates injectionsAm J Health-Syst Pharm2008651761-6
Stucki MCFleury-Souverain SSautter AMDevelopment of ready-to-use ketamine hydrochloride syringes for safe use in post-operative painEurop J Hosp Pharm Sci20081414-8
Shields DEAclan JSzatkowski AChemical stability of admixtures containing ziconotide 25 mcg/mL and morphine sulfate 10 mg/mL or 20 mg/mL during simulated intrathecal administrationInt J Pharmaceut Compound200812553-7
Donnelly RFCorman CPhysical compatibility and chemical stability of a concentrated solution of atropine sulfate (2 mg/mL) for use as an antidote in nerve agent casualtiesInt J Pharmaceut Compound200812550-2
Junker ARoy SDesroches MCStability of oxaliplatin solutionAnn Pharmacother200943390-1
GlaxoSmithKline LLC. Imitrex^® (sumatriptan) injection prescribing information. Durham, NC; 2023 Feb.
Anon. Information for healthcare professionals ceftriaxone (marketed as Rocephin and generics). FDA Update 4/14/2009. www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm084263.htm
Martinez JNAlminana MASales ODEstablidad en suero fisiologico del busulfan intravenoso en un envase de poliolefinasFarm Hosp200832344-8
Schmid RKoren GKlein JThe stability of a ketamine-morphine solutionAnesth Analg200294898-900
Lau MHHackman CMorgan DJCompatibility of ketamine and morphine injectionsPain199875389-90
Trissel LATrusley CKupiec TCCompatibility and stability of palonosetron hydrochloride and propofol during simulated Y-site administrationInt J Pharmaceut Compound20091378-80
Valverde Molina EGonzalez Muniz VGomez-Maldonado JStability of pantoprazole in parenteral nutrition unitsFarm Hosp200832290-2
Donnelly RFWillman EAndolfatto GStability of ketamine-propofol mixtures for procedural sedation and analgesia in the emergency departmentCan J Hosp Pharm200861426-30
McCluskey SVGraner KKKemp JStability of fentanyl 5 µg/mL diluted with 0.9% sodium chloride injection and stored in polypropylene syringesAm J Health-Syst Pharm200966860-3
Aloumanis VBen MKupiec TCDrug compatibility with a new generation of VISIV polyolefin infusion solution containersInt J Pharmaceut Compound200913162-5
Xu MWArren FWBartlett MGStability of low-concentration ceftazidime in 0.9% sodium chloride injection and balanced salt solutions in plastic syringes under various storage conditionsInt J Pharmaceut Compound200913166-9
Canann DTyler LSBarker BVisual compatibility of i.v. medications routinely used in bone marrow transplant recipientsAm J Health-Syst Pharm200966727-9
Newland AMMauro VFAlexander KSPhysical compatibility of metoprolol tartrate injection with selected cardiovascular agentsAm J Health-Syst Pharm200966986-7
Vazquez RLe Hoang MDMartin JSimultaneous quantification of water-soluble and fat-soluble vitamins in parenteral nutrition admixtures by HPLC-UV-MS/MSEur J Hosp Pharm Sci20091528-35
Donnelly RFPhysical compatibility and chemical stability of ketamine-morphine mixtures in polypropylene syringesCan J Hosp Pharm20096228-33
Walker SIazzetta JLaw SExtended stability of pantoprazole for injection in 0.9% sodium chloride or 5% dextrose at 4°C and 23°CCan J Hosp Pharm200962135-41
Ensom MHHDecarie DLeung KStability of hydromorphone-ketamine solutions in glass bottles, plastic syringes, and IV bags for pediatric useCan J Hosp Pharm200962112-8
Pourroy BBausset EMBoulamery AIncompatibility of imipenem-cilastatin and amoxicillinAm J Health-Syst Pharm2009661253-4
Eugia US LLC. Nafcillin for injection prescribing information. East Windsor, NJ; 2022 Dec.
Gole DJ, Ilias J, Vermeersch H, et al. Stability of ceftobiprole for injection (500 mg) in representative infusion fluids and containers. ASHP Summer Meeting Poster. Jun 2009
Newton DWDriscoll DFCalcium and phosphate compatibility: revisited againAm J Health-Syst Pharm20086573-80
Eroles AABafalluy IMArnaiz JASStability of docetaxel diluted to 0.3 to 0.9 mg/mL with 0.9% sodium chloride injection and stored in polyolefin or glass containersAm J Health-Syst Pharm2009661565-8
Michel M (Medical Information, Eisai, Woodcliff Lake, NJ): Personal communication; 2016 Jan 12.
Donnelly RFStability of aseptically prepared tazocin solutions in polyvinyl chloride bagsCan J Hosp Pharm200962226-31
Galanti LLebitassy MPHecq JDLong-term stability of 5-fluorouracil in 0.9% sodium chloride after freezing, microwave thawing, and refrigerationCan J Hosp Pharm20096234-8
Eugia US LLC. Nafcillin for injection pharmacy bulk package prescribing information. East Windsor, NJ; 2022 Dec.
Baxter Healthcare Corporation. Nafcillin injection in PL 2040 plastic container prescribing information. Deerfield, IL; 2018 Sep.
Almoazen HBhattacharjee HSamsa ACStability of mesna in ReadyMed infusion devicesAnn Pharmacother201044224-5
Athanapoulos AHecq JDVanbeckbergen DLong-term stability of tramadol chlorhydrate and metoclopramide hydrochloride in dextrose 5% polyolefin bag at 4°CJ Oncol Pharm Pract200915195-200
Reviewers' comments (personal observations) on infliximab.
Walker SELaw SGarland JStability of norepinephrine solutions in normal saline and 5% dextrose in waterCan J Hosp Pharm201063113-8
Moriyama BHenning SAJin HPhysical compatibility of magnesium sulfate and sodium bicarbonate in a pharmacy-compounded hemofiltration solutionAm J Health-Syst Pharm201067562-5
Pascuet EDonnelly RFGarceau DBuffered lidocaine hydrochloride solution with and without epinephrine: stability in polypropylene syringesCan J Hosp Pharm200962375-80
He JFigueroa DATze-Peng LStability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25°CAm J Health-Syst Pharm671191-4
Wear JMcPherson TBKolling WMStability of sodium bicarbonate solutions in polyolefin bagsAm J Health-Syst Pharm2010671026-9
Khondkar DChopra PMcArter JPChemical stability of hydromorphone hydrochloride in patient-controlled analgesia injectorInt J Pharmaceut Compound201014160-4
Walker SEIazetta JLaw SStability of commonly used antibiotic solutions in an elastomeric infusion deviceCan J Hosp Pharm201063212-4
Baker DSWaldrop BArnold JCompatibility and stability of cefotaxime, vancomycin, and ciprofloxacin in antibiotic solutions containing heparinInt J Pharmaceut Compound201014346-9
Hospira, Inc. Dyloject^® (diclofenac sodium) injection for intravenous use prescribing information. Lake Forest, IL; 2014 Dec.
Rolin CHecq JDVanbeckbergen DFStability of ondansetron and dexamethasone infusion upon refrigerationAnn Pharmacother201145130-1
Strong DKDecarie DEnsom MHHStability of levothyroxine in sodium chloride for IV administrationCan J Hosp Pharm201063437-43
Cote DLok CEBattistella MStability of trisodium citrate and gentamicin solution for catheter locks after storage in plastic syringes at room temperatureCan J Hosp Pharm201063304-11
Schulz LElder EJones KStability of sodium nitroprusside and sodium thiosulfate 1:10 intravenous admixtureHosp Pharm201045779-84
Singh BN, Dedhiya MG, DiNunzio J, et al. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm. 2011; 68:2163-9
Amri ABen Achour AChachaty EMicrobiology and physicochemical stability of oxycodone hydrochloride solutions for patient-controlled delivery systemsJ Pain Symptom Manage20104087-94
Tsiouris MUlmer MYurcho JFStability and compatibility of reconstituted caspofungin in select elastomeric infusion devicesInt J Pharmaceut Compound201014436-9
Tennant D (Senior Medical Information Specialist, Hospira, Inc., Lake Forest, IL): Personal communication; 2011 Mar 22.
Housman STTessier PRNicolau DPPhysical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administrationAm J Health Syst Pharm2011682265-70
Theravance. Vibativ^® (telavancin) for injection for intravenous use prescribing information. South San Francisco, CA; 2014 Mar.
Allergan USA, Inc. Teflaro^® (ceftaroline fosamil) for injection prescribing information. Madison, NJ; 2019 Sep.
UCB, Inc. Keppra^® (levetiracetam) injection prescribing information. Smyrna, GA; 2022 Sep.
WG Critical Care, LLC. Levetiracetam in sodium chloride injection prescribing information. Paramus, NJ; 2021 Apr.
UCBCares Medical Information. Keppra^® (levetiracetam) injection: Stability, compatibility and osmolality. 2019 Feb 18.
Hospira, Inc. Ondansetron injection prescribing information. Lake Forest, IL; 2021 Jul.
Gland Pharma Limited. Ondansetron injection prescribing information. Hyderabad, India; 2021 Jun.
Cumberland Pharmaceuticals Inc. Vaprisol^® (conivaptan hydrochloride) injection prescribing information. Nashville, TN; 2017 Sep.
Howard MSBoddu SHMauro VFCompatibility of conivaptan injection with select cardiovascular medicationsAm J Health Syst Pharm2014711534-5
Mallinckrodt Hospital Products Inc. Ofirmev^® (acetaminophen) injection prescribing information. Hazelwood, MO; 2020 Jun.
Lu C (Director Medical Affairs, Cadence Pharmaceuticals, San Diego, CA): Personal communication; 2012 Nov 5.
Hamdi MLentschener CBazin CCompatibility and stability of binary mixtures of acetaminophen, nefopam, ketoprofen and ketamine in infusion solutionsEur J Anaesthesiol20092623-7
Havard L (Service de Pharmacie, Hôpital Européen Georges-Pompidou, Paris): Personal communication; 2012 Nov 30.
Ang R, Kupiec TC, Breitmeyer JB, et al. IV acetaminophen in-use stability and compatibility with common IV fluids and IV medications. Presented at 111th Annual Meeting of the American Society of Clinical Pharmacology and Therapeutics. Atlanta, GA: 2010 March 17-20.
Kwiatkowski JLJohnson CEWagner DSExtended stability of intravenous acetaminophen in syringes and opened vialsAm J Health Syst Pharm2012691999-2001
Hospira Worldwide, Inc. Pamidronate disodium injection solution for intravenous infusion prescribing information. Lake Forest, IL; 2009 Sep.
Bedford Laboratories. Pamidronate disodium injection solution and lyophilized powder for solution for intravenous infusion prescribing information. Bedford, OH; 2012 Aug.
Hospira, Inc. Precedex^® (dexmedetomidine hydrochloride) injection prescribing information. Lake Forest, IL; 2022 Aug.
Anderson CRMacKay MWHolley MStability of dexmedetomidine 4 mcg/mL in polypropylene syringesAm J Health Syst Pharm201269595-7
Wyeth Pharmaceuticals Inc. Protonix^® I.V. (pantoprazole sodium) for injection for intravenous use prescribing information. Philadelphia, PA; 2017 Jul.
Donnelly RFStability of pantoprazole sodium in glass vials, polyvinyl chloride minibags, and polypropylene syringesCan J Hosp Pharm201164192-8
Sanofi-Aventis U.S. LLC. Eloxatin^® (oxaliplatin) injection for intravenous use prescribing information. Bridgewater, NJ; 2013 Aug.
Pfizer Labs. Oxaliplatin injection for intravenous use prescribing information. New York, NY; 2012 Jul.
Caraco Pharmaceutical Laboratories, Ltd. Oxaliplatin for injection for intravenous use prescribing information. Detroit, MI; 2012 Sep.
Eiden CPhilibert LBekhtari KPhysicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bagsAm J Health Syst Pharm2009661929-33
JHP Pharmaceuticals, LLC. Oxytocin injection prescribing information. Rochester, MI; 2012 Feb.
JHP Pharmaceuticals, LLC. Pitocin^® (oxytocin) injection pharmacy bulk package prescribing information. Rochester, MI; 2012 Apr.
APP Pharmaceuticals, LLC. Oxytocin injection solution for intravenous infusion or intramuscular use prescribing information. Schaumburg, IL; 2007 Dec.
Swedish Orphan Biovitrum AB. Kineret^® (anakinra) for injection for subcutaneous use prescribing information. Stockholm, Sweden; 2013 Oct.
Teva Pharmaceuticals USA, Inc. Trisenox^® (arsenic trioxide) injection for intravenous administration prescribing information. North Wales, PA; 2016 Aug.
Cumberland Pharmaceuticals Inc. Acetadote® (acetylcysteine) injection prescribing information. Nashville, TN; 2021 Oct.
Pfizer Injectables. Eraxis^® (anidulafungin) for injection prescribing information. New York, NY; 2018 Jan.
Pfizer Injectables. Zithromax^® (azithromycin) for injection prescribing information. New York, NY; 2017 Mar.
Bristol-Myers Squibb Company. Azactam^® (aztreonam) for injection prescribing information. Princeton, NJ; 2013 Jun.
Bristol-Myers Squibb Company. Azactam^® (aztreonam) injection in GALAXY plastic container (PL 2040) for intravenous use prescribing information. Princeton, NJ; 2013 Jun.
Fresenius Kabi USA, LLC. Aztreonam for injection prescribing information. Lake Zurich, IL; 2013 Sep.
Hospira, Inc. Hextend^® (6% hetastarch in lactated electrolyte injection) prescribing information. Lake Forest, IL; 2014 Nov.
AbbVie Inc. Nimbex^® (cisatracurium besylate) injection prescribing information. North Chicago, IL; 2013 Jan.
Baxter Healthcare Corporation. Brevibloc^® (esmolol hydrochloride) injection for intravenous use prescribing information. Deerfield, IL; 2014 Apr.
Eisai Inc. Aloxi^® (palonosetron HCl) injection prescribing information. Woodcliff Lake, NJ; 2015 Dec.
Teva Pharmaceuticals USA. Pancuronium bromide injection prescribing information. Sellersville, PA; 2011 Oct.
Hospira, Inc. Pancuronium bromide injection prescribing information. Lake Forest, IL; 2013 Nov.
Amgen, Inc. Neupogen^® (filgrastim) prescribing information. Thousand Oaks, CA; 2013 Sep.
Kaushal GSayre BEPrettyman TStability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bagsAm J Health Syst Pharm201370894-9
Bedford Laboratories. Diltiazem hydrochloride injection prescribing information. Bedford, OH; 2007 Feb.
Hospira, Inc. Diltiazem hydrochloride for injection for continuous intravenous infusion not for bolus ADD-Vantage^® vials prescribing information. Lake Forest, IL; 2008 Jan.
Sanofi-Aventis U.S. LLC. Zaltrap^® (ziv-aflibercept) injection for intravenous infusion prescribing information. Bridgewater, NJ; 2013 Oct.
Fierro L (Medical Information Services, sanofi-aventis, Bridgewater, NJ): Personal communication; 2012 Dec 4.
GlaxoSmithKline. Flolan^® (epoprostenol sodium) for injection prescribing information. Research Triangle Park, NC; 2018 May.
Actelion Pharmaceuticals US, Inc. Veletri^® (epoprostenol) for injection prescribing information. South San Francisco, CA; 2016 Jul.
Teva Pharmaceuticals USA, Inc. Epoprostenol sodium for injection prescribing information. North Wales, PA; 2017 Aug.
Lambert OBandilla DStability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertensionDrug Des Devel Ther20126235-44
Fresenius Kabi USA, LLC. Levothyroxine sodium for injection prescribing information. Lake Zurich, IL; 2013 Apr.
Frenette AJMacLean RDWilliamson DStability of levothyroxine injection in glass, polyvinyl chloride, and polyolefin containersAm J Health Syst Pharm2011681723-8
APP Pharmaceuticals, LLC. Levothyroxine sodium for injection prescribing information. Schaumburg, IL; 2008 Jan.
Pfizer Injectables. Cyklokapron^® (tranexamic acid) injection prescribing information. New York, NY; 2020 Jun.
Riley J (Medical Information, Pfizer, New York, NY): Personal communication; 2013 Apr 30.
Exela Pharma Sciences, LLC. Tranexamic acid in sodium chloride injection prescribing information. Lenoir, NC; 2020 Jul.
CRASH-2 trial collaboratorsShakur HRoberts IEffects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trialLancet201037623-32
Roberts IShakur HKer KAntifibrinolytic drugs for acute traumatic injuryCochrane Database Syst Rev201212CD004896
Spahn DRBouillon BCerny VManagement of bleeding and coagulopathy following major trauma: an updated European guidelineCrit Care201317R76
Saleem N (Medical Information, Amgen, Thousand Oaks, CA): Personal communication; 2014 Apr 4.
Astellas Pharma US, Inc. Mycamine^® (micafungin sodium) for injection for IV infusion only prescribing information. Northbrook, IL; 2013 Jun.
Fleischbein EMontgomery PAZhou CSVisual compatibility of micafungin sodium and levofloxacin injectionsAm J Health Syst Pharm2012692130
Akorn, Inc. Levofloxacin injection prescribing information. Lake Forest, IL; 2020 May.
EUSA Pharma (USA), Inc. Erwinaze^® (asparaginase Erwinia chrysanthemi) for injection for intramuscular use prescribing information. Langhorne, PA; 2014 Mar.
Takeda Pharmaceutical America, Inc. Velcade^® (bortezomib) for injection prescribing information. Lexington, MA; 2022 Aug.
Gilbar PSeger ACDeaths reported from the accidental intrathecal administration of bortezomibJ Oncol Pharm Pract201218377-8
Medtronic, Inc. Lioresal^® Intrathecal (baclofen injection) prescribing information. Minneapolis, MN; 2013 Oct.
CNS Therapeutics Inc. Gablofen^® (baclofen injection) prescribing information. St. Paul, MN; 2013 Mar.
Anderson CBoehme SOuellette JPhysical and chemical compatibility of injectable acetaminophen during simulated y-site administrationHosp Pharm20144942-7
Anderson C (Clinical Pharmacist, Primary Children's Hospital, Salt Lake City, UT): Personal communication; 2014 Jan 28.
Hospira, Inc. Isuprel^® (isoproterenol hydrochloride) injection solution prescribing information. Lake Forest, IL; 2013 Jul.
Apotex Inc. Butorphanol tartrate injection solution prescribing information. Toronto, Ontario; 2005 Aug.
West-Ward Pharmaceuticals. Butorphanol tartrate injection solution prescribing information. Eatontown, NJ; 2009 Sep.
Akorn, Inc. Inapsine^® (droperidol) injection for intravenous or intramuscular use only prescribing information. Lake Forest, IL; 2011 Oct.
American Regent, Inc. Droperidol injection solution for IV or IM use only prescribing information. Shirley, NY; 2005 Nov.
Chen FCFang BXLi PCompatibility of butorphanol and droperidol in 0.9% sodium chloride injectionAm J Health Syst Pharm201370515-9
Beauregard NBertrand NDufour APhysical compatibility of calcium gluconate and magnesium sulfate injectionsAm J Health Syst Pharm20126998
Allergan USA, Inc. Dalvance^® (dalbavancin) for injection prescribing information. Madison, NJ; 2018 Oct.
Merck & Co., Inc. Noxafil^® (posaconazole) injection for intravenous use, delayed-release tablets for oral use, and oral suspension prescribing information. Whitehouse Station, NJ; 2020 Sep.
Dutta S (Medical Information, Merck, North Wales, PA): Personal communication; 2014 Jun 3.
Merck & Co., Inc. Sivextro^® (tedizolid phosphate) for injection for intravenous use and tablets for oral use prescribing information. Whitehouse Station, NJ; 2020 Oct.
Freeman C (Medical Information, Cubist Pharmaceuticals, Lexington, MA): Personal communication; 2014 Aug 19.
Wyeth Pharmaceuticals LLC. Tygacil^® (tigecycline) for injection prescribing information. Philadelphia, PA; 2018 Apr.
Bracco Diagnostics Inc. Isovue^® 300. 370 (iopamidol injection) imaging bulk package prescribing information. Monroe Township, NJ; 2023 Apr.
Ludwig S (Corresponding Author): Personal communication; 2014 May 8.
Wyeth Pharmaceuticals LLC. Zosyn^® (piperacillin and tazobactam) for injection and Zosyn^® (piperacillin and tazobactam) injection prescribing information. Philadelphia, PA; 2022 Apr.
Hospira, Inc. Piperacillin and tazobactam for injection ADD-Vantage ^® vials prescribing information. Lake Forest, IL; 2022 May.
Wockhardt USA LLC. Piperacillin and tazobactam for injection pharmacy bulk package prescribing information. Parsippany, NJ; 2021 Sep.
Wockhardt USA LLC. Piperacillin and tazobactam for injection prescribing information. Parsippany, NJ; 2021 Dec.
(Medical Information, Pfizer): Personal communication; 2014.
Merck & Co., Inc. Renflexis^® (infliximab-abda) for injection prescribing information. Whitehouse Station, NJ; 2019 Jun.
Gilead Sciences, Inc. Vistide^® (cidofovir) injection prescribing information. Foster City, CA; 2010 Sep.
Heritage Pharmaceuticals Inc. Cidofovir injection prescribing information. Eatontown, NJ; 2013 Oct.
JHP Pharmaceuticals, LLC. Brevital^® sodium (methohexital sodium) for injection prescribing information. Rochester, MI; 2014 Feb.
Melinta Therapeutics, Inc. Orbactiv^® (oritavancin) for injection prescribing information. Lincolnshire, IL; 2019 Dec.
Kumar AMann HJVisual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administrationAm J Health Syst Pharm2010671640-4
Novartis Pharmaceuticals Corporation. Sandimmune^® (cyclosporine) capsules, oral solution, and injection prescribing information. East Hanover, NJ; 2015 Mar.
Li MForest JMCoursol CStability of cyclosporine solutions stored in polypropylene-polyolefin bags and polypropylene syringesAm J Health Syst Pharm2011681646-50
Li MCoursol CLeclair GStability of cyclosporine diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in ethylene-vinyl acetate containersAm J Health Syst Pharm2013701970-2
Desai NRShah SMCohen JZosyn (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosidesTher Clin Risk Manag20084303-14
Nichols KRDemarco MWVertin MDY-site compatibility of vancomycin and piperacillin/tazobactam at commonly utilized pediatric concentrationsHosp Pharm20134844-7
Lam WJBhowmick TGross AUsing higher doses to compensate for tubing residuals in extended-infusion piperacillin-tazobactamAnn Pharmacother201347886-91
Leung EVenkatesan NLy SCPhysical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusionsAm J Health Syst Pharm2013701163-6
Fresenius Kabi USA, LLC. Bleomycin sulfate for injection prescribing information. Lake Zurich, IL; 2014 Feb.
Hospira, Inc. Bleomycin for injection prescribing information. Lake Forest, IL; 2013 Jan.
Fresenius Kabi USA, LLC. Cladribine injection prescribing information. Lake Zurich, IL; 2013 May.
Teva Pharmaceuticals USA. Carboplatin injection prescribing information. North Wales, PA; 2016 Jan.
Accord Healthcare, Inc. Carboplatin injection prescribing information. Durham, NC; 2019 July.
Fresenius Kabi USA, LLC. Cytarabine injection prescribing information. Lake Zurich, IL; 2021 May.
Hospira, Inc. Cytarabine injection for intravenous, intrathecal and subcutaneous use only prescribing information. Lake Forest, IL; 2020 Jun.
Hospira, Inc. Cytarabine injection pharmacy bulk package prescribing information. Lake Forest. IL; 2020 Jun.
Hospira, Inc. Cytarabine injection for intravenous or subcutaneous use only prescribing information. Lake Forest, IL; 2020 Jun.
Recordati Rare Diseases Inc. Cosmegen^® (dactinomycin) for injection prescribing information. Lebanon, NJ; 2013 Feb.
APP Pharmaceuticals, LLC. Vinblastine sulfate injection prescribing information. Schaumburg, IL; 2011 Oct.
Hospira, Inc. Vincristine sulfate injection prescribing information. Lake Forest, IL; 2021 Feb.
Hospira, Inc. Mitoxantrone hydrochloride injection concentrate prescribing information. Lake Forest, IL; 2013 Feb.
Pfizer Labs. Mitoxantrone hydrochloride injection concentrate prescribing information. New York, NY; 2013 May.
Teva Parenteral Medicines, Inc. Daunorubicin hydrochloride injection prescribing information. Irvine, CA; 2012 Sep.
Fresenius Kabi USA, LLC. Etoposide injection prescribing information. Lake Zurich, IL; 2022 Mar.
Merck & Co., Inc. Intron^® A (interferon alfa-2b, recombinant) for injection prescribing information. Whitehouse Station, NJ; 2014 Oct.
Merck & Co., Inc. Intron^® A (interferon alfa-2b, recombinant) powder for solution instructions for use. Whitehouse Station, NJ; 2011 Feb.
Fresenius Kabi USA, LLC. Fluorouracil injection solution pharmacy bulk package prescribing information. Lake Zurich, IL; 2017 Jan.
Fresenius Kabi USA, LLC. Fluorouracil injection solution prescribing information. Lake Zurich; 2019 Oct.
Accord Healthcare, Inc. Fluorouracil injection solution pharmacy bulk package prescribing information. Durham, NC; 2016 Nov.
Accord Healthcare, Inc. Fluorouracil injection solution prescribing information. Durham, NC; 2017 Feb.
Merck & Co., Inc. Zerbaxa^® (ceftolozane and tazobactam) for injection prescribing information. Whitehouse Station, NJ; 2019 Jun.
Johnson PR (Medical Information, Cubist Pharmaceuticals, Lexington, MA): Personal Communication; 2014 Dec 23.
BioCryst Pharmaceuticals, Inc. Rapivab^® (peramivir) injection prescribing information. Durham, NC; 2021 Jan.
Lipiäinen TPeltoniemi MSarkhel SFormulation and Stability of Cytokine TherapeuticsJ Pharm Sci2014
Baxter Healthcare Corporation. Cyclophosphamide powder for injection. Deerfield, IL; 2014 Oct.
Jansen JJOldland ARKiser THEvaluation of phenylephrine stability in polyvinyl chloride bagsHosp Pharm201449455-7
Pharmacia and Upjohn Company. Idamycin PFS^® (idarubicin hydrochloride injection) prescribing information. New York, NY; 2014 Dec.
Teva Parenteral Medicines, Inc. Idarubicin hydrochloride injection prescribing information. Irvine, CA; 2011 Sep.
Hospira, Inc. Methotrexate injection prescribing information. Lake Forest, IL; 2021 Jun.
West-Ward Pharmaceuticals Corp. Methotrexate injection prescribing information. Eatontown, NJ; 2018 Aug.
Fresenius Kabi USA, LLC. Methotrexate sodium for injection prescribing information. Lake Zurich, IL; 2020 May.
Antares Pharma, Inc. Otrexup^® (methotrexate) injection for subcutaneous use prescribing information. Ewing, NJ; 2019 Dec.
Medexus Pharma Inc. Rasuvo^® (methotrexate) injection for subcutaneous use prescribing information. Chicago, IL; 2020 Mar..
Almagambetova EHutchinson DBlais DMStability of diluted adenosine solutions in polyolefin infusion bagsHosp Pharm201348484-8
Walker SECharbonneau LFLaw SStability of Bortezomib 2.5 mg/mL in Vials and Syringes Stored at 4°C and Room Temperature (23°C)Can J Hosp Pharm201467102-7
Merck & Co., Inc. Invanz^® (ertapenem) for injection prescribing information. Whitehouse Station, NJ; 2014 Sep.
Jain JGSutherland CNicolau DPStability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20°CAm J Health Syst Pharm2014711480-4
Dutta S (Medical Information, Merck, North Wales, PA): Personal communication; 2015 Feb 6.
McCluskey SVVu NRueter JStability of nitroglycerin 110 mcg/mL stored in polypropylene syringesInt J Pharm Compd2013 Nov-Dec17515-9
Merck & Co., Inc. Cubicin^® (daptomycin) for injection prescribing information. Whitehouse Station, NJ; 2021 Oct.
Ortega RSalmerón-García ACabeza JStability of daptomycin 5 mg/mL and heparin sodium 100 units/mL combined in lactated Ringer's injection and stored in polypropylene syringes at 4 and -20°CAm J Health Syst Pharm201471956-9
Parra MACampanero MASádaba BEffect of glucose concentration on the stability of daptomycin in peritoneal solutionsPerit Dial Int2013 Jul-Aug33458-61
Peyro Saint Paul LAlbessard FGaillard CDaptomycin compatibility in peritoneal dialysis solutionsPerit Dial Int2011 Jul-Aug31492-5
Hossain MAFriciu MAubin SStability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containersAm J Health Syst Pharm201471669-73
Otsuka America Pharmaceutical, Inc. Busulfex^® (busulfan) injection prescribing information. Rockville, MD; 2018 Jan.
Cueto-Sola MBelda-Furió MBorrell-García CIncompatibility of undiluted busulfan injection with a needle-free valveAm J Health Syst Pharm2014711436-7
Patel RPLi KShastri MStability of ampicillin and amoxicillin in peritoneal dialysis solutionsAm J Health Syst Pharm20157213-4
Woodcock J. Food and Drug Administration. FDA Letter re: Docket nos. FDA-2005-P-0003, FDA-2006-P-0019, FDA-2006-P-0331, and FDA-2006-P-0391: Determine that the discontinued formulation Zosyn (piperacillin and tazobactam for injection), was not discontinued for safety and efficacy reasons. Rockville, MD; US Food and Drug Administration. From regulations.gov website (www.regulations.gov/#!documentDetail;D=FDA-2012-P-0507-0001). Accessed 2015 Feb 26.
Donnelly RFStability of cefazolin sodium in polypropylene syringes and polyvinylchloride minibagsCan J Hosp Pharm201164241-5
McCluskey SVSztajnkrycer MDJenkins DAStability of tranexamic acid in 0.9% sodium chloride, stored in type 1 glass vials and ethylene/propylene copolymer plastic containersInt J Pharm Compd2014 Sep-Oct18432-7
de Guzman RPolykratis IASondeen JLStability of tranexamic acid after 12-week storage at temperatures from -20°c to 50°cPrehosp Emerg Care2013 Jul-Sep17394-400
Kaltenbach MHutchinson DJBollinger JEStability of diluted adenosine solutions in polyvinyl chloride infusion bagsAm J Health Syst Pharm2011681533-6
Hutchinson D. (Associate Professor, Wegmans School of Pharmacy at St. John Fisher College, Rochester, NY): Personal communication; 2015 Mar 8.
Astellas Pharma US, Inc. Adenocard^® IV (adenosine) injection for rapid bolus intravenous use prescribing information. Northbrook, IL; 2012 May.
Astellas Pharma US, Inc. Adenoscan^® (adenosine) injection for intravenous use prescribing information. Northbrook, IL; 2014 Aug.
Fresenius Kabi USA, LLC. Adenosine injection for rapid bolus intravenous use prescribing information. Schaumburg, IL; 2013 Jan.
Teva Pharmaceuticals USA, Inc. Treanda^® (bendamustine hydrochloride) injection and for injection prescribing information. North Wales, PA; 2018 Nov.
Food and Drug Administration. Treanda (bendamustine hydrochloride) solution by Teva: FDA statement - not compatible with closed system transfer devices, adapters, and syringes containing polycarbonate or acrylonitrile-butadiene-styrene. 2015 Mar 10. From FDA website. Accessed 2015 Mar 12.
(US Medical Information, Teva Pharmaceuticals, North Wales, PA): Personal communication; 2015 Mar 12.
Hurtukova D. Dear healthcare provider letter regarding important safety and incompatibility information for Treanda^® (bedamustine HCl) injection (45 mg/0.5 mL or 180 mg/2 mL solution). North Wales, PA: Teva Pharmaceuticals USA; 2015 Mar 9. From the FDA website. Accessed 2015 Mar 12.
Merck Sharp & Dohme Corp. Emend^® (fosaprepitant dimeglumine) for injection prescribing information. Whitehouse Station, NJ; 2020 Apr.
Sun SSchaller JPlacek JCompatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroidsCancer Chemother Pharmacol201372509-13
Par Pharmaceutical. Vasostrict^® (vasopressin) injection prescribing information. Chestnut Ridge, NY; 2022 Jun.
Musaji N (Medical Affairs, Par Pharmaceutical, Inc., Parsippany, NJ): Personal communication; 2015.
American Regent, Inc. Vasopressin injection prescribing information. Shirley, NY; 2011 May.
Certo J (Medical Information, Recordati Rare Diseases, Lebanon, NJ): Personal communication; 2015 Jun 3.
Allergan USA, Inc. Avycaz^® (ceftazidime and avibactam sodium) for injection prescribing information. Madison, NJ; 2020 Dec.
Guan J (Medical Information, Actavis, Parsippany, NJ): Personal communication; 2015 Jun 12.
Astellas Pharma US, Inc. Cresemba^® (isavuconazonium sulfate) capsules and for injection prescribing information. Northbrook, IL; 2015 Jun.
Sanofi-Aventis U.S. LLC. Ferrlecit^® (sodium ferric gluconate complex in sucrose injection) prescribing information. Bridgewater, NJ; Apr 2015.
Baribeault DShort-term stability of a new generic sodium ferric gluconate in complex with sucroseCurr Med Res Opin2011272241-3
Bracco Diagnostics Inc. Isovue-M^® 200. 300 (iopamidol injection) prescribing information. Monroe Township, NJ; 2021 Jun.
American Regent, Inc. Torsemide injection prescribing information. Shirley, NY; 2014 Feb.
Heritage Pharmaceuticals, Inc. Acetazolamide sodium injection prescribing information. Eatontown, NJ; 2014 Dec.
Sanofi-Aventis U.S. LLC. Taxotere^® (docetaxel) injection concentration prescribing information. Bridgewater, NJ; 2014 Nov.
Hospira, Inc. Docetaxel injection prescribing information. Lake Forest, IL; 2014 Jul.
Accord Healthcare, Inc. Docetaxel injection prescribing information. Durham, NC; 2014 Jul.
Sun Pharmaceutical Industries, Inc. Docefrez^® (docetaxel) for injection prescribing information. Cranbury, NJ; 2014 Nov.
Pfizer Injectables. Docetaxel injection prescribing information. New York, NY; 2014 Nov.
Sandoz. Docetaxel injection solution prescribing information. Princeton, NJ; 2014 Nov.
Actavis Inc. Docetaxel injection concentrate prescribing information. Morristown, NJ; 2014 Sep.
Food and Drug Administration. Drug safety communication: FDA warns that cancer drug docetaxel may cause symptoms of alcohol intoxication after treatment. Rockville, MD; 2014 Jun 20. From FDA website. Accessed 2015 Jul 16.
Hikma Pharmaceuticals USA Inc. Flumazenil injection prescribing information. Berkeley Heights, NJ; 2020 Jul.
Colby LH (Programming Services, Merck, West Point, PA): Personal communication; 1968 Dec 16.
Hospira, Inc. Foscavir^® (foscarnet sodium) injection prescribing information. Lake Forest, IL; 2014 Nov.
The Medicines Company. Kengreal^® (cangrelor) for injection prescribing information. Parsippany, NJ; 2015 Jun.
Talon Therapeutics, Inc. Marqibo^® (vincristine sulfate liposome injection) prescribing information. South San Francisco, CA; 2012 Oct.
Mirza AMithal NAlcohol intoxication with the new formulation of docetaxelClin Oncol (R Coll Radiol)201123560-1
Parker EALetter: Correction in stability data for isuprel hydrochloride admixturesAm J Hosp Pharm197633528
Eisai Inc. Halaven^® (eribulin mesylate) injection prescribing information. Woodcliff Lake, NJ; 2015 Oct.
Spindeldreier KThiesen JLipp HPPhysico-chemical stability of eribulin mesylate containing concentrate and ready-to-administer solutionsJ Oncol Pharm Pract201420183-9
Institute for Safe Medication Practices. Loss of drug potency. ISMP Medication Safety Alert! Acute Care edition. Horsham, PA; 2015 Jul. From ISMP website. Accessed 2015 Sep 14.
X-GEN Pharmaceuticals, Inc. Acetazolamide for injection prescribing information. Big Flats NY; 2013 Mar.
Hikma Pharmaceuticals USA, Inc. Ativan^® (lorazepam) injection prescribing information. Berkeley Heights, NJ; 2021 Feb.
Abelgas M (Medical Communications, Hospira, Lake Forest, IL): Personal communication; 2014 Sep 9.
Hospira, Inc. Lorazepam injection prescribing information. Lake Forest, IL; 2021 May.
Barr JFraser GLPuntillo KClinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unitCrit Care Med201341263-306
Janssen Biotech, Inc. Remicade^® (infliximab) lyophilized concentrate for injection prescribing information. Horsham, PA; 2020 May.
Thompson CA. Stability findings raise issue of syringes as storage containers. ASHP Pharmacy News. Bethesda, MD; 2015 Jul. From ASHP website. Accessed 2015 Sep 14.
Noe B. BD Medical. July 31, 2015 letter to US syringe customers. Franklin Lakes, NJ; 2015 July. From BD website. Accessed 2015 Sep 14.
BD Medical. Technical update to July 31, 2015 letter to US syringe customers. Franklin Lakes. 2015 Jul. From BD website. Accessed 2015 Sep 14.
US Food and Drug Administration. FDA alert: Compounded or repackaged drugs stored in Becton-Dickinson (BD) 3 mL and 5 mL syringes: FDA alert - do not use unless there is no suitable alternative. 2015 Aug 18. From FDA website. Accessed 2015 Sep 14.
Institute for Safe Medication Practices. ISMP comments on BD syringe potency issues. ISMP Medication Safety Alert! Acute Care edition. Horsham, PA; 2015 Aug. From ISMP website. Accessed 2015 Sep 14.
Wesolowski A. BD Medical. September 1, 2015 letter to US syringe customers. Franklin Lakes, NJ; 2015 July. From BD website. Accessed 2015 Sep 14.
Noe BE (BD Medical, Franklin Lakes, NJ): Personal communication; 2015 Sep 3.
US Food and Drug Administration. FDA alert: FDA expands warning on Becton-Dickinson (BD) syringes being used to store compounded or repackaged drugs. 2015 Sep 8. From FDA website. Accessed 2015 Sep 14.
US Food and Drug Administration. FDA warns against using Treanda injection (solution) with closed system transfer devices, adapters, and syringes containing polycarbonate or acrylonitrile-butadiene-styrene; provides list of compatible devices. 2015 Sep 4. From FDA website. Accessed 2015 Sep 16.
Hurtukova D. Dear healthcare provider letter regarding update: important safety and compatibility information for Treanda^® (bendamustine HCl) injection (45 mg/0.5 mL or 180 mg/2 mL solution). North Wales, PA: Teva Pharmaceuticals USA; 2015 Sep 2. From the FDA website. Accessed 2015 Sep 15.
Tyree D (Medical Information, Otsuka): Personal communication; 2015 Sep.
Food and Drug Administration. Center for Drug Evaluation and Research. Application number: NDA 20-954: Pharmacology review(s). From FDA website.
Merck & Co., Inc. Integrilin^® (eptifibatide) injection prescribing information. Whitehouse Station, NJ; 2014 Apr.
Wieland K (Global Medical Information, Merck, North Wales, PA): Personal communication; 2015 Oct 8.
B. Braun Medical Inc. Hespan® (6% hetastarch in 0.9% sodium chloride injection) prescribing information. Bethlehem, PA; 2013 Dec.
Hikma Pharmaceuticals USA, Inc. Phenylephrine hydrochloride injection prescribing information. Eatontown, NJ; 2019 Jun.
Exela Pharma Sciences, LLC. Vazculep^® (phenylephrine hydrochloride) injection prescribing information. Lenoir, NC; 2021 Mar.
Biotest Pharmaceuticals Corporation. Bivigam^® (immune globulin intravenous [human], 10% liquid) prescribing information. Boca Raton, FL; 2013 Oct.
CSL Behring LLC. Carimune^® NF, Nanofiltered (immune globulin intravenous [human], lyophilized) prescribing information. Kankakee, IL; 2013 Sep.
Grifols Biologicals Inc. Flebogamma^® 5% DIF (immune globulin intravenous [human], 5% liquid) prescribing information. Los Angeles, CA; 2015 Apr.
Grifols Biologicals Inc. Flebogamma^® 10% DIF (immune globulin intravenous [human], 10% liquid) prescribing information. Los Angeles, CA; 2015 Mar.
Grifols Therapeutics Inc. GamaSTAN^® S/D (immune globulin [human]) prescribing information. Research Triangle Park, NC; 2013 Sep.
Baxter Healthcare Corporation. Gammagard^® S/D (immune globulin intravenous [human], IgA less than 1 microgram per mL in a 5% solution) prescribing information. Westlake Village, CA; 2014 Apr.
Baxter Healthcare Corporation. Gammagard Liquid^® (immune globulin infusion [human], 10%) prescribing information. Westlake Village, CA; 2014 Apr.
Kedrion Biopharma, Inc. Gammaked^® (immune globulin injection [human], 10%) prescribing information. Fort Lee, NJ; 2013 Sep.
BPL Inc. Gammaplex^® (immune globulin intravenous [human], 5% liquid) prescribing information. Raleigh, NC; 2015 July.
Grifols Therapeutics Inc. Gammunex^®-C (immune globulin injection [human], 10%) prescribing information. Research Triangle Park, NC; 2014 Jul.
CSL Behring LLC. Hizentra^® (immune globulin subcutaneous [human], 20% liquid) prescribing information. Kankakee, IL; 2015 Jan.
Baxter Healthcare Corporation. HyQvia^® (immune globulin infusion [human] 10% with recombinant human hyaluronidase) prescribing information. Westlake Village, CA; 2014 Sep.
Octapharma USA Inc. Octagam^® (immune globulin intravenous [human] 5%) prescribing information. Hoboken, NJ; 2013 Sep.
Octapharma USA Inc. Octagam^®10% (immune globulin intravenous [human]) prescribing information. Hoboken, NJ; 2014 Dec.
CSL Behring LLC. Privigen^® (immune globulin intravenous [human], 10% liquid) prescribing information. Kankakee, IL; 2013 Nov.
Astellas Pharma US, Inc. AmBisome^® (amphotericin B) liposome for injection prescribing information. Northbrook, IL; 2012 May.
Pauner A (Medical Affairs, Astellas, Northbrook, IL): Personal communication; 2015 Oct 23.
APP Pharmaceuticals, LLC. Floxuridine for injection prescribing information. Schaumburg, IL; 2008 Jan.
APP Fresenius Kabi USA, LLC. Doxy^® 100 & 200 (doxycycline) for injection prescribing information. Lake Zurich, IL; 2013 Sep.(
Sigma-Tau Pharmaceuticals, Inc. Abelcet^® (amphotericin B lipid complex) injection prescribing information. Gaithersburg, MD; 2013 Mar.
Manley HJGrabe DWNorcross MStability of amphotericin B-lipid complex (Abelcet) in peritoneal dialysis solutionsPerit Dial Int2000 Jan-Feb2087-90
Hamil K (Medical Information, Sigma-Tau, Gaithersburg, IL): Personal communication; 2015 Nov 2.
Stein MRThe new generation of liquid intravenous immunoglobulin formulations in patient care: a comparison of intravenous immunoglobulinsPostgrad Med2010122176-84
Bolli RWoodtli KBärtschi ML-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutionsBiologicals201038150-7
Janssen Scientific Affairs. JanssenMD^® Professional Information Resource. Infliximab: Storage and stability of unreconstituted infliximab. Updated 2020 Jul 9. From Janssen website. Accessed 2020 Aug 13.
Janssen Scientific Affairs. JanssenMD^® Professional Information Resource. Infliximab: Stability of reconstituted vials. Updated 2019 May 31. From Janssen website. Accessed 2020 Aug 13.
Janssen Scientific Affairs. JanssenMD^® Professional Information Resource. Infliximab: Stability of prepared Infusions. Updated 2019 Jun 6. From Janssen website. Accessed 2020 Aug 13.
Janssen Scientific Affairs. JanssenMD^® Professional Information Resource. Infliximab: Reconstitution/dilution in 0.45% sodium chloride. Updated 2020 Jul 21. From Janssen website. Accessed 2020 Aug 13.
Janssen Scientific Affairs. JanssenMD^® Professional Information Resource. Infliximab: Removal of non-PVC equipment requirement. Updated 2019 Dec 17. From Janssen website. Accessed 2020 Aug 13.
Ilett K (Emeritus Professor of Pharmacology, University of Western Australia, Perth, Australia): Personal communication; 2015 Nov 16.
Genentech, Inc. Rituxan^® (rituximab) injection prescribing information. South San Francisco, CA; 2016 Apr.
Paul MVieillard VJaccoulet ELong-term stability of diluted solutions of the monoclonal antibody rituximabInt J Pharm2012436282-90
Norkus D (Medical Communications, Genentech, South San Francisco, CA): Personal communication; 2015 Nov 20.
Genentech, Inc. Herceptin^® (trastuzumab) intravenous infusion prescribing information. South San Francisco, CA; 2016 Mar.
Norkus D (Medical Communications, Genentech, South San Francisco, CA): Personal communication; 2015 Nov 20.
Kaiser JKrämer IPhysicochemical stability of diluted trastuzumab infusion solutions in polypropylene infusion bagsInt J Pharm Compd201115515-20
Pabari RMRyan BAhmad WPhysical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutionsCurr Pharm Biotechnol201314220-5
Glover ZWGennaro LYadav SCompatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministrationJ Pharm Sci2013102794-812
Genentech, Inc. Perjeta^® (pertuzumab) injection prescribing information. South San Francisco, CA; 2016 Mar.
Hope Pharmaceuticals. Sodium thiosulfate injection prescribing information. Scottsdale, AZ; 2023 Nov.
Hope Pharmaceuticals. Nithidote^® (sodium nitrite injection and sodium thiosulfate injection) prescribing information. Scottsdale, AZ; 2021 Jan.
Boehringer Ingelheim Pharmaceuticals, Inc. Praxbind^® (idarucizumab) injection prescribing information. Ridgefield, CT; 2015 Oct.
Amgen Inc. Blincyto^® (blinatumomab) for injection prescribing information. Thousand Oaks, CA; 2017 Nov.
Gu ZWong ARaquinio EStability of reconstituted telavancin drug product in frozen intravenous bagsHosp Pharm201550609-14
Gu ZParra CWong APost-reconstitution stability of telavancin with commonly used diluents and intravenous infusion solutionsCurr Ther Res201577105-10
Teva Pharmaceuticals USA, Inc. Bendeka^® (bendamustine hydrochloride) injection prescribing information. North Wales, PA; 2018 Jul.
Eagle Pharmaceuticals, Inc. Docetaxel injection prescribing information. Woodcliff Lake, NJ; 2015 Dec.
Food and Drug Administration Center for Devices and Radiological Health. Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices. 2001 Sep. From FDA website. Accessed 2015 Jul 30.
National Toxicology Program, U.S. Department of Health and Human Services, Center for the Evaluation of Risks to Human Reproduction. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Di(2-Ethylhexyl) Phthalate (DEHP). NIH Publication No. 06-4476. 2006 Nov.
AstraZeneca Pharmaceuticals LP. Merrem^® I.V. (meropenem for injection) prescribing information. Wilmington, DE; 2015 Apr.
B. Braun Medical Inc. Meropenem and sodium chloride injection prescribing information. Bethlehem, PA; 2015 Apr.
Berthoin KLe Duff CSMarchand-Brynaert JStability of meropenem and doripenem solutions for administration by continuous infusionJ Antimicrob Chemother2010651073-5
Viaene EChanteux HServais HComparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units)Antimicrob Agents Chemother2002462327-32
Manning LWright CIngram PRContinuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stabilityPLoS One20149e102023
Chen LYChen JWaters VIncompatibility of ciprofloxacin and meropenem injectionsAm J Health Syst Pharm2013701966, 1970
Tran MDSharley NWard MStability of amoxycillin, clindamycin and meropenem in peritoneal dialysis solutionJ Pharm Pract Res201242218-22
Keel RASutherland CACrandon JLStability of doripenem, imipenem and meropenem at elevated room temperaturesInt J Antimicrob Agents201137184-5
Park KHChung DJStability study of docetaxel solution (0.9%, saline) using Non-PVC and PVC tubes for intravenous administrationBiomater Res2015192
Merck and Co., Inc. Bridion^® (sugammadex) injection prescribing information. Whitehouse Station, NJ;2015 Dec.
Hanci VKiraz HAÖmür DPrecipitation in Gallipoli: sugammadex / amiodarone & sugammadex / dobutamine & sugammadex / protamineBraz J Anesthesiol201363163-4
Alston TAPrecipitation of sugammadex by protamineJ Clin Anesth201123593
Raphael CDZhao FHughes SEA Pilot Chemical and Physical Stability Study of Extemporaneously Compounded Levetiracetam Intravenous SolutionJ Pain Palliat Care Pharmacother201529370-3
McCrory C (Medical Information, Merck, North Wales, PA): Personal communication; 2016 Feb 16.
Par Pharmaceutical. Ketalar^® (ketamine hydrochloride) injection prescribing information. Chestnut Ridge, NY; 2018 Jul.
Hospira, Inc. Ketamine hydrochloride injection prescribing information. Lake Forest, IL; 2020 Apr.
Donnelly RFStability of diluted ketamine packaged in glass vialsCan J Hosp Pharm201366198
Chen FXiong HYang JButorphanol and ketamine combined in infusion solutions for patient-controlled analgesia administration: a long-term stability studyMed Sci Monit2015211138-45
Chen FCXiong HLiu HMCompatibility of butorphanol with granisetron in 0.9% sodium chloride injection packaged in glass bottles or polyolefin bagsAm J Health Syst Pharm2015721374-8
Chen FCShi XYLi PStability of butorphanol-tropisetron mixtures in 0.9% sodium chloride injection for patient-controlled analgesia useMedicine (Baltimore)201594e432
Ikeda RVermeulen LCLau EStability of infliximab in polyvinyl chloride bagsAm J Health Syst Pharm2012691509-12
Teva Pharmaceuticals USA. Granisetron hydrochloride injection prescribing information. Sellersville, PA; 2014 Aug.
Fresenius Kabi USA, LLC. Granisetron hydrochloride injection prescribing information. Lake Zurich, IL; 2015 Feb.
Akorn, Inc. Granisetron hydrochloride injection prescribing information. Lake Forest, IL; 2015 Sep.
Cipla USA, Inc. Granisetron hydrochloride injection prescribing information. Miami, FL; 2015 Jul.
Astellas Pharma US, Inc. Prograf^® (tacrolimus) capsules and injection prescribing information. Northbrook, IL; 2015 May.
Lee JHGoldspiel BRRyu SStability of tacrolimus solutions in polyolefin containersAm J Health Syst Pharm201673137-42
Goldspiel BR (Corresponding Author): Personal communication; 2016 Feb 21.
Mylan Institutional LLC. Fomepizole injection prescribing information. Rockford, IL; 2012 Sep.
Paladin Labs (USA) Inc. Antizol^® (fomepizole) injection prescribing information. Dover, DE; 2009 Apr.
Oak Pharmaceuticals, Inc. Sodium Diuril^® (chlorothiazide sodium) injection prescribing information. Whitehouse Station, NJ; 2012 May.
Fresenius Kabi USA, LLC. Chlorothiazide sodium injection prescribing information. Schaumburg, IL; 2013 Feb.
McCluskey SVGardner BGraner KKStability of chlorothiazide sodium in polypropylene syringesAm J Health Syst Pharm2015721292-7
Sanofi-Aventis U.S. LLC. Elitek (rasburicase) powder for solution for intravenous infusion prescribing information. Bridgewater, NJ; 2015 Mar.
Genentech USA, Inc. Boniva^® (ibandronate) injection prescribing information. South San Francisco, CA; 2015 Apr.
Heritage Pharmaceuticals Inc. Ibandronate sodium injection prescribing information. Eatontown, NJ; 2015 Oct.
Bhattacharya SParekh SDedhiya MIn-use stability of ceftaroline fosamil in elastomeric home infusion systems and MINI-BAG Plus containersInt J Pharm Compd2015 Sep-Oct19432-6
Novartis Pharmaceuticals Corporation. Reclast^® (zoledronic acid) injection prescribing information. East Hanover, NJ; 2015 Apr.
Novartis Pharmaceuticals Corporation. Zometa^® (zoledronic acid) injection prescribing information. East Hanover, NJ; 2015 Jun.
Caraco Pharmaceutical Laboratories, Ltd. Zoledronic acid for injection prescribing information. Detroit, MI; 2012 Nov.
Sagent Pharmaceuticals. Zoledronic acid injection prescribing information. Schaumburg, IL; 2015 Oct.
Hospira, Inc. Zoledronic acid injection prescribing information. Lake Forest, IL; 2015 Dec.
Sagent Pharmaceuticals. Zoledronic acid injection prescribing information. Schaumburg, IL; 2015 Sep.
Merck & Co., Inc. Temodar^® (temozolomide) capsules and for injection prescribing information. Whitehouse Station, NJ; 2015 Sep.
UCB, Inc. Briviact^® (brivaracetam) tablets, oral solution, and injection prescribing information. Smyrna, GA; 2016 Feb.
Merrimack Pharmaceuticals, Inc. Onivyde^® (irinotecan liposome injection) prescribing information. Cambridge, MA; 2015 Oct.
Jazz Pharmaceuticals, Inc. Defitelio^® (defibrotide sodium) injection prescribing information. Palo Alto, CA; 2016 Mar.
Correard FSavry AGauthier-Villano LVisual compatibility of defibrotide with selected drugs during simulated Y-site administrationAm J Health Syst Pharm2014711288-91
JHP Pharmaceuticals, LLC. Coly-Mycin^® M Parenteral (colistimethate for injection) prescribing information. Rochester, MI; 2013 Jan.
Perrigo. Colistimethate for injection prescribing information. Minneapolis, MN; 2013 Sep.
Abdulla Avan Leeuwen RWde Vries Schultink AHStability of colistimethate sodium in a disposable elastomeric infusion deviceInt J Pharm2015486367-9
National Alert Network (NAN). Warning! Dosing confusion with colistimethate for injection. 2011 Jun 29. NAN Alert. Accessed 2016 Apr 12.
Healan AMGray WFuchs EJStability of colistimethate sodium in aqueous solutionAntimicrob Agents Chemother2012566432-3
Wallace SJLi JRayner CRStability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patientsAntimicrob Agents Chemother2008523047-51
American Regent. Provayblue^® (methylene blue) injection prescribing information. Shirley, NY; 2016 Apr.
Foushee JAFox LMGormley LRPhysical compatibility of cisatracurium with selected drugs during simulated Y-site administrationAm J Health Syst Pharm201572483-6
Akorn, Inc. Methylene blue injection prescribing information. Lake Forest, IL; 2011 Jun.
Par Pharmaceutical Companies, Inc. Dantrium^® Intravenous (dantrolene sodium) for injection prescribing information. Spring Valley, NY; 2015 Feb.
US WorldMeds, LLC. Revonto^® (dantrolene sodium) for injection prescribing information. Louisville, KY; 2014 Jul.
Eagle Pharmaceuticals, Inc. Ryanodex^® (dantrolene sodium) for injectable suspension prescribing information. Woodcliff Lake, NJ; 2014 Jul.
Bedford Laboratories. Polymyxin B for injection prescribing information. Bedford, OH; 2011 Jun.
X-GEN Pharmaceuticals, Inc. Polymyxin B for injection prescribing information. Big Flats, NY; 2015 May.
Pharmacia & Upjohn Company. Lincocin^® (lincomycin hydrochloride) injection prescribing information. New York, NY; 2014 Oct.
X-GEN Pharmaceuticals. Lincomycin injection prescribing information. Big Flats, NY; 2015 Apr.
Czarniak PBoddy MSunderland BStability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluidsDrug Des Devel Ther2016101029-34
Jazz Pharmaceuticals, Inc. Prialt^® (ziconotide) solution for intrathecal infusion prescribing information. Palo Alto, CA; 2013 Feb.
Bazin CPoirier ALDupoiron DInfluence of pH and temperature on ziconotide stability in intrathecal analgesic admixtures in implantable pumps and syringesInt J Pharm2015487285-91
Medtronic. Medical device safety notification: increased risk of motor stall and loss of or change in therapy with unapproved drug formulations. From Medtronic for healthcare professionals website. professional.medtronic.com. 2012 Nov.
Dupoiron DRichard HChabert-Desnot VIn vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumpsNeuromodulation201417472-82; discussion 482
Singh RChen JMiller TSolution stability of Captisol-stability melphalan (Evomela) versus Propyelene glycol-based melphalan hydrochloride injectionPharm De Technol20161-6
Spectrum Pharmaceuticals, Inc. Evomela^® (melphalan) for injection prescribing information. Irvine, CA; 2017 Sep.
Mylan Institutional LLC. Melphalan hydrochloride for injection prescribing information. Rockford, IL; 2016 Feb.
Desmaris RPMercier LPaci AStability of Melphalan in 0.9% Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous InjectionDrugs R D201515253-9
Mylan Institutional LLC. Moxifloxacin hydrochloride injection prescribing information. Rockford, IL; 2019 Oct.
Fresenius Kabi USA, LLC. Moxifloxacin hydrochloride injection prescribing information. Lake Zurich, IL; 2020 Mar.
Janssen Products, LP. Yondelis^® (trabectedin) for injection prescribing information. Horsham, PA; 2015 Oct.
Payne B (Medical Information, Janssen, Titusville, NJ): Personal communication; 2016 May 3.
WG Critical Care, LLC. Dexmedetomidine hydrochloride injection prescribing information. Paramus, NJ; 2021 Dec.
Fresenius Kabi USA, LLC. Dexmedetomidine hydrochloride injection prescribing information. Lake Zurich, IL; 2020 Nov.
Hospira, Inc. Precedex^® (dexmedetomidine hydrochloride) injection prescribing information. Lake Forest, IL; 2008 Oct.
CSL Behring LLC. Kcentra^® (prothrombin complex concentrate [human]) prescribing information. Kankakee, IL; 2014 Sep.
Pharmacia & Upjohn Co. Zyvox^® (linezolid) injection, tablets and oral suspension prescribing information. New York, NY; 2015 Jul.
Hospira, Inc. Linezolid injection solution prescribing information. Lake Forest, IL; 2015 Jun.
Pfizer Inc. Inflectra^® (infliximab-dyyb) for injection prescribing information. New York, NY; 2019 Jun.
GlaxoSmithKline. Argatroban injection prescribing information. Research Triangle Park, NC; 2016 May.
The Medicines Company. Argatroban injection prescribing information. Parsippany, NJ; 2016 May.
Sandoz Inc. Argatroban injection in 0.9% sodium chloride prescribing information. Princeton, NJ; 2016 May.
Teva Pharmaceuticals USA, Inc. Argatroban injection in 0.9% sodium chloride prescribing information. New Wales, PA; 2016 May.
Fresenius Kabi. Argatroban injection prescribing information. Lake Zurich, IL; 2016 May.
West-Ward Pharmaceuticals. Argatroban injection prescribing information. Eatontown, NJ; 2016 May.
Jakimczuk PJChurchwell MDHoward MSCompatibility of argatroban injection with select antiarrhythmic drugsAm J Health Syst Pharm2014711831-2
Pharmacia & Upjohn Company. Corvert^® (ibutilide fumarate) injection prescribing information. New York, NY; 2006 Feb.
Huvelle SGodet MHecq JDLong-term stability of ketamine hydrochloride 50mg/ml injection in 3ml syringesAnn Pharm Fr201674283-7
Robiyanto RZaidi STShastri MDStability of Tigecycline in Different Types of Peritoneal Dialysis SolutionsPerit Dial Int2016 Jul-Aug36410-4
Acrotech Biopharma, LLC. Fusilev^® (levoleucovorin) for injection and injection prescribing information. East Windsor, NJ; 2020 Nov.
Meitheal Pharmaceuticals Inc. Levoleucovorin injection prescribing information. Chicago, IL; 2020 Dec.
Randhawa AShah ADay CCompatibility of daptomycin with commercially available syringe filtersHosp Pharm2015507-8
Day C (Corresponding Author): Personal communication; 2016 Jun 20.
Chiesi USA, Inc. Cleviprex^® (clevidipine) injectable emulsion prescribing information. Cary, NC; 2022 Sep.
UCB, Inc. Vimpat^® (lacosamide) tablet, injection, and oral solution prescribing information. Smyrna, GA; 2015 Jun.
Pharmacia and Upjohn Company. Camptosar^® (irinotecan hydrochloride) injection prescribing information. New York, NY; 2016 Apr.
Hospira, Inc. Irinotecan hydrochloride injection prescribing information. Lake Forest, IL; 2015 Nov.
Actavis Pharma, Inc. Irinotecan hydrochloride injection prescribing information. Parsippany, NJ; 2014 Jun.
Wyeth Pharmaceuticals Inc. Torisel^® kit (temsirolimus) injection prescribing information. Philadelphia, PA; 2016 Jul.
Alvogen, Inc. Midazolam injection prescribing information. Pine Brook, NJ; 2017 Jun.
Manning MCChou DKMurphy BMStability of protein pharmaceuticals: an updatePharm Res201027544-75
Bardin CAstier AVulto AGuidelines for the practical stability studies of anticancer drugs: a European consensus conferenceAnn Pharm Fr201169221-31
Sreedhara AGlover ZKPiros NStability of IgG1 monoclonal antibodies in intravenous infusion bags under clinical in-use conditionsJ Pharm Sci201210121-30
Kolesar JMVermeulen LAssays for biological agentsAm J Health Syst Pharm2013701101
Vigneron JAstier ATrittler RSFPO and ESOP recommendations for the practical stability of anticancer drugs: an updateAnn Pharm Fr201371376-89
Ricci MSFrazier MMoore JIn-use physicochemical and microbiological stability of biological parenteral productsAm J Health Syst Pharm201572396-407
Sanofi-Aventis U.S. LLC. Clolar^® (clofarabine) injection prescribing information. Bridgewater, NJ; 2015 Dec.
Poujol SBressolle FSolassol IStability of ready-to-use temsirolimus infusion solution (100mg/L) in polypropylene containers under different storage conditionsAnn Pharm Fr201270155-62
Genzyme Europe B.V. Evoltra® (clofarabine) concentrate. Annex I: Summary of product characteristics. Naarden, Netherlands. 2016 Apr.
Kaiser JKrämer ILong-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutionsJ Oncol Pharm Pract201218213-21
Sigma-Tau Pharmaceuticals, Inc. Carnitor^® (levocarnitine) injection prescribing information. Gaithersburg, MD; 2015 Apr.
American Regent, Inc. Levocarnitine injection prescribing information. Shirley, NY; 2016 Apr.
Celgene Corporation. Abraxane^® (paclitaxel protein-bound particles) for injectable suspension (albumin-bound) prescribing information. Summit, NJ; 2015 Jul.
West-Ward Pharmaceuticals. Dopram^® (doxapram hydrochloride) injection prescribing information. Eatontown, NJ; 2011 Nov.
Merck & Co., Inc. Cubicin^® RF (daptomycin) for injection prescribing information. Whitehouse Station, NJ; 2021 Oct.
Fresenius Kabi USA, LLC. Daptomycin for injection prescribing information. Lake Zurich, IL; 2021 Sep.
Hospira, Inc. Sodium bicarbonate injection prescribing information. Lake Forest, IL; 2005 Oct.
Fresenius Kabi USA, LLC. Sodium bicarbonate injection prescribing information. Lake Zurich, IL; 2013 Aug.
Hospira, Inc. Neut^® (sodium bicarbonate) injection prescribing information. Lake Forest, IL; 2013 Feb.
The Medicines Company. Minocin^® (minocycline) for injection prescribing information. Parsippany, NJ; 2015 Apr.
Lebitasy MHecq JDAthanassopoulos AEffect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bagsJ Clin Pharm Ther200934423-8
Sanogo SSilimbani PGaggeri RStability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bagsJ Oncol Pharm Pract202127288-296
Pfizer Inc. Synercid^® (quinupristin and dalfopristin) injection prescribing information. New York, NY; 2016 Aug.
Rubinstein EProkocimer PTalbot GHSafety and tolerability of quinupristin/dalfopristin: administration guidelinesJ Antimicrob Chemother199944 Suppl A37-46
Healan A (Corresponding Author): Personal communication; 2016 Sep 20.
Talwar S (Global Health Science, The Medicines Company, Parsippany, NJ): Personal communication; 2016 Sep 19.
Pfizer Inc. Vfend^® (voriconazole) tablets, for oral suspension, and for injection prescribing information. New York, NY; 2017 Aug.
Fresenius Kabi. Esmolol hydrochloride injection prescribing information. Lake Zurich, IL; 2016 Feb.
WG Critical Care, LLC. Esmolol hydrochloride in water for injection prescribing information. Paramus, NJ; 2016 Apr.
Iovance Biotherpeutics, Inc. Proleukin^® (aldesleukin) for injection prescribing information. Philadelphia, PA; 2024 Feb.
Medicis. Calcium Disodium Versenate^® (edetate calcium disodium) injection prescribing information. Scottsdale, AZ; 2012 Oct.
Howland MA. Antidotes in depth: edetate calcium disodium (CaNa₂EDTA). In: Hoffman RS, Howland MA, Lewin NA et al, eds. Goldfrank's Toxicologic Emergencies. 10th ed. New York: McGraw-Hill; 2014:1241-4.
(Medical Information, Sigma Tau Pharmaceuticals): Personal communication; 2016 Oct 6.
Baxalta US Inc. Cuvitru^® (immune globulin subcutaneous [human], 20% solution) prescribing information. Westlake Village, CA; 2016 Sep.
Hospira, Inc. Corlopam^® (fenoldopam mesylate) injection prescribing information. Lake Forest, IL; 2015 Dec.
Hart MAcott SPhysical and chemical stability of Taxotere (docetaxel) one-vial (20 mg/mL) infusion solution following refrigerated storageEcancermedicalscience20104202
Lee S (Medical Information, Chiesi, Cary, NC): Personal communication; 2016 Sep 30.
Ghazi IHamada YNicolau DPPhysical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administrationAm J Health Syst Pharm2016731769-1776
Sullivan TForest JMLeclair GCompatibility of cloxacillin sodium with selected intravenous drugs during simulated Y-Site administrationHosp Pharm201550214-20
Chan ATawfik GCheng WPhysical incompatibility between parenteral cloxacillin and vancomycinCan J Hosp Pharm201366310-2
Nicolau DP (Corresponding Author): Personal communication; 2016 Oct 28.
SteriMax Inc. Cloxacillin for injection prescribing information. Oakville, Ontario; 2016 Feb.
Hospira, Inc. Enalaprilat injection prescribing information. Lake Forest, IL; 2010 Mar.
Fresenius Kabi. Midazolam injection pharmacy bulk package prescribing information. Lake Zurich, IL; 2017 Jun.
Fresenius Kabi USA, LLC. Intralipid^® 20% (lipid injectable emulsion) prescribing information. Lake Zurich, IL; 2023 Jun.
Fresenius Kabi USA, LLC. Intralipid^® 20% (lipid injectable emulsion) pharmacy bulk package prescribing information. Lake Zurich, IL; 2023 Jun.
Fresenius Kabi USA, LLC. Intralipid^® 30% (lipid injectable emulsion) pharmacy bulk package prescribing information. Lake Zurich, IL; 2024 Mar.
B. Braun Medical Inc. Nutrilipid^® 20% (lipid injectable emulsion) prescribing information. Bethlehem, PA; 2023 May.
Fresenius Kabi USA, LLC. Smoflipid^® 20% (lipid injectable emulsion) prescribing information. Lake Zurich, IL; 2023 Jun.
Mirtallo JMAyers PBoullata JASPEN Lipid Injectable Emulsion Safety Recommendations, Part 1: Background and Adult ConsiderationsNutr Clin Pract202035769-782
Collins L (Medical Information, B. Braun Medical): Personal communication; 2016 Sep 20.
Patten L (Medical Affairs, Fresenius Kabi USA, LLC, Lake Zurich, IL): Personal communication; 2016 Sep 20.
Ayers PAdams SBoullata JA.S.P.E.N. parenteral nutrition safety consensus recommendationsJPEN J Parenter Enteral Nutr2014 Mar-Apr38296-333
Institute for Safe Medication Practices. IV fat emulsion needs a filter. ISMP Medication Safety Alert! Nurse Advise-ERR. 2014; 14:4-5.
Janu MBrodská HVecka MComparison of long-term stability of parenteral all-in-one admixtures containing new lipid emulsions prepared under hospital pharmacy conditionsMedicina (Kaunas)201147323-33
Thabit AKHamada YNicolau DPPhysical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administrationAm J Health Syst Pharm201774e47-e54
So WKim LThabit AKPhysical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administrationAm J Health Syst Pharm201774e55-e63
Fresenius Kabi. Kabiven^® (amino acids, electrolytes, dextrose and lipid injectable emulsion) for intravenous use prescribing information. Uppsala, Sweden; 2016 Apr.
Fresenius Kabi. PeriKabiven^® (amino acids, electrolytes, dextrose and lipid injectable emulsion) for intravenous use prescribing information. Uppsala, Sweden; 2016 Apr.
Mauro VF (Corresponding Author): Personal communication; 2017 Apr 5.
Baxter Healthcare Corporation. 20% ProSol^® (amino acid injection) pharmacy bulk package prescribing information. Deerfield, IL; 2014 Apr.
B. Braun Medical Inc. TrophAmine^® (amino acid injections) prescribing information. Irvine, CA; 2013 Nov.
Wojuade E (Corresponding Author): Personal communication; 2017 Apr 28.
Yousaf FZaidi STWanandy TStability of cefepime in pH-neutral peritoneal dialysis solutions packaged in dual-compartment bagsPerit Dial Int2016 Jul-Aug36457-9
Feutry FSimon NGenay SStability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC-UV stability-indicating methodDrug Dev Ind Pharm201642166-174
Hecq JDRolin CGodet MLong-term stability of esomeprazole in 5% dextrose infusion polyolefin bags at 5 degrees C +/- 3 degrees C after microwave freeze-thaw treatmentInt J Pharm Compd2015 Nov-Dec19521-4
Briot TVrignaud SLagarce FStability of micafungin sodium solutions at different concentrations in glass bottles and syringesInt J Pharm2015492137-40
Karlage KEarhart ZGreen-Boesen KStability of midazolam hydrochloride injection 1-mg/mL solutions in polyvinyl chloride and polyolefin bagsAm J Health Syst Pharm2011681537-40
Perks WIazzetta JChan PCExtended stability of sodium phosphate solutions in polyvinyl chloride bagsCan J Hosp Pharm2017 Jan-Feb707-12
Walker S (Corresponding Author): Personal communication; 2017 May 3.
Myers ALZhang YKawedia JDStability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bagsAm J Health Syst Pharm2016732083-2088
Amgen Inc. Vectibix^® (panitumumab) injection prescribing information. Thousand Oaks, CA; 2021 Aug.
Mylan Institutional LLC. Amiodarone hydrochloride injection prescribing information. Morgantown, WV; 2020 Jul.
Pfizer Inc. Cerebyx^® (fosphenytoin sodium) injection prescribing information. New York, NY; 2017 Mar.
West-Ward Pharmaceuticals. Fosphenytoin sodium injection prescribing information. Eatontown, NJ; 2017 Feb.
Valeant Pharmaceuticals North America LLC. Nitropress (sodium nitroprusside) injection prescribing information. Bridgewater, NJ; 2016 Oct.
Exela Pharma Sciences, LLC. Nipride RTU (sodium nitroprusside) in 0.9% sodium chloride injection prescribing information. Lenoir, NC; 2017 Mar.
Anderson CRCollins DLaursen TStability of sodium nitroprusside in 5% dextrose stored at 4°C in polypropylene syringes protected from lightInt J Pharm Compd2016 Sep-Oct20435-437
Roerig. Unasyn^® (ampicillin sodium/sulbactam sodium) prescribing information. New York, NY; 2024 Jun. (IDIS) (PubMed)
Hospira, Inc. Azithromycin for injection prescribing information. Lake Forest, IL; 2017 May.
The Medicines Company. Angiomax^® (bivalirudin) for injection prescribing information. Parsippany, NJ; 2016 Mar.
Hospira, Inc. Bumetanide injection prescribing information. Lake Forest, IL; 2017 Apr.
Fresenius Kabi. Calcium gluconate injection prescribing information. Lake Zurich, IL;2018 Jul.
Exela Pharma Sciences, LLC. Exela Pharma Sciences, LLC receives approval for Nipride RTU (sodium nitroprusside) in 0.9% sodium chloride injection, the first ready to use sodium nitroprusside injection. 2017 Mar 9. From Exela Pharma Sciences website. Accessed 2017 May 24.www.exelapharma.com/exela-pharma-sciences-llc-receives-approval-for-nipride-rtu-sodium-nitroprusside-in-0-9-sodium-chloride-injection-the-first-ready-to-use-sodium-nitroprusside-injection/
Sandoz Inc. Ampicillin sodium for injection prescribing information. Princeton, NJ; 2015 Aug.
Sandoz Inc. Ampicillin sodium for injection in ADD-Vantage vials prescribing information. Princeton, NJ; 2011 Jun.
Sandoz Inc. Ampicillin sodium for injection pharmacy bulk package prescribing information. Princeton, NJ; 2015 Aug.
Hospira, Inc. Ampicillin sodium for injection prescribing information. Lake Forest, IL; 2015 Aug.
Hospira, Inc. Maxipime^® (cefepime hydrochloride) for injection prescribing information. Lake Forest, IL; 2017 May.
Baxter Healthcare Corporation. Cefepime hydrochloride injection prescribing information. Deerfield, IL; 2016 May.
B. Braun Medical Inc. Cefepime hydrochloride for injection and dextrose injection prescribing information. Bethlehem, PA; 2015 Nov.
Carlier MStove VVerstraete AGStability of generic brands of meropenem reconstituted in isotonic salineMinerva Anestesiol201581283-7
Novartis Pharmaceuticals Corporation. Methergine^® (methylergonovine maleate) tablets and injection prescribing information. East Hanover, NJ; 2012 Jun.
Dewulf JGalanti LGodet MLong-term stability of acyclovir in 0.9% NaCl infusion polyolefin bags at 5±3°C after freeze-thaw treatment: a generic product versus the brand nameAnn Pharm Fr201573108-13
Hospira, Inc. Sodium phosphates injection prescribing information. Lake Forest, IL; 2018 Jan.
Fresenius Kabi. Dilaudid^® (hydromorphone hydrochloride) injection and Dilaudid-HP^® (hydromorphone hydrochloride) injection prescribing information. Lake Zurich, IL; 2017 Feb
Hospira, Inc. Hydromorphone hydrochloride injection prescribing information. Lake Forest, IL; 2016 Dec.
Akorn, Inc. Hydromorphone hydrochloride injection high potency formulation prescribing information. Lake Forest, IL; 2015 Feb.
Hospira, Inc. Hydromorphone hydrochloride injection high potency formulation prescribing information. Lake Forest, IL; 2017 Mar.
West-Ward Pharmaceuticals. Hydromorphone hydrochloride injection prescribing information. Eatontown, NJ; 2011 Jun.
Drakovich Y (Medical Affairs, Fresenius Kabi, Lake Zurich, IL): Personal communication; 2017 Jun 27.
Hospira, Inc. Bivalirudin for injection ADD-Vantage vials prescribing information. Lake Forest, IL; 2016 May.
West-Ward Pharmaceuticals. Bumetanide injection prescribing information. Eatontown, NJ; 2014 Oct.
Pipkin JD. Aztreonam. In: Connors KA, Amidon GL, Stella VJ, eds. Chemical stability of pharmaceuticals: a handbook for pharmacists. 2nd ed. New York: John Wiley; 1986:250-6.
APP Pharmaceuticals, LLC. Pentam^® 300 (pentamidine isethionate for injection) prescribing information. Schaumburg, IL; 2008 Mar.
Sturgeon A (Medical Affairs, Fresenius Kabi): Personal communication; 2017 Mar 23.
Fresenius Kabi. Calcium gluconate injection prescribing information. Lake Zurich, IL; 2015 Aug.
Arnott MAHay JCroft SLPentamidine: which salt?Lancet198811057-8
Pentamidine: which salt?Lancet198811395
Dorlo TPKager PAPentamidine dosage: a base/salt confusionPLoS Negl Trop Dis20082e225
Genentech, Inc. Actemra^® (tocilizumab) injection prescribing information. South San Francisco, CA; 2022 Dec.
Lundbeck. Carnexiv^® (carbamazepine) injection prescribing information. Deerfield, IL; 2016 Oct.
Hospira, Inc. Amidate^® (etomidate) injection prescribing information. Lake Forest, IL; 2017 Apr.
Liebel-Flarsheim Company LLC. Conray 30 (iothalamate meglumine) 30% injection prescribing information. Raleigh, NC; 2017 Mar.
Liebel-Flarsheim Company LLC. Conray 45 (iothalamate meglumine) 45% injection prescribing information. Raleigh, NC; 2017 Mar.
Liebel-Flarsheim Company LLC. Conray (iothalamate meglumine) 60% injection prescribing information. Raleigh, NC; 2017 Mar.
Liebel-Flarsheim Company LLC. Cysto-Conray^® II (iothalamate meglumine) 17.2% injection prescribing information. Raleigh, NC; 2016 Sep.
Qilu Pharmaceutical Co., Ltd. Cefepime hydrochloride for injection prescribing information. Jinan, China; 2016 Feb.
Celgene Corporation. Vidaza^® (azacitidine) for injection prescribing information. Summit, NJ; 2016 Aug.
Actavis Pharma, Inc. Azacitidine for injection prescribing information. Parsippany, NJ; 2018 Jan.
Celgene Europe Ltd. Vidaza® (azacitidine) for injection. Annex I: Summary of product characteristics. Uxbridge, United Kingdom. 2017 Jun.
Food and Drug Administration. Center for Drug Evaluation and Research. Application number: 208216Orig1s000: Medical review(s). From FDA website.
Savry ACorreard FVillano LGKeeping sterile water for injection cold enough for reconstitution of azacitidine in isolatorsAm J Health Syst Pharm201471180-1
Walker SECharbonneau LFLaw SStability of azacitidine in sterile water for injectionCan J Hosp Pharm201265352-9
Duriez AVigneron JHZenier HAStability of azacitidine suspensionsAnn Pharmacother201145546
Melinta Therapeutics, Inc. Baxdela^® (delafloxacin) tablets and for injection prescribing information. Lincolnshire, IL; 2021 Feb.
Barnes SD (Medical Affairs, Melinta Therapeutics, Lincolnshire, IL): Personal communication; 2017 Aug 2.
Lee S (Medical Information, Chiesi, Cary, NC): Personal communication; 2016 Nov 3.
Katip WVisual compatibility of colistin injection with other antibiotics during simulated Y-site administrationAm J Health Syst Pharm2017741099-1102
Par Pharmaceutical, Inc. Corphedra^® (ephedrine sulfate) injection prescribing information. Chestnut Ridge, NY; 2017 Jan.
Akorn, Inc. Ephedrine sulfate injection prescribing information. Lake Forest, IL; 2017 Jul.
WG Critical Care, LLC. Paclitaxel injection prescribing information. Paramus, NJ; 2013 Jun.
Hospira, Inc. Paclitaxel injection prescribing information. Lake Forest, IL; 2013 Jul.
Sandoz, Inc. Paclitaxel injection prescribing information. Princeton, NJ; 2015 Mar.
Teva Parenteral Medicines, Inc. Paclitaxel injection prescribing information. North Wales, PA; 2015 Jul.
Pazand S (Medical Information, WG Critical Care, Paramus, NJ): Personal communication; 2017 Oct 11.
Genentech, Inc. Kadcyla^® (ado-trastuzumab emtansine) for injection prescribing information. South San Francisco, CA; 2022 Feb.
Merck Sharp & Dohme LLC. Cancidas^® (caspofungin acetate) for injection prescribing information. Rahway, NJ; 2020 May.
Fresenius Kabi USA, LLC. Caspofungin acetate for injection prescribing information. Lake Zurich, IL; 2021 Jul.
Gland Pharma Limited. Caspofungin acetate for injection prescribing information. Hyderabad, India; 2022 Jan.
X-GEN Pharmaceuticals, Inc. Voriconazole for injection prescribing information. Big Flats, NY; 2017 Mar.
Sandoz Inc. Voriconazole for injection prescribing information. Princeton, NJ; 2016 Feb.
Adams AIMorimoto LNMeneghini LZTreatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bagsBraz J Infect Dis200812400-4
Myers ALZhang YPKawedia JDStability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bagsJ Oncol Pharm Pract20162231-6
Sanofi-Avenits U.S. LLC. Lovenox^® (enoxaparin sodium) injection prescribing information. Bridgewater, NJ; 2013 Oct.
Patel RPNarkowicz CJacobson GAIn vitro stability of enoxaparin solutions (20 mg/mL) diluted in 4% glucoseClin Ther2008301880-5
Summerhayes RChan MIgnjatovic VStability and sterility of diluted enoxaparin under three different storage conditionsJ Paediatr Child Health201147299-301
Moffett BSDinh KPlacencia JStability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable SolutionJ Pediatr Pharmacol Ther2016 Jul-Aug21322-326
Sanofi US Medical Information. Lovenox^® (enoxaparin sodium): Stability and Sterility Following Repackaging. Updated 2017 Jul 11. From Sanofi website. Accessed 2017 Oct 19.
Sanofi US Medical Information. Lovenox^® (enoxaparin sodium): Storage. Updated 2017 Sep 21. From Sanofi website. Accessed 2017 Oct 19.
West-Ward Pharmaceuticals. Pantoprazole sodium for injection prescribing information. Eatontown, NJ; 2017 Jun.
AuroMedics Pharma LLC. Pantoprazole sodium for injection prescribing information. East Windsor, NJ; 2017 Aug.
Zargar SAJavid GKhan BAPantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trialJ Gastroenterol Hepatol200621716-21
Barkun ANBardou MKuipers EJInternational consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleedingAnn Intern Med2010152101-13
Genentech USA, Inc. Cytovene^®-IV (ganciclovir sodium) for injection prescribing information. South San Francisco, CA; 2017 Jul.
Exela Pharma Sciences. Ganciclovir injection prescribing information. Lenoir, NC; 2017 Sep.
Guichard NBonnabry PRudaz SLong-term stability of ganciclovir in polypropylene containers at room temperatureJ Oncol Pharm Pract2017
Patel RPNarkowicz CJacobson GAInvestigation of freezing- and thawing-induced biological, chemical, and physical changes to enoxaparin solutionJ Pharm Sci2009981118-28
Patel RPNarkowicz CJacobson GAInvestigation of the effect of heating on the chemistry and antifactor Xa activity of enoxaparinJ Pharm Sci2009981700-11
Par Pharmaceutical, Inc. Ganciclovir sodium for injection prescribing information. Chestnut Ridge, NY; 2016 Sep.
Amneal Biosciences LLC. Tepadina^® (thiotepa) for injection prescribing information. Bridgewater, NJ; 2017 May.
West-Ward Pharmaceuticals. Thiotepa for injection prescribing information. Eatontown, NJ; 2015 Feb.
Jazz Pharmaceuticals, Inc. Vyxeos^® (daunorubicin and cytarabine) liposome for injection prescribing information. Palo Alto, CA; 2017 Aug.
ImClone LLC. Erbitux^® (cetuximab) injection prescribing information. Branchburg, NJ; 2021 Sep.
Novo Nordisk. NovoSeven^® RT (coagulation factor VIIa [recombinant]) for injection prescribing information. Plainsboro, NJ; 2020 Jul.
Hema Biologics. Sevenfact^® (coagulation factor VIIa [recombinant]-jncw) for injection prescribing information. Louisville, KY; 2020 Apr.
Sandoz Inc. Rocuronium bromide prescribing information. Princeton, NJ; 2019 Mar.
American Regent, Inc. Injectafer^® (ferric carboxymaltose) injection prescribing information. Shirley, NY; 2013 Jul.
Philipp EBraitsch MBichsel TDiluting ferric carboxymaltose in sodium chloride infusion solution (0.9% w/v) in polypropylene bottles and bags: effects on chemical stabilityEur J Hosp Pharm Sci Pract20162322-27
West-Ward Pharmaceuticals. Phenytoin sodium injection prescribing information. Eatontown, NJ; 2016 Dec.
Pharmacia & Upjohn Co. Ellence^® (epirubicin hydrochloride) injection prescribing information. New York, NY; 2020 Aug.
Bennis YSavry ACorreard FStability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolizationInt J Pharm2015495956-62
Melinta Therapeutics, Inc. Vabomere^® (meropenem and vaborbactam) for injection prescribing information. Lincolnshire, IL; 2019 Feb.
Kidd JMAvery LMAsempa TEPhysical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site AdministrationClin Ther201840261-269
Wojuade E (Global Health Science, The Medicines Company, Parsippany, NJ): Personal communication; 2017 Oct 13.
Kidd JM (Corresponding Author): Personal communication; 2018 Sep 27.
Marquis KHohlfelder BSzumita PMStability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion BagsInt J Pharm Compd2017 Sep-Oct21436-439
Pharmacia & Upjohn Co. Cleocin Phosphate^® (clindamycin) injection and (clindamycin) injection in 5% dextrose prescribing information. New York, NY; 2017 Sep.
Baxter Healthcare Corporation. Clindamycin in 0.9% sodium chloride injection prescribing information. Deerfield, IL; 2017 Apr.
Akorn, Inc. Clindamycin in 5% dextrose injection prescribing information. Lake Forest, IL; 2017 May.
Sandoz Inc. Clindamycin in 5% dextrose injection prescribing information. Princeton, NJ; 2017 May.
Alvogen, Inc. Clindamycin phosphate injection prescribing information. Pine Brook, NJ; 2017 Jun.
Hahn Z (Medical Information, Baxter Healthcare Corporation): Personal communication; 2018 Jan 9.
(Medical Information, Akorn): Personal communication; 2018 Jan 9.
US Food and Drug Administration. FDA alert: FDA notifies healthcare professionals that Becton-Dickinson replaced problematic rubber stoppers in its syringes. 2018 Jan 12. From FDA website. Accessed 2018 Jan 16.
Pharmacia & Upjohn Co. Zinecard^® (dexrazoxane) for injection prescribing information. New York, NY; 2016 Oct.
Mylan Institutional LLC. Dexrazoxane for injection prescribing information. Rockford, IL; 2015 May.
Cumberland Pharmaceuticals Inc. Totect^® (dexrazoxane) for injection prescribing information. Nashville, TN; 2017 Jun.
Zhang YPMyers ALTrinh VAPhysical and chemical stability of reconstituted and diluted dexrazoxane infusion solutionsJ Oncol Pharm Pract20142058-64
Lilly USA, LLC. Alimta^® (pemetrexed) for injection prescribing information. Indianapolis, IN; 2017 Oct.
La Jolla Pharmaceutical Company. Giapreza^® (angiotensin II) injection prescribing information. San Diego, CA; 2017 Dec.
Merck & Co., Inc. Prevymis^® (letermovir) tablets and injection prescribing information. Whitehouse Station, NJ; 2017 Nov.
Guichard NBonnabry PRudaz SStability of busulfan solutions in polypropylene syringes and infusion bags as determined with an original assayAm J Health Syst Pharm2017741887-1894
Hospira, Inc. Procainamide hydrochloride injection prescribing information. Lake Forest, IL; 2016 Nov.
International Medication Systems, Limited. Procainamide hydrochloride injection prescribing information. So. El Monte, CA; 2016 Oct.
Donnelly RFStability of Procainamide Injection in Clear Glass Vials and Polyvinyl Chloride BagsHosp Pharm201752704-708
Pfizer, Inc. Fragmin^® (dalteparin sodium) injection prescribing information. New York, NY; 2017 May.
Kirkham KMunson JMMcCluskey SVStability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene SyringesInt J Pharm Compd2017 Sep-Oct21426-429
Du Repaire TVigne PGuedon AVisual compatibility of blinatumomab with selected drugs during simulated Y-site administrationAm J Health Syst Pharm2017741217-1218
Roche Products Pty Limited. Rivotril^® (clonazepam). New South Wales, Australia; 2017 Jun.
Roche Products (New Zealand) Limited. New Zealand data sheet for Rivotril^®. Auckland, New Zealand; 2017 Jun.
Laboratórios Azevedos. Summary of product characteristics: omeprazole sodium. Amadora, Portugal; 2017 Apr.
Sandoz Limited. Summary of product characteristics: omeprazole sodium. Surrey, United Kingdom; 2017 Nov.
Accord Healthcare Limited. Summary of product characteristics: omeprazole. Middlesex, United Kingdom; 2017 Nov.
Sandoz Limited. Summary of product characteristics: omeprazole sodium and solvent for omeprazole sodium. Surrey, United Kingdom; 2016 Nov.
Sanofi-Aventis. Summary of product characteristics: Targocid^® (teicoplanin) 200 and 400 mg powder for solution for injection/infusion or oral solution. Surrey, United Kingdom; 2017 Dec.
Sanofi-Aventis. Product information: Targocid^® (teicoplanin). New South Wales, Australia; 2017 May.
Sanofi-Aventis. New Zealand data sheet for Targocid^® (teicoplanin) 400 mg. Auckland, New Zealand; 2017 Mar.
Generics (UK) Limited. Summary of product characteristics: Teicoplanin 100, 200, and 400 mg powder for solution for injection/infusion or oral solution. Hertfordshire, United Kingdom; 2017 Oct.
Sandoz Pty Ltd. Product information: Teicoplanin 400 mg injection. New South Wales, Australia; 2017 Dec.
Pourroy B (Corresponding Author): Personal communication; 2018 Feb 27.
Maher MJensen KJLee DStability of Ampicillin in Normal Saline and Buffered Normal SalineInt J Pharm Compd2016 Jul-Aug20338-342
Tobudic SDonath OVychytil AStability of anidulafungin in two standard peritoneal dialysis fluidsPerit Dial Int2014 Nov-Dec34798-802
Sturgeon A (Medical Affairs, Fresenius Kabi USA, LLC, Lake Zurich, IL): Personal communication; 2018 Mar 19.
Lesher K (Medical Information, B. Braun Medical): Personal communication; 2016 Mar 26.
Hahn Z (Medical Information, Baxter Healthcare Corporation): Personal communication; 2016 Mar 26.
AbbVie Inc. Depacon^® (valproate sodium) injection prescribing information. North Chicago, IL; 2017 Apr.
Frank MIBoddu SHMauro VFPhysical compatibility of valproate sodium injection with dobutamine and dopamineAm J Health Syst Pharm201774280-281
Actavis Pharma, Inc. Melphalan hydrochloride for injection prescribing information. Parsippany, NJ; 2015 Oct.
Fresenius Kabi USA, LLC. Melphalan hydrochloride for injection prescribing information. Lake Zurich, IL; 2016 Aug.
Tham A (Medical Information, Spectrum Pharmaceuticals): Personal communication; 2017 May 8.
Helsinn Therapeutics, Inc. Akynzeo^® (netupitant and palonosetron) capsules and (fosnetupitant and palonosetron) for injection prescribing information. Iselin, NJ; 2018 Apr.
Portola Pharmaceuticals, Inc. Andexxa^® (coagulation factor Xa [recombinant], inactivated-zhzo) for injection prescribing information. South San Francisco, CA; 2018 Dec.
Singla P (Medical Information, La Jolla Pharmaceutical Company, San Diego, CA): Personal communication; 2018 Mar 29.
Cipla USA, Inc. Zemdri^® (plazomicin) injection prescribing information. Warren, NJ; 2020 Jan.
Asempa TEAvery LMKidd JMPhysical compatibility of plazomicin with select i.v. drugs during simulated Y-site administrationAm J Health-Syst Pharm2018751048-1056
Asempa TE (Corresponding Author): Personal Communication; 2018 Sep 27.
Tetraphase Pharmaceuticals. Inc. Xerava (eravacycline) for injection prescribing information. Watertown, MA; 2019 Oct.
Paratek Pharmaceuticals, Inc. Nuzyra^® (omadacycline) for injection and tablets prescribing information. Boston, MA; 2021 May.
Heron Therapeutics. Cinvanti^® (aprepitant) injectable emulsion prescribing information. San Diego, CA; 2019 Oct.
Food and Drug Administration. Center for Drug Evaluation and Research. Application number: 209296Orig1s000: Summary review. From FDA website.
Brophy GMBell RClaassen JGuidelines for the evaluation and management of status epilepticusNeurocrit Care2012173-23
Venkataraman VWheless JWSafety of rapid intravenous infusion of valproate loading doses in epilepsy patientsEpilepsy Res199935147-53
Annual meeting of the American Epilepsy Society. Los Angeles, California, USA. December 1-6, 2000. AbstractsEpilepsia200041 Suppl 71-278
Ramsay RECantrell DCollins SDSafety and tolerance of rapidly infused Depacon. A randomized trial in subjects with epilepsyEpilepsy Res200352189-201
Wheless JWVazquez BRKanner AMRapid infusion with valproate sodium is well tolerated in patients with epilepsyNeurology2004631507-8
Limdi NAKnowlton RKCofield SSSafety of rapid intravenous loading of valproateEpilepsia200748478-83
Fresenius Kabi USA, LLC. Omegaven^® (fish oil triglycerides) injectable emulsion prescribing information. Lake Zurich, IL; 2023 Jun.
Hospira, Inc. Atropine sulfate injection in LifeShield Abboject glass syringes prescribing information. Lake Forest, IL; 2018 Mar.
Hospira, Inc. Atropine sulfate injection in Ansyr plastic syringes prescribing information. Lake Forest, IL; 2018 Jul.
Fresenius Kabi USA, LLC. Atropine sulfate injection prescribing information. Lake Zurich, IL; 2018 Jan.
American Regent, Inc. Atropine sulfate injection prescribing information. Shirley, NY; 2009 Jan.
International Medication Systems, Limited. Atropine sulfate injection prescribing information. South El Monte, CA; 2013 Feb.
West-Ward Pharmaceuticals. Atropine sulfate injection prescribing information. Eatontown, NJ; 2011 Jun.
Meridian Medical Technologies, Inc. Atropen^® (atropine) auto-injector prescribing information; Columbia, MD; 2005 Nov.
Omotani SAoe MEsaki SCompatibility of intravenous fat emulsion with antibiotics for secondary piggyback infusionAnn Nutr Metab201873227-233
Hospira, Inc. Voluven^® (6% hydroxyethyl starch 130/0.4 in sodium chloride 0.9% injection) prescribing information. Lake Forest, IL; 2014 Aug.
Studer NMYassin AHKeen DECompatibility of hydroxyethyl starch and tranexamic acid for battlefield co-administrationMil Med20161811305-1307
Aeberhard CSteuer CSaxer CPhysicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practiceEur J Pharm Sci201796449-455
Eagle Pharmaceuticals, Inc. Bendamustine hydrochloride injection prescribing information. Woodcliff Lake, NJ; 2018 May.
Watróbska-Swietlikowska DStability of commercial parenteral lipid emulsions repacking to polypropylene syringesPLoS One201914e0214451
Watróbska-Swietlikowska D (Corresponding Author): Personal communication; 2019 Apr 25.
Accord Healthcare, Inc. Tigecycline for injection prescribing information. Durham, NC; 2018 Jan.
Fresenius Kabi USA, LLC. Tigecycline for injection prescribing information. Lake Zurich, IL; 2019 Apr.
Sage Therapeutics, Inc. Zulresso^® (brexanolone) injection prescribing information. Cambridge, MA; 2019 Jun.
(Medical Information, Sage Therapeutics, Cambridge, MA): Personal communication; 2019 May 24.
Mylan Institutional LLC. Ultiva^® (remifentanil hydrochloride) prescribing information. Rockford, IL; 2017 Dec.
Fresenius Kabi USA, LLC. Vancomycin hydrochloride for injection prescribing information. Lake Zurich, IL; 2018 May.
Mylan Institutional. Vancomycin hydrochloride for injection prescribing information. Rockford, IL: 2019 Feb.
Hospira, Inc. Vancomycin hydrochloride for injection prescribing information. Lake Forest, IL; 2019 Mar.
Fresenius Kabi USA, LLC. Vancomycin hydrochloride for injection pharmacy bulk package prescribing information. Lake Zurich, IL; 2017 Aug.
Hospira, Inc. Vancomycin hydrochloride for injection pharmacy bulk package prescribing information. Lake Forest, IL; 2018 Oct.
Samson Medical Technologies, LLC. Vancomycin hydrochloride for injection pharmacy bulk package prescribing information. Cherry Hill, NJ; 2018 Dec.
Baxter Healthcare Corporation. Vancomycin injection prescribing information. Deerfield, IL; 2018 Oct.
Xellia Pharmaceuticals USA, LLC. Vancomycin injection prescribing information. Raleigh, NC; 2019 Feb.
Hospira, Inc. Vancomycin hydrochloride for injection ADD-Vantage vials prescribing information. Lake Forest, IL; 2018 Oct.
Wei YYang JWBoddu SHCompatibility, stability, and efficacy of vancomycin combined with gentamicin or ethanol in sodium citrate as a catheter lock solutionHosp Pharm201752685-690
Scheetz MH (Corresponding Author): Personal communication; 2017 Oct 28.
Berti ADHutson PRSchulz LTCompatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusionAm J Health Syst Pharm201572390-5
Wade JCooper MRagan RSimulated Y-Site compatibility of vancomycin and piperacillin-tazobactamHosp Pharm201550376-9
Teibel HMKnoderer CANichols KRCompatibility of vancomycin and oxacillin during simulated Y-Site deliveryHosp Pharm201550710-3
O'Donnell JNVenkatesan NManek MVisual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrationsAm J Health Syst Pharm201673241-6
Huvelle SGodet MHecq JDLong-term stability of vancomycin hydrochloride in glucose 5% polyolefin bags: the brand name versus a generic productInt J Pharm Compd2016 Sep-Oct20416-420
Meyer KSantarossa MDanziger LHCompatibility of ceftazidime-avibactam, ceftolozane-tazobactam, and piperacillin-tazobactam with vancomycin in dextrose 5% in waterHosp Pharm201752221-228
Kufel WDMiller CDJohnson PRY-site incompatibility between premix concentrations of vancomycin and piperacillin-tazobactam: do current compatibility testing methodologies tell the whole story?Hosp Pharm201752132-137
Dotson BLynn SSavakis KPhysical compatibility of 4% sodium citrate with selected antimicrobial agentsAm J Health Syst Pharm2010671195-8
Churchwell MD (Corresponding Author): Personal communication; 2019 July 10.
West-Ward Pharmaceuticals. Duramorph^® (morphine sulfate) injection prescribing information. Eatontown, NJ; 2016 Dec.
West-Ward Pharmaceuticals. Infumorph^® (morphine sulfate) injection prescribing information. Eatontown, NJ; 2016 Dec.
Piramal Critical Care, Inc. Mitigo^® (morphine sulfate) injection prescribing information. Bethlehem, PA; 2018 Aug.
Hospira, Inc. Morphine sulfate injection prescribing information. Lake Forest, IL; 2016 Dec.
Hospira, Inc. Morphine sulfate injection prescribing information. Lake Forest, IL; 2019 Mar.
Meridian Medical Technologies, Inc. Morphine sulfate injection prescribing information. Columbia, MD; 2016 Dec.
Fresenius Kabi USA, LLC. Morphine sulfate injection prescribing information. Lake Zurich, IL; 2018 May.
Hospira, Inc. Morphine sulfate injection concentrate prescribing information. Lake Forest, IL; 2018 Mar.
Kistner CEnsom MHDecarie DCompatibility and stability of morphine sulphate and naloxone hydrochloride in 0.9% sodium chloride for injectionCan J Hosp Pharm201366163-70
Robert JSorrieul JRossignol EChemical stability of morphine, ropivacaine, and ziconotide in combination for intrathecal analgesiaInt J Pharm Compd2017 Jul-Aug21347-351
Al Madfai FZaidi STRMing LCPhysical and chemical stability of ceftaroline in an elastomeric infusion deviceEur J Hosp Pharm201825e115-e119
Sandoz Inc. Anectine^® (succinylcholine chloride) injection prescribing information. Princeton, NJ; 2023 Nov.
Hospira, Inc. Quelicin^® (succinylcholine chloride) injection prescribing information. Lake Forest, IL; 2022 Nov.
Hikma Pharmaceuticals USA Inc. Succinylcholine chloride injection prescribing information. Berkeley Heights, NJ; 2024 Apr.
Eugia US LLC. Sumatriptan injection prescribing information. E. Windsor, NJ; 2023 Jul.
Fresenius Kabi USA, LLC. Diprivan^® (propofol) injectable emulsion prescribing information. Lake Zurich, IL; 2017 Nov.
Dr. Reddy's Laboratories, Inc. Propofol injectable emulsion prescribing information. Princeton, NJ; 2017 Sep.
Hospira, Inc. Propofol injectable emulsion prescribing information. Lake Forest, IL; 2018 Jul.
Sagent Pharmaceuticals. Propofol injectable emulsion prescribing information. Schaumburg, IL; 2017 Jun.
Actavis Pharma, Inc. Propofol injectable emulsion prescribing information. Parsippany, NJ; 2017 Nov.
O'Connor SZhang YLChristians URemifentanil and propofol undergo separation and layering when mixed in the same syringe for total intravenous anesthesiaPaediatr Anaesth201626703-9
Merck and Co., Inc. Recarbrio^® (imipenem, cilastatin, and relebactam) for injection prescribing information. Whitehouse Station, NJ; 2020 Jun.
Lu DHarmanjeet HWanandy TPhysicochemical stability of extemporaneously prepared clonidine solutions for use in neonatal abstinence syndromeJ Clin Pharm Ther2019
Al Madfai FValah BZaidi STRStability of dobutamine in continuous ambulatory delivery devicesJ Clin Pharm Ther201843530-535
Lardinois BPector JDelcave CLong-term physicochemical stability of concentrated solutions of noradrenaline bitartrate in polypropylene syringes for administration in the intensive care unitInt J Pharm Compd2018 Jul-Aug22335-339
D'Huart EVigneron JClarot IPhysicochemical stability of norepinephrine bitartrate in polypropylene syringes at high concentrations for intensive care unitsAnn Pharm Fr201977212-221
Mody VShah SPatel JCompatibility of norepinephrine bitartrate with levofloxacin and moxifloxacin during simulated Y-site administrationInt J Pharm Compd2016 May-Jun20236-238
Patel NTaki MTunstell PStability of dobutamine 500 mg in 50 mL syringes prepared using a central intravenous additive serviceEur J Hosp Pharm20121952-6
Takeda Pharmaceuticals America, Inc. Entyvio^® (vedolizumab) for injection prescribing information. Lexington, MA; 2024 Mar.
Nabriva Therapeutics US, Inc. Xenleta^® (lefamulin) injection and tablets prescribing information. King of Prussia, PA; 2019 Aug.
Taylor RSunderland BLuna GEvaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluidsDrug Des Devel Ther2017112087-2097
Poeppl WRainer-Harbach EKussmann MCompatibility of linezolid with commercial peritoneal dialysis solutionsAm J Health Syst Pharm2018751467-1477
Genentech USA, Inc. Cellcept^® (mycophenolate mofetil) capsules, tablets, for oral suspension, and for injection prescribing information. South San Francisco, CA; 2019 Feb.
Fawaz SBarton SWhitney LStability of meropenem after reconstitution for administration by prolonged infusionHosp Pharm201954190-196
Ghany K (Medical Information, Nabriva Therapeutics, King of Prussia, PA): Personal communication; 2019 Oct 16.
Zydus Pharmaceuticals. Mycophenolate mofetil for injection prescribing information. Pennington, NJ; 2018 Nov.
Ezquer-Garin CFerriols-Lisart RAlós-Almiñana MStability of mycophenolate mofetil in polypropylene 5% dextrose infusion bags and chemical compatibility associated with the use of the Equashield closed-system transfer deviceBiomed Chromatogr201933e4529
Harmanjeet HZaidi STRMing LCPhysicochemical stability of voriconazole in elastomeric devicesEur J Hosp Pharm201825e88-e92
Khaleel IZaidi STRShastri MDInvestigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusionsEur J Hosp Pharm201825e102-e108
Lardinois BBaltzis ABraibant MLong-term physicochemical stability of concentrated solutions of sodium valproate in polypropylene syringes for administration in the intensive care unitInt J Pharm Compd2019 Jul-Aug23320-323
Mehta AMVan den Hoven JMRosing HStability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapyInt J Pharm201547923-7
Carr AWohlrab CYoung PStability of intravenous vitamin C solutions: a technical reportCrit Care Resusc201820180-181
Hospira, Inc. Gemcitabine for injection prescribing information. Lake Forest, IL; 2019 Jul.
Lilly USA, LLC. Gemzar^® (gemcitabine) for injection prescribing information. Indianapolis, IN; 2019 May.
Accord Healthcare, Inc. Gemcitabine injection prescribing information. Durham, NC; 2019 Jun.
Hospira, Inc. Gemcitabine injection prescribing information. Lake Forest, IL; 2019 Jun.
Sun Pharmaceutical Industries, Inc. Infugem^® (gemcitabine in sodium chloride injection) prescribing information. Cranbury, NJ; 2019 Jun.
Shionogi Inc. Fetroja^® (cefiderocol) for injection prescribing information. Florham Park, NJ; 2020 Sep.
Avery LMChen IHReyes SAssessment of the physical compatibility of eravacycline and common parenteral drugs during simulated Y-site administrationClin Ther2019412162-2170
Foushee JAMeredith PFox LMY-site physical compatibility of beta-blocker infusions with intensive care unit admixturesInt J Pharm Compd2016 Jul-Aug20328-332
Cumberland Pharmaceuticals, Inc. Caldolor^® (ibuprofen) injection prescribing information. Nashville, TN; 2019 Jul.
Curti CSouab HKLamy EStability studies of antipyocyanic beta-lactam antibiotics used in continuous infusionPharmazie201974357-362
Raverdy VAmpe EHecq JDStability and compatibility of vancomycin for administration by continuous infusionJ Antimicrob Chemother2013681179-82
Ranganathan DNaicker SWallis SCStability of antibiotics for intraperitoneal administration in Extraneal 7.5% icodextrin peritoneal dialysis bags (STAB Study)Perit Dial Int2016 Jul-Aug36421-6
Lessard JCaron ESchérer HCompatibility of Y-site injection of meropenem trihydrate with 101 other injectable drugsHosp Pharm20191-6
Sabins DDiep TMcCartan PStability and compatibility of diphenhydramine hydrochloride in intravenous admixtures: a new look at an old drugHosp Pharm201954330-334
Recordati Rare Diseases, Inc. NeoProfen^® (ibuprofen lysine) injection prescribing information. Lebanon, NJ; 2018 Jun.
Holt RJSiegert SWKrishna APhysical compatibility of ibuprofen lysine injection with selected drugs during simulated Y-site injectionJ Pediatr Pharmacol Ther200813156-61
Hospira, Inc. Metoprolol tartrate injection in vials prescribing information. Lake Forest; IL 2017 Aug.
Hospira, Inc. Metoprolol tartrate injection in syringe cartridges and ampuls prescribing information. Lake Forest; IL 2017 Aug.
Patel A (Medical Information, Shionogi, Florham Park, NJ): Personal communication; 2020 Jan 21.
Closset MHecq JDSoumoy LPhysical stability of highly concentrated injectable drugs solutions used in intensive care unitsAnn Pharm Fr201775185-188
Garcia JGarg ASong YCompatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusionPLoS One201813e0190577
Forest JM (Corresponding Author): Personal communication; 2020 Feb 11.
Acacia Pharma Inc. Barhemsys^® (amisulpride) injection prescribing information. Indianapolis, IN; 2020 Feb.
Pharmacosmos Therapeutics Inc. Monoferric^® (ferric derisomaltose) injection prescribing information. Wachtung, NJ; 2020 Jan.
AMAG Pharmaceuticals, Inc. Feraheme^® (ferumoxytol) injection prescribing information. Waltham, MA; 2019 Oct.
American Regent, Inc. Venofer^® (iron sucrose) injection prescribing information. Shirley, NY; 2019 Jan.
Baudax Bio, Inc. Anjeso^® (meloxicam) injection prescribing information. Malvern, PA; 2020 Feb.
GlaxoSmithKline UK. Amoxil^® vials for injection 500 mg summary of product characteristics (SmPC). Middlesex, United Kingdom; 2018 Jan.
GlaxoSmithKline UK. Amoxil^® vials for injection 1 g summary of product characteristics (SmPC). Middlesex, United Kingdom; 2018 Jan.
Douglas Pharmaceuticals Ltd. New Zealand Data Sheet for Ibiamox^® 250, 500, and 1000 mg powder for injection. Auckland, New Zealand; 2018 Apr.
Binson GGrignon CLe Moal GOvercoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumpsPLoS One201914e0221391
Vázquez-Sánchez RSánchez-Rubio-Ferrández JCórdoba-Díaz DStability of carboplatin infusion solutions used in desensitization protocolJ Oncol Pharm Pract2019251076-1081
Sandoz Canada Inc. Amoxicillin sodium and potassium clavulanate for injection product monograph. Quebec, Canada; 2020 Jan.
GlaxoSmithKline NZ Limited. New Zealand Data Sheet for Augmentin^® 600 mg and 1.2 g powder for injection. Auckland, New Zealand; 2019 Oct.
GlaxoSmithKline UK. Augmentin^® Intravenous summary of product characteristics (SmPC). Middlesex, United Kingdom; 2020 Mar.
DeAngelis MFerrara AGregory KStability of 2 mg/mL adenosine solution in polyvinyl chloride and polyolefin infusion bagsHosp Pharm20185373-74
Zhao F (Corresponding Author): Personal communication; 2020 Apr 30.
Tobudic SPrager IKussmann MCompatibility of aztreonam in four commercial peritoneal dialysis fluidsSci Rep2020101788
Patel RPJacob JSedeeq MStability of cefazolin in polyisoprene elastomeric infusion devicesClin Ther201840664-667
Harmanjeet HJani HZaidi STRStability of peritoneal dialysis solutionsPerit Dial Int2020896860820902590
Vercheval CStreel SServais ACStability of 90 mg/mL cefuroxime sodium solution for administration by continuous infusionJ Chemother2018 Oct - Dec30371-374
Teligent Pharma, Inc. Zinacef^® (cefuroxime for injection) prescribing information. Buena, NJ; 2020 Feb.
Cies JJMoore WSChopra AStability of furosemide and chlorothiazide stored in syringesAm J Health Syst Pharm2015722182-8
van der Schaar JAJGrouls RFranssen EJFStability of furosemide 5 mg/mL in polypropylene syringesInt J Pharm Compd2019 Sep-Oct23414-417
Lardinois BDimitriou ADelcave CLong-term physicochemical stability of concentrated solutions of isosorbide dinitrate in polypropylene syringes for administration in the intensive care unitInt J Pharm Compd2020 Jan-Feb2464-68
Merus Labs Luxco II S.à R.L. Isoket^® (isosorbide dinitrate) 0.5 mg/mL solution for infusion or injection. Luxembourg; 2018 May.
Torbay Pharmaceuticals. Isosorbide dinitrate 0.05% w/v solution for injection or infusion. Devon, United Kingdom; 2019 Feb.
Merus Labs Luxco II S.à R.L. Isoket^® (isosorbide dinitrate) 1 mg/mL concentrate for solution for injection or infusion. Luxembourg; 2019 Dec.
Torbay Pharmaceuticals. Isosorbide dinitrate 0.1% w/v concentrate for solution for injection or infusion. Devon, United Kingdom; 2019 Feb.
Allergan USA, Inc. INFeD^® (iron dextran) injection prescribing information. Madison, NJ; 2018 Nov.
Koutroubakis IEOustamanolakis PKarakoidas CSafety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel diseaseDig Dis Sci2010552327-31
Lew IMullarkey TAdamson RTIntegrated care of anemia in chronic kidney disease patients: concepts in intravenous iron management: part oneHosp Pharm201045225-36
Reddy CMKathula SKAli SASafety and efficacy of total dose infusion of iron dextran in iron deficiency anaemiaInt J Clin Pract200862413-5
Auerbach MPappadakis JABahrain HSafety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemiaAm J Hematol201186860-2
Auerbach MMacdougall IThe available intravenous iron formulations: History, efficacy, and toxicologyHemodial Int201721 Suppl 1S83-S92
Gilead Sciences, Inc. Veklury^® (remdesivir) for injection and injection prescribing information. Foster City, CA; 2024 Jun.
Foy GPoinsignon VMercier LMicrobiological and physico-chemical stability of ketamine solution for patient-controlled analgesia systemsJ Hosp Clin Pharm2015131-37
Gu JQin WChen FLong-term stability of tramadol and ketamine solutions for patient-controlled analgesia deliveryMed Sci Monit2015212528-34
Closset MHecq JDGonzalez EDoes an interaction exist between ketamine hydrochloride and Becton Dickinson syringes?Eur J Hosp Pharm201724230-234
Daouphars MHervouët CHBohn PPhysicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia useEur J Hosp Pharm201825214-217
Daouphars M (Corresponding Author): Personal communication; 2020 May 18.
Beiler BBarraud DVigneron JPhysicochemical stability of an admixture of lidocaine and ketamine in polypropylene syringe used in opioid-free anaesthesiaEur J Hosp Pharm202027e79-e83
Chen IHMartin EKNicolau DPAssessment of meropenem and vaborbactam room temperature and refrigerated stability in polyvinyl chloride bags and elastomeric devicesClin Ther202042606-613
Gilliot SMasse MFeutry FLong-term stability of ready-to-use 1-mg/mL midazolam solutionAm J Health-Syst Pharm202077681-689
Hospira, Inc. Midazolam hydrochloride injection prescribing information. Lake Forest, IL; 2018 Aug.
Hospira, Inc. Midazolam hydrochloride (preservative-free) injection prescribing information. Lake Forest, IL; 2018 Aug.
Hospira, Inc. Midazolam hydrochloride (preservative-free) injection prescribing information. Lake Forest, IL; 2019 May.
Meridian Medical Technologies, Inc. Seizalam^® (midazolam hydrochloride) injection prescribing information. Columbia, MD; 2018 Oct.
Fresenius Kabi USA, LLC. Potassium phosphates injection prescribing information. Lake Zurich, IL; 2019 Nov.
CMP Pharma Inc. Potassium phosphates injection prescribing information. Farmville, NC; 2019 Oct.
Hospira, Inc. Potassium phosphates injection prescribing information. Lake Forest, IL; 2017 Jun.
Al Madfai FZaida STMing LCStability of milrinone in continuous ambulatory delivery devicesAm J Health-Syst Pharm201875e241-e245
GlaxoSmithKline UK. Ventolin^® 500 micrograms injection summary of product characteristics (SmPC). Middlesex, United Kingdom; 2019 Oct.
GlaxoSmithKline UK. Ventolin^® solution for IV infusion summary of product characteristics (SmPC). Middlesex, United Kingdom; 2019 Oct.
GlaxoSmithKline NZ Limited. New Zealand Data Sheet for Ventolin^® injection 500 micrograms/mL and Ventolin^® solution for intravenous infusion 5 mg/5 mL. Auckland, New Zealand; 2018 Dec.
Lardinois BBaltzis ADelcave CLong-term physicochemical stability of concentrated solutions of salbutamol (albuterol) in polypropylene syringes for use in the intensive care unit and in obstetricsInt J Pharm Compd2019 Sep-Oct23434-437
Godet MSimar JClosset MStability of concentrated solution of vancomycin hydrochloride in syringes for intensive care unitsPharm Technol Hosp Pharm2018323-30
d'Huart ÉVigneron JCharmillon APhysicochemical stability of vancomycin at high concentrations in polypropylene syringesCan J Hosp Pharm2019 Sep-Oct72360-368
Ghazi IMEl Nekidy WSAsay RSimultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approachPLoS One202015e0233335
Ghazi IM DrEl Nekidy WS DrSood A MrY-site Administration of Imipenem/Cilastatin/Relebactam With Common Intravenous MedicationsClin Ther202042475-485
Ghazi I (Corresponding Author): Personal communication; 2020 July 8.
Hanifah SKennedy RBall PExtended compatibility of fentanyl and ketamine in dextrose 5Anaesthesiol Intensive Ther201850221-225
Hanifah S (Corresponding Author): Personal communication; 2020 May 20.
Young BLKhan MAChapman TJEvaluation of the physicochemical and functional stability of diluted Remsima® upon extended storage--A study compliant with NHS (UK) guidanceInt J Pharm2015496421-31
Vieillard VAstier ASauzay COne-month stability study of a biosimilar of infliximab (Remsima^®) after dilution and storage at 4°C and 25°CAnn Pharm Fr20177517-29
Kim JChung JPark SEvaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab)Eur J Hosp Pharm201825157-164
Tokhadze NChennell PLe Basle YStability of infliximab solutions in different temperature and dilution conditionsJ Pharm Biomed Anal2018150386-395
Hermosilla JSánchez-Martín RPérez-Robles RComparative stability studies of different infliximab and biosimilar CT-P13 clinical solutions by combined use of physicochemical analytical techniques and enzyme-linked immunosorbent assay (ELISA)BioDrugs201933193-205
Amgen Inc. Avsola^® (infliximab-axxq) for injection prescribing information. Thousand Oaks, CA; 2019 Dec.
Sankaranarayanan S (Global Medical Information, Merck, North Wales, PA): Personal communication; 2020 Sep 9.
Institute for Safe Medication Practices. Dangerous wrong-route errors with tranexamic acid-a major cause for concern. ISMP Medication Safety Alert! Acute Care edition. Horsham, PA; 2019 May 23. From ISMP website. Accessed 2020 Sep 24.
Patel SRobertson BMcConachie ICatastrophic drug errors involving tranexamic acid administered during spinal anaesthesiaAnaesthesia201974904-914
Palanisamy AKinsella SMSpinal tranexamic acid - a new killer in townAnaesthesia201974831-833
National Alert Network (NAN). Dangerous wrong-route errors with tranexamic acid. 2020 Sep 9. NAN Alert. Accessed 2020 Sep 10.
Teva Pharmaceutical USA, Inc. Fosaprepitant for injection prescribing information. North Wales, PA; 2019 Sep.
Martínez-Gómez MAGil AMOltra BPPhysico-chemical stability of mixtures of fosaprepitant used in clinical practiceJ Anal Bioanal Tech20145197
Huvelle SGodet MGalanti LLong-term stability comparison between an original and a generic version of piperacillin/tazobactam in dextrose 5% infusion polyolefin bags at 5 ± 3 °C after microwave freeze-thaw treatmentPharm Technol Hosp Pharm20183143-151
Trevena, Inc. Olinvyk^® (oliceridine fumarate) injection prescribing information. Chesterbrook, PA; 2020 Nov.
Sridhran K (Medical Information, Trevena, Chesterbrook, PA): Personal communication; 2020 Aug 26.
Food and Drug Administration. Center for Drug Evaluation and Research. Application number: 210730Orig1s000: Product Quality Review(s). From FDA website.
Merck Sharp & Dohme Limited. Remicade^® (infliximab) summary of product characteristics. Hoddesdon, United Kingdom; 2019 Oct.
Biogen Biosimilars. Flixabi^® (infliximab) summary of product characteristics. Berkshire, United Kingdom; 2020 Oct.
Pfizer Limited. Inflectra^® (infliximab) summary of product characteristics. Sandwich, United Kingdom; 2020 Oct.
Celltrion Healthcare UK Limited. Remsima^® (infliximab) summary of product characteristics. Slough, United Kingdom; 2020 Nov.
Hospira, Inc. Sterile water for injection prescribing information. Lake Forest, IL; 2021 May.
Medefil, Inc. Sterile water for injection prescribing information. Glendale Heights, IL; 2020 Sep.
Baxter Healthcare Corporation. Sterile water for injection prescribing information. Deerfield, IL; 2014 Sep.
Walker SEIazzetta JLaw SAdministration of intravenous ascorbic acid-practical considerations for cliniciansNutrients2019111994
Food and Drug Administration. Center for Drug Evaluation and Research. Application number: 209112Orig1s000: Product Quality Review(s). From FDA website.
ASHP. Standardize 4 Safety: Pediatric Continuous Infusion Standards. Updated 2024 Sep. From ASHP website. Accessed 2024 Sep 24. Updates may be available at ASHP website. www.ashp.org/pharmacy-practice/standardize-4-safety-initiative.
ASHP. Standardize 4 Safety. Adult Continuous Infusion Standards. Updated 2024 Sep. From ASHP website. Accessed 2024 Sep 24. Updates may be available at ASHP website. www.ashp.org/pharmacy-practice/standardize-4-safety-initiative.
Pharmacia and Upjohn Company LLC. Prostin VR Pediatric^® (alprostadil) injection prescribing information. New York, NY; 2013 Apr.
Teva Pharmaceuticals USA, Inc. Alprostadil injection prescribing information. Parsippany, NJ; 2020 Feb.
Genentech, Inc. Activase^® (alteplase) for injection prescribing information. South San Francisco, CA; 2018 Feb.
Genentech, Inc. Cathflo^® Activase^® (alteplase) for injection prescribing information. South San Francisco, CA; 2019 Feb.
APP Pharmaceuticals, LLC. Amiodarone hydrochloride injection prescribing information. Schaumburg, IL; 2008 Apr.
Sagent Pharmaceuticals, Inc. Amiodarone hydrochloride injection prescribing information. Schaumburg, IL; 2020 Jul.
Baxter Healthcare Corporation. Nexterone^® (amiodarone hydrochloride) premixed injection prescribing information. Deerfield, IL; 2016 Nov.
Yourk J (Medical Information, Pfizer, New York, NY): Personal communication; 2020 Dec 14.
Fresenius Kabi USA, LLC. Furosemide injection prescribing information. Lake Zurich, IL; 2016 Mar.
Hospira, Inc. Furosemide injection prescribing information. Lake Forest, IL; 2018 May.
Baxter Healthcare Corporation. Furosemide injection prescribing information. Deerfield, IL; 2018 Oct.
Novartis Pharmaceuticals Corporation. Sandostatin^® (octreotide acetate) injection prescribing information. East Hanover, NJ; 2020 Jun.
Hikma Pharmaceuticals USA Inc. Octreotide acetate injection prescribing information. Berkeley Heights, NJ; 2020 Jun.
Sagent Pharmaceuticals. Octreotide acetate injection prescribing information. Schaumburg, IL; 2019 May.
Teva Pharmaceuticals USA, Inc. Octreotide acetate injection prescribing information. North Wales, PA; 2019 May.
Novartis Pharmaceuticals Corporation. Sandostatin^® LAR Depot (octreotide acetate) for injectable suspension prescribing information. East Hanover, NJ; 2019 Apr.
Sun Pharmaceutical Industries, Inc. Bynfezia Pen^® (octreotide acetate) injection prescribing information. Cranbury, NJ; 2020 Apr.
Akorn, Inc. Nembutal^® (pentobarbital sodium) injection prescribing information. Lake Forest, IL; 2019 Apr.
Akorn, Inc. Terbutaline sulfate injection prescribing information. Lake Forest, IL; 2011 Mar.
United Biomedical Inc. Terbutaline sulfate injection prescribing information. Hauppauge, NY; 2019 Jan.
APP Pharmaceuticals, LLC. Terbutaline sulfate injection prescribing information. Schaumburg, IL; 2011 Feb.
Hikma Pharmaceuticals USA Inc. Terbutaline sulfate injection prescribing information. Eatontown, NJ; 2020 Oct.
Food and Drug Administration. Drug safety communication: New warnings against use of terbutaline to treat preterm labor. Rockville, MD; 2011 Feb 17. From FDA website. Accessed 2021 Feb 2.
Global Initiative for Asthma. Global strategy for asthma management and prevention. 2020. From Global Initiative for Asthma website. Accessed 2021 Feb 2.
Sun Pharmaceutical Industries, Inc. Vecuronium bromide for injection prescribing information. Cranbury, NJ; 2018 Mar.
Lu JLiu QKupiec TCPhysical compatibility of cefiderocol with selected intravenous drugs during simulated Y-site administrationInt J Pharm Compd20212552-61
O'Donnell JNXu ALodise TPIntravenous compatibility of ceftazidime-avibactam and aztreonam using simulated and actual Y-site administrationClin Ther2020421580-1586.e2
De Basagoiti AKatsumiti AAbascal SPhysical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care unitsEur J Pediatr20211801169-1176
Griffith SNStapleton EPadilla SPhysical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administrationAm J Health Syst Pharm2020771938-1940
Hanifah SNugroho BChabib LCompatibility of acetaminophen with central nervous system medications during simulated Y-site injectionAnaesthesiol Intensive Ther20205223-27
Foushee JAMeredith PFox LMY-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patientsAm J Health Syst Pharm2020771144-1148
B. Braun Medical Inc. Acetaminophen injection prescribing information. Bethlehem, PA; 2021 Feb.
Fresenius Kabi. Acetaminophen injection prescribing information. Lake Zurich, IL; 2020 Nov.
Vu N (Corresponding Author): Personal communication; 2021 Mar 8.
Acacia Pharma, Inc. Byfavo^® (remimazolam) for injection prescribing information. Indianapolis, IN; 2021 Jun.
Hospira, Inc. Dobutamine concentrate for injection prescribing information. Lake Forest, IL; 2017 Nov.
Hospira, Inc. Dobutamine in dextrose injection prescribing information. Lake Forest, IL; 2019 May.
Baxter Health Corporation. Dobutamine hydrochloride in dextrose injection prescribing information. Deerfield, IL; 2019 Mar.
Hospira, Inc. Dopamine hydrochloride concentrate for injection prescribing information. Lake Forest, IL; 2019 Feb.
Hospira, Inc. Dopamine hydrochloride in dextrose injection prescribing information. Lake Forest, IL; 2018 Mar.
Baxter Healthcare Corporation. Dopamine hydrochloride and dextrose injection prescribing information. Deerfield, IL; 2017 Jul.
Polo CD'Huart ELesperlette GCompatibility of injectable posaconazole with drugs commonly used in a hematology care unitPharm Technol Hosp Pharm2020520200011
Melinta Therapeutics, LLC. Kimyrsa^® (oritavancin) for injection prescribing information. Lincolnshire, IL; 2021 Mar.
Campino Villegas A (Corresponding Author): Personal communication; 2021 Apr 6.
Baxter Healthcare Corporation. Milrinone lactate in 5% dextrose injection prescribing information. Deerfield, IL; 2018 May.
Hikma Pharmaceuticals USA Inc. Milrinone lactate injection prescribing information. Berkeley Heights, NJ; 2020 Jul.
Pharmacia & Upjohn Co. Solu-Cortef^® (hydrocortisone sodium succinate) for injection prescribing information. New York, NY; 2020 Sep.
Polo C (Corresponding Author): Personal communication; 2021 Apr 14.
Hanifah S (Corresponding Author): Personal communication; 2021 Apr 15.
Akorn, Inc. Fentanyl citrate injection prescribing information. Lake Forest, IL; 2019 Oct.
Hikma Pharmaceuticals USA Inc. Fentanyl citrate injection prescribing information. Eatontown, NJ; 2019 Oct.
Hospira, Inc. Fentanyl citrate injection prescribing information. Lake Forest, IL; 2019 Dec.
Fresenius Kabi USA, LLC. Fentanyl citrate injection prescribing information. Lake Zurich, IL; 2020 Sep.
Hospira, Inc. Fentanyl citrate injection prescribing information. Lake Forest, IL; 2020 May.
Hikma Pharmaceuticals USA Inc. Labetalol hydrochloride in sodium chloride injection and labetalol hydrochloride in dextrose injection prescribing information. Berkeley Heights, NJ; 2020 Dec.
Hospira, Inc. Labetalol hydrochloride injection prescribing information. Lake Forest, IL; 2018 Apr.
Hospira, Inc. Labetalol hydrochloride injection prescribing information. Lake Forest, IL; 2018 Apr.
Akorn, Inc. Labetalol hydrochloride injection prescribing information. Lake Forest, IL; 2018 May.
Baxter Healthcare Corporation. Labetalol hydrochloride injection prescribing information. Deerfield, IL; 2020 Jul.
Ali AK (Medical Information, Pfizer, New York, NY): Personal communication; 2021 Apr 19.
Hospira, Inc. Naloxone hydrochloride injection prescribing information. Lake Forest, IL; 2019 Apr.
Hospira, Inc. Naloxone hydrochloride injection prescribing information. Lake Forest, IL; 2019 Aug.
International Medication Systems, Limited. Naloxone hydrochloride injection prescribing information. South El Monte, CA; 2016 Mar.
Hikma Pharmaceuticals USA Inc. Naloxone hydrochloride injection prescribing information. Eatontown, NJ; 2019 Dec.
Chiesi USA, Inc. Cardene IV (nicardipine hydrochloride in dextrose) and (nicardipine hydrochloride in sodium chloride) injection prescribing information. Cary, NC; 2019 Jan.
Hikma Pharmaceuticals USA Inc. Nicardipine hydrochloride injection and nicardipine hydrochloride in 0.9% sodium chloride injection prescribing information. Eatontown, NJ; 2020 Jan.
American Regent, Inc. Nicardipine hydrochloride injection prescribing information. Shirley, NY; 2020 May.
AuroMedics Pharma LLC. Nicardipine hydrochloride injection prescribing information. E. Windsor, NJ; 2019 Jun.
Baxter Healthcare Corporation. Nitroglycerin in 5% dextrose injection prescribing information. Deerfield, IL; 2016 Aug.
American Regent, Inc. Nitroglycerin injection prescribing information. Shirley, NY; 2005 Nov.
Eton Pharmaceuticals, Inc. Rezipres^® (ephedrine hydrochloride) injection prescribing information. Deer Park, IL; 2021 Jun.
Griffiths WIng HFleury-Souverain SThe stability of ready-to-use (RTU) ephedrine hydrochloride in polypropylene syringes for use in maternal hypotensionEur J Hosp Pharm Sci200511107-10
Otsuka America Pharmaceutical, Inc. Dacogen^® (decitabine) for injection prescribing information. Rockville, MD; 2020 Jun.
Sun Pharmaceutical Industries, Inc. Decitabine for injection prescribing information. Cranbury, NJ; 2020 Jul.
Cipla USA, Inc. Decitabine for injection prescribing information. Warren, NJ; 2020 Jul.
Kim SHHeeb RMKrämer IPhysicochemical stability of reconstituted decitabine (Dacogen^®) solutions and ready-to-administer infusion bags when stored refrigerated or frozenPharm Technol Hosp Pharm20172145-57
Janssen-Cilag International. Summary of product characteristics: Dacogen^® (decitabine) 50 mg powder for concentrate for solution for infusion. Beerse, Belgium; 2017 May.
Ottoboni TLerner LSanthouse AStability of Aprepitant Injectable Emulsion in Alternate Infusion Bags, in Refrigerated Storage, and Admixed with Dexamethasone and PalonosetronDrug Des Devel Ther2021152519-2527
Mylan Institutional LLC.Sulfamethoxazole and trimethoprim injection prescribing information. Morgantown, WV; 2020 Dec.
Teva Pharmaceuticals USA, Inc. Sulfamethoxazole and trimethoprim injection prescribing information. North Wales, PA; 2019 Apr.
Chen PChen FLei JPhysical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia AdministrationDrug Des Devel Ther2020144179-4187
Eton Pharmaceuticals, Inc. Biorphen^® (phenylephrine) injection prescribing information. Deer Park, Il; 2021 May.
Holyk AALindner AHLindner SEPhysical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administrationAm J Health Syst Pharm202279e27-e33
APP Pharmaceuticals, LLC. Dacarbazine for injection prescribing information. Schaumburg, IL; 2008 Jan.
H2-Pharma, LLC. Etopophos^® (etoposide phosphate) for injection prescribing information. Montgomery, AL; 2019 Dec.
West-Ward Pharmaceuticals. Daunorubicin hydrochloride injection prescribing information. Eatontown, NJ; 2015 May.
Estan-Cerezo GMatoses-Chirivella CSoriano-Irigaray LStability and compatibility of ondansetron with haloperidol in parenteral admixturesEur J Hosp Pharm201825200-203
Mylan Institutional LLC. Haloperidol lactate injection prescribing information. Morgantown, WV; 2021 Jan.
Sagent Pharmaceuticals. Haloperidol lactate injection prescribing information. Schaumburg, IL; 2020 Dec,
Fresenius Kabi USA, LLC. Haloperidol lactate injection prescribing information. Lake Zurich, IL; 2020 Mar.
Teva Pharmaceuticals USA, Inc. Vincasar PFS^® (vincristine sulfate) injection prescibing information. Parsippany, NJ; 2020 Sep
Institute for Safe Medication Practices. 2020-2021 ISMP targeted medication safety best practices for hospitals. Horsham, PA; 2020 Feb 21. From ISMP website. Accessed 2021 Sep 8.
World Health Organization. Vincristine (and other vinca alkaloids) should only be given intravenously via a minibag. Information Exchange System Alert No. 115. 2007 Jul 18.
Hikma Pharmaceuticals USA, Inc. Diphenhydramine hydrochloride injection prescribing information. Berkeley Heights, NJ; 2019 Dec.
Mylan Institutional LLC. Diphenhydramine hydrochloride injection prescribing information. Morgantown, WV; 2021 Jun.
Fresenius Kabi USA, LLC. Diphenhydramine hydrochloride injection prescribing information. Lake Zurich, IL; 2016 Jul.
Micro Labs USA Inc. Diphenhydramine hydrochloride injection prescribing information. Basking Ridge, NJ; 2018 Sep.
Hospira, Inc. Metoclopramide injection prescribing information. Lake Forest, IL; 2018 Apr.
Fresenius Kabi USA, LLC. Metoclopramide hydrochloride injection prescribing information. Lake Zurich, IL; 2016 May.
Avet Pharmaceuticals Inc. Metoclopramide hydrochloride injection prescribing information. East Brunswick, NJ; 2020 Jul.
BPI Labs LLC. Tetracaine HCl injection prescribing information. Largo, FL; 2020 Mar.
Akorn, Inc. Tetracaine HCl injection prescribing information. Lake Forest, IL; 2018 Nov.
Baxter Healthcare Corporation. Mesna injection prescribing information. Deerfield; IL; 2018 Dec.
Fresenius Kabi USA, LLC. Mesna injection prescribing information. Lake Zurich, IL; 2019 Apr.
Sagent Pharmaceuticals. Mesna injection prescribing information. Schaumburg, IL; 2021 Jan.
Pfizer Canada ULC. Fluorouracil injection USP product monograph. Quebec, Canada; 2019 Aug.
Cumberland Pharmaceuticals, Inc. RediTrex^® (methotrexate) injection prescribing information. Nashville, TN; 2019 Nov.
Fresenius Kabi USA, LLC. Dexamethasone sodium phosphate injection prescribing information. Lake Zurich, IL; 2017 Mar.
Fresenius Kabi USA, LLC. Dexamethasone sodium phosphate injection prescribing information. Lake Zurich, IL; 2020 Jul.
Gilliot SMasse MGenay SLong-term stability of ready-to-use norepinephrine solution at 0.2 and 0.5 mg/mLEur J Hosp Pharm202027e93-e98
Fresenius Kabi USA, LLC. Protamine sulfate injection prescribing information. Lake Zurich, IL; 2017 Apr.
Gupta DSoori RPhysical Incompatibility Between Protamine Sulfate and Ceftriaxone SodiumJ Cardiothorac Vasc Anesth201731e50-e51
Sandoz Inc. Ceftriaxone sodium for injection prescribing information. Princeton, NJ; 2020 Jul.
Sandoz Inc. Ceftriaxone sodium for injection pharmacy bulk package prescribing information. Princeton, NJ; 2020 Jul.
Hospira, Inc. Ceftriaxone sodium for injection ADD-Vantage vials prescribing information. Lake Forest, IL; 2020 Aug.
B. Braun Medical Inc. Ceftriaxone sodium for injection and dextrose injection prescribing information. Bethlehem, PA; 2021 Mar.
Baxter Healthcare Corporation. Ceftriaxone sodium injection prescribing information. Deerfield, IL; 2018 May.
Ross ARBoddu SHSMauro VFPhysical compatibility of milrinone with levofloxacin and ceftriaxone injectionAm J Health Syst Pharm2018751010-1012
Samson Medical Technologies, LLC. Ceftriaxone sodium for injection pharmacy bulk package prescribing information. Cherry Hill, NJ; 2020 Nov.
Tan XHu JIncompatibility between irinotecan and fluorouracil injectionsAm J Health Syst Pharm201673755
Fresenius Kabi USA, LLC. Nesacaine^® and Nesacaine^® MPF (chloroprocaine hydrochloride) injection prescribing information. Lake Zurich, IL; 2019 Apr.
B. Braun Medical Inc. Clorotekal^® (chloroprocaine hydrochloride) injection prescribing information. Bethlehem, PA; 2018 Jan.
Fresenius Kabi USA, LLC. Naropin^® (ropivacaine hydrochloride) injection prescribing information. Lake Zurich, IL; 2020 Jun.
Sagent Pharmaceuticals. Ropivacaine hydrochloride injection prescribing information. Schaumburg, IL; 2019 Jul.
Hospira, Inc. Marcaine^® (bupivacaine hydrochloride) and Marcaine^® with epinephrine (bupivacaine hydrochloride and epinephrine bitartrate) injection prescribing information. Lake Forest, IL; 2020 Aug.
Fresenius Kabi USA, LLC. Sensorcaine^®, Sensorcaine^® MPF (bupivacaine hydrochloride), Sensorcaine^® with epinephrine, and Sensorcaine^® MPF with epinephrine (bupivacaine hydrochloride and epinephrine bitartrate) injection prescribing information. Lake Zurich, IL; 2019 Mar.
Hospira, Inc. Marcaine^® Spinal (bupivacaine hydrochloride in dextrose) injection prescribing information. Lake Forest, IL; 2018 Nov.
Pfizer Laboratories. Revatio^® (sildenafil citrate) tablets, powder for suspension, and injection prescribing information. New York, NY; 2020 Feb.
Al Hadithy AFde Goede ALEckhardt MStability of sildenafil (Revatio^®) dilutions in dextrose 5%Intensive Care Med2011371899
Luu YThigpen JBrown SDStability of sildenafil in combination with heparin and dopamineAm J Health Syst Pharm201774e64-e71
Ross ELSalinas APetty KCompatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixingAm J Health Syst Pharm2020771980-1985
Hospira, Inc. Bortezomib for injection prescribing information. Lake Forest, IL; 2022 Dec.
Ross EL (Corresponding Author): Personal communication; 2021 Dec 15.
Mylan Institutional LLC. Methadone hydrochloride injection prescribing information. Morgantown, WV; 2021 Jun.
Mylan Institutional LLC. Duraclon^® (clonidine hydrochloride injection) prescribing information. Morgantown, WV; 2021 Mar.
West-Ward Pharmaceuticals. Clonidine hydrochloride injection prescribing information. Eatontown, NJ; 2011 Mar.
AlSalman FHowlett MBreatnach CSupporting the use of sildenafil infusions in paediatric and neonatal intensive care - A compatibility studyEur J Pharm Biopharm2020151153-161
Koller AKKrebs SDörje FMedication Safety in Intravenous Therapy: A Compatibility Study of Clonidine with Drugs Frequently Used in Intensive CarePharmaceutics202013
AuroMedics Pharma LLC. Verapamil hydrochloride injection prescribing information. East Windsor, NJ; 2021 Oct.
Macorigh CGuibbert VCasanova MStability study of hydromorphone and bupivacaine mixture by HPLC-UVEur J Hosp Pharm20202795-99
Donnelly RFWong KSpencer JPhysical compatibility of high-concentration bupivacaine with hydromorphone, morphine, and fentanylCan J Hosp Pharm201063154-5
Bianchi FGinggen ATardy YStability and compatibility of drug mixtures in an implantable infusion systemAnaesthesia200863972-8
Stevens M (Medical Information, Gilead Sciences, Inc., Foster City, CA): Personal communication; 2022 Feb 10.
Hospira, Inc. Daptomycin for injection prescribing information. Lake Forest, IL; 2021 Jun.
Baxter Healthcare Corporation. Dapzura RT (daptomycin for injection) prescribing information. Deerfield, IL; 2022 Jan.
Sagent Pharmaceuticals. Daptomycin for injection prescribing information. Schaumburg, IL; 2020 Nov.
Hikma Pharmaceuticals USA Inc. Chlorpromazine hydrochloride injection prescribing information. Berkeley Heights, NJ; 2020 Mar.
Hospira, Inc. Diazepam injection prescribing information. Lake Forest, IL; 2021 Feb.
Civica, Inc. Diazepam injection prescribing information. Lehi, UT; 2021 Jul.
Hospira, Inc. Diazepam injection prescribing information. Lake Forest, IL; 2021 Feb.
Pfizer Labs. Heparin sodium injection prescribing information. New York, NY; 2020 Feb.
Fresenius Kabi USA, LLC. Heparin sodium injection prescribing information. Lake Zurich, IL; 2021 Oct.
Hikma Pharmaceuticals USA Inc. Heparin sodium injection prescribing information. Eatontown, NJ; 2020 Feb.
Hospira, Inc. Sodium acetate injection prescribing information. Lake Forest, IL; 2020 Nov.
Hospira, Inc. Sodium acetate injection pharmacy bulk package prescribing information. Lake Forest, IL; 2020 Nov.
Fresenius Kabi USA, LLC. Sodium acetate injection pharmacy bulk package prescribing information. Lake Zurich, IL; 2017 Dec.
Hospira, Inc. Potassium acetate injection prescribing information. Lake Forest, IL; 2020 Nov.
Hospira, Inc. Potassium acetate injection pharmacy bulk package prescribing information. Lake Forest, IL; 2020 Nov.
Fresenius Kabi USA, LLC. Acyclovir sodium injection prescribing information. Lake Zurich, IL; 2020 Oct.
Hikma Pharmaceuticals USA Inc. Acyclovir for injection prescribing information. Berkeley Heights, NJ; 2021 Feb.
Legeron RBougueon GBerroneau ALong-term physicochemical stability of acyclovir 5 mg/mL solution stored in polypropylene bags as a simulated hospital stock preparationAm J Health Syst Pharm202178806-812
Baxter Healthcare Corporation. Metronidazole injection in plastic container prescribing information. Deerfield, IL; 2021 Dec.
B. Braun Medical Inc. Metronidazole injection prescribing information. Bethlehem, PA; 2021 Dec.
B. Braun Medical Inc. Heparin sodium and dextrose injection prescribing information. Bethlehem, PA; 2021 Aug.
Hospira, Inc. Heparin sodium in sodium chloride injection prescribing information. Lake Forest, IL; 2022 Mar.
Medefil, Inc. Heparin lock flush syringe. Glendale Heights, IL; 2016 Dec.
Fresenius Kabi USA, LLC. Heparin lock flush solution. Lake Zurich, IL; 2014 Jul.
Hospira, Inc. Heparin sodium injection prescribing information. Lake Forest, IL; 2021 May.
Hospira, Inc. Heparin sodium in sodium chloride injection prescribing information. Lake Forest, IL;2020 Jul.
Kandel SZaidi STRWanandy STStability of ceftazidime and heparin in four different types of peritoneal dialysis solutionsPerit Dial Int20183849-56
Hines SPleasance SCompatibility of an injectable high strength oxycodone formulation with typical diluents, syringes, tubings, infusion bags and drugs for potential co-administrationEur J Hosp Pharm Pract20091532-8
Napp Pharmaceuticals Limited. Oxynorm^® (oxycodone hydrochloride) 10 and 50 mg/mL solution for injection or infusion summary of product characteristics. Cambridge, United Kingdom. 2022 Apr 13.
Buga IUzoma JIReindel KPhysical and chemical stability of dexamethasone sodium phosphate in intravenous admixtures used to prevent chemotherapy-induced nausea and vomitingHosp Pharm202156215-220
McGuire TRNarducci WAFox JLCompatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutionsAm J Hosp Pharm1993501410-4
Fresenius Kabi USA, LLC. Magnesium sulfate injection prescribing information. Lake Zurich, IL; 2017 Aug.
Fresenius Kabi USA, LLC. Magnesium sulfate injection prescribing information. Lake Zurich, IL; 2021 Sep.
Hospira, Inc. Magnesium sulfate in water injection prescribing information. Lake Forest, IL; 2019 Mar.
Hospira, Inc. Magnesium sulfate in dextrose injection prescribing information. Lake Forest, IL; 2019 Apr.
Houlihan SDecarie DBenes CMagnocaine: physical compatibility and chemical stability of magnesium sulphate and lidocaine hydrochloride in prefilled syringesJ Obstet Gynaecol Can201638936-944.e3
Fresenius Kabi USA, LLC. Xylocaine^® and Xylocaine^® MPF (lidocaine hydrochloride and lidocaine hydrochloride and epinephrine bitartrate) injection prescribing information. Lake Zurich, IL; 2020 Aug.
Hospira, Inc. Lidocaine hydrochloride injection prescribing information. Lake Forest, IL; 2018 Apr.
B. Braun Medical Inc. Lidocaine hydrochloride and dextrose 5% injection prescribing information. Bethlehem, PA; 2019 Nov.
Genentech, Inc. TNKase^® (tenecteplase) for injection prescribing information. South San Francisco, CA; 2018 Aug.
Semba CPWeck SRazavi MKTenecteplase: stability and bioactivity of thawed or diluted solutions used in peripheral thrombolysisJ Vasc Interv Radiol200314475-9
Lentz YKJoyce MLam XIn vitro stability and compatibility of tenecteplase in central venous access devicesHemodial Int201115264-72
Henkel EVella RFenning AThe effect of high storage temperature on the stability and efficacy of lyophilized tenecteplasePrehosp Disaster Med202035501-507
Sanofi. Nozinan^® (levomepromazine hydrochloride) 25 mg/mL solution for injection/infusion summary of product characteristics. Berkshire, United Kingdom. 2022 Oct 5.
Pharmacy Retailing (NZ) Ltd. New Zealand Data Sheet for Nozinan^® (levomepromazine hydrochloride) 25 mg/mL injection. Auckland, New Zealand; 2022 Jun 20.
Sanofi-Aventis Canada, Inc. Nozinan^® (methotrimeprazine hydrochloride injection, USP) product monograph. Quebec, Canada; 2020 Feb 18.
USP. Methotrimeprazine injection. In: USP-NF. Rockville, MD: USP; May 1, 2020. DOI: doi.org/10.31003/USPNF_M51530_04_01.
Fresenius Kabi USA, LLC. Thiamine hydrochloride injection prescribing information. Lake Zurich, IL; 2019 Sep.
Mylan Institutional LLC. Thiamine hydrochloride injection prescribing information. Morgantown, WV; 2021 Apr.
Nexus Pharmaceuticals, Inc. Papaverine hydrochloride injection prescribing information. Lincolnshire, IL; 2021 Feb.
American Regent, Inc. Papaverine hydrochloride injection prescribing information. Shirley, NY; 2009 Jan.
USP. Papaverine hydrochloride injection. In: USP-NF. Rockville, MD: USP; May 1, 2018. DOI: doi.org/10.31003/USPNF_M60640_03_01
Hospira, Inc. Ciprofloxacin injection in 5% Dextrose injection prescribing information. Lake Forest, IL; 2020 Jul.
Kussmann MFerth AObermüller MCompatibility of ciprofloxacin with commercial peritoneal dialysis solutionsSci Rep201996512
WG Critical Care, LLC. Levofloxacin injection prescribing information. Paramus, NJ; 2021 Mar.
American Regent, Inc. Vasopressin injection prescribing information. Shirley, NY; 2022 Aug.
Loeuille GD'Huart EVigneron JStability Studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial TherapyAntibiotics (Basel)202211
D'Huart E (Corresponding Author): Personal communication; 2022 Sep 15.
SIGA Technologies, Inc. TPOXX^® tecovirimat monohydrate capsules and injection prescribing information. Corvallis, OR; 2022 May.
SIGA Technologies, Inc. Dear healthcare provider letter regarding proper preparation and administration of TPOXX^® (tecovirimat) injection for intravenous infusion. Corvallis, OR; 2022 Aug 22.
Fresenius Kabi USA, LLC. Dexmedetomidine hydrochloride in 0.9% sodium chloride injection prescribing information. Lake Zurich, IL; 2020 Apr.
Slayback Pharma LLC. Dexmedetomidine hydrochloride in 0.9% sodium chloride injection prescribing information. Princeton, NJ; 2021 Apr.
Bustin ARamsey EZHanna BDCompatibility of treprostinil sodium and dopamine hydrochloride during simulated Y-site administrationAm J Health Syst Pharm202077649-657
United Therapeutics Corp. Remodulin^® (treprostinil) injection and diluent for Remodulin prescribing information. Research Triangle Park, NC; 2021 Jul.
Shakeraneh PRobinson RKufel WDChemical and Physical Stability of an Admixture Containing Cefepime and Vancomycin in Lactated Ringer SolutionHosp Pharm202156338-342
Hikma Pharmaceuticals USA, Inc. Leucovorin calcium for injection prescribing information. Berkeley Heights, NJ; 2021 Oct.
Fresenius Kabi USA, LLC. Leucovorin calcium for injection prescribing information. Lake Zurich, IL; 2022 Jan.
Fresenius Kabi USA, LLC. Leucovorin calcium injection prescribing information. Lake Zurich, IL; 2018 May.
Karbownik ASzalek EUrjasz HStability of calcium folinate (Teva) in concentrate after re-use and in dilute infusions in 0.9% NaCl in polyethylene bagsActa Pol Pharm201370301-7
Sagent Pharmaceuticals. Oxacillin for injection prescribing information. Schaumburg, IL; 2018 Jun.
USP. Neostigmine methylsulfate injection. In: USP-NF. Rockville, MD. Accessed 2022 Oct 1. DOI: doi.org/10.31003/USPNF_M56450_02_01.
Hameln Pharma Ltd. Neostigmine methylsulfate injection summary of product characteristics. Gloucester, United Kingdom; 2021 May 18.
Sagent Pharmaceuticals. Oxacillin for injection prescribing information. Schaumburg, IL; 2018 Jun.
Sagent Pharmaceuticals. Oxacillin for injection pharmacy bulk package prescribing information. Schaumburg, IL; 2020 Apr.
Baxter Healthcare Corporation. Oxacillin injection in plastic container prescribing information. Deerfield, IL; 2018 Sep.
Nivagen Pharmaceuticals, Inc. Phenobarbital sodium injection prescribing information. Sacramento, CA; 2021 Sep.
BPI Labs, LLC. Phenobarbital sodium injection prescribing information. Largo, FL; 2022 Jan.
Hospira, Inc. Sodium lactate injection prescribing information. Lake Forest, IL; 2017 Nov.
Hospira, Inc. Potassium chloride for injection prescribing information. Lake Forest, IL; 2022 Oct.
Baxter Healthcare Corporation. Potassium chloride injection in plastic container prescribing information. Deerfield, IL; 2022 Jun.
Hospira, Inc. Sodium chloride concentrate for injection prescribing information. Lake Forest, IL; 2017 Sep.
Hospira, Inc. Sodium chloride concentrate for injection prescribing information. Lake Forest, IL; 2020 Jun.
Baxter Healthcare Corporation. Sodium chloride injection in plastic container prescribing information. Deerfield, IL; 2019 May.
Baxter Healthcare Corporation. Sodium chloride 3% and 5% injection in plastic container prescribing information. Deerfield, IL; 2018 May.
USP. Ascorbic acid injection. In: USP-NF. Rockville, MD: USP; 2022 July 1. DOI: doi.org/10.31003/USPNF_M6050_04_01
USP. Lincomycin injection. In: USP-NF. Rockville, MD: USP;2018 May 1. DOI: doi.org/10.31003/USPNF_M45358_03_01
USP. Pentobarbital sodium injection. In: USP-NF. Rockville, MD: USP; 2018 May 1. DOI: doi.org/10.31003/USPNF_M62410_03_01
USP. Epinephrine injection. In: USP-NF. Rockville, MD: USP; 2018 May 1. DOI: doi.org/10.31003/USPNF_M29530_03_01
Mallinckrodt Hospital Products Inc. Terlivaz^® (terlipressin) for injection prescribing information. Bedminster, NJ; 2022 Nov.
Bui TNNSandar SLuna GAn investigation of reconstituted terlipressin infusion stability for use in hepatorenal syndromeSci Rep20201021037
Czarniak P (Corresponding Author): Personal communication; 2022 Nov 11.
Genentech, Inc. Tecentriq^® (atezolizumab) injection for intravenous infusion prescribing information. South San Francisco, CA; 2022 Jan.
Hui AYin JLiu WProlonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous BagsInt J Pharm Compd202125246-257
Pharmacia & Upjohn Co. Solu-Medrol^® (methylprednisolone sodium succinate) for injection prescribing information. New York, NY; 2021 Oct.
Guo ZChen PLiu LCompatibility and stability of methylprednisolone sodium succinate and granisetron hydrochloride in 0.9% sodium chloride solutionMedicine (Baltimore)2022101e29674
Pharmacia & Upjohn Co. Depo-Medrol^® (methylprednisolone acetate) injectable suspension prescribing information. New York, NY; 2021 May.
Pharmacia & Upjohn Co. Depo-Medrol^® (methylprednisolone acetate) injectable suspension single-dose vial prescribing information. New York, NY; 2021 May.
Merck Sharp & Dohme Corp. Keytruda^® (pembrolizumab) for injection prescribing information. Whitehouse Station, NJ; 2022 Aug.
Sundaramurthi PChadwick SNarasimhan CPhysicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bagJ Oncol Pharm Pract202026641-646
Bristol-Myers Squibb Company. Opdivo^® (nivolumab) for injection prescribing information. Princeton, NJ; 2022 Jul.
Bristol-Myers Squibb Company. Yervoy^® (ipilimumab) for injection prescribing information. Princeton, NJ; 2022 May
AstraZeneca. Imfinzi^® (durvalumab) for injection prescribing information. Wilmington, DE; 2022 Nov.
EMD Serono, Inc. Bavencio^® (avelumab) for injection prescribing information. Rockland, MA; 2022 Jul.
Regeneron Pharmaceuticals, Inc. Libtayo^® (cemiplimab-rwlc) for injection prescribing information. Tarrytown, NY; 2022 Nov.
GlaxoSmithKline. Jemperli^® (dostarlimab-gxly) for injection prescribing information. Research Triangle Park, NC; 2022 Apr
AstraZeneca. Imjudo^® (tremelimumab-actl) for injection prescribing information. Wilmington, DE; 2022 Nov.
Friciu MMMonfort ADubé PAStability of N-Acetylcysteine 60 mg/mL in Extemporaneously Compounded Injectable SolutionsCan J Hosp Pharm202174344-349
Anderson CMacKay MStability of Fentanyl Citrate, Hydromorphone Hydrochloride, Ketamine Hydrochloride, Midazolam, Morphine Sulfate, and Pentobarbital Sodium in Polypropylene SyringesPharmacy (Basel)20153379-385
Kondo MYoshida NYoshida MPhysical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administrationAm J Health Syst Pharm202380e53-e58
Wyeth Pharmaceuticals LLC. BeneFIX^® (coagulation factor IX [recombinant]) for injection prescribing information. Philadelphia, PA; 2022 Nov.
Baxalta US Inc. Rixubis^® (coagulation factor IX [recombinant]) for injection prescribing information. Lexington, MA; 2020 Jun.
Medexus Pharma, Inc. Ixinity^® (coagulation factor IX [recombinant]) for injection prescribing information. Chicago; IL;2022 Nov.
Pfizer Injectables. Pfizerpen^® (penicillin G potassium) for injection prescribing information. New York, NY; 2022 Nov.
Sandoz Inc. Penicillin G potassium for injection prescribing information. Princeton, NJ; 2020 Sep.
Baxter Healthcare Corporation. Penicillin G potassium injection in PL 2040 plastic container prescribing information. Deerfield, IL; 2021 May.
Storm MCBroyles JEHerrera ORStability of 4 Intravenous Drug Formulations in Prefilled Syringes Stored Frozen for Up to 60 DaysHosp Pharm20225761-68
Herrera O (Corresponding Author): Personal communication; 2023 Feb 8.
Hikma Pharmaceuticals USA Inc. Famotidine injection prescribing information. Berkeley Heights, NJ; 2021 Jun.
Baxter Healthcare Corporation. Famotidine injection in Galaxy plastic container prescribing information. Deerfield, IL; 2018 May.
Hikma Pharmaceuticals USA Inc. Cefazolin for injection prescribing information. Berkeley Heights, NJ; 2020 Jun.
B. Braun Medical Inc. Cefazolin for injection and dextrose injection prescribing information. Bethlehem, PA; 2021 Jul.
Baxter Healthcare Corporation. Cefazolin injection prescribing information. Deerfield, IL; 2021 Jul.
WG Critical Care, LLC. Cefazolin for injection pharmacy bulk package prescribing information. Paramus, NJ; 2019 Mar.
Hikma Pharmaceuticals USA Inc. Cefotaxime for injection prescribing information. Berkeley Heights, NJ; 2021 Jun.
West-Ward Pharmaceuticals Corp. Cefotaxime for injection pharmacy bulk package prescribing information. Eatontown, NJ; 2018 Jul.
Fresenius Kabi USA, LLC. Cefoxitin for injection prescribing information. Lake Zurich, IL; 2021 May.
WG Critical Care, LLC. Cefoxitin for injection pharmacy bulk package prescribing information. Paramus, NJ; 2019 Mar.
B. Braun Medical Inc. Cefoxitin for injection and dextrose injection prescribing information. Bethlehem, PA; 2019 Jul.
Teligent Pharma, Inc. Fortaz^® (ceftazidime for injection) prescribing information. Buena, NJ; 2019 Feb.
Hospira, Inc. Tazicef^® (ceftazidime for injection) ADD-Vantage ^® vials prescribing information. Lake Forest, IL; 2021 Aug.
Hospira, Inc. Tazicef^® (ceftazidime for injection) pharmacy bulk package prescribing information. Lake Forest, IL; 2022 Mar.
Hospira, Inc. Tazicef^® (ceftazidime for injection) prescribing information. Lake Forest, IL; 2022 Mar.
Fresenius Kabi USA, LLC. Cefotetan for injection prescribing information. Lake Zurich, IL; 2020 Jan.
Sandoz Inc. Penicillin G sodium for injection prescribing information. Princeton, NJ; 2020 May.
Kenneally AMAgbana PGardner BCompatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administrationAm J Health Syst Pharm202380164-170
Hikma Pharmaceuticals USA Inc. Cafcit^® injection (caffeine citrate injection) prescribing information. Eatontown, NJ; 2019 Dec.
Fraser BDStability of caffeine citrate injection in polypropylene syringes at room temperatureAm J Health Syst Pharm1997541106-1108
Fresenius Kabi USA, LLC. Calcium gluconate in sodium chloride injection prescribing information. Lake Zurich, IL; 2021 Jun.
WG Critical Care, LLC. Calcium gluconate in sodium chloride injection prescribing information. Paramus, NJ; 2021 Oct.
Sanofi-aventis U.S. LLC. Rifadin^® (rifampin capsules) and Rifadin^® IV (rifampin for injection) prescribing information. Bridgewater, NJ; 2023 Feb.
Fresenius Kabi USA, LLC. Rifampin for injection prescribing information. Lake Zurich, IL; 2022 Jul.
Sandoz Inc. Isoniazid injection prescribing information. Princeton, NJ; 2019 Apr.
Lee JHMoriyama BHenning SAStability of isoniazid injection in i.v. solutionsAm J Health Syst Pharm201875622-626
Provention Bio, Inc.. Tzield^® (teplizumab-mzwv) injection prescribing information. Red Bank, NJ; 2022 Nov.
TG Therapeutics, Inc. Briumvi^® (ublituximab-xiiy) injection prescribing information. Morrisville, NC; 2022 Dec.
Theratechnologies Inc. Trogarzo^® (ibalizumab-uiyk) injection prescribing information. Montreal, QC; 2022 Oct.
Fresenius Kabi USA, LLC. Polocaine^® and Polocaine^® MPF (mepivacaine hydrochloride) injection prescribing information. Lake Zurich, IL; 2019 Apr.
Hospira, Inc. Atracurium besylate injection prescribing information. Lake Forest, IL; 2021 Jul.
Merck & Co., Inc. Primaxin^® (imipenem and cilastatin) for injection prescribing information. Rahway, NJ; 2022 May.
Fresenius Kabi USA, LLC. Imipenem and cilastatin for injection prescribing information. Lake Zurich, IL; 2022 Mar.
Covis Pharma US, Inc. Lanoxin^® (digoxin) injection prescribing information. Zug, Switzerland; 2022 Nov.
Hikma Pharmaceuticals USA Inc. Digoxin injection prescribing information. Berkeley Heights, NJ; 2022 May.
Friciu MMarcelin RBBédard PStability of Compounded Digoxin Solution 0.05 mg/mL for InjectionHosp Pharm202257294-299
D'Huart EVigneron JLider PPhysicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bagsEur J Hosp Pharm20202743-48
Melinta Therapeutics, LLC. Rezzayo^® (rezafungin for injection) prescribing information. Lincolnshire, IL; 2023 Mar.
Lee TMVillareal CLMeyer LMY-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care MedicationsHosp Pharm202156282-286
LaJolla Pharmaceutical Company. Xacduro^® (sulbactam for injection and durlobactam for injection) prescribing information. Waltham, MA; 2023 May.
Fresenius Kabi USA, LLC. Chloramphenicol sodium succinate for injection prescribing information. Lake Zurich, IL; 2016 Oct.
Laforgia MAmodio LColangiulo SLC-MS/MS Analysis on Infusion Bags and Filled Syringes of Decitabine: New Data on Physicochemical Stability of an Unstable MoleculeACS Omega2022725239-25243
Laforgia M (Corresponding Author): Personal communication; 2023 Aug 8.
Sagent Pharmaceuticals. Fluconazole in sodium chloride injection prescribing information. Schaumburg, IL; 2022 Jun.
Woodward Pharma Services LLC. Fluconazole in sodium chloride injection prescribing information. Wixom, MI; 2020 Feb.
Schroeder H (Medical Communications, Innoviva Specialty Therapeutics, Waltham, MA): Personal communication; 2023 July 31.
Fresenius Kabi USA, LLC. Gentamicin injection prescribing information. Lake Zurich, IL; 2021 Apr.
Fresenius Kabi USA, LLC. Gentamicin injection (pediatric) prescribing information. Lake Zurich, IL; 2021 Jul.
Hospira, Inc. Gentamicin sulfate injection prescribing information. Lake Forest, IL; 2022 Oct.
Baxter Healthcare Corporation. Gentamicin sulfate in 0.9% sodium chloride injection in plastic container. Deerfield, IL; 2022 Oct.
Hospira, Inc. Tobramycin injection prescribing information. Lake Forest, IL; 2022 Oct.
Fresenius Kabi USA, LLC. Tobramycin injection prescribing information. Lake Zurich, IL; 2018 Apr.
Fresenius Kabi USA, LLC. Tobramycin injection pharmacy bulk package prescribing information. Lake Zurich, IL; 2018 Apr.
XGen Pharmaceuticals DJB, Inc. Tobramycin for injection prescribing information. Big Flats, NY; 2023 Mar.
Hospira, Inc. Tobramycin injection in 0.9% sodium chloride injection prescribing information. Lake Forest, IL; 2023 Mar.
Avet Pharmaceuticals Inc. Amikacin sulfate injection prescribing information. East Brunswick, NJ; 2023 Mar.
Akorn Operating Company LLC. Alfentanil hydrochloride injection prescribing information. Gurnee, IL; 2022 May.
Mylan Institutional LLC. Aloprim^® (allopurinol) for injection prescribing information. Morgantown, WV; 2022 Feb.
Hikma Pharmaceuticals USA Inc. Benztropine mesylate injection prescribing information. Berkeley Heights, NJ; 2020 Feb.
USP. Benztropine mesylate injection. In: USP-NF. Rockville, MD: USP; May 1, 2018. DOI: https://doi. org/10.31003/USPNF_M64870_03_01.
Par Pharmaceutical. Buprenorphine hydrochloride injection prescribing information. Chestnut Ridge, NY; 2022 Jul.
Hospira, Inc. Buprenorphine hydrochloride injection prescribing information. Lake Forest, IL; 2022 Oct.
Indivior Inc. Sublocade^® (buprenorphine extended-release injection) prescribing information. North Chesterfield, VA; 2023 Mar.
Accord Healthcare, Inc. Dodex^® Injectable (cyanocobalamin injection) prescribing information. Durham, NC; 2020 Sep.
American Regent, Inc. Cyanocobalamin injection prescribing information. Shirley, NY; 2021 Jan.
Fresenius Kabi USA, LLC. Dimenhydrinate injection prescribing information. Lake Zurich, IL; 2008 Apr.
USP. Dimenhydrinate injection. In: USP-NF. Rockville, MD: USP; Sep 1, 2021. DOI: https://doi.org/10.31003/USPNF_M26390_02_01.
Fresenius Kabi USA, LLC. Folic acid injection prescribing information. Lake Zurich, IL; 2016 Nov.
Fresenius Kabi USA, LLC. Pyridoxine hydrochloride injection prescribing information. Lake Zurich, IL; 2019 Sep.
Casper Pharma LLC. Aquasol A^® Parenteral (water-miscible vitamin A palmitate injection) prescribing information. East Brunswick, NJ; 2019 Oct.
Akorn, Inc. 2022 Feb. Sufentanil citrate injection prescribing information. Lake Forest, IL; 2022 Feb.
Hospira, Inc. Sufentanil citrate injection prescribing information. Lake Forest, IL; 2023 Jul
Bower JWright KBurdette JPrepared omadacycline for injection: Nine-day stability and sterility in an elastomeric pumpSAGE Open Med20221020503121221135568
Wright, K (Corresponding Author): Personal communication; 2023 Aug 29.
Sorrieul JRobert JGibory VStability of sufentanil and baclofen mixtures for intrathecal analgesia at different concentrations in polypropylene syringesAnn Pharm Fr201876444-452
Sorrieul JRobert JVincent LStability of Morphine Sulfate-Clonidine and Sufentanil-Clonidine MixturesNeuromodulation2023261195-1207
Hikma Pharmaceuticals USA Inc. Dihydroergotamine mesylate injection prescribing information. Berkeley Heights, NJ; 2022 May.
Sagent Pharmaceuticals. Dihydroergotamine mesylate injection prescribing information. Schaumburg, IL; 2018 May.
Genentech, Inc. Lunsumio^® (mosunetuzumab-axgb) injection prescribing information. South San Francisco, CA; 2022 Dec.
Ross ELPetty KSalinas APhysical Compatibility of Y-site Pediatric Drug Administration: A Call for Question of US Pharmacopeia StandardsJ Pediatr Pharmacol Ther20232884-92
Van Matre ETRice PJWempe MFExtended Stability of Vasopressin Injection in Polyvinyl Chloride Bags and Polypropylene Syringes and Its Impact on Critically Ill Patient Care and Medication WasteHosp Pharm202358205-211
Van Matre ETRice PJWempe MFExtended Stability of Isoproterenol Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light Blocking BagsHosp Pharm202358183-187
Hikma Pharmaceuticals USA Inc. Azathioprine sodium for injection prescribing information. Berkeley Heights, NJ; 2020 Mar.
Butler DAMoolick KMcCray DCompatibility of Omadacycline With Select Parenteral Products in Simulated Y-site AdministrationClin Ther2023451137-1141
Fresenius Kabi USA, LLC. Cisplatin injection prescribing information. Lake Zurich, IL; 2017 Mar.
WG Critical Care, LLC. Cisplatin for injection prescribing information. Paramus, NJ; 2021 Sep.
Ruiz VHShen YAbouelhassan YPhysical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administrationAm J Health Syst Pharm2023
Pfizer, Inc. Doxorubicin Hydrochloride injection prescribing information. New York, NY; 2020 May.
Hikma Pharmaceuticals USA Inc. Doxorubicin hydrochloride for injection prescribing information. Berkeley Heights, NJ; 2021 Mar.
Amneal Pharmaceuticals, LLC. Doxorubicin hydrochloride for injection prescribing information. Bridgewater, NJ; 2021 Feb.
Sun Pharmaceutical Industries, Inc. Doxorubicin hydrochloride liposome injection prescribing information. Cranbury, NJ; 2022 Jun.
AstraZeneca. Nexium^® I.V. (esomeprazole sodium) for injection prescribing information. Wilmington, DE; 2023 Jul.
Gland Pharma Limited. Esomeprazole for injection prescribing information. Hyderabad, India; 2023 Jul. (
ASHP. Standardize 4 Safety: Patient Controlled Analgesia (PCA) and Epidural Standards. Updated 2023 Nov. From ASHP website. Accessed 2023 Dec 18. Updates may be available at ASHP website.www.ashp.org/pharmacy-practice/standardize-4-safety-initiative.
Carpanese DRossi VDi Paolo VProlonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix^®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparationsInt J Pharm2024649123643
Janssen Biotech, Inc. Rybrevant^® (amivantamab-vmjw) injection prescribing information. Horsham, PA; 2022 Nov.
Allecra Therapeutics SAS. Exblifep^® (cefepime and enmetazobactam) for injection prescribing information. Saint Louis, France; 2024 Feb.
Knoll LKraemer IThiesen JPhysicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperatureEur J Hosp Pharm20233011-16
Sime FBWallis SJamieson CEvaluation of the stability of aciclovir in elastomeric infusion devices used for outpatient parenteral antimicrobial therapyEur J Hosp PharmPublished Online First: 2023 Dec 6
Nelson LDwyer PCorris MStability of pemetrexed disodium in sodium chloride 0.9% w/v intravenous Viaflo infusion bagsEur J Hosp Pharm202330e2-e9
Closset MOnorati SColsoul MLLong-term physicochemical stability of 5-fluorouracil at selected standardised rounded doses in polyolefin bagsJ Oncol Pharm Pract2023291878-1883
Senarathna SMDKGStrunk TPetrovski MPhysical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settingsEur J Hosp PharmPublished Online First: 2023 Oct 23
Batty K (Corresponding Author): Personal communication; 2024 Apr 4.
Hendrickx TCJBalcaen KDHBaert MPhysicochemical and biological stability of diluted vedolizumab in intravenous infusion bagsEur J Hosp Pharm2024
Foy FLuna GMartinez JAn investigation of the stability of meropenem in elastomeric infusion devicesDrug Des Devel Ther2019132655-2665
Novartis Pharmaceuticals Corporation. Desferal^® (deferoxamine mesylate) for injection prescribing information. East Hanover, NJ; 2022 Sep.
Hospira, Inc. Deferoxamine mesylate for injection prescribing information. Lake Forest, IL; 2023 Nov.
Baxter Healthcare Corporation. Protopam^® (pralidoxime chloride) for injection prescribing information. Deerfield, IL; 2018 Jan.
Baxter Healthcare Corporation. Ifex^® (ifosfamide) for injection prescribing information. Deerfield, IL; 2018 Jul.
Masse MGenay SMartin Mena AEvaluation of the stability of vancomycin solutions at concentrations used in clinical servicesEur J Hosp Pharm202027e87-e92
Roerig. Unasyn^® (ampicillin sodium and sulbactam sodium) for injection pharmacy bulk package prescribing information. New York, NY; 2024 Jun.
Ezquer-Garin CFerriols-Lisart RMartinez-López LMStability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperaturesPharmazie202075172-176
Eli Lilly and Company. Kisunla^® (donanemab-azbt) injection prescribing information. Indianapolis, IN; 2024 Jul. (
Hope Pharmaceuticals. Sodium nitrite injection prescribing information. Scottsdale, AZ; 2021 Jan.
D'Huart EVigneron JRanchon FPhysico-chemical stability of sodium thiosulfate infusion solutions in polyolefin bags at room temperature over a period of 24 hoursPharm Technol Hosp Pharm20183135-42
Fennec Pharmaceuticals Inc. Pedmark^® (sodium thiosulfate injection) prescribing information. Hoboken, NJ; 2022 Sep.
BTG International Inc. Cyanokit^® (hydroxocobalamin for injection) prescribing information. West Conshohocken, PA; 2021 May.
Actavis Pharma, Inc. Hydroxocobalamin injection prescribing information. Parsippany, NJ; 2017 Jan.
Eisai Inc. Leqembi^® (lecanemab-irmb) injection prescribing information. Nutley, NJ; 2023 Jul.
Vieillard VLe Guyader GJallades AExtended physicochemical stability of cetuximab in opened vials and infusion bags when stored at 4°C and 25°CJ Oncol Pharm Pract202430142-150
Vieillard V (Corresponding Author): Personal communication; 2024 Jul 31.
Alexion Pharmaceuticals, Inc. Ultomiris^® (ravulizumab-cwvz) injection prescribing information. Boston, MA; 2024 Jun.
Alexion Pharmaceuticals, Inc. Soliris^® (eculizumab) injection prescribing information. Boston, MA; 2024 Jun.
Espinosa-Bosch MSanchez-Rojas FBosch-Ojeda CStability of mixtures of ondansetron and haloperidol stored in infusors at different temperaturesEur J Hosp Pharm201825e134-e138
Sánchez-Rojas F (Corresponding Author): Personal communication; 2024 May 27.
Beran CHoward MSBaki GPhysical Compatibility of Intravenous Ondansetron Hydrochloride and Nafcillin SodiumInt J Pharm Compd202428329-333
Jamieson CDrummond FHills TAssessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapyJAC Antimicrob Resist20213dlab141
Wyeth Pharmaceuticals LLC. Premarin^® Intravenous (conjugated estrogens, USP) for injection prescribing information. Philadelphia, PA; 2024 Feb.
Fresenius Kabi USA, LLC. Sodium phosphates injection prescribing information. Lake Zurich, IL; 2021 Nov.
Genentech, Inc. Piasky^® (crovalimab-akkz) injection prescribing information. South San Francisco, CA; 2024 Jun.
Baxter Healthcare Corporation. Clinolipid^® (lipid injectable emulsion) prescribing information. Deerfield, IL; 2024 Apr.
Genzyme Corporation. Thymoglobulin^® (anti-thymocyte globulin [rabbit]) for injection) for injection prescribing information. Cambridge, MA; 2024 Jun.
Pfizer Inc. Atgam^® (lymphocyte immune globulin, anti-thymocyte globulin [equine]) injection prescribing information. New York, NY; 2023 Sep.
Amgen, Inc. Epogen^® (eopetin alfa) injection prescribing information. Thousand Oaks, CA; 2024 Apr.
Janssen Products, LP. Procrit^® injection prescribing information. Horsham, PA; 2024 Apr.
Janssen Scientific Affairs, LLC. Procrit FDA-Approved Routes of Administration & Minimizing Pain at the Site of Subcutaneous Injection. Updated 2023 Aug 21. From Janssen Science website www.janssenscience.com. Accessed 2024 Sep 19.
Janssen Scientific Affairs, LLC. Procrit Syringe Stability. Updated 2023 Aug 22. From Janssen Science website www.janssenscience.com. Accessed 2024 Sep 19.
Pfizer Laboratories. Retacrit^® (epoetin alfa-epbx) injection prescribing information. New York, NY; 2024 Jun.
Pfizer Medical Information. Retacrit (epoetin alfa-epbx) Temperature Excursions. From Pfizer Medical Information website www.pfizermedicalinformation.com. Accessed 2024 Sep 20.
Sandoz Canada Inc. Infuvite^® Adult (multiple vitamins injection) prescribing information. Boucherville, QC, Canada; 2016 Oct.
Sandoz Canada Inc. Infuvite^® Pediatric (multiple vitamins injection) prescribing information. Boucherville, QC, Canada; 2016 Oct.
Esteban-Cartelle BSerrano DRPérez Menéndez-Conde CStability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practiceMicrobiol Spectr202412e0206423
Colsoul MLBreuer AGoderniaux NLong-Term Stability of Lorazepam in Sodium Chloride 0.9% Stored at Different Temperatures in Different ContainersHosp Pharm202055188-192
Amneal Pharmaceuticals LLC. Boruzu^® (bortezomib) injection prescribing information. Bridgewater, NJ; 2024 Sep.
Law SCharbonneau FIazzetta JStability of Generic Formulations of Bortezomib 1.0 and 2.5 mg/mL in Vials and Syringes Stored at 4°C and Room Temperature (23°C or 25°C)Can J Hosp Pharm20217457-69
Gómez ÁBenéitez García MCBarrueco NPhysicochemical stability of bortezomib solutions for subcutaneous administrationSci Rep2024148975
Baxter Healthcare Corporation. Clinolipid stability out of overwrap (3.0). From Baxter US Medical Information website. Accessed 2024 Sep 14.
Baxter Healthcare Corporation. Introducing Clinolipid (lipid injectable emulsion) into your parenteral nutrition (PN) program. 2024 May. From Baxter website. Accessed 2024 Sep 14.

section name header

References